-- -- PostgreSQL database dump -- -- Dumped from database version 10.11 -- Dumped by pg_dump version 10.11 SET statement_timeout = 0; SET lock_timeout = 0; SET idle_in_transaction_session_timeout = 0; SET client_encoding = 'UTF8'; SET standard_conforming_strings = on; SELECT pg_catalog.set_config('search_path', '', false); SET check_function_bodies = false; SET xmloption = content; SET client_min_messages = warning; SET row_security = off; ALTER TABLE IF EXISTS ONLY public.tdkey2tc DROP CONSTRAINT IF EXISTS tdgo2tc_2_tc; ALTER TABLE IF EXISTS ONLY public.tdgo2tc DROP CONSTRAINT IF EXISTS tdgo2tc_2_tc; ALTER TABLE IF EXISTS ONLY public.tdkey2tc DROP CONSTRAINT IF EXISTS tdgo2tc_2_kw; ALTER TABLE IF EXISTS ONLY public.tdgo2tc DROP CONSTRAINT IF EXISTS tdgo2tc_2_go; ALTER TABLE IF EXISTS ONLY public.td2tc DROP CONSTRAINT IF EXISTS td2tc_2_td; ALTER TABLE IF EXISTS ONLY public.synonyms DROP CONSTRAINT IF EXISTS synonym_2_struct; ALTER TABLE IF EXISTS ONLY public.synonyms DROP CONSTRAINT IF EXISTS synonym_2_parent; ALTER TABLE IF EXISTS ONLY public.structure_type DROP CONSTRAINT IF EXISTS structure_type_2_type; ALTER TABLE IF EXISTS ONLY public.structure_type DROP CONSTRAINT IF EXISTS structure_type_2_struct; ALTER TABLE IF EXISTS ONLY public.structures DROP CONSTRAINT IF EXISTS struct_2_stem; ALTER TABLE IF EXISTS ONLY public.struct2obprod DROP CONSTRAINT IF EXISTS struct_2_obprod; ALTER TABLE IF EXISTS ONLY public.struct2parent DROP CONSTRAINT IF EXISTS struct2parent_2_struct; ALTER TABLE IF EXISTS ONLY public.struct2parent DROP CONSTRAINT IF EXISTS struct2parent_2_parent; ALTER TABLE IF EXISTS ONLY public.struct2drgclass DROP CONSTRAINT IF EXISTS struct2drgclass_2_struct; ALTER TABLE IF EXISTS ONLY public.struct2drgclass DROP CONSTRAINT IF EXISTS struct2drgclass_2_drgclass; ALTER TABLE IF EXISTS ONLY public.struct2atc DROP CONSTRAINT IF EXISTS struct2atc_2_struct; ALTER TABLE IF EXISTS ONLY public.struct2atc DROP CONSTRAINT IF EXISTS struct2atc_2_atc; ALTER TABLE IF EXISTS ONLY public.section DROP CONSTRAINT IF EXISTS section_2_label; ALTER TABLE IF EXISTS ONLY public.reference DROP CONSTRAINT IF EXISTS reference_2_reftype; ALTER TABLE IF EXISTS ONLY public.prd2label DROP CONSTRAINT IF EXISTS prd_2_prd; ALTER TABLE IF EXISTS ONLY public.prd2label DROP CONSTRAINT IF EXISTS prd_2_label; ALTER TABLE IF EXISTS ONLY public.pka DROP CONSTRAINT IF EXISTS pka_2_struct; ALTER TABLE IF EXISTS ONLY public.pharma_class DROP CONSTRAINT IF EXISTS pharma_class_2_struct; ALTER TABLE IF EXISTS ONLY public.pdb DROP CONSTRAINT IF EXISTS pdb_2_struct; ALTER TABLE IF EXISTS ONLY public.omop_relationship DROP CONSTRAINT IF EXISTS omop_relationship_struct_id_fkey; ALTER TABLE IF EXISTS ONLY public.struct2obprod DROP CONSTRAINT IF EXISTS obprod_2_struct; ALTER TABLE IF EXISTS ONLY public.ob_patent DROP CONSTRAINT IF EXISTS obpat_2_usecode; ALTER TABLE IF EXISTS ONLY public.ob_exclusivity DROP CONSTRAINT IF EXISTS obexcl_2_exclcode; ALTER TABLE IF EXISTS ONLY public.act_table_full DROP CONSTRAINT IF EXISTS moa_2_ref; ALTER TABLE IF EXISTS ONLY public.identifier DROP CONSTRAINT IF EXISTS identifier_2_struct; ALTER TABLE IF EXISTS ONLY public.identifier DROP CONSTRAINT IF EXISTS identifier_2_idtype; ALTER TABLE IF EXISTS ONLY public.faers DROP CONSTRAINT IF EXISTS faers_2_struct; ALTER TABLE IF EXISTS ONLY public.doid_xref DROP CONSTRAINT IF EXISTS doid_xref_2_doid; ALTER TABLE IF EXISTS ONLY public.ddi DROP CONSTRAINT IF EXISTS ddi_2_drug_class2; ALTER TABLE IF EXISTS ONLY public.ddi DROP CONSTRAINT IF EXISTS ddi_2_drug_class1; ALTER TABLE IF EXISTS ONLY public.ddi DROP CONSTRAINT IF EXISTS ddi_2_ddi_risk; ALTER TABLE IF EXISTS ONLY public.act_table_full DROP CONSTRAINT IF EXISTS bioact_2_ref; ALTER TABLE IF EXISTS ONLY public.atc_ddd DROP CONSTRAINT IF EXISTS atc_ddd_2_struct; ALTER TABLE IF EXISTS ONLY public.approval DROP CONSTRAINT IF EXISTS approval_2_type; ALTER TABLE IF EXISTS ONLY public.approval DROP CONSTRAINT IF EXISTS approval_2_struct; ALTER TABLE IF EXISTS ONLY public.active_ingredient DROP CONSTRAINT IF EXISTS active_ingredient_ndc_product_code_fkey; ALTER TABLE IF EXISTS ONLY public.active_ingredient DROP CONSTRAINT IF EXISTS active_ingredient_2_struct; ALTER TABLE IF EXISTS ONLY public.act_table_full DROP CONSTRAINT IF EXISTS act_table_full_2_target_dict; ALTER TABLE IF EXISTS ONLY public.act_table_full DROP CONSTRAINT IF EXISTS act_table_full_2_target_class; ALTER TABLE IF EXISTS ONLY public.act_table_full DROP CONSTRAINT IF EXISTS act_table_full_2_struct; ALTER TABLE IF EXISTS ONLY public.act_table_full DROP CONSTRAINT IF EXISTS act_table_full_2_act_type; DROP INDEX IF EXISTS public.xref_source_idx; DROP INDEX IF EXISTS public.sql121023161238850; DROP INDEX IF EXISTS public.sql120925163230921; DROP INDEX IF EXISTS public.sql120925163230920; DROP INDEX IF EXISTS public.sql120523120921131; DROP INDEX IF EXISTS public.sql120418113711390; DROP INDEX IF EXISTS public.sql120412004634310; DROP INDEX IF EXISTS public.sql120412004620930; DROP INDEX IF EXISTS public.sql120404123859152; DROP INDEX IF EXISTS public.sql120404123658531; DROP INDEX IF EXISTS public.sql100501183943930; DROP INDEX IF EXISTS public.ob_product_prodno_idx; DROP INDEX IF EXISTS public.ob_product_appno_idx; DROP INDEX IF EXISTS public.ob_patent_prodno_idx; DROP INDEX IF EXISTS public.ob_patent_applno_idx; DROP INDEX IF EXISTS public.index_ijc_connect_items; ALTER TABLE IF EXISTS ONLY public.structures DROP CONSTRAINT IF EXISTS uniq_structures_id; ALTER TABLE IF EXISTS ONLY public.synonyms DROP CONSTRAINT IF EXISTS syn_lname_uq; ALTER TABLE IF EXISTS ONLY public.property_type DROP CONSTRAINT IF EXISTS symbol; ALTER TABLE IF EXISTS ONLY public.structure_type DROP CONSTRAINT IF EXISTS struct_id_type_uq; ALTER TABLE IF EXISTS ONLY public.struct2atc DROP CONSTRAINT IF EXISTS struct2atc_id_key; ALTER TABLE IF EXISTS ONLY public.faers_female DROP CONSTRAINT IF EXISTS sql200913054200240; ALTER TABLE IF EXISTS ONLY public.faers_male DROP CONSTRAINT IF EXISTS sql200913054154500; ALTER TABLE IF EXISTS ONLY public.lincs_signature DROP CONSTRAINT IF EXISTS sql180509154922471; ALTER TABLE IF EXISTS ONLY public.lincs_signature DROP CONSTRAINT IF EXISTS sql180509154922470; ALTER TABLE IF EXISTS ONLY public.faers DROP CONSTRAINT IF EXISTS sql180422234202640; ALTER TABLE IF EXISTS ONLY public.pka DROP CONSTRAINT IF EXISTS sql180408153602180; ALTER TABLE IF EXISTS ONLY public.ob_patent_use_code DROP CONSTRAINT IF EXISTS sql161127133626130; ALTER TABLE IF EXISTS ONLY public.ob_exclusivity_code DROP CONSTRAINT IF EXISTS sql161127133109120; ALTER TABLE IF EXISTS ONLY public.ob_patent DROP CONSTRAINT IF EXISTS sql161127120038110; ALTER TABLE IF EXISTS ONLY public.ob_exclusivity DROP CONSTRAINT IF EXISTS sql161127115514940; ALTER TABLE IF EXISTS ONLY public.struct2obprod DROP CONSTRAINT IF EXISTS sql161126154450310; ALTER TABLE IF EXISTS ONLY public.ob_product DROP CONSTRAINT IF EXISTS sql161126154442460; ALTER TABLE IF EXISTS ONLY public.dbversion DROP CONSTRAINT IF EXISTS sql160415165555160; ALTER TABLE IF EXISTS ONLY public.act_table_full DROP CONSTRAINT IF EXISTS sql160219095125231; ALTER TABLE IF EXISTS ONLY public.synonyms DROP CONSTRAINT IF EXISTS sql150826201920375; ALTER TABLE IF EXISTS ONLY public.synonyms DROP CONSTRAINT IF EXISTS sql150826201920374; ALTER TABLE IF EXISTS ONLY public.synonyms DROP CONSTRAINT IF EXISTS sql150826201920371; ALTER TABLE IF EXISTS ONLY public.synonyms DROP CONSTRAINT IF EXISTS sql150826201920370; ALTER TABLE IF EXISTS ONLY public.pharma_class DROP CONSTRAINT IF EXISTS sql150603161251841; ALTER TABLE IF EXISTS ONLY public.pharma_class DROP CONSTRAINT IF EXISTS sql150603161251830; ALTER TABLE IF EXISTS ONLY public.struct2parent DROP CONSTRAINT IF EXISTS sql150529131801300; ALTER TABLE IF EXISTS ONLY public.parentmol DROP CONSTRAINT IF EXISTS sql150523184644290; ALTER TABLE IF EXISTS ONLY public.parentmol DROP CONSTRAINT IF EXISTS sql150523184621160; ALTER TABLE IF EXISTS ONLY public.parentmol DROP CONSTRAINT IF EXISTS sql150523184351770; ALTER TABLE IF EXISTS ONLY public.doid_xref DROP CONSTRAINT IF EXISTS sql150426005334632; ALTER TABLE IF EXISTS ONLY public.doid_xref DROP CONSTRAINT IF EXISTS sql150426005334630; ALTER TABLE IF EXISTS ONLY public.doid DROP CONSTRAINT IF EXISTS sql150425232401221; ALTER TABLE IF EXISTS ONLY public.doid DROP CONSTRAINT IF EXISTS sql150425232401220; ALTER TABLE IF EXISTS ONLY public.pdb DROP CONSTRAINT IF EXISTS sql150123095054722; ALTER TABLE IF EXISTS ONLY public.pdb DROP CONSTRAINT IF EXISTS sql150123095054720; ALTER TABLE IF EXISTS ONLY public.tdgo2tc DROP CONSTRAINT IF EXISTS sql141211235052890; ALTER TABLE IF EXISTS ONLY public.target_go DROP CONSTRAINT IF EXISTS sql141211234759820; ALTER TABLE IF EXISTS ONLY public.tdkey2tc DROP CONSTRAINT IF EXISTS sql141211195643960; ALTER TABLE IF EXISTS ONLY public.target_keyword DROP CONSTRAINT IF EXISTS sql141211160454700; ALTER TABLE IF EXISTS ONLY public.action_type DROP CONSTRAINT IF EXISTS sql141210123613761; ALTER TABLE IF EXISTS ONLY public.action_type DROP CONSTRAINT IF EXISTS sql141210123613760; ALTER TABLE IF EXISTS ONLY public.td2tc DROP CONSTRAINT IF EXISTS sql141205191436250; ALTER TABLE IF EXISTS ONLY public.target_dictionary DROP CONSTRAINT IF EXISTS sql141205191111190; ALTER TABLE IF EXISTS ONLY public.protein_type DROP CONSTRAINT IF EXISTS sql141203213631731; ALTER TABLE IF EXISTS ONLY public.protein_type DROP CONSTRAINT IF EXISTS sql141203213631730; ALTER TABLE IF EXISTS ONLY public.target_component DROP CONSTRAINT IF EXISTS sql141203005155671; ALTER TABLE IF EXISTS ONLY public.target_component DROP CONSTRAINT IF EXISTS sql141203005155670; ALTER TABLE IF EXISTS ONLY public.target_component DROP CONSTRAINT IF EXISTS sql141203005155660; ALTER TABLE IF EXISTS ONLY public.reference DROP CONSTRAINT IF EXISTS sql141129210458574; ALTER TABLE IF EXISTS ONLY public.reference DROP CONSTRAINT IF EXISTS sql141129210458573; ALTER TABLE IF EXISTS ONLY public.reference DROP CONSTRAINT IF EXISTS sql141129210458572; ALTER TABLE IF EXISTS ONLY public.reference DROP CONSTRAINT IF EXISTS sql141129210458571; ALTER TABLE IF EXISTS ONLY public.reference DROP CONSTRAINT IF EXISTS sql141129210458570; ALTER TABLE IF EXISTS ONLY public.approval DROP CONSTRAINT IF EXISTS sql141031231617263; ALTER TABLE IF EXISTS ONLY public.approval DROP CONSTRAINT IF EXISTS sql141031231617260; ALTER TABLE IF EXISTS ONLY public.approval_type DROP CONSTRAINT IF EXISTS sql141031231522061; ALTER TABLE IF EXISTS ONLY public.approval_type DROP CONSTRAINT IF EXISTS sql141031231522060; ALTER TABLE IF EXISTS ONLY public.struct_type_def DROP CONSTRAINT IF EXISTS sql141016095933601; ALTER TABLE IF EXISTS ONLY public.struct_type_def DROP CONSTRAINT IF EXISTS sql141016095933600; ALTER TABLE IF EXISTS ONLY public.struct2drgclass DROP CONSTRAINT IF EXISTS sql140608153701271; ALTER TABLE IF EXISTS ONLY public.struct2drgclass DROP CONSTRAINT IF EXISTS sql140608153701270; ALTER TABLE IF EXISTS ONLY public.identifier DROP CONSTRAINT IF EXISTS sql140607225949710; ALTER TABLE IF EXISTS ONLY public.id_type DROP CONSTRAINT IF EXISTS sql140607012055121; ALTER TABLE IF EXISTS ONLY public.id_type DROP CONSTRAINT IF EXISTS sql140607012055120; ALTER TABLE IF EXISTS ONLY public.atc_ddd DROP CONSTRAINT IF EXISTS sql140512172435200; ALTER TABLE IF EXISTS ONLY public.ddi DROP CONSTRAINT IF EXISTS sql140411131553960; ALTER TABLE IF EXISTS ONLY public.ddi_risk DROP CONSTRAINT IF EXISTS sql140411131027290; ALTER TABLE IF EXISTS ONLY public.attr_type DROP CONSTRAINT IF EXISTS sql140410123913681; ALTER TABLE IF EXISTS ONLY public.attr_type DROP CONSTRAINT IF EXISTS sql140410123913680; ALTER TABLE IF EXISTS ONLY public.drug_class DROP CONSTRAINT IF EXISTS sql140409195222371; ALTER TABLE IF EXISTS ONLY public.drug_class DROP CONSTRAINT IF EXISTS sql140409195222370; ALTER TABLE IF EXISTS ONLY public.ref_type DROP CONSTRAINT IF EXISTS sql140401160903571; ALTER TABLE IF EXISTS ONLY public.ref_type DROP CONSTRAINT IF EXISTS sql140401160903570; ALTER TABLE IF EXISTS ONLY public.inn_stem DROP CONSTRAINT IF EXISTS sql140212001438201; ALTER TABLE IF EXISTS ONLY public.inn_stem DROP CONSTRAINT IF EXISTS sql140212001438200; ALTER TABLE IF EXISTS ONLY public.prd2label DROP CONSTRAINT IF EXISTS sql130919144750040; ALTER TABLE IF EXISTS ONLY public.target_class DROP CONSTRAINT IF EXISTS sql130710170452610; ALTER TABLE IF EXISTS ONLY public.atc DROP CONSTRAINT IF EXISTS sql130424125636181; ALTER TABLE IF EXISTS ONLY public.atc DROP CONSTRAINT IF EXISTS sql130424125636180; ALTER TABLE IF EXISTS ONLY public.omop_relationship DROP CONSTRAINT IF EXISTS sql121023161238820; ALTER TABLE IF EXISTS ONLY public.structure_type DROP CONSTRAINT IF EXISTS sql120925163230900; ALTER TABLE IF EXISTS ONLY public.struct2atc DROP CONSTRAINT IF EXISTS sql120523120921130; ALTER TABLE IF EXISTS ONLY public.product DROP CONSTRAINT IF EXISTS sql120412001426700; ALTER TABLE IF EXISTS ONLY public.active_ingredient DROP CONSTRAINT IF EXISTS sql120404123859150; ALTER TABLE IF EXISTS ONLY public.section DROP CONSTRAINT IF EXISTS sql120404123658530; ALTER TABLE IF EXISTS ONLY public.label DROP CONSTRAINT IF EXISTS sql120404123647220; ALTER TABLE IF EXISTS ONLY public.data_source DROP CONSTRAINT IF EXISTS sql100517171435170; ALTER TABLE IF EXISTS ONLY public.structures DROP CONSTRAINT IF EXISTS sql100501171817150; ALTER TABLE IF EXISTS ONLY public.product DROP CONSTRAINT IF EXISTS prd_ndc_uniq; ALTER TABLE IF EXISTS ONLY public.prd2label DROP CONSTRAINT IF EXISTS prd2label_id_key; ALTER TABLE IF EXISTS ONLY public.ijc_connect_structures DROP CONSTRAINT IF EXISTS pk_ijc_connect_structures; ALTER TABLE IF EXISTS ONLY public.ijc_connect_items DROP CONSTRAINT IF EXISTS pk_ijc_connect_items; ALTER TABLE IF EXISTS ONLY public.omop_relationship DROP CONSTRAINT IF EXISTS omoprel_struct_concept_uq; ALTER TABLE IF EXISTS ONLY public.identifier DROP CONSTRAINT IF EXISTS identifier_unique; ALTER TABLE IF EXISTS ONLY public.ddi DROP CONSTRAINT IF EXISTS ddi_tuple_uq; ALTER TABLE IF EXISTS ONLY public.ddi_risk DROP CONSTRAINT IF EXISTS ddi_risk_uq; ALTER TABLE IF EXISTS ONLY public.structures DROP CONSTRAINT IF EXISTS cas_reg_no_uq; ALTER TABLE IF EXISTS public.tdkey2tc ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.tdgo2tc ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.target_dictionary ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.target_component ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.target_class ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.synonyms ALTER COLUMN syn_id DROP DEFAULT; ALTER TABLE IF EXISTS public.structures ALTER COLUMN cd_id DROP DEFAULT; ALTER TABLE IF EXISTS public.structure_type ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.struct_type_def ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.struct2drgclass ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.struct2atc ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.section ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.reference ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.ref_type ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.protein_type ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.property_type ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.property ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.product ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.prd2label ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.pka ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.pharma_class ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.pdb ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.parentmol ALTER COLUMN cd_id DROP DEFAULT; ALTER TABLE IF EXISTS public.omop_relationship ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.ob_product ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.ob_patent ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.ob_exclusivity ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.lincs_signature ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.inn_stem ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.identifier ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.id_type ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.faers_male ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.faers_female ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.faers ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.drug_class ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.doid_xref ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.ddi_risk ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.ddi ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.attr_type ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.atc_ddd ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.atc ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.approval_type ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.approval ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.active_ingredient ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.action_type ALTER COLUMN id DROP DEFAULT; DROP SEQUENCE IF EXISTS public.tdkey2tc_id_seq; DROP TABLE IF EXISTS public.tdkey2tc; DROP SEQUENCE IF EXISTS public.tdgo2tc_id_seq; DROP TABLE IF EXISTS public.tdgo2tc; DROP TABLE IF EXISTS public.td2tc; DROP TABLE IF EXISTS public.target_keyword; DROP TABLE IF EXISTS public.target_go; DROP SEQUENCE IF EXISTS public.target_dictionary_id_seq; DROP TABLE IF EXISTS public.target_dictionary; DROP SEQUENCE IF EXISTS public.target_component_id_seq; DROP TABLE IF EXISTS public.target_component; DROP SEQUENCE IF EXISTS public.target_class_id_seq; DROP TABLE IF EXISTS public.target_class; DROP SEQUENCE IF EXISTS public.synonyms_syn_id_seq; DROP TABLE IF EXISTS public.synonyms; DROP SEQUENCE IF EXISTS public.structures_cd_id_seq; DROP TABLE IF EXISTS public.structures; DROP SEQUENCE IF EXISTS public.structure_type_id_seq; DROP TABLE IF EXISTS public.structure_type; DROP SEQUENCE IF EXISTS public.struct_type_def_id_seq; DROP TABLE IF EXISTS public.struct_type_def; DROP TABLE IF EXISTS public.struct2parent; DROP SEQUENCE IF EXISTS public.struct2drgclass_id_seq; DROP TABLE IF EXISTS public.struct2drgclass; DROP SEQUENCE IF EXISTS public.struct2atc_id_seq; DROP TABLE IF EXISTS public.struct2atc; DROP SEQUENCE IF EXISTS public.section_id_seq; DROP TABLE IF EXISTS public.section; DROP SEQUENCE IF EXISTS public.reference_id_seq; DROP TABLE IF EXISTS public.reference; DROP SEQUENCE IF EXISTS public.ref_type_id_seq; DROP TABLE IF EXISTS public.ref_type; DROP SEQUENCE IF EXISTS public.protein_type_id_seq; DROP TABLE IF EXISTS public.protein_type; DROP SEQUENCE IF EXISTS public.property_type_id_seq; DROP TABLE IF EXISTS public.property_type; DROP SEQUENCE IF EXISTS public.property_id_seq; DROP TABLE IF EXISTS public.property; DROP SEQUENCE IF EXISTS public.product_id_seq; DROP TABLE IF EXISTS public.product; DROP SEQUENCE IF EXISTS public.prd2label_id_seq; DROP TABLE IF EXISTS public.prd2label; DROP SEQUENCE IF EXISTS public.pka_id_seq; DROP TABLE IF EXISTS public.pka; DROP SEQUENCE IF EXISTS public.pharma_class_id_seq; DROP TABLE IF EXISTS public.pharma_class; DROP SEQUENCE IF EXISTS public.pdb_id_seq; DROP TABLE IF EXISTS public.pdb; DROP SEQUENCE IF EXISTS public.parentmol_cd_id_seq; DROP TABLE IF EXISTS public.parentmol; DROP SEQUENCE IF EXISTS public.omop_relationship_id_seq; DROP VIEW IF EXISTS public.omop_relationship_doid_view; DROP TABLE IF EXISTS public.omop_relationship; DROP SEQUENCE IF EXISTS public.ob_product_id_seq; DROP VIEW IF EXISTS public.ob_patent_view; DROP TABLE IF EXISTS public.ob_patent_use_code; DROP SEQUENCE IF EXISTS public.ob_patent_id_seq; DROP TABLE IF EXISTS public.ob_patent; DROP VIEW IF EXISTS public.ob_exclusivity_view; DROP TABLE IF EXISTS public.struct2obprod; DROP TABLE IF EXISTS public.ob_product; DROP SEQUENCE IF EXISTS public.ob_exclusivity_id_seq; DROP TABLE IF EXISTS public.ob_exclusivity_code; DROP TABLE IF EXISTS public.ob_exclusivity; DROP SEQUENCE IF EXISTS public.lincs_signature_id_seq; DROP TABLE IF EXISTS public.lincs_signature; DROP TABLE IF EXISTS public.label; DROP SEQUENCE IF EXISTS public.inn_stem_id_seq; DROP TABLE IF EXISTS public.inn_stem; DROP TABLE IF EXISTS public.ijc_connect_structures; DROP TABLE IF EXISTS public.ijc_connect_items; DROP SEQUENCE IF EXISTS public.identifier_id_seq; DROP TABLE IF EXISTS public.identifier; DROP SEQUENCE IF EXISTS public.id_type_id_seq; DROP TABLE IF EXISTS public.id_type; DROP VIEW IF EXISTS public.faers_top; DROP SEQUENCE IF EXISTS public.faers_male_id_seq; DROP TABLE IF EXISTS public.faers_male; DROP SEQUENCE IF EXISTS public.faers_id_seq; DROP SEQUENCE IF EXISTS public.faers_female_id_seq; DROP TABLE IF EXISTS public.faers_female; DROP TABLE IF EXISTS public.faers; DROP SEQUENCE IF EXISTS public.drug_class_id_seq; DROP TABLE IF EXISTS public.drug_class; DROP SEQUENCE IF EXISTS public.doid_xref_id_seq; DROP TABLE IF EXISTS public.doid_xref; DROP TABLE IF EXISTS public.doid; DROP SEQUENCE IF EXISTS public.ddi_risk_id_seq; DROP TABLE IF EXISTS public.ddi_risk; DROP SEQUENCE IF EXISTS public.ddi_id_seq; DROP TABLE IF EXISTS public.ddi; DROP TABLE IF EXISTS public.dbversion; DROP TABLE IF EXISTS public.data_source; DROP SEQUENCE IF EXISTS public.attr_type_id_seq; DROP TABLE IF EXISTS public.attr_type; DROP SEQUENCE IF EXISTS public.atc_id_seq; DROP SEQUENCE IF EXISTS public.atc_ddd_id_seq; DROP TABLE IF EXISTS public.atc_ddd; DROP TABLE IF EXISTS public.atc; DROP SEQUENCE IF EXISTS public.approval_type_id_seq; DROP TABLE IF EXISTS public.approval_type; DROP SEQUENCE IF EXISTS public.approval_id_seq; DROP TABLE IF EXISTS public.approval; DROP SEQUENCE IF EXISTS public.active_ingredient_id_seq; DROP TABLE IF EXISTS public.active_ingredient; DROP SEQUENCE IF EXISTS public.action_type_id_seq; DROP TABLE IF EXISTS public.action_type; DROP TABLE IF EXISTS public.act_table_full; DROP SCHEMA IF EXISTS public; -- -- Name: public; Type: SCHEMA; Schema: -; Owner: - -- CREATE SCHEMA public; -- -- Name: SCHEMA public; Type: COMMENT; Schema: -; Owner: - -- COMMENT ON SCHEMA public IS 'standard public schema'; SET default_tablespace = ''; SET default_with_oids = false; -- -- Name: act_table_full; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.act_table_full ( act_id integer NOT NULL, struct_id integer NOT NULL, target_id integer NOT NULL, target_name character varying(200), target_class character varying(50), accession character varying(1000), gene character varying(1000), swissprot character varying(1000), act_value double precision, act_unit character varying(100), act_type character varying(100), act_comment character varying(1000), act_source character varying(100), relation character varying(5), moa smallint, moa_source character varying(100), act_source_url character varying(500), moa_source_url character varying(500), action_type character varying(50), first_in_class smallint, tdl character varying(500), act_ref_id integer, moa_ref_id integer, organism character varying(150) ); -- -- Name: TABLE act_table_full; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.act_table_full IS 'bioactivity data aggregated from multiple resources'; -- -- Name: action_type; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.action_type ( id integer NOT NULL, action_type character varying(50) NOT NULL, description character varying(200) NOT NULL, parent_type character varying(50) ); -- -- Name: TABLE action_type; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.action_type IS 'drug modulatory action types'; -- -- Name: action_type_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.action_type_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: action_type_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.action_type_id_seq OWNED BY public.action_type.id; -- -- Name: active_ingredient; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.active_ingredient ( id integer NOT NULL, active_moiety_unii character varying(20), active_moiety_name character varying(4000), unit character varying(20), quantity double precision, substance_unii character varying(20), substance_name character varying(4000), ndc_product_code character varying(20), struct_id integer, quantity_denom_unit character varying(20), quantity_denom_value double precision ); -- -- Name: TABLE active_ingredient; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.active_ingredient IS 'active ingredients listed in FDA drug labels'; -- -- Name: active_ingredient_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.active_ingredient_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: active_ingredient_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.active_ingredient_id_seq OWNED BY public.active_ingredient.id; -- -- Name: approval; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.approval ( id integer NOT NULL, struct_id integer NOT NULL, approval date, type character varying(200) NOT NULL, applicant character varying(100), orphan boolean ); -- -- Name: TABLE approval; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.approval IS 'approval dates by drug regualtory agencies'; -- -- Name: approval_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.approval_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: approval_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.approval_id_seq OWNED BY public.approval.id; -- -- Name: approval_type; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.approval_type ( id integer NOT NULL, descr character varying(200) ); -- -- Name: TABLE approval_type; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.approval_type IS 'listing of drug regulatory agencies'; -- -- Name: approval_type_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.approval_type_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: approval_type_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.approval_type_id_seq OWNED BY public.approval_type.id; -- -- Name: atc; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.atc ( id integer NOT NULL, code character(7) NOT NULL, chemical_substance character varying(250) NOT NULL, l1_code character(1) NOT NULL, l1_name character varying(200) NOT NULL, l2_code character(3) NOT NULL, l2_name character varying(200) NOT NULL, l3_code character(4) NOT NULL, l3_name character varying(200) NOT NULL, l4_code character(5) NOT NULL, l4_name character varying(200) NOT NULL, chemical_substance_count integer ); -- -- Name: TABLE atc; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.atc IS 'WHO ATC codes'; -- -- Name: atc_ddd; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.atc_ddd ( id integer NOT NULL, atc_code character(7), ddd real NOT NULL, unit_type character varying(10), route character varying(20), comment character varying(100), struct_id integer NOT NULL ); -- -- Name: TABLE atc_ddd; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.atc_ddd IS 'WHO Defined Daily Dose, the DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults'; -- -- Name: atc_ddd_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.atc_ddd_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: atc_ddd_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.atc_ddd_id_seq OWNED BY public.atc_ddd.id; -- -- Name: atc_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.atc_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: atc_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.atc_id_seq OWNED BY public.atc.id; -- -- Name: attr_type; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.attr_type ( id integer NOT NULL, name character varying(100) NOT NULL, type character varying(20) NOT NULL ); -- -- Name: TABLE attr_type; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.attr_type IS 'listing of generic attribute types'; -- -- Name: attr_type_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.attr_type_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: attr_type_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.attr_type_id_seq OWNED BY public.attr_type.id; -- -- Name: data_source; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.data_source ( src_id smallint NOT NULL, source_name character varying(100) ); -- -- Name: TABLE data_source; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.data_source IS 'listing of datasources'; -- -- Name: dbversion; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.dbversion ( version bigint NOT NULL, dtime timestamp without time zone NOT NULL ); -- -- Name: TABLE dbversion; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.dbversion IS 'current database version'; -- -- Name: ddi; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.ddi ( id integer NOT NULL, drug_class1 character varying(500) NOT NULL, drug_class2 character varying(500) NOT NULL, ddi_ref_id integer NOT NULL, ddi_risk character varying(200) NOT NULL, description character varying(4000), source_id character varying(200) ); -- -- Name: TABLE ddi; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.ddi IS 'Drug-Drug and Drug class - Drug class interaction table'; -- -- Name: ddi_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.ddi_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: ddi_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.ddi_id_seq OWNED BY public.ddi.id; -- -- Name: ddi_risk; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.ddi_risk ( id integer NOT NULL, risk character varying(200) NOT NULL, ddi_ref_id integer NOT NULL ); -- -- Name: TABLE ddi_risk; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.ddi_risk IS 'Qualitative assesments of drug-drug interactions severity'; -- -- Name: ddi_risk_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.ddi_risk_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: ddi_risk_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.ddi_risk_id_seq OWNED BY public.ddi_risk.id; -- -- Name: doid; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.doid ( id integer NOT NULL, label character varying(1000), doid character varying(50), url character varying(100) ); -- -- Name: TABLE doid; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.doid IS 'listing on Disease-Ontology concepts'; -- -- Name: doid_xref; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.doid_xref ( id integer NOT NULL, doid character varying(50), source character varying(50), xref character varying(50) ); -- -- Name: TABLE doid_xref; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.doid_xref IS 'Disease-Ontology terms mappings to external resources'; -- -- Name: doid_xref_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.doid_xref_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: doid_xref_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.doid_xref_id_seq OWNED BY public.doid_xref.id; -- -- Name: drug_class; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.drug_class ( id integer NOT NULL, name character varying(500) NOT NULL, is_group smallint DEFAULT 0 NOT NULL, source character varying(100) ); -- -- Name: TABLE drug_class; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.drug_class IS 'groupings of drugs used to derive Drug-Drug and Drug class - Drug class interactions'; -- -- Name: drug_class_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.drug_class_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: drug_class_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.drug_class_id_seq OWNED BY public.drug_class.id; -- -- Name: faers; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.faers ( id integer NOT NULL, struct_id integer, meddra_name character varying(200) NOT NULL, meddra_code bigint NOT NULL, level character varying(5), llr double precision, llr_threshold double precision, drug_ae integer, drug_no_ae integer, no_drug_ae integer, no_drug_no_ae integer ); -- -- Name: TABLE faers; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.faers IS 'Adverse events from FDA FAERS database'; -- -- Name: COLUMN faers.llr; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON COLUMN public.faers.llr IS 'Likelihood Ratio based on method described in http://dx.doi.org/10.1198/jasa.2011.ap10243'; -- -- Name: COLUMN faers.llr_threshold; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON COLUMN public.faers.llr_threshold IS 'Likelihood Ratio threshold based on method described in http://dx.doi.org/10.1198/jasa.2011.ap10243'; -- -- Name: COLUMN faers.drug_ae; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON COLUMN public.faers.drug_ae IS 'number of patients taking drug and having adverse event'; -- -- Name: COLUMN faers.drug_no_ae; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON COLUMN public.faers.drug_no_ae IS 'number of patients taking drug and not having adverse event'; -- -- Name: COLUMN faers.no_drug_ae; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON COLUMN public.faers.no_drug_ae IS 'number of patients not taking drug and having adverse event'; -- -- Name: COLUMN faers.no_drug_no_ae; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON COLUMN public.faers.no_drug_no_ae IS 'number of patients not taking drug and not having adverse event'; -- -- Name: faers_female; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.faers_female ( id integer NOT NULL, struct_id integer, meddra_name character varying(200) NOT NULL, meddra_code bigint NOT NULL, level character varying(5), llr double precision, llr_threshold double precision, drug_ae integer, drug_no_ae integer, no_drug_ae integer, no_drug_no_ae integer ); -- -- Name: faers_female_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.faers_female_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: faers_female_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.faers_female_id_seq OWNED BY public.faers_female.id; -- -- Name: faers_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.faers_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: faers_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.faers_id_seq OWNED BY public.faers.id; -- -- Name: faers_male; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.faers_male ( id integer NOT NULL, struct_id integer, meddra_name character varying(200) NOT NULL, meddra_code bigint NOT NULL, level character varying(5), llr double precision, llr_threshold double precision, drug_ae integer, drug_no_ae integer, no_drug_ae integer, no_drug_no_ae integer ); -- -- Name: faers_male_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.faers_male_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: faers_male_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.faers_male_id_seq OWNED BY public.faers_male.id; -- -- Name: faers_top; Type: VIEW; Schema: public; Owner: - -- CREATE VIEW public.faers_top AS SELECT rank_filter.struct_id, rank_filter.meddra_name FROM ( SELECT faers.id, faers.struct_id, faers.meddra_name, faers.meddra_code, faers.level, faers.llr, faers.llr_threshold, faers.drug_ae, faers.drug_no_ae, faers.no_drug_ae, faers.no_drug_no_ae, rank() OVER (PARTITION BY faers.struct_id ORDER BY faers.llr DESC) AS rank FROM public.faers WHERE (faers.llr > faers.llr_threshold)) rank_filter WHERE (rank_filter.rank <= 30); -- -- Name: id_type; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.id_type ( id integer NOT NULL, type character varying(50) NOT NULL, description character varying(500), url character varying(500) ); -- -- Name: TABLE id_type; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.id_type IS 'list external identifiers sources'; -- -- Name: id_type_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.id_type_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: id_type_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.id_type_id_seq OWNED BY public.id_type.id; -- -- Name: identifier; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.identifier ( id integer NOT NULL, identifier character varying(50) NOT NULL, id_type character varying(50) NOT NULL, struct_id integer NOT NULL, parent_match boolean ); -- -- Name: TABLE identifier; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.identifier IS 'mapping to external drug resouces'; -- -- Name: identifier_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.identifier_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: identifier_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.identifier_id_seq OWNED BY public.identifier.id; -- -- Name: ijc_connect_items; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.ijc_connect_items ( id character varying(32) NOT NULL, username character varying(128), type character varying(200) NOT NULL, data text ); -- -- Name: ijc_connect_structures; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.ijc_connect_structures ( id character varying(32) NOT NULL, structure_hash character varying(64) NOT NULL, structure text ); -- -- Name: inn_stem; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.inn_stem ( id integer NOT NULL, stem character varying(50), definition character varying(1000) NOT NULL, national_name character varying(20), length smallint, discontinued boolean ); -- -- Name: TABLE inn_stem; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.inn_stem IS 'listing of WHO INN stems based on http://www.who.int/medicines/services/inn/stembook/en/'; -- -- Name: inn_stem_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.inn_stem_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: inn_stem_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.inn_stem_id_seq OWNED BY public.inn_stem.id; -- -- Name: label; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.label ( id character varying(50) NOT NULL, category character varying(100), title character varying(1000), effective_date date, assigned_entity character varying(500), pdf_url character varying(500) ); -- -- Name: TABLE label; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.label IS 'FDA drug labels SPL identifiers and categories'; -- -- Name: lincs_signature; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.lincs_signature ( id integer NOT NULL, struct_id1 integer, struct_id2 integer, is_parent1 boolean, is_parent2 boolean, cell_id character varying(10), rmsd double precision, rmsd_norm double precision, pearson double precision, euclid double precision ); -- -- Name: lincs_signature_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.lincs_signature_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: lincs_signature_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.lincs_signature_id_seq OWNED BY public.lincs_signature.id; -- -- Name: ob_exclusivity; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.ob_exclusivity ( id integer NOT NULL, appl_type character(1), appl_no character(6), product_no character(3), exclusivity_code character varying(10), exclusivity_date date ); -- -- Name: TABLE ob_exclusivity; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.ob_exclusivity IS 'Exclusivity data for FDA Orange book pharmaceutical products'; -- -- Name: ob_exclusivity_code; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.ob_exclusivity_code ( code character varying(10) NOT NULL, description character varying(500) ); -- -- Name: TABLE ob_exclusivity_code; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.ob_exclusivity_code IS 'Exclusivity codes from FDA Orange book'; -- -- Name: ob_exclusivity_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.ob_exclusivity_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: ob_exclusivity_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.ob_exclusivity_id_seq OWNED BY public.ob_exclusivity.id; -- -- Name: ob_product; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.ob_product ( id integer NOT NULL, ingredient character varying(500), trade_name character varying(200), applicant character varying(50), strength character varying(500), appl_type character(1), appl_no character(6), te_code character varying(20), approval_date date, rld smallint, type character varying(5), applicant_full_name character varying(200), dose_form character varying(50), route character varying(100), product_no character(3) ); -- -- Name: TABLE ob_product; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.ob_product IS 'FDA Orange book pharmaceutical products'; -- -- Name: struct2obprod; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.struct2obprod ( struct_id integer NOT NULL, prod_id integer NOT NULL, strength character varying(4000) ); -- -- Name: ob_exclusivity_view; Type: VIEW; Schema: public; Owner: - -- CREATE VIEW public.ob_exclusivity_view AS SELECT DISTINCT ON (struct2obprod.struct_id, struct2obprod.strength, ob_product.trade_name, ob_product.applicant, ob_product.appl_type, ob_product.appl_no, ob_product.type, ob_product.dose_form, ob_product.route, ob_exclusivity.exclusivity_date, ob_exclusivity_code.description) struct2obprod.struct_id, struct2obprod.strength, ob_product.trade_name, ob_product.applicant, ob_product.appl_type, ob_product.appl_no, ob_product.approval_date, ob_product.type, ob_product.dose_form, ob_product.route, ob_exclusivity.exclusivity_date, ob_exclusivity_code.description FROM public.ob_product, public.ob_exclusivity, public.ob_exclusivity_code, public.struct2obprod WHERE ((ob_product.appl_no = ob_exclusivity.appl_no) AND (ob_product.product_no = ob_exclusivity.product_no) AND ((ob_exclusivity.exclusivity_code)::text = (ob_exclusivity_code.code)::text) AND (ob_product.id = struct2obprod.prod_id)); -- -- Name: ob_patent; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.ob_patent ( id integer NOT NULL, appl_type character(1), appl_no character(6), product_no character(3), patent_no character varying(200), patent_expire_date date, drug_substance_flag character(1), drug_product_flag character(1), patent_use_code character varying(10), delist_flag character(1) ); -- -- Name: TABLE ob_patent; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.ob_patent IS 'Patent data for FDA Orange book pharmaceutical products'; -- -- Name: ob_patent_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.ob_patent_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: ob_patent_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.ob_patent_id_seq OWNED BY public.ob_patent.id; -- -- Name: ob_patent_use_code; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.ob_patent_use_code ( code character varying(10) NOT NULL, description character varying(500) ); -- -- Name: TABLE ob_patent_use_code; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.ob_patent_use_code IS 'Patent use codes from FDA Orange book'; -- -- Name: ob_patent_view; Type: VIEW; Schema: public; Owner: - -- CREATE VIEW public.ob_patent_view AS SELECT DISTINCT ON (struct2obprod.struct_id, struct2obprod.strength, ob_patent.patent_no, ob_patent_use_code.description, ob_product.trade_name, ob_product.applicant, ob_product.appl_type, ob_product.appl_no, ob_product.type, ob_product.dose_form, ob_product.route) struct2obprod.struct_id, struct2obprod.strength, ob_patent.patent_no, ob_patent_use_code.description, ob_product.trade_name, ob_product.applicant, ob_product.appl_type, ob_product.appl_no, ob_product.type, ob_product.dose_form, ob_product.route, ob_product.approval_date, ob_patent.patent_expire_date FROM public.ob_product, public.ob_patent, public.ob_patent_use_code, public.struct2obprod WHERE ((ob_product.appl_no = ob_patent.appl_no) AND (ob_product.product_no = ob_patent.product_no) AND ((ob_patent.patent_use_code)::text = (ob_patent_use_code.code)::text) AND (ob_product.id = struct2obprod.prod_id)); -- -- Name: ob_product_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.ob_product_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: ob_product_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.ob_product_id_seq OWNED BY public.ob_product.id; -- -- Name: omop_relationship; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.omop_relationship ( id integer NOT NULL, struct_id integer NOT NULL, concept_id integer NOT NULL, relationship_name character varying(256) NOT NULL, concept_name character varying(256) NOT NULL, umls_cui character(8), snomed_full_name character varying(500), cui_semantic_type character(4), snomed_conceptid bigint ); -- -- Name: TABLE omop_relationship; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.omop_relationship IS 'drug indications/contra-indications/off-label use based on OMOP v4 and manual annotations'; -- -- Name: omop_relationship_doid_view; Type: VIEW; Schema: public; Owner: - -- CREATE VIEW public.omop_relationship_doid_view AS SELECT omop_relationship.id, omop_relationship.struct_id, omop_relationship.concept_id, omop_relationship.relationship_name, omop_relationship.concept_name, omop_relationship.umls_cui, omop_relationship.snomed_full_name, omop_relationship.cui_semantic_type, omop_relationship.snomed_conceptid, d.doid FROM (public.omop_relationship LEFT JOIN ( SELECT doid_xref.xref, string_agg((doid_xref.doid)::text, ','::text) AS doid FROM public.doid_xref WHERE ((doid_xref.source)::text ~~ 'SNOMED%'::text) GROUP BY doid_xref.xref) d ON ((omop_relationship.snomed_conceptid = (d.xref)::bigint))); -- -- Name: omop_relationship_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.omop_relationship_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: omop_relationship_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.omop_relationship_id_seq OWNED BY public.omop_relationship.id; -- -- Name: parentmol; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.parentmol ( cd_id integer NOT NULL, name character varying(250), cas_reg_no character varying(50), inchi character varying(32672), nostereo_inchi character varying(32672), molfile text, molimg bytea, smiles character varying(32672), inchikey character(27) ); -- -- Name: TABLE parentmol; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.parentmol IS 'parent drug molecules for active ingredients formulated as prodrugs'; -- -- Name: parentmol_cd_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.parentmol_cd_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: parentmol_cd_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.parentmol_cd_id_seq OWNED BY public.parentmol.cd_id; -- -- Name: pdb; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.pdb ( id integer NOT NULL, struct_id integer NOT NULL, pdb character(4) NOT NULL, chain_id character varying(3), accession character varying(20), title character varying(1000), pubmed_id integer, exp_method character varying(50), deposition_date date, ligand_id character varying(20) ); -- -- Name: TABLE pdb; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.pdb IS 'mapping to PDB protein-drug complexes'; -- -- Name: pdb_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.pdb_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: pdb_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.pdb_id_seq OWNED BY public.pdb.id; -- -- Name: pharma_class; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.pharma_class ( id integer NOT NULL, struct_id integer, type character varying(20) NOT NULL, name character varying(1000) NOT NULL, class_code character varying(20), source character varying(100) ); -- -- Name: TABLE pharma_class; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.pharma_class IS 'pharmacologic classifications of drugs from multiple resources'; -- -- Name: pharma_class_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.pharma_class_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: pharma_class_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.pharma_class_id_seq OWNED BY public.pharma_class.id; -- -- Name: pka; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.pka ( id integer NOT NULL, struct_id integer NOT NULL, pka_level character varying(5), value double precision, pka_type character(1) NOT NULL ); -- -- Name: TABLE pka; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.pka IS 'logarithm of acid dissociation constant calculated using MoKa 3.0.0'; -- -- Name: pka_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.pka_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: pka_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.pka_id_seq OWNED BY public.pka.id; -- -- Name: prd2label; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.prd2label ( ndc_product_code character varying(20) NOT NULL, label_id character varying(50) NOT NULL, id integer NOT NULL ); -- -- Name: TABLE prd2label; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.prd2label IS 'mappings between FDA drug labels and pharmaceutical products associated with these labels'; -- -- Name: prd2label_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.prd2label_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: prd2label_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.prd2label_id_seq OWNED BY public.prd2label.id; -- -- Name: product; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.product ( id integer NOT NULL, ndc_product_code character varying(20) NOT NULL, form character varying(250), generic_name character varying(4000), product_name character varying(1000), route character varying(50), marketing_status character varying(500), active_ingredient_count integer ); -- -- Name: TABLE product; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.product IS 'pharmaceutical products associated with FDA drug labels'; -- -- Name: product_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.product_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: product_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.product_id_seq OWNED BY public.product.id; -- -- Name: property; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.property ( id integer NOT NULL, property_type_id integer, property_type_symbol character varying(10), struct_id integer, value double precision, reference_id integer, reference_type character varying(50), source character varying(80) ); -- -- Name: property_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.property_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: property_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.property_id_seq OWNED BY public.property.id; -- -- Name: property_type; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.property_type ( id integer NOT NULL, category character varying(20), name character varying(80), symbol character varying(10), units character varying(10) ); -- -- Name: property_type_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.property_type_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: property_type_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.property_type_id_seq OWNED BY public.property_type.id; -- -- Name: protein_type; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.protein_type ( id integer NOT NULL, type character varying(50) NOT NULL ); -- -- Name: TABLE protein_type; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.protein_type IS 'simple classification of protein types interacting with drugs'; -- -- Name: protein_type_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.protein_type_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: protein_type_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.protein_type_id_seq OWNED BY public.protein_type.id; -- -- Name: ref_type; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.ref_type ( id integer NOT NULL, type character varying(50) NOT NULL ); -- -- Name: TABLE ref_type; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.ref_type IS 'listing of reference types'; -- -- Name: ref_type_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.ref_type_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: ref_type_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.ref_type_id_seq OWNED BY public.ref_type.id; -- -- Name: reference; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.reference ( id integer NOT NULL, pmid integer, doi character varying(50), document_id character varying(200), type character varying(50), authors character varying(4000), title character varying(500), isbn10 character(10), url character varying(1000), journal character varying(100), volume character varying(20), issue character varying(20), dp_year integer, pages character varying(50) ); -- -- Name: TABLE reference; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.reference IS 'external references for drug bioactivities and mechanism of action'; -- -- Name: reference_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.reference_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: reference_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.reference_id_seq OWNED BY public.reference.id; -- -- Name: section; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.section ( id integer NOT NULL, text text, label_id character varying(50), code character varying(20), title character varying(4000) ); -- -- Name: TABLE section; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.section IS 'FDA SPL drug label sections'; -- -- Name: section_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.section_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: section_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.section_id_seq OWNED BY public.section.id; -- -- Name: struct2atc; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.struct2atc ( struct_id integer NOT NULL, atc_code character(7) NOT NULL, id integer NOT NULL ); -- -- Name: TABLE struct2atc; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.struct2atc IS 'mapping between structures table and WHO ATC codes'; -- -- Name: struct2atc_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.struct2atc_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: struct2atc_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.struct2atc_id_seq OWNED BY public.struct2atc.id; -- -- Name: struct2drgclass; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.struct2drgclass ( id integer NOT NULL, struct_id integer NOT NULL, drug_class_id integer NOT NULL ); -- -- Name: TABLE struct2drgclass; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.struct2drgclass IS 'mapping between structures and drug_class tables'; -- -- Name: struct2drgclass_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.struct2drgclass_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: struct2drgclass_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.struct2drgclass_id_seq OWNED BY public.struct2drgclass.id; -- -- Name: struct2parent; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.struct2parent ( struct_id integer NOT NULL, parent_id integer NOT NULL ); -- -- Name: TABLE struct2parent; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.struct2parent IS 'mapping between prodrugs in structures table and active parent molecules'; -- -- Name: struct_type_def; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.struct_type_def ( id integer NOT NULL, type character varying(50), description character varying(200) ); -- -- Name: TABLE struct_type_def; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.struct_type_def IS 'simple classification of chemical entities in structures table'; -- -- Name: struct_type_def_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.struct_type_def_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: struct_type_def_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.struct_type_def_id_seq OWNED BY public.struct_type_def.id; -- -- Name: structure_type; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.structure_type ( id integer NOT NULL, struct_id integer, type character varying(50) DEFAULT 'UNKNOWN'::character varying NOT NULL ); -- -- Name: TABLE structure_type; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.structure_type IS 'mapping between chemical entities in structures table and types defined in struct_type_def'; -- -- Name: structure_type_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.structure_type_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: structure_type_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.structure_type_id_seq OWNED BY public.structure_type.id; -- -- Name: structures; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.structures ( cd_id integer NOT NULL, cd_formula character varying(100), cd_molweight double precision, id integer NOT NULL, clogp double precision, alogs double precision, cas_reg_no character varying(50), tpsa real, lipinski integer, name character varying(250), no_formulations integer, stem character varying(50), molfile text, mrdef character varying(32672), enhanced_stereo boolean DEFAULT false NOT NULL, arom_c integer, sp3_c integer, sp2_c integer, sp_c integer, halogen integer, hetero_sp2_c integer, rotb integer, molimg bytea, o_n integer, oh_nh integer, inchi character varying(32672), smiles character varying(32672), rgb integer, fda_labels integer, inchikey character(27), status character varying(10) ); -- -- Name: TABLE structures; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.structures IS 'chemical entities in active pharmaceutical ingredients table'; -- -- Name: COLUMN structures.rgb; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON COLUMN public.structures.rgb IS 'number of rigid bonds'; -- -- Name: structures_cd_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.structures_cd_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: structures_cd_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.structures_cd_id_seq OWNED BY public.structures.cd_id; -- -- Name: synonyms; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.synonyms ( syn_id integer NOT NULL, id integer, name character varying(250) NOT NULL, preferred_name smallint, parent_id integer, lname character varying(250) DEFAULT 'GENERATED ALWAYS AS ( LCASE(NAME) )'::character varying ); -- -- Name: TABLE synonyms; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.synonyms IS 'unamiguous list of synonyms assigned to chemical entities in structures and parentmol tables'; -- -- Name: synonyms_syn_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.synonyms_syn_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: synonyms_syn_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.synonyms_syn_id_seq OWNED BY public.synonyms.syn_id; -- -- Name: target_class; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.target_class ( l1 character varying(50) NOT NULL, id integer NOT NULL ); -- -- Name: TABLE target_class; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.target_class IS 'ChEMBL-db target classification system, level 1 only'; -- -- Name: target_class_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.target_class_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: target_class_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.target_class_id_seq OWNED BY public.target_class.id; -- -- Name: target_component; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.target_component ( id integer NOT NULL, accession character varying(20), swissprot character varying(20), organism character varying(150), name character varying(200), gene character varying(25), geneid bigint, tdl character varying(5) ); -- -- Name: TABLE target_component; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.target_component IS 'protein components of taregt interacting with drugs'; -- -- Name: target_component_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.target_component_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: target_component_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.target_component_id_seq OWNED BY public.target_component.id; -- -- Name: target_dictionary; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.target_dictionary ( id integer NOT NULL, name character varying(200) NOT NULL, target_class character varying(50) DEFAULT 'Unclassified'::character varying NOT NULL, protein_components smallint DEFAULT 0 NOT NULL, protein_type character varying(50), tdl character varying(500) ); -- -- Name: TABLE target_dictionary; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.target_dictionary IS 'target entities interacting with drugs'; -- -- Name: target_dictionary_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.target_dictionary_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: target_dictionary_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.target_dictionary_id_seq OWNED BY public.target_dictionary.id; -- -- Name: target_go; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.target_go ( id character(10) NOT NULL, term character varying(200), type character(1) ); -- -- Name: TABLE target_go; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.target_go IS 'Gene Ontology terms'; -- -- Name: target_keyword; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.target_keyword ( id character(7) NOT NULL, descr character varying(4000), category character varying(50), keyword character varying(200) ); -- -- Name: TABLE target_keyword; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.target_keyword IS 'keywords extracted from Unirpot protein entries'; -- -- Name: td2tc; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.td2tc ( target_id integer NOT NULL, component_id integer NOT NULL ); -- -- Name: TABLE td2tc; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.td2tc IS 'mapping between drug target entities and protein components'; -- -- Name: tdgo2tc; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.tdgo2tc ( id integer NOT NULL, go_id character(10) NOT NULL, component_id integer ); -- -- Name: TABLE tdgo2tc; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.tdgo2tc IS 'mapping between protein components and GO terms'; -- -- Name: tdgo2tc_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.tdgo2tc_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: tdgo2tc_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.tdgo2tc_id_seq OWNED BY public.tdgo2tc.id; -- -- Name: tdkey2tc; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE public.tdkey2tc ( id integer NOT NULL, tdkey_id character(7) NOT NULL, component_id integer ); -- -- Name: TABLE tdkey2tc; Type: COMMENT; Schema: public; Owner: - -- COMMENT ON TABLE public.tdkey2tc IS 'mapping between protein components and Uniprot keywords'; -- -- Name: tdkey2tc_id_seq; Type: SEQUENCE; Schema: public; Owner: - -- CREATE SEQUENCE public.tdkey2tc_id_seq AS integer START WITH 1 INCREMENT BY 1 NO MINVALUE NO MAXVALUE CACHE 1; -- -- Name: tdkey2tc_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - -- ALTER SEQUENCE public.tdkey2tc_id_seq OWNED BY public.tdkey2tc.id; -- -- Name: action_type id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.action_type ALTER COLUMN id SET DEFAULT nextval('public.action_type_id_seq'::regclass); -- -- Name: active_ingredient id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.active_ingredient ALTER COLUMN id SET DEFAULT nextval('public.active_ingredient_id_seq'::regclass); -- -- Name: approval id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.approval ALTER COLUMN id SET DEFAULT nextval('public.approval_id_seq'::regclass); -- -- Name: approval_type id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.approval_type ALTER COLUMN id SET DEFAULT nextval('public.approval_type_id_seq'::regclass); -- -- Name: atc id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.atc ALTER COLUMN id SET DEFAULT nextval('public.atc_id_seq'::regclass); -- -- Name: atc_ddd id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.atc_ddd ALTER COLUMN id SET DEFAULT nextval('public.atc_ddd_id_seq'::regclass); -- -- Name: attr_type id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.attr_type ALTER COLUMN id SET DEFAULT nextval('public.attr_type_id_seq'::regclass); -- -- Name: ddi id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.ddi ALTER COLUMN id SET DEFAULT nextval('public.ddi_id_seq'::regclass); -- -- Name: ddi_risk id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.ddi_risk ALTER COLUMN id SET DEFAULT nextval('public.ddi_risk_id_seq'::regclass); -- -- Name: doid_xref id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.doid_xref ALTER COLUMN id SET DEFAULT nextval('public.doid_xref_id_seq'::regclass); -- -- Name: drug_class id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.drug_class ALTER COLUMN id SET DEFAULT nextval('public.drug_class_id_seq'::regclass); -- -- Name: faers id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.faers ALTER COLUMN id SET DEFAULT nextval('public.faers_id_seq'::regclass); -- -- Name: faers_female id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.faers_female ALTER COLUMN id SET DEFAULT nextval('public.faers_female_id_seq'::regclass); -- -- Name: faers_male id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.faers_male ALTER COLUMN id SET DEFAULT nextval('public.faers_male_id_seq'::regclass); -- -- Name: id_type id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.id_type ALTER COLUMN id SET DEFAULT nextval('public.id_type_id_seq'::regclass); -- -- Name: identifier id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.identifier ALTER COLUMN id SET DEFAULT nextval('public.identifier_id_seq'::regclass); -- -- Name: inn_stem id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.inn_stem ALTER COLUMN id SET DEFAULT nextval('public.inn_stem_id_seq'::regclass); -- -- Name: lincs_signature id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.lincs_signature ALTER COLUMN id SET DEFAULT nextval('public.lincs_signature_id_seq'::regclass); -- -- Name: ob_exclusivity id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.ob_exclusivity ALTER COLUMN id SET DEFAULT nextval('public.ob_exclusivity_id_seq'::regclass); -- -- Name: ob_patent id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.ob_patent ALTER COLUMN id SET DEFAULT nextval('public.ob_patent_id_seq'::regclass); -- -- Name: ob_product id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.ob_product ALTER COLUMN id SET DEFAULT nextval('public.ob_product_id_seq'::regclass); -- -- Name: omop_relationship id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.omop_relationship ALTER COLUMN id SET DEFAULT nextval('public.omop_relationship_id_seq'::regclass); -- -- Name: parentmol cd_id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.parentmol ALTER COLUMN cd_id SET DEFAULT nextval('public.parentmol_cd_id_seq'::regclass); -- -- Name: pdb id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.pdb ALTER COLUMN id SET DEFAULT nextval('public.pdb_id_seq'::regclass); -- -- Name: pharma_class id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.pharma_class ALTER COLUMN id SET DEFAULT nextval('public.pharma_class_id_seq'::regclass); -- -- Name: pka id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.pka ALTER COLUMN id SET DEFAULT nextval('public.pka_id_seq'::regclass); -- -- Name: prd2label id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.prd2label ALTER COLUMN id SET DEFAULT nextval('public.prd2label_id_seq'::regclass); -- -- Name: product id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.product ALTER COLUMN id SET DEFAULT nextval('public.product_id_seq'::regclass); -- -- Name: property id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.property ALTER COLUMN id SET DEFAULT nextval('public.property_id_seq'::regclass); -- -- Name: property_type id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.property_type ALTER COLUMN id SET DEFAULT nextval('public.property_type_id_seq'::regclass); -- -- Name: protein_type id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.protein_type ALTER COLUMN id SET DEFAULT nextval('public.protein_type_id_seq'::regclass); -- -- Name: ref_type id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.ref_type ALTER COLUMN id SET DEFAULT nextval('public.ref_type_id_seq'::regclass); -- -- Name: reference id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.reference ALTER COLUMN id SET DEFAULT nextval('public.reference_id_seq'::regclass); -- -- Name: section id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.section ALTER COLUMN id SET DEFAULT nextval('public.section_id_seq'::regclass); -- -- Name: struct2atc id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.struct2atc ALTER COLUMN id SET DEFAULT nextval('public.struct2atc_id_seq'::regclass); -- -- Name: struct2drgclass id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.struct2drgclass ALTER COLUMN id SET DEFAULT nextval('public.struct2drgclass_id_seq'::regclass); -- -- Name: struct_type_def id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.struct_type_def ALTER COLUMN id SET DEFAULT nextval('public.struct_type_def_id_seq'::regclass); -- -- Name: structure_type id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.structure_type ALTER COLUMN id SET DEFAULT nextval('public.structure_type_id_seq'::regclass); -- -- Name: structures cd_id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.structures ALTER COLUMN cd_id SET DEFAULT nextval('public.structures_cd_id_seq'::regclass); -- -- Name: synonyms syn_id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.synonyms ALTER COLUMN syn_id SET DEFAULT nextval('public.synonyms_syn_id_seq'::regclass); -- -- Name: target_class id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.target_class ALTER COLUMN id SET DEFAULT nextval('public.target_class_id_seq'::regclass); -- -- Name: target_component id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.target_component ALTER COLUMN id SET DEFAULT nextval('public.target_component_id_seq'::regclass); -- -- Name: target_dictionary id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.target_dictionary ALTER COLUMN id SET DEFAULT nextval('public.target_dictionary_id_seq'::regclass); -- -- Name: tdgo2tc id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.tdgo2tc ALTER COLUMN id SET DEFAULT nextval('public.tdgo2tc_id_seq'::regclass); -- -- Name: tdkey2tc id; Type: DEFAULT; Schema: public; Owner: - -- ALTER TABLE ONLY public.tdkey2tc ALTER COLUMN id SET DEFAULT nextval('public.tdkey2tc_id_seq'::regclass); -- -- Data for Name: act_table_full; Type: TABLE DATA; Schema: public; Owner: - -- COPY public.act_table_full (act_id, struct_id, target_id, target_name, target_class, accession, gene, swissprot, act_value, act_unit, act_type, act_comment, act_source, relation, moa, moa_source, act_source_url, moa_source_url, action_type, first_in_class, tdl, act_ref_id, moa_ref_id, organism) FROM stdin; 218475 5375 1366 Nuclear factor NF-kappa-B p105 subunit Cytosolic other P19838 NFKB1 NFKB1_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/31132753 INHIBITOR \N Tclin \N 2750 Homo sapiens 218476 5375 755 5'-AMP-activated protein kinase catalytic subunit alpha-1 Kinase Q13131 PRKAA1 AAPK1_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/31132753 INHIBITOR \N Tclin \N 2750 Homo sapiens 218477 5375 4392 SARS-CoV-2 Virus \N \N \N 6 \N EC50 Vero E6 cells SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/32149769 \N INHIBITOR \N \N 2751 \N \N 218478 1893 4392 SARS-CoV-2 Virus \N \N \N 5.53000000000000025 \N EC50 Activity determined against Vero E6 cells SCIENTIFIC LITERATURE = \N \N http://dx.doi.org/10.26434/chemrxiv.12039888.v1 \N INHIBITOR \N \N 2752 \N \N 218479 3972 4392 SARS-CoV-2 Virus \N \N \N 5.69000000000000039 \N IC50 Activity determined against Vero/hSLAM cell SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/32251768 \N INHIBITOR \N \N 2753 \N \N 218480 1912 4392 SARS-CoV-2 Virus \N \N \N 6.54999999999999982 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://dx.doi.org/10.1101/2020.03.20.999730 \N INHIBITOR \N \N 2754 \N \N 218481 276 4392 SARS-CoV-2 Virus \N \N \N 5.66999999999999993 \N EC50 in vitro inhibition of SAR-CoV2 replication SCIENTIFIC LITERATURE = \N \N http://dx.doi.org/10.1101/2020.04.03.023846 \N INHIBITOR \N \N 2755 \N \N 218482 1395 4392 SARS-CoV-2 Virus \N \N \N 5.34999999999999964 \N EC50 Activity determined against Vero E6 cells SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/32194981 \N INHIBITOR \N \N 2756 \N \N 218483 1001 4392 SARS-CoV-2 Virus \N \N \N 6.33999999999999986 \N EC50 Activity determined against Vero E6 cells SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/32251767 \N INHIBITOR \N \N 2757 \N \N 218484 4677 4392 SARS-CoV-2 Virus \N \N \N 5.58999999999999986 \N EC50 Activity determined against Vero E6 cells SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/32251767 \N INHIBITOR \N \N 2757 \N \N 218485 607 4392 SARS-CoV-2 Virus \N \N \N 5.95000000000000018 \N EC50 Activity determined against Vero E6 cells SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/32020029 \N INHIBITOR \N \N 2758 \N \N 218487 924 4393 Main protease (M-PRO) Enzyme P0DTD1 REP R1AB_SARS2 6.25999999999999979 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://dx.doi.org/10.1101/2020.03.23.004580 \N INHIBITOR \N \N 2760 \N Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) 218490 5377 4392 SARS-CoV-2 Virus \N \N \N 6.51999999999999957 \N IC50 Activity determined against Vero E6 cells SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/32253226 \N INHIBITOR \N \N 2762 \N \N 218491 5378 4392 SARS-CoV-2 Virus \N \N \N 5.29000000000000004 \N EC50 Activity determined against Vero E6 cells SCIENTIFIC LITERATURE = \N \N http://dx.doi.org/10.1101/2020.03.11.986836 \N INHIBITOR \N \N 2763 \N \N 218492 633 4392 SARS-CoV-2 Virus \N \N \N 5.36000000000000032 \N IC50 Activity determined against Vero E6 cells. Possible target viral NSP15 (uridylate-specific endoribonuclease) SCIENTIFIC LITERATURE = \N \N http://dx.doi.org/10.1101/2020.03.11.987016 \N INHIBITOR \N \N 2759 \N \N 218493 2580 749 Cathepsin L1 Enzyme P07711 CTSL CATL1_HUMAN 5.78000000000000025 \N IC50 Teicoplanin potently prevents the entrance of 2019-nCoV-Spike-pseudoviruses into the cytoplasm SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://dx.doi.org/10.1101/2020.02.05.935387 http://dx.doi.org/10.1101/2020.02.05.935387 INHIBITOR \N Tclin 2761 2761 Homo sapiens 218494 5379 545 Platelet-derived growth factor receptor alpha Kinase P16234 PDGFRA PGFRA_HUMAN 9.61999999999999922 \N IC50 PDGFRA D842V (exon 18) mutant SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/29093181 https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf INHIBITOR \N Tclin 2765 2764 Homo sapiens 218495 5379 383 Mast/stem cell growth factor receptor Kit Kinase P10721 KIT KIT_HUMAN 9.57000000000000028 \N IC50 KIT D816V (exon 17) SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/29093181 https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf INHIBITOR \N Tclin 2765 2764 Homo sapiens 218497 5379 4396 Mast/stem cell growth factor receptor Kit Kinase P05532 Kit KIT_MOUSE 7.66000000000000014 \N IC50 Inhibition of KIT D816Y mutant autophosphorylation in P815 cell line SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/29093181 \N INHIBITOR \N Tclin 2765 \N Mus musculus 218499 5380 4397 Histone-lysine N-methyltransferase EZH2 Enzyme Q15910 EZH2 EZH2_HUMAN 7.95999999999999996 \N IC50 Mechanism of Action DRUG LABEL = 1 DRUG LABEL https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211723s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211723s000lbl.pdf INHIBITOR \N Tclin 2766 2766 Homo sapiens 217428 5277 4111 Ileal sodium/bile acid cotransporter Transporter Q12908 SLC10A2 NTCP2_HUMAN 9.2757240000000003 \N IC50 \N SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://dx.doi.org/10.1016/S0016-5085(10)61017-7 http://dx.doi.org/10.1016/S0016-5085(10)61017-7 INHIBITOR \N Tclin 2004 2004 Homo sapiens 217429 5276 1047 Cystic fibrosis transmembrane conductance regulator Ion channel P13569 CFTR CFTR_HUMAN \N \N \N \N UNKNOWN \N 1 DRUG LABEL \N https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210491lbl.pdf PHARMACOLOGICAL CHAPERONE \N Tclin \N 2005 Homo sapiens 217430 5275 258 Somatostatin receptor type 2 GPCR P30874 SSTR2 SSR2_HUMAN \N \N \N \N UNKNOWN \N 1 DRUG LABEL \N https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208700s000lbl.pdf AGONIST \N Tclin \N 2006 Homo sapiens 217431 5271 3193 Growth hormone secretagogue receptor type 1 GPCR Q92847 GHSR GHSR_HUMAN 7.80999999999999961 \N IC50 In a radioligand displacement assay using 125I-labeled ghrelin as the probe, and human pituitary gland samples. IUPHAR = 1 DRUG LABEL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9745 https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205598s000lbl.pdf AGONIST \N Tclin 2008 2007 Homo sapiens 217432 2717 1847 5-hydroxytryptamine receptor 2C GPCR P08909 Htr2c 5HT2C_RAT 6.70000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=213 \N ANTAGONIST \N \N \N \N Rattus norvegicus 217433 2781 1970 5-hydroxytryptamine receptor 3A Ion channel P23979 Htr3a 5HT3A_MOUSE 7.09999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2294 \N ANTAGONIST \N \N \N \N Mus musculus 217434 897 1970 5-hydroxytryptamine receptor 3A Ion channel P23979 Htr3a 5HT3A_MOUSE 5.25999999999999979 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2298 \N BLOCKER \N \N \N \N Mus musculus 217435 2162 1970 5-hydroxytryptamine receptor 3A Ion channel P23979 Htr3a 5HT3A_MOUSE 4.5 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4051 \N BLOCKER \N \N \N \N Mus musculus 217436 660 1855 5-hydroxytryptamine receptor 4 GPCR Q62758 Htr4 5HT4R_RAT 8 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=240 \N AGONIST \N \N \N \N Rattus norvegicus 217437 1043 4017 5-hydroxytryptamine receptor 5A Unclassified P30966 Htr5a 5HT5A_MOUSE 8.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=149 \N ANTAGONIST \N \N \N \N Mus musculus 215569 2601 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 8.41000000000000014 \N Ki \N PDSP \N \N \N \N \N \N \N Tclin \N \N Homo sapiens 217438 1775 4017 5-hydroxytryptamine receptor 5A Unclassified P30966 Htr5a 5HT5A_MOUSE 7.20000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=134 \N ANTAGONIST \N \N \N \N Mus musculus 217439 3659 4017 5-hydroxytryptamine receptor 5A Unclassified P30966 Htr5a 5HT5A_MOUSE 6 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=102 \N ANTAGONIST \N \N \N \N Mus musculus 217440 1043 2011 5-hydroxytryptamine receptor 6 GPCR P31388 Htr6 5HT6R_RAT 8.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=149 \N AGONIST \N \N \N \N Rattus norvegicus 217441 1621 2011 5-hydroxytryptamine receptor 6 GPCR P31388 Htr6 5HT6R_RAT 8.69999999999999929 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=17 \N AGONIST \N \N \N \N Rattus norvegicus 217442 1588 2011 5-hydroxytryptamine receptor 6 GPCR P31388 Htr6 5HT6R_RAT 8.30000000000000071 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=43 \N AGONIST \N \N \N \N Rattus norvegicus 217443 180 2011 5-hydroxytryptamine receptor 6 GPCR P31388 Htr6 5HT6R_RAT 7.20000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=200 \N ANTAGONIST \N \N \N \N Rattus norvegicus 217444 191 2011 5-hydroxytryptamine receptor 6 GPCR P31388 Htr6 5HT6R_RAT 8.19999999999999929 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=201 \N ANTAGONIST \N \N \N \N Rattus norvegicus 217445 888 2011 5-hydroxytryptamine receptor 6 GPCR P31388 Htr6 5HT6R_RAT 8.30000000000000071 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=121 \N ANTAGONIST \N \N \N \N Rattus norvegicus 217446 1723 2011 5-hydroxytryptamine receptor 6 GPCR P31388 Htr6 5HT6R_RAT 7.5 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=133 \N ANTAGONIST \N \N \N \N Rattus norvegicus 217447 1775 2011 5-hydroxytryptamine receptor 6 GPCR P31388 Htr6 5HT6R_RAT 6.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=134 \N ANTAGONIST \N \N \N \N Rattus norvegicus 217448 1796 2011 5-hydroxytryptamine receptor 6 GPCR P31388 Htr6 5HT6R_RAT 7.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=135 \N ANTAGONIST \N \N \N \N Rattus norvegicus 217449 722 2011 5-hydroxytryptamine receptor 6 GPCR P31388 Htr6 5HT6R_RAT 8.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=38 \N ANTAGONIST \N \N \N \N Rattus norvegicus 217450 1613 2011 5-hydroxytryptamine receptor 6 GPCR P31388 Htr6 5HT6R_RAT 7.79999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=205 \N ANTAGONIST \N \N \N \N Rattus norvegicus 217451 1982 2011 5-hydroxytryptamine receptor 6 GPCR P31388 Htr6 5HT6R_RAT 8.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=47 \N ANTAGONIST \N \N \N \N Rattus norvegicus 217452 2389 2011 5-hydroxytryptamine receptor 6 GPCR P31388 Htr6 5HT6R_RAT 6.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=96 \N ANTAGONIST \N \N \N \N Rattus norvegicus 217453 403 1777 5-hydroxytryptamine receptor 7 GPCR P32305 Htr7 5HT7R_RAT 8 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=35 \N AGONIST \N \N \N \N Rattus norvegicus 217454 1588 1777 5-hydroxytryptamine receptor 7 GPCR P32305 Htr7 5HT7R_RAT 9.30000000000000071 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=43 \N AGONIST \N \N \N \N Rattus norvegicus 217455 2105 1777 5-hydroxytryptamine receptor 7 GPCR P32305 Htr7 5HT7R_RAT 9 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=48 \N AGONIST \N \N \N \N Rattus norvegicus 217456 180 1777 5-hydroxytryptamine receptor 7 GPCR P32305 Htr7 5HT7R_RAT 7 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=200 \N ANTAGONIST \N \N \N \N Rattus norvegicus 217457 1524 1777 5-hydroxytryptamine receptor 7 GPCR P32305 Htr7 5HT7R_RAT 6.70000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=88 \N ANTAGONIST \N \N \N \N Rattus norvegicus 217458 1982 1777 5-hydroxytryptamine receptor 7 GPCR P32305 Htr7 5HT7R_RAT 7 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=47 \N ANTAGONIST \N \N \N \N Rattus norvegicus 217459 2543 1777 5-hydroxytryptamine receptor 7 GPCR P32305 Htr7 5HT7R_RAT 6.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=54 \N ANTAGONIST \N \N \N \N Rattus norvegicus 217460 1499 3933 Beta-3 adrenergic receptor Unclassified P25962 Adrb3 ADRB3_MOUSE 5.29999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=536 \N AGONIST \N \N \N \N Mus musculus 217461 431 3933 Beta-3 adrenergic receptor Unclassified P25962 Adrb3 ADRB3_MOUSE 6.29999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=570 \N ANTAGONIST \N \N \N \N Mus musculus 217462 2303 3933 Beta-3 adrenergic receptor Unclassified P25962 Adrb3 ADRB3_MOUSE 6.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=564 \N ANTAGONIST \N \N \N \N Mus musculus 217464 4186 4116 B1 bradykinin receptor GPCR P97583 Bdkrb1 BKRB1_RAT 6.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=667 \N ANTAGONIST \N \N \N \N Rattus norvegicus 217465 2780 505 Extracellular calcium-sensing receptor GPCR P41180 CASR CASR_HUMAN 4.40000000000000036 \N Kd \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=717 \N ALLOSTERIC MODULATOR \N Tclin \N \N Homo sapiens 217466 1942 4102 Voltage-dependent L-type calcium channel subunit alpha-1C Ion channel Q01815 Cacna1c CAC1C_MOUSE 8 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2524 \N GATING INHIBITOR \N \N \N \N Mus musculus 217467 1937 1882 Voltage-dependent L-type calcium channel subunit alpha-1D Ion channel P27732 Cacna1d CAC1D_RAT 6.59999999999999964 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2523 \N GATING INHIBITOR \N \N \N \N Rattus norvegicus 217468 1942 4117 Voltage-dependent L-type calcium channel subunit alpha-1D Ion channel Q99246 Cacna1d CAC1D_MOUSE 7 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2524 \N GATING INHIBITOR \N \N \N \N Mus musculus 217469 2878 3945 Voltage-dependent N-type calcium channel subunit alpha-1B Unclassified Q02294 Cacna1b CAC1B_RAT 10.3000000000000007 \N IC50 \N IUPHAR = \N \N \N \N BLOCKER \N \N \N \N Rattus norvegicus 217470 992 4054 Voltage-dependent T-type calcium channel subunit alpha-1G Ion channel O54898 Cacna1g CAC1G_RAT 7 \N IC50 \N IUPHAR = \N \N \N \N BLOCKER \N \N \N \N Rattus norvegicus 217341 5256 2142 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Kinase P42336 PIK3CA PK3CA_HUMAN 9.30103015899658203 \N IC50 \N SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/24170767 https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209936s000lbl.pdf INHIBITOR \N Tclin 690 691 Homo sapiens 215570 4115 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN 8.40893539300000015 \N Ki \N PDSP \N \N \N \N \N \N \N Tclin \N \N Homo sapiens 217342 5256 704 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Kinase O00329 PIK3CD PK3CD_HUMAN 9.15490150451660156 \N IC50 \N SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/24170767 https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209936s000lbl.pdf INHIBITOR \N Tclin 690 691 Homo sapiens 217343 5256 2313 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Kinase P42338 PIK3CB PK3CB_HUMAN 8.43179798126220703 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/24170767 \N INHIBITOR \N Tchem 690 \N Homo sapiens 217344 5256 2314 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Kinase P48736 PIK3CG PK3CG_HUMAN 8.19381999969482422 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/24170767 \N INHIBITOR \N Tclin 690 \N Homo sapiens 217345 5257 397 Potassium channel subfamily K member 2 Ion channel O95069 KCNK2 KCNK2_HUMAN 7.22184896469116211 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/21293470 \N BLOCKER \N Tclin 692 \N Homo sapiens 217346 1407 953 Acid-sensing ion channel 1 Ion channel P78348 ASIC1 ASIC1_HUMAN 3.5299999999999998 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/28949138 \N BLOCKER \N Tchem 693 \N Homo sapiens 217347 5259 2322 Cyclin-dependent kinase 4 Kinase P11802 CDK4 CDK4_HUMAN 9.22184874999999948 \N Ki \N SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/24919854 https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208716Orig1s000lbl.pdf INHIBITOR \N Tclin 794 793 Homo sapiens 217348 5259 1950 Cyclin-dependent kinase 6 Kinase Q00534 CDK6 CDK6_HUMAN 8.61978875800000033 \N Ki \N SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/24919854 https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208716Orig1s000lbl.pdf INHIBITOR \N Tclin 794 793 Homo sapiens 217349 5261 529 Prostaglandin F2-alpha receptor GPCR P43088 PTGFR PF2R_HUMAN 8.59999999999999964 \N Ki Value based on agonist activity of latanoprost. IUPHAR ~ 1 SCIENTIFIC LITERATURE http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9635 http://www.ncbi.nlm.nih.gov/pubmed/21396362 AGONIST \N Tclin \N 894 Homo sapiens 217350 5262 4109 DNA terminase complex Enzyme F5HC79|F5HCU8|F5HGI9 TRM1|TRM2|TRM3 TRM1_HCMVM|TRM2_HCMVM|TRM3_HCMVM 8.67778070499999998 \N EC50 \N DRUG LABEL = 1 DRUG LABEL https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209939Orig1s000,209940Orig1s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209939Orig1s000,209940Orig1s000lbl.pdf INHIBITOR \N Tclin 994 994 Human cytomegalovirus (strain Merlin) 217352 5263 4110 Interleukin-5 receptor subunit alpha Membrane receptor Q01344 IL5RA IL5RA_HUMAN 10.9586073099999997 \N Kd \N DRUG LABEL = 1 DRUG LABEL https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761070s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761070s000lbl.pdf ANTIBODY BINDING \N Tclin 995 995 Homo sapiens 217353 5014 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 6.795880017 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/24947465 \N AGONIST \N Tclin 391 \N Homo sapiens 217355 5014 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 8.20065945099999993 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/24947465 \N AGONIST \N Tchem 391 \N Homo sapiens 217357 5014 130 5-hydroxytryptamine receptor 1B GPCR P28222 HTR1B 5HT1B_HUMAN 7.49485002199999961 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/24947465 \N \N \N Tclin 391 \N Homo sapiens 217358 5014 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 7.46852108299999973 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/24947465 \N \N \N Tclin 391 \N Homo sapiens 217359 5014 284 5-hydroxytryptamine receptor 5A GPCR P47898 HTR5A 5HT5A_HUMAN 6.85387196399999965 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/24947465 \N \N \N Tchem 391 \N Homo sapiens 217360 5014 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 7.23657200600000028 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/24947465 \N \N \N Tchem 391 \N Homo sapiens 217361 5014 106 Alpha-1A adrenergic receptor GPCR P35348 ADRA1A ADA1A_HUMAN 8.42021640299999952 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/24947465 \N \N \N Tclin 391 \N Homo sapiens 217362 5014 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 7.82390874100000033 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/24947465 \N \N \N Tclin 391 \N Homo sapiens 217363 5014 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 7.76955107900000019 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/24947465 \N \N \N Tclin 391 \N Homo sapiens 217364 5014 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN 7.22914798800000025 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/24947465 \N \N \N Tclin 391 \N Homo sapiens 217365 5014 55 Beta-2 adrenergic receptor GPCR P07550 ADRB2 ADRB2_HUMAN 7.17392519699999998 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/24947465 \N \N \N Tclin 391 \N Homo sapiens 217366 5014 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 7.53760200199999986 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/24947465 \N INHIBITOR \N Tclin 391 \N Homo sapiens 217367 5014 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 6.85698519999999956 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/24947465 \N INHIBITOR \N Tclin 391 \N Homo sapiens 217368 5014 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 6.02456819100000018 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/24947465 \N INHIBITOR \N Tclin 391 \N Homo sapiens 217369 5267 1700 Glucagon-like peptide 1 receptor GPCR P43220 GLP1R GLP1R_HUMAN 9.42021640299999952 \N IC50 \N SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/26308095 https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209637lbl.pdf AGONIST \N Tclin 996 1096 Homo sapiens 217370 5269 713 Rho-associated protein kinase 2 Kinase O75116 ROCK2 ROCK2_HUMAN 8.3767510000000005 \N Ki \N SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/27072905 https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208254lbl.pdf INHIBITOR \N Tclin 1097 1197 Homo sapiens 216941 1900 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 7.52287864685058594 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/22711801 \N \N \N Tclin 659 \N Homo sapiens 216942 331 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 5.86486721038818359 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/22711801 \N \N \N Tclin 659 \N Homo sapiens 216944 331 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.1605219841003418 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/22711801 \N \N \N Tclin 659 \N Homo sapiens 216945 331 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 6.26360368728637695 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/22711801 \N \N \N Tclin 659 \N Homo sapiens 216946 6 150 Intermediate conductance calcium-activated potassium channel protein 4 Ion channel O15554 KCNN4 KCNN4_HUMAN 7.59999999999999964 \N IC50 \N IUPHAR = \N \N \N \N BLOCKER \N Tchem \N \N Homo sapiens 216947 6 907 Voltage-dependent L-type calcium channel subunit alpha-1F Ion channel O60840 CACNA1F CAC1F_HUMAN 6 \N IC50 \N IUPHAR ~ \N \N \N \N GATING INHIBITOR \N Tclin \N \N Homo sapiens 216948 6 1853 Voltage-dependent L-type calcium channel subunit alpha-1C Ion channel P22002 Cacna1c CAC1C_RAT 6 \N IC50 \N IUPHAR = \N \N \N \N GATING INHIBITOR \N \N \N \N Rattus norvegicus 216949 6 1960 Voltage-dependent L-type calcium channel subunit alpha-1S Ion channel Q02485 Cacna1s CAC1S_RAT 6 \N IC50 \N IUPHAR = \N \N \N \N GATING INHIBITOR \N \N \N \N Rattus norvegicus 216950 91 3939 P2X purinoceptor 2 Unclassified P49653 P2rx2 P2RX2_RAT 5.84999999999999964 \N EC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1713 \N AGONIST \N \N \N \N Rattus norvegicus 216951 91 580 P2X purinoceptor 1 Ion channel P51575 P2RX1 P2RX1_HUMAN 7.25 \N EC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1713 \N AGONIST \N Tchem \N \N Homo sapiens 216952 91 4096 P2X purinoceptor 5 Unclassified P51578 P2rx5 P2RX5_RAT 6 \N EC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1713 \N AGONIST \N \N \N \N Rattus norvegicus 216953 91 4095 P2X purinoceptor 6 Unclassified P51579 P2rx6 P2RX6_RAT 6 \N EC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1713 \N AGONIST \N \N \N \N Rattus norvegicus 216954 91 3915 Transient receptor potential cation channel subfamily M member 4 Unclassified Q7TN37 Trpm4 TRPM4_MOUSE 6.09999999999999964 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1713 \N BLOCKER \N \N \N \N Mus musculus 216955 91 2607 P2X purinoceptor 4 Ion channel Q99571 P2RX4 P2RX4_HUMAN 6.29999999999999982 \N EC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1713 \N AGONIST \N Tchem \N \N Homo sapiens 216956 91 3977 P2X purinoceptor 4 Unclassified Q9JJX6 P2rx4 P2RX4_MOUSE 6 \N EC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1713 \N AGONIST \N \N \N \N Mus musculus 216957 138 4068 Prostaglandin E2 receptor EP3 subtype Unclassified P34980 Ptger3 PE2R3_RAT 9.34999999999999964 \N EC50 \N IUPHAR = \N \N \N \N AGONIST \N \N \N \N Rattus norvegicus 216958 138 2152 Prostaglandin E2 receptor EP4 subtype GPCR P43114 Ptger4 PE2R4_RAT 9.19999999999999929 \N Ki \N IUPHAR = \N \N \N \N AGONIST \N \N \N \N Rattus norvegicus 216959 138 3975 Prostacyclin receptor Unclassified P43252 Ptgir PI2R_MOUSE 7.5 \N Ki \N IUPHAR = \N \N \N \N AGONIST \N \N \N \N Mus musculus 216960 138 4093 Prostaglandin E2 receptor EP1 subtype Unclassified P70597 Ptger1 PE2R1_RAT 7 \N Ki \N IUPHAR = \N \N \N \N AGONIST \N \N \N \N Rattus norvegicus 216961 138 2151 Prostaglandin E2 receptor EP2 subtype GPCR Q62928 Ptger2 PE2R2_RAT 8 \N Ki \N IUPHAR = \N \N \N \N AGONIST \N \N \N \N Rattus norvegicus 216962 138 3273 Cation channel sperm-associated protein 4 Ion channel Q7RTX7 CATSPER4 CTSR4_HUMAN 6.29999999999999982 \N EC50 Patch clamp electrophysiology. IUPHAR = \N \N \N \N ACTIVATOR \N Tchem \N \N Homo sapiens 216963 138 3272 Cation channel sperm-associated protein 3 Ion channel Q86XQ3 CATSPER3 CTSR3_HUMAN 6.29999999999999982 \N EC50 Patch clamp electrophysiology. IUPHAR = \N \N \N \N ACTIVATOR \N Tchem \N \N Homo sapiens 216964 138 3270 Cation channel sperm-associated protein 1 Ion channel Q8NEC5 CATSPER1 CTSR1_HUMAN 6.29999999999999982 \N EC50 Patch clamp electrophysiology IUPHAR = \N \N \N \N ACTIVATOR \N Tchem \N \N Homo sapiens 216965 138 3271 Cation channel sperm-associated protein 2 Ion channel Q96P56 CATSPER2 CTSR2_HUMAN 6.29999999999999982 \N EC50 Patch clamp electrophysiology. IUPHAR = \N \N \N \N ACTIVATOR \N Tchem \N \N Homo sapiens 216966 158 4064 Sodium/hydrogen exchanger 5 Unclassified Q14940 SLC9A5 SL9A5_HUMAN 4.67999999999999972 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2421 \N INHIBITOR \N \N \N \N Homo sapiens 216967 176 4072 Sodium channel protein type 5 subunit alpha Unclassified P15389 Scn5a SCN5A_RAT 5.70000000000000018 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2566 \N BLOCKER \N \N \N \N Rattus norvegicus 216968 179 1865 D(3) dopamine receptor GPCR P19020 Drd3 DRD3_RAT 7.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=963 \N ANTAGONIST \N \N \N \N Rattus norvegicus 216969 180 1847 5-hydroxytryptamine receptor 2C GPCR P08909 Htr2c 5HT2C_RAT 8.09999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=200 \N ANTAGONIST \N \N \N \N Rattus norvegicus 216970 180 1763 5-hydroxytryptamine receptor 2A GPCR P14842 Htr2a 5HT2A_RAT 8.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=200 \N ANTAGONIST \N \N \N \N Rattus norvegicus 216971 180 1787 5-hydroxytryptamine receptor 7 GPCR P32304 Htr7 5HT7R_MOUSE 6.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=200 \N ANTAGONIST \N \N \N \N Mus musculus 216972 180 3990 G protein-activated inward rectifier potassium channel 2 Ion channel P48542 Kcnj6 KCNJ6_MOUSE 4 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=200 \N BLOCKER \N \N \N \N Mus musculus 216973 191 1847 5-hydroxytryptamine receptor 2C GPCR P08909 Htr2c 5HT2C_RAT 8.69999999999999929 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=201 \N ANTAGONIST \N \N \N \N Rattus norvegicus 216974 191 1763 5-hydroxytryptamine receptor 2A GPCR P14842 Htr2a 5HT2A_RAT 9 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=201 \N ANTAGONIST \N \N \N \N Rattus norvegicus 216975 191 1777 5-hydroxytryptamine receptor 7 GPCR P32305 Htr7 5HT7R_RAT 7.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=201 \N ANTAGONIST \N \N \N \N Rattus norvegicus 216976 242 1878 D(4) dopamine receptor GPCR P30729 Drd4 DRD4_RAT 7.29999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=34 \N ANTAGONIST \N \N \N \N Rattus norvegicus 216977 242 2011 5-hydroxytryptamine receptor 6 GPCR P31388 Htr6 5HT6R_RAT 6.79999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=34 \N AGONIST \N \N \N \N Rattus norvegicus 216978 242 1777 5-hydroxytryptamine receptor 7 GPCR P32305 Htr7 5HT7R_RAT 7.79999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=34 \N AGONIST \N \N \N \N Rattus norvegicus 216979 274 4091 Potassium voltage-gated channel subfamily KQT member 1 Unclassified P97414 Kcnq1 KCNQ1_MOUSE 5.29999999999999982 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2588 \N BLOCKER \N \N \N \N Mus musculus 216980 333 3963 Sodium-dependent neutral amino acid transporter B(0)AT1 Unclassified Q695T7 SLC6A19 S6A19_HUMAN 4.36000000000000032 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7601 \N INHIBITOR \N \N \N \N Homo sapiens 216981 343 494 Prostaglandin E2 receptor EP4 subtype GPCR P35408 PTGER4 PE2R4_HUMAN 5.13999999999999968 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1967 \N AGONIST \N Tclin \N \N Homo sapiens 215867 5203 699 Poly [ADP-ribose] polymerase 1 Enzyme P09874 PARP1 PARP1_HUMAN 8.5 \N IC50 \N SCIENTIFIC LITERATURE = 1 DRUG LABEL http://dx.doi.org/10.1021/acs.jmedchem.6b00990 http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/209115s000lbl.pdf INHIBITOR \N Tclin 629 628 Homo sapiens 215868 5203 34 Poly [ADP-ribose] polymerase 2 Enzyme Q9UGN5 PARP2 PARP2_HUMAN 7.55000019073486328 \N IC50 \N SCIENTIFIC LITERATURE = 1 DRUG LABEL http://dx.doi.org/10.1021/acs.jmedchem.6b00990 http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/209115s000lbl.pdf INHIBITOR \N Tclin 629 628 Homo sapiens 215869 5203 3508 Poly [ADP-ribose] polymerase 3 Enzyme Q9Y6F1 PARP3 PARP3_HUMAN 6.3899998664855957 \N IC50 \N SCIENTIFIC LITERATURE = 1 DRUG LABEL http://dx.doi.org/10.1021/acs.jmedchem.6b00990 http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/209115s000lbl.pdf INHIBITOR \N Tclin 629 628 Homo sapiens 215870 5203 3727 Poly [ADP-ribose] polymerase 4 Enzyme Q9UKK3 PARP4 PARP4_HUMAN 6.07999992370605469 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://dx.doi.org/10.1021/acs.jmedchem.6b00990 \N INHIBITOR \N \N 629 \N Homo sapiens 215871 5203 2537 Tankyrase-1 Enzyme O95271 TNKS TNKS1_HUMAN 6.84000015258789062 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://dx.doi.org/10.1021/acs.jmedchem.6b00990 \N INHIBITOR \N Tchem 629 \N Homo sapiens 215872 5203 2365 Tankyrase-2 Enzyme Q9H2K2 TNKS2 TNKS2_HUMAN 6.05000019073486328 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://dx.doi.org/10.1021/acs.jmedchem.6b00990 \N INHIBITOR \N Tchem 629 \N Homo sapiens 215874 5203 3728 Poly [ADP-ribose] polymerase 10 Enzyme Q53GL7 PARP10 PAR10_HUMAN 6.25 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://dx.doi.org/10.1021/acs.jmedchem.6b00990 \N INHIBITOR \N \N 629 \N Homo sapiens 215875 5203 3729 Poly [ADP-ribose] polymerase 12 Enzyme Q9H0J9 PARP12 PAR12_HUMAN 5.17999982833862305 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://dx.doi.org/10.1021/acs.jmedchem.6b00990 \N INHIBITOR \N \N 629 \N Homo sapiens 215876 5203 3730 Poly [ADP-ribose] polymerase 14 Enzyme Q460N5 PARP14 PAR14_HUMAN 5.05000019073486328 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://dx.doi.org/10.1021/acs.jmedchem.6b00990 \N INHIBITOR \N \N 629 \N Homo sapiens 215878 5203 3731 Poly [ADP-ribose] polymerase 15 Enzyme Q460N3 PARP15 PAR15_HUMAN 4.48999977111816406 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://dx.doi.org/10.1021/acs.jmedchem.6b00990 \N INHIBITOR \N \N 629 \N Homo sapiens 215879 5201 2863 Phosphodiesterase 4 Enzyme P27815|Q07343|Q08493|Q08499 PDE4A|PDE4B|PDE4C|PDE4D PDE4A_HUMAN|PDE4B_HUMAN|PDE4C_HUMAN|PDE4D_HUMAN 6.30980396270751953 \N IC50 \N SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/20188549 http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207695s000lbl.pdf INHIBITOR \N Tclin|Tclin|Tclin|Tclin 630 631 Homo sapiens 215880 5202 679 Tyrosine-protein kinase JAK1 Kinase P23458 JAK1 JAK1_HUMAN 8.22914791107177734 \N IC50 \N SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/20363976 http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004085/WC500223723.pdf INHIBITOR \N Tclin 632 648 Homo sapiens 215881 5202 712 Tyrosine-protein kinase JAK2 Kinase O60674 JAK2 JAK2_HUMAN 8.2441253662109375 \N IC50 \N SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/20363976 http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004085/WC500223723.pdf INHIBITOR \N Tclin 632 648 Homo sapiens 215882 5202 2137 Non-receptor tyrosine-protein kinase TYK2 Kinase P29597 TYK2 TYK2_HUMAN 7.27572393417358398 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/20363976 \N INHIBITOR \N Tclin 632 \N Homo sapiens 215883 5209 387 Epidermal growth factor receptor Kinase P00533 EGFR EGFR_HUMAN 8.69896984100341797 \N IC50 \N SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/22959248 http://www.ncbi.nlm.nih.gov/pubmed/22088449 INHIBITOR \N Tclin 633 634 Homo sapiens 215884 5210 387 Epidermal growth factor receptor Kinase P00533 EGFR EGFR_HUMAN 8.03621196746826172 \N IC50 HCC827 cells expressing EGFR(DEL19) SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/27357069 http://www.ncbi.nlm.nih.gov/pubmed/27357069 INHIBITOR \N Tclin 635 635 Homo sapiens 215887 5208 36 Heat-stable enterotoxin receptor Enzyme P25092 GUCY2C GUC2C_HUMAN 6.72124624252319336 \N EC50 Stimulation of cGMP synthesis in T84 cells SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/26558155 http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208745lbl.pdf AGONIST \N Tclin 637 636 Homo sapiens 215890 4299 3496 Cytochrome P450 3A Enzyme P08684|P20815|P24462|Q9HB55 CYP3A4|CYP3A43|CYP3A5|CYP3A7 CP343_HUMAN|CP3A4_HUMAN|CP3A5_HUMAN|CP3A7_HUMAN 6.02733421325683594 \N Ki Inactivation of Human Hepatic Microsomal CYP3A-Dependent Midazolam 1'-Hydroxylase Activity SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/24900196 http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203094s005lbl.pdf INHIBITOR \N Tclin|Tclin|Tclin|Tclin 638 639 Homo sapiens 215891 5188 382 Tyrosine-protein kinase ABL1 Kinase P00519 ABL1 ABL1_HUMAN 7.51427841186523438 \N IC50 \N SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/25676420 http://www.ncbi.nlm.nih.gov/pubmed/25676420 INHIBITOR \N Tclin 640 640 Homo sapiens 215892 5211 542 Vascular endothelial growth factor receptor 2 Kinase P35968 KDR VGFR2_HUMAN 9 \N IC50 \N SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/21443688 http://www.ncbi.nlm.nih.gov/pubmed/21443688 INHIBITOR \N Tclin 641 641 Homo sapiens 215893 5211 383 Mast/stem cell growth factor receptor Kit Kinase P10721 KIT KIT_HUMAN 6.36754274368286133 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/21443688 \N INHIBITOR \N Tclin 641 \N Homo sapiens 215894 5211 540 Proto-oncogene tyrosine-protein kinase receptor Ret Kinase P07949 RET RET_HUMAN 7.88605642318725586 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/21443688 \N INHIBITOR \N Tclin 641 \N Homo sapiens 215895 5211 532 Proto-oncogene tyrosine-protein kinase Src Kinase P12931 SRC SRC_HUMAN 6.27572393417358398 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/21443688 \N INHIBITOR \N Tclin 641 \N Homo sapiens 215896 1736 2857 Muscarinic acetylcholine receptor GPCR P08172|P08173|P08912|P11229|P20309 CHRM1|CHRM2|CHRM3|CHRM4|CHRM5 ACM1_HUMAN|ACM2_HUMAN|ACM3_HUMAN|ACM4_HUMAN|ACM5_HUMAN \N \N \N \N KEGG DRUG \N 1 KEGG DRUG http://www.kegg.jp/entry/D00721 http://www.kegg.jp/entry/D00721 ANTAGONIST \N Tclin|Tclin|Tclin|Tclin|Tclin \N \N Homo sapiens 215897 2815 437 Voltage-dependent L-type calcium channel subunit alpha-1S Ion channel Q13698 CACNA1S CAC1S_HUMAN \N \N \N \N UNKNOWN \N 1 IUPHAR \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2406 BLOCKER \N Tclin \N \N Homo sapiens 215898 1545 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN \N \N \N \N KEGG DRUG \N 1 KEGG DRUG http://www.kegg.jp/entry/D01847 http://www.kegg.jp/entry/D01847 ANTAGONIST \N Tclin \N \N Homo sapiens 215899 2165 66 Prostaglandin G/H synthase 1 Enzyme P23219 PTGS1 PGH1_HUMAN \N \N \N \N KEGG DRUG \N 1 KEGG DRUG http://www.kegg.jp/entry/D08374 http://www.kegg.jp/entry/D08374 INHIBITOR \N Tclin \N \N Homo sapiens 215900 2165 56 Prostaglandin G/H synthase 2 Enzyme P35354 PTGS2 PGH2_HUMAN \N \N \N \N KEGG DRUG \N 1 KEGG DRUG http://www.kegg.jp/entry/D08374 http://www.kegg.jp/entry/D08374 INHIBITOR \N Tclin \N \N Homo sapiens 215863 5186 3726 Toxin B Enzyme P18177 toxB TOXB_CLODI 9 \N Kd \N DRUG LABEL = 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761046s000lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761046s000lbl.pdf ANTIBODY BINDING \N \N 625 625 Clostridioides difficile 215865 5183 545 Platelet-derived growth factor receptor alpha Kinase P16234 PDGFRA PGFRA_HUMAN 10.4000000000000004 \N Kd BIAcore assay IUPHAR = 1 DRUG LABEL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9172 http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761038lbl.pdf ANTIBODY BINDING \N Tclin \N 624 Homo sapiens 215866 5179 2990 Interleukin-17 receptor Membrane receptor Q8NAC3|Q96F46 IL17RA|IL17RC I17RA_HUMAN|I17RC_HUMAN 9.19999980926513672 \N Kd \N IUPHAR = 1 SCIENTIFIC LITERATURE http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7540 http://www.ncbi.nlm.nih.gov/pubmed/22455412 ANTIBODY BINDING \N Tclin|Tclin \N 626 Homo sapiens 215857 2370 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.8356471061706543 \N Kd \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/9537821 \N \N \N Tclin 623 \N Homo sapiens 215858 616 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.97469425201416016 \N Kd \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/9537821 \N \N \N Tclin 623 \N Homo sapiens 215859 616 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.84163761138916016 \N Kd \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/9537821 \N \N \N Tclin 623 \N Homo sapiens 215860 916 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.42021656036376953 \N Kd \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/9537821 \N \N \N Tclin 623 \N Homo sapiens 215861 916 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.6575775146484375 \N Kd \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/9537821 \N \N \N Tclin 623 \N Homo sapiens 215538 5174 3022 Integrin alpha-L/beta-2 Adhesion P05107|P20701 ITGAL|ITGB2 ITAL_HUMAN|ITB2_HUMAN 8.04575729370117188 \N IC50 inhibition of ICAM-1 binding to LFA-1 in HuT 78 cell line SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/24900456 http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208073s000lbl.pdf ANTAGONIST \N Tclin|Tclin 615 616 Homo sapiens 215539 5001 1769 Kappa-type opioid receptor GPCR P41144 OPRK1 OPRK_CAVPO 7.25963735580444336 \N Ki \N DRUG LABEL = \N \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206940s000lbl.pdf \N AGONIST \N \N 331 \N Cavia porcellus 215540 4374 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 7.88605642318725586 \N Ki \N DRUG LABEL = 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208524s000lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208524s000lbl.pdf AGONIST \N Tclin 617 617 Homo sapiens 215542 4374 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.83268260955810547 \N Ki \N DRUG LABEL = \N \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208524s000lbl.pdf \N \N \N Tclin 617 \N Homo sapiens 215544 4374 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 7.03621196746826172 \N Ki \N DRUG LABEL = \N \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208524s000lbl.pdf \N \N \N Tclin 617 \N Homo sapiens 215545 5176 3652 uric acid Metabolite \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125293s085lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125293s085lbl.pdf OXIDATIVE ENZYME \N \N 619 619 \N 215546 5177 2940 T-cell surface glycoprotein CD3 Surface antigen P04234|P07766|P09693 CD3D|CD3E|CD3G CD3D_HUMAN|CD3E_HUMAN|CD3G_HUMAN \N \N \N Mechanism of Action UNKNOWN \N 1 IUPHAR \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6889 ANTIBODY BINDING \N Tclin|Tclin|Tclin \N \N Homo sapiens 215547 3325 2478 G-protein coupled receptor 35 GPCR Q9HC97 GPR35 GPR35_HUMAN 8.79317378997802734 \N EC50 GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2 SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/24113750 \N AGONIST \N Tchem 620 \N Homo sapiens 215548 1889 2478 G-protein coupled receptor 35 GPCR Q9HC97 GPR35 GPR35_HUMAN 6.01322841644287109 \N EC50 GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2 SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/24113750 \N AGONIST \N Tchem 620 \N Homo sapiens 215550 4353 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 7.19381999969482422 \N Ki inhibition of [3H]-pyrilamine binding to human recombinant histamine H1-receptors SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/16274260 http://www.ncbi.nlm.nih.gov/pubmed/16274260 ANTAGONIST \N Tclin 118 118 Homo sapiens 215551 1005 125 Angiotensin-converting enzyme Enzyme P12821 ACE ACE_HUMAN 4.29999999999999982 \N IC50 \N IUPHAR = 1 IUPHAR http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6322 http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6322 INHIBITOR \N Tclin \N \N Homo sapiens 215553 1006 125 Angiotensin-converting enzyme Enzyme P12821 ACE ACE_HUMAN 7.5 \N IC50 \N IUPHAR = 1 IUPHAR http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6332 http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6332 INHIBITOR \N Tclin \N \N Homo sapiens 215555 2741 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 9.69897000399999953 \N Ki \N PDSP \N \N \N \N \N \N \N Tclin \N \N Homo sapiens 215556 621 106 Alpha-1A adrenergic receptor GPCR P35348 ADRA1A ADA1A_HUMAN 9.55284196899999927 \N Ki \N PDSP \N \N \N \N \N \N \N Tclin \N \N Homo sapiens 215557 1626 378 Melatonin receptor type 1A GPCR P48039 MTNR1A MTR1A_HUMAN 9.53760200199999986 \N Ki \N PDSP \N \N \N \N \N \N \N Tclin \N \N Homo sapiens 215558 2741 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 9.45593195600000058 \N Ki \N PDSP \N \N \N \N \N \N \N Tchem \N \N Homo sapiens 215559 623 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 9.36653154400000076 \N Ki \N PDSP \N \N \N \N \N \N \N Tclin \N \N Homo sapiens 215560 623 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 9.19382002599999915 \N Ki \N PDSP \N \N \N \N \N \N \N Tchem \N \N Homo sapiens 215561 1211 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 9.06550154900000038 \N Ki \N PDSP \N \N \N \N \N \N \N Tclin \N \N Homo sapiens 215562 403 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN 8.85999999999999943 \N Ki \N PDSP \N \N \N \N \N \N \N Tclin \N \N Homo sapiens 215563 820 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 8.85387196399999965 \N Ki \N PDSP \N \N \N \N \N \N \N Tclin \N \N Homo sapiens 215564 1211 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 8.795880017 \N Ki \N PDSP \N \N \N \N \N \N \N Tchem \N \N Homo sapiens 215565 2332 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 8.72124639899999998 \N Ki \N PDSP \N \N \N \N \N \N \N Tclin \N \N Homo sapiens 215566 820 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 8.69897000399999953 \N Ki \N PDSP \N \N \N \N \N \N \N Tclin \N \N Homo sapiens 215567 3201 1208 Glutamate receptor ionotropic, kainate 4 Ion channel Q16099 GRIK4 GRIK4_HUMAN 8.64016451800000063 \N Ki \N PDSP \N \N \N \N \N \N \N Tclin \N \N Homo sapiens 215568 2741 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 8.45593195600000058 \N Ki \N PDSP \N \N \N \N \N \N \N Tclin \N \N Homo sapiens 215571 1707 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 8.2757241300000004 \N Ki \N PDSP \N \N \N \N \N \N \N Tclin \N \N Homo sapiens 215572 2723 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN 8.27002571400000086 \N Ki \N PDSP \N \N \N \N \N \N \N Tclin \N \N Homo sapiens 215573 1707 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 8.25181197300000058 \N Ki \N PDSP \N \N \N \N \N \N \N Tclin \N \N Homo sapiens 215574 751 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 8.22184874999999948 \N Ki \N PDSP \N \N \N \N \N \N \N Tclin \N \N Homo sapiens 215575 4115 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 8.18708664300000066 \N Ki \N PDSP \N \N \N \N \N \N \N Tclin \N \N Homo sapiens 215576 2346 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 8.1249387370000008 \N Ki \N PDSP \N \N \N \N \N \N \N Tclin \N \N Homo sapiens 215577 1707 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 7.95860731500000007 \N Ki \N PDSP \N \N \N \N \N \N \N Tclin \N \N Homo sapiens 215107 4399 2683 Thrombopoietin receptor Membrane receptor P40238 MPL TPOR_HUMAN 7.41999999999999993 \N EC50 \N IUPHAR = 1 IUPHAR http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6961 http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6961 AGONIST \N Tclin \N \N Homo sapiens 215118 5137 3024 Interferon alpha/beta receptor Membrane receptor P17181|P48551 IFNAR1|IFNAR2 INAR1_HUMAN|INAR2_HUMAN \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125499s009lbl.pdf AGONIST \N Tclin|Tclin \N 586 Homo sapiens 215119 5139 3024 Interferon alpha/beta receptor Membrane receptor P17181|P48551 IFNAR1|IFNAR2 INAR1_HUMAN|INAR2_HUMAN \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103628s5258lbl.pdf AGONIST \N Tclin|Tclin \N 587 Homo sapiens 215120 5140 3024 Interferon alpha/beta receptor Membrane receptor P17181|P48551 IFNAR1|IFNAR2 INAR1_HUMAN|INAR2_HUMAN \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103471s5188lbl.pdf AGONIST \N Tclin|Tclin \N 588 Homo sapiens 215121 5141 334 Plasminogen Enzyme P00747 PLG PLMN_HUMAN \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103172s5203lbl.pdf ACTIVATOR \N Tclin \N 589 Homo sapiens 215122 5142 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 9.30000019073486328 \N Ki 1 nM [3H]ketanserin binding in cell membranes SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/16469866 http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207318lbl.pdf INVERSE AGONIST \N Tclin 590 591 Homo sapiens 215123 5142 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 8.80000019073486328 \N Ki 3 nM [3H]mesulergine binding in cell membranes SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/16469866 \N INVERSE AGONIST \N Tclin 590 \N Homo sapiens 215124 5143 632 Catechol O-methyltransferase Enzyme P21964 COMT COMT_HUMAN 9 \N Ki \N SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/24847974 http://www.ncbi.nlm.nih.gov/pubmed/24847974 INHIBITOR \N Tclin 592 592 Homo sapiens 215128 5149 337 Lutropin-choriogonadotropic hormone receptor GPCR P22888 LHCGR LSHR_HUMAN \N \N \N \N CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201464 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201464 AGONIST \N Tclin \N \N Homo sapiens 215129 1867 3702 Serine protease hepsin Enzyme P05981 HPN HEPS_HUMAN 9.27999973297119141 \N Ki \N CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL273264 \N \N \N Tchem \N \N Homo sapiens 215130 1867 3708 Hepatocyte growth factor activator Enzyme Q04756 HGFAC HGFA_HUMAN 7.59999990463256836 \N Ki \N CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL273264 \N \N \N Tchem \N \N Homo sapiens 215134 1996 3715 Monoacylglycerol lipase ABHD6 Enzyme Q9BV23 ABHD6 ABHD6_HUMAN 7.32000017166137695 \N IC50 \N CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175247 \N \N \N Tchem \N \N Homo sapiens 215136 2073 3711 Folate receptor alpha Membrane receptor P15328 FOLR1 FOLR1_HUMAN 7.38000011444091797 \N IC50 \N CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225072 \N \N \N Tchem \N \N Homo sapiens 215139 2172 3716 Ubiquitin carboxyl-terminal hydrolase 1 Enzyme O94782 USP1 UBP1_HUMAN 5.69999980926513672 \N IC50 \N CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1423 \N \N \N Tchem \N \N Homo sapiens 215140 2353 3711 Folate receptor alpha Membrane receptor P15328 FOLR1 FOLR1_HUMAN 7.82000017166137695 \N IC50 \N CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225071 \N \N \N Tchem \N \N Homo sapiens 215141 2448 3717 Dipeptidyl peptidase 2 Enzyme Q9UHL4 DPP7 DPP2_HUMAN 4.21999979019165039 \N IC50 \N CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1422 \N \N \N Tchem \N \N Homo sapiens 215142 2452 3718 Myeloblastin Unclassified P24158 PRTN3 PRTN3_HUMAN 6.46999979019165039 \N IC50 \N CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76688 \N \N \N Tchem \N \N Homo sapiens 215143 2697 3707 Krueppel-like factor 10 Unclassified Q13118 KLF10 KLF10_HUMAN 4.30000019073486328 \N IC50 \N CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1324 \N \N \N Tbio \N \N Homo sapiens 215144 5110 3719 Alpha-galactosidase A Enzyme P06280 GLA AGAL_HUMAN 7.15000009536743164 \N IC50 \N CHEMBL = 1 DRUG LABEL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL110458 http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004059/WC500208434.pdf PHARMACOLOGICAL CHAPERONE \N Tclin \N 598 Homo sapiens 215098 5133 525 Apoptosis regulator Bcl-2 Cytosolic other P10415 BCL2 BCL2_HUMAN 11 \N Ki Mechanism of Action SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/23291630 http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208573s000lbl.pdf INHIBITOR \N Tclin 583 584 Homo sapiens 215099 5133 861 Bcl-2-like protein 1 Cytosolic other Q07817 BCL2L1 B2CL1_HUMAN 7.31875896453857422 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/23291630 \N INHIBITOR \N Tchem 583 \N Homo sapiens 215100 5133 3486 Apoptosis regulator Bcl-W Cytosolic other Q92843 BCL2L2 B2CL2_HUMAN 6.61083412170410156 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/23291630 \N INHIBITOR \N Tchem 583 \N Homo sapiens 215102 2407 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 8.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=941 \N AGONIST \N Tclin \N \N Homo sapiens 215104 2407 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 10.2200000000000006 \N Ki \N IUPHAR = 1 IUPHAR http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=941 http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=941 AGONIST \N Tclin \N \N Homo sapiens 215105 2407 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 5.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=941 \N AGONIST \N Tclin \N \N Homo sapiens 215106 5135 6 DNA DNA \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/103532s5175lbl.pdf HYDROLYTIC ENZYME \N \N \N 585 \N 189280 1892 6 DNA DNA \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021877s005lbl.pdf OTHER \N \N \N 452 \N 215031 5082 3690 aspargine Amino acid \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/103411s5180lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/103411s5180lbl.pdf HYDROLYTIC ENZYME \N \N 531 531 \N 215032 5080 2544 Genome polyprotein Polyprotein P27958 \N POLG_HCVH 11.3979396820068359 \N EC50 Mechanism of Action DRUG LABEL = 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208261Orig1s000lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208261Orig1s000lbl.pdf INHIBITOR \N \N 532 532 Hepatitis C virus genotype 1a (isolate H) 215033 5080 2536 Genome polyprotein Polyprotein P26663 \N POLG_HCVBK 11.5228786468505859 \N EC50 Mechanism of Action DRUG LABEL = 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208261Orig1s000lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208261Orig1s000lbl.pdf INHIBITOR \N \N 532 532 Hepatitis C virus genotype 1b (isolate BK) 215034 5080 3694 Genome polyprotein Polyprotein O39929 \N POLG_HCVED 12.5228786468505859 \N EC50 Mechanism of Action DRUG LABEL = 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208261Orig1s000lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208261Orig1s000lbl.pdf INHIBITOR \N \N 532 532 Hepatitis C virus genotype 4a (isolate ED43) 215035 5081 2544 Genome polyprotein Polyprotein P27958 \N POLG_HCVH 12.3979396820068359 \N EC50 Mechanism of Action DRUG LABEL = 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208261Orig1s000lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208261Orig1s000lbl.pdf INHIBITOR \N \N 532 532 Hepatitis C virus genotype 1a (isolate H) 215036 5081 2536 Genome polyprotein Polyprotein P26663 \N POLG_HCVBK 12.301030158996582 \N EC50 Mechanism of Action DRUG LABEL = 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208261Orig1s000lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208261Orig1s000lbl.pdf INHIBITOR \N \N 532 532 Hepatitis C virus genotype 1b (isolate BK) 215037 5081 3694 Genome polyprotein Polyprotein O39929 \N POLG_HCVED 12.5228786468505859 \N EC50 Mechanism of Action DRUG LABEL = 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208261Orig1s000lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208261Orig1s000lbl.pdf INHIBITOR \N \N 532 532 Hepatitis C virus genotype 4a (isolate ED43) 215038 2345 237 Progesterone receptor Nuclear hormone receptor P06401 PGR PRGR_HUMAN \N \N \N Mechanism of Action KEGG DRUG \N 1 KEGG DRUG http://www.kegg.jp/entry/D05679 http://www.kegg.jp/entry/D05679 AGONIST \N Tclin \N \N Homo sapiens 215040 4867 2752 Potassium-transporting ATPase Transporter P20648|P51164 ATP4A|ATP4B ATP4A_HUMAN|ATP4B_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/2154989 http://www.ncbi.nlm.nih.gov/pubmed/2154989 INHIBITOR \N Tclin|Tclin 536 536 Homo sapiens 215042 3961 2752 Potassium-transporting ATPase Transporter P20648|P51164 ATP4A|ATP4B ATP4A_HUMAN|ATP4B_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/11304936 http://www.ncbi.nlm.nih.gov/pubmed/11304936 INHIBITOR \N Tclin|Tclin 537 537 Homo sapiens 215044 642 2921 Voltage-gated L-type calcium channel Ion channel Q01668|Q13936 CACNA1C|CACNA1D CAC1C_HUMAN|CAC1D_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/9298526 http://www.ncbi.nlm.nih.gov/pubmed/9298526 BLOCKER \N Tclin|Tclin 539 539 Homo sapiens 215046 727 16 bile acids Metabolite \N \N \N \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/4859983 http://www.ncbi.nlm.nih.gov/pubmed/4859983 CHELATING AGENT \N \N 541 541 \N 215047 837 2921 Voltage-gated L-type calcium channel Ion channel Q01668|Q13936 CACNA1C|CACNA1D CAC1C_HUMAN|CAC1D_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/2547493 http://www.ncbi.nlm.nih.gov/pubmed/2547493 BLOCKER \N Tclin|Tclin 543 543 Homo sapiens 215048 927 251 Acetylcholinesterase Enzyme P22303 ACHE ACES_HUMAN \N \N \N Mechanism of Action KEGG DRUG \N 1 KEGG DRUG http://www.kegg.jp/entry/D01228 http://www.kegg.jp/entry/D01228 INHIBITOR \N Tclin \N \N Homo sapiens 215049 1631 2921 Voltage-gated L-type calcium channel Ion channel Q01668|Q13936 CACNA1C|CACNA1D CAC1C_HUMAN|CAC1D_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/8287905 BLOCKER \N Tclin|Tclin \N 544 Homo sapiens 215051 1934 2921 Voltage-gated L-type calcium channel Ion channel Q01668|Q13936 CACNA1C|CACNA1D CAC1C_HUMAN|CAC1D_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/7898101 BLOCKER \N Tclin|Tclin \N 545 Homo sapiens 215052 2960 3695 Nucleotide-binding oligomerization domain-containing protein 2 Cytosolic other Q9HC29 NOD2 NOD2_HUMAN \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000802/WC500026565.pdf http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000802/WC500026565.pdf ACTIVATOR \N Tclin 546 546 Homo sapiens 215054 1763 2 iron Inorganic material \N \N \N \N \N \N Mechanism of Action (Fe3+ >> Fe2+) SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/10533013 http://www.ncbi.nlm.nih.gov/pubmed/10533013 OTHER \N \N 548 548 \N 215063 4099 2921 Voltage-gated L-type calcium channel Ion channel Q01668|Q13936 CACNA1C|CACNA1D CAC1C_HUMAN|CAC1D_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/17213004 http://www.ncbi.nlm.nih.gov/pubmed/17213004 BLOCKER \N Tclin|Tclin 552 552 Homo sapiens 214976 5066 334 Plasminogen Enzyme P00747 PLG PLMN_HUMAN \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL \N http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/UCM200875.pdf ACTIVATOR \N Tclin \N 477 Homo sapiens 214977 5067 2484 Proteasome subunit beta type-5 Enzyme P28074 PSMB5 PSB5_HUMAN 8.4685211181640625 \N IC50 \N SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/20160034 http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/208462lbl.pdf INHIBITOR \N Tclin 479 478 Homo sapiens 214978 5067 2483 Proteasome subunit beta type-2 Enzyme P49721 PSMB2 PSB2_HUMAN 5.4559321403503418 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/20160034 \N INHIBITOR \N Tclin 479 \N Homo sapiens 214979 5067 2482 Proteasome subunit beta type-1 Enzyme P20618 PSMB1 PSB1_HUMAN 7.50863838195800781 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/20160034 \N INHIBITOR \N Tclin 479 \N Homo sapiens 214980 5068 1364 Synaptic vesicle glycoprotein 2A Transporter Q7L0J3 SV2A SV2A_HUMAN 7.09999990463256836 \N Ki \N SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/18500360 http://www.ncbi.nlm.nih.gov/pubmed/18500360 MODULATOR \N Tclin 480 480 Homo sapiens 189242 5031 1720 C-C chemokine receptor type 4 GPCR P51679 CCR4 CCR4_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/22686619 ANTIBODY BINDING \N Tclin \N 435 Homo sapiens 214981 5063 3575 Lymphocyte differentiation antigen CD38 Tumour-associated antigen P28907 CD38 CD38_HUMAN 8.22000000000000064 \N Kd \N IUPHAR = 1 DRUG LABEL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7395 http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/761036Orig1s000lbledt.pdf ANTIBODY BINDING \N Tclin \N 481 Homo sapiens 214982 5070 3690 aspargine Amino acid \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/101063s5169lbl.pdf HYDROLYTIC ENZYME \N \N \N 482 \N 214983 5071 387 Epidermal growth factor receptor Kinase P00533 EGFR EGFR_HUMAN \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125547s000lbl.pdf ANTIBODY BINDING \N Tclin \N 483 Homo sapiens 214984 2437 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/1982751 ANTAGONIST \N Tclin \N 485 Homo sapiens 214985 3579 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/13499132 ANTAGONIST \N Tclin \N 487 Homo sapiens 214986 1852 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/13757612 ANTAGONIST \N Tclin \N 488 Homo sapiens 214987 2131 313 Amine oxidase [flavin-containing] A Enzyme P21397 MAOA AOFA_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/17404836 INHIBITOR \N Tclin \N 489 Homo sapiens 214988 2131 286 Amine oxidase [flavin-containing] B Enzyme P27338 MAOB AOFB_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/17404836 INHIBITOR \N Tclin \N 489 Homo sapiens 214990 4865 313 Amine oxidase [flavin-containing] A Enzyme P21397 MAOA AOFA_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/5889715 INHIBITOR \N Tclin \N 490 Homo sapiens 214992 4865 286 Amine oxidase [flavin-containing] B Enzyme P27338 MAOB AOFB_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/5889715 INHIBITOR \N Tclin \N 490 Homo sapiens 214993 2152 137 Sodium channel protein type 1 subunit alpha Ion channel P35498 SCN1A SCN1A_HUMAN \N \N \N Mechanism of Action CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16 BLOCKER \N Tclin \N \N Homo sapiens 214994 2152 139 Sodium channel protein type 3 subunit alpha Ion channel Q9NY46 SCN3A SCN3A_HUMAN \N \N \N Mechanism of Action CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16 BLOCKER \N Tclin \N \N Homo sapiens 214995 2152 141 Sodium channel protein type 8 subunit alpha Ion channel Q9UQD0 SCN8A SCN8A_HUMAN \N \N \N Mechanism of Action CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16 BLOCKER \N Tclin \N \N Homo sapiens 214996 2152 142 Sodium channel protein type 9 subunit alpha Ion channel Q15858 SCN9A SCN9A_HUMAN \N \N \N Mechanism of Action CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16 BLOCKER \N Tclin \N \N Homo sapiens 214997 5072 3691 SLAM family member 7 Membrane receptor Q9NQ25 SLAMF7 SLAF7_HUMAN \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/761035s000lbl.pdf ANTIBODY BINDING \N Tclin \N 493 Homo sapiens 214998 934 2311 Transient receptor potential cation channel subfamily M member 8 Ion channel Q7Z2W7 TRPM8 TRPM8_HUMAN 4.59999999999999964 \N EC50 \N IUPHAR = 1 SCIENTIFIC LITERATURE http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2430 http://www.ncbi.nlm.nih.gov/pubmed/15306801 ACTIVATOR \N Tclin \N 494 Homo sapiens 215000 2291 445 Potassium voltage-gated channel subfamily A member 5 Ion channel P22460 KCNA5 KCNA5_HUMAN 4.40000000000000036 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2561 \N BLOCKER \N Tclin \N \N Homo sapiens 215001 839 2 iron Inorganic material \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020212s017lbl.pdf CHELATING AGENT \N \N \N 500 \N 215002 4937 540 Proto-oncogene tyrosine-protein kinase receptor Ret Kinase P07949 RET RET_HUMAN 8.31875896453857422 \N IC50 time-resolved fluorescence resonance energy transfer assay to examine each compound’s ability to phosphorylate substrate peptide Biotin-EGPWLEEEEEAYGWMDF in the presence of the drug and 30 umol/L ATP SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/25349307 http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/208434s000lbl.pdf INHIBITOR \N Tclin 504 503 Homo sapiens 215003 5077 341 Prostacyclin receptor GPCR P43119 PTGIR PI2R_HUMAN 7.69896984100341797 \N Ki \N SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/26291199 http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207947s000lbl.pdf AGONIST \N Tclin 506 507 Homo sapiens 189273 2206 313 Amine oxidase [flavin-containing] A Enzyme P21397 MAOA AOFA_HUMAN 7.408935546875 \N Ki Monoamine oxidase A (human liver form) inhibitor induced spectral changes SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/12781338 http://www.ncbi.nlm.nih.gov/pubmed/9368911 INHIBITOR \N Tclin 445 444 Homo sapiens 189274 5046 1728 Dual specificity mitogen-activated protein kinase kinase 1 Kinase Q02750 MAP2K1 MP2K1_HUMAN 9.04575729370117188 \N IC50 \N SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/24900486 http://www.ncbi.nlm.nih.gov/pubmed/22084396 INHIBITOR \N Tclin 446 456 Homo sapiens 189275 5047 371 Peroxisome proliferator-activated receptor alpha Nuclear hormone receptor Q07869 PPARA PPARA_HUMAN 9.18708705902099609 \N EC50 PPRE-luc transactivation assay in HepG2 cells transfected with hPPAR-alpha and hPPAR-gamma receptors SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/26171220 http://www.ncbi.nlm.nih.gov/pubmed/26171220 AGONIST \N Tclin 448 448 Homo sapiens 189276 5047 395 Peroxisome proliferator-activated receptor gamma Nuclear hormone receptor P37231 PPARG PPARG_HUMAN 8.52287864685058594 \N EC50 PPRE-luc transactivation assay in HepG2 cells transfected with hPPAR-alpha and hPPAR-gamma receptors SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/26171220 http://www.ncbi.nlm.nih.gov/pubmed/26171220 AGONIST \N Tclin 448 448 Homo sapiens 189277 5048 788 Histamine H3 receptor GPCR Q9Y5N1 HRH3 HRH3_HUMAN 9.79588031768798828 \N Ki [35S]GTP-gamma-S binding in HEK-293 cells stably expressing the human H3 SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/17005916 http://www.ncbi.nlm.nih.gov/pubmed/21615387 INVERSE AGONIST \N Tclin 449 450 Homo sapiens 189278 5051 3668 collagen Metabolite \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125338s085s087s088lbl.pdf HYDROLYTIC ENZYME \N \N \N 451 \N 189281 5052 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 9.4685211181640625 \N Ki Mechanism of Action DRUG LABEL = 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207533s000lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207533s000lbl.pdf PARTIAL AGONIST \N Tclin 454 454 Homo sapiens 189282 5052 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 8.76955127716064453 \N Ki Mechanism of Action DRUG LABEL = 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207533s000lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207533s000lbl.pdf PARTIAL AGONIST \N Tclin 454 454 Homo sapiens 189284 5052 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 8.4685211181640625 \N Ki Mechanism of Action DRUG LABEL = 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207533s000lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207533s000lbl.pdf ANTAGONIST \N Tclin 454 454 Homo sapiens 189285 5052 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 9.09691047668457031 \N Ki \N DRUG LABEL = \N \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207533s000lbl.pdf \N \N \N Tclin 454 \N Homo sapiens 189286 5052 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 7.35654735565185547 \N Ki \N DRUG LABEL = \N \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207533s000lbl.pdf \N \N \N Tchem 454 \N Homo sapiens 189287 5052 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 7.82390880584716797 \N Ki \N DRUG LABEL = \N \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207533s000lbl.pdf \N \N \N Tclin 454 \N Homo sapiens 189289 5052 105 5-hydroxytryptamine receptor 7 GPCR P34969 HTR7 5HT7R_HUMAN 7.408935546875 \N Ki \N DRUG LABEL = \N \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207533s000lbl.pdf \N \N \N Tclin 454 \N Homo sapiens 189290 5052 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 7.21467018127441406 \N Ki \N DRUG LABEL = \N \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207533s000lbl.pdf \N \N \N Tclin 454 \N Homo sapiens 189292 999 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 8.88605690002441406 \N Ki Mechanism of Action DRUG LABEL = 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20706slr011_emadine_lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20706slr011_emadine_lbl.pdf ANTAGONIST \N Tclin 457 457 Homo sapiens 189294 5054 550 Dipeptidyl peptidase 4 Enzyme P27487 DPP4 DPP4_HUMAN 9.09691047668457031 \N Ki Mechanism of Action SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/24660890 http://www.ncbi.nlm.nih.gov/pubmed/24660890 INHIBITOR \N Tclin 458 458 Homo sapiens 189295 5056 3669 potassium Inorganic material \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205739s000lbl.pdf CHELATING AGENT \N \N \N 459 \N 189296 5057 620 Insulin receptor Kinase P06213 INSR INSR_HUMAN \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021629s030lbl.pdf AGONIST \N Tclin \N 462 Homo sapiens 189222 5022 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 9 \N Ki \N SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/12177684 http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022526lbl.pdf AGONIST \N Tclin 416 417 Homo sapiens 189223 5022 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 7.30980396270751953 \N Ki \N SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/12177684 http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022526lbl.pdf ANTAGONIST \N Tclin 416 417 Homo sapiens 189224 5022 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 8.39793968200683594 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/12177684 \N ANTAGONIST \N Tchem 416 \N Homo sapiens 189225 5022 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 6.51570034027099609 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/12177684 \N \N \N Tclin 416 \N Homo sapiens 189227 5022 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 6.43889856338500977 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/12177684 \N \N \N Tclin 416 \N Homo sapiens 189230 5022 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 7.0491485595703125 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/20840530 \N ANTAGONIST \N Tclin 418 \N Homo sapiens 189231 5022 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 7.05403947830200195 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/20840530 \N ANTAGONIST \N Tclin 418 \N Homo sapiens 189232 5022 284 5-hydroxytryptamine receptor 5A GPCR P47898 HTR5A 5HT5A_HUMAN 6.09258842468261719 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/20840530 \N \N \N Tchem 418 \N Homo sapiens 189233 4496 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 9.33999999999999986 \N Ki Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay CHEMBL = 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200986 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200986 INVERSE AGONIST \N Tclin \N \N Homo sapiens 189235 626 221 Calcium-activated potassium channel subunit alpha-1 Ion channel Q12791 KCNMA1 KCMA1_HUMAN 4.52287864685058594 \N EC50 Chlorzoxazone-stimulated activity of BK(Ca) channels in neuroblastoma IMR-32 cells SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/12480161 http://www.ncbi.nlm.nih.gov/pubmed/12480161 OPENER \N Tclin 423 423 Homo sapiens 189236 5026 3005 Interleukin-11 receptor Membrane receptor P40189|Q14626 IL11RA|IL6ST I11RA_HUMAN|IL6RB_HUMAN \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/103694s1008lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/103694s1008lbl.pdf AGONIST \N Tclin|Tclin 425 425 Homo sapiens 189237 5027 417 Substance-P receptor GPCR P25103 TACR1 NK1R_HUMAN 9.18045616149902344 \N Ki CHO cells expressing the human NK1 receptor SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/22497992 http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206500s000lbl.pdf ANTAGONIST \N Tclin 430 431 Homo sapiens 189238 5028 3660 Triglycerides Metabolite \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL \N http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004004/WC500192715.pdf HYDROLYTIC ENZYME \N \N \N 432 \N 189239 5028 3659 Cholesteryl esters Metabolite \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL \N http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004004/WC500192715.pdf HYDROLYTIC ENZYME \N \N \N 432 \N 189240 5025 3003 Granulocyte macrophage colony-stimulating factor receptor Membrane receptor P15509|P32927 CSF2RA|CSF2RB CSF2R_HUMAN|IL3RB_HUMAN 8.30103015899658203 \N Kd Mechanism of Action SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/2001448 http://www.ncbi.nlm.nih.gov/pubmed/2001448 AGONIST \N Tclin|Tclin 433 433 Homo sapiens 189241 5030 3662 glycogen Metabolite \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125141s219lbl.pdf HYDROLYTIC ENZYME \N \N \N 434 \N 189243 5033 3663 hyaluronic acid Metabolite \N \N \N \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021665s005lbl.pdf HYDROLYTIC ENZYME \N \N \N 436 \N 189244 4731 2760 GABA A receptor alpha-2/beta-2/gamma-2 Ion channel P18507|P47869|P47870 GABRA2|GABRB2|GABRG2 GBRA2_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN 6.88605642318725586 \N IC50 inhibition of GABA-induced Cl- current in human GABAA receptor expressed in Xenopus oocytes SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/17234181 \N NEGATIVE MODULATOR \N Tclin|Tclin|Tclin 437 \N Homo sapiens 189245 4731 2804 GABA A receptor alpha-1/beta-1/gamma-2 Ion channel P14867|P18505|P18507 GABRA1|GABRB1|GABRG2 GBRA1_HUMAN|GBRB1_HUMAN|GBRG2_HUMAN 6.82390880584716797 \N IC50 inhibition of GABA-induced Cl- current in human GABAA receptor expressed in Xenopus oocytes SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/17234181 \N NEGATIVE MODULATOR \N Tclin|Tclin|Tclin 437 \N Homo sapiens 189246 4731 2731 GABA-A receptor alpha-1/beta-2/gamma-2 Ion channel P14867|P18507|P47870 GABRA1|GABRB2|GABRG2 GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN 6.69896984100341797 \N IC50 inhibition of GABA-induced Cl- current in human GABAA receptor expressed in Xenopus oocytes SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/17234181 \N NEGATIVE MODULATOR \N Tclin|Tclin|Tclin 437 \N Homo sapiens 189247 1739 2731 GABA-A receptor alpha-1/beta-2/gamma-2 Ion channel P14867|P18507|P47870 GABRA1|GABRB2|GABRG2 GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN 4.40999984741210938 \N EC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/26056160 \N POSITIVE ALLOSTERIC MODULATOR \N Tclin|Tclin|Tclin 438 \N Homo sapiens 189248 1739 2738 GABA-A receptor alpha-1/beta-3/gamma-2 Ion channel P14867|P18507|P28472 GABRA1|GABRB3|GABRG2 GBRA1_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN 4.51999998092651367 \N EC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/26056160 \N POSITIVE ALLOSTERIC MODULATOR \N Tclin|Tclin|Tclin 438 \N Homo sapiens 189249 1739 2760 GABA A receptor alpha-2/beta-2/gamma-2 Ion channel P18507|P47869|P47870 GABRA2|GABRB2|GABRG2 GBRA2_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN 4.6100001335144043 \N EC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/26056160 \N POSITIVE ALLOSTERIC MODULATOR \N Tclin|Tclin|Tclin 438 \N Homo sapiens 189250 1739 2793 GABA A receptor alpha-3/beta-2/gamma-2 Ion channel P18507|P34903|P47870 GABRA3|GABRB2|GABRG2 GBRA3_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN 4.30999994277954102 \N EC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/26056160 \N POSITIVE ALLOSTERIC MODULATOR \N Tclin|Tclin|Tclin 438 \N Homo sapiens 189251 1739 2796 GABA A receptor alpha-4/beta-2/delta Ion channel O14764|P47870|P48169 GABRA4|GABRB2|GABRD GBRA4_HUMAN|GBRB2_HUMAN|GBRD_HUMAN 4.17000007629394531 \N EC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/26056160 \N POSITIVE ALLOSTERIC MODULATOR \N Tclin|Tclin|Tclin 438 \N Homo sapiens 189252 1739 3664 GABA A receptor alpha-4/beta-3/delta Ion channel O14764|P28472|P48169 GABRA4|GABRB3|GABRD GBRA4_HUMAN|GBRB3_HUMAN|GBRD_HUMAN 3.91000008583068848 \N EC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/26056160 \N AGONIST \N Tclin|Tclin|Tclin 438 \N Homo sapiens 189208 2738 3 copper Inorganic material \N \N \N \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/6121964 http://www.ncbi.nlm.nih.gov/pubmed/6121964 CHELATING AGENT \N \N 398 398 \N 189209 5016 3654 Proprotein convertase subtilisin/kexin type 9 Enzyme Q8NBP7 PCSK9 PCSK9_HUMAN 9.41999999999999993 \N Kd \N IUPHAR = 1 DRUG LABEL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6744 http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125559Orig1s000lbl.pdf INHIBITOR \N Tclin \N 403 Homo sapiens 189210 5017 3011 Interleukin-1 receptor, type I Membrane receptor P14778|Q9NPH3 IL1R1|IL1RAP IL1AP_HUMAN|IL1R1_HUMAN 7.82000017166137695 \N Kd Mechanism of Action IUPHAR = 1 DRUG LABEL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6972 http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/103950s5150lbl.pdf ANTAGONIST \N Tclin|Tclin \N 402 Homo sapiens 189211 5018 3658 globotriaosylceramide (GL-3) Metabolite \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/103979s5135lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/103979s5135lbl.pdf HYDROLYTIC ENZYME \N \N 405 405 \N 189213 4002 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE CAROPPO, R, EFFECT OF NIPEROTIDINE ON HYDROGEN-ION SECRETION AND ELECTRICAL PARAMETERS OF ISOLATED ASTRIC-MUCOSA, Curr. Ther. Res.-Clin. Exp., 1990, 48, 1, 20-29 CAROPPO, R, EFFECT OF NIPEROTIDINE ON HYDROGEN-ION SECRETION AND ELECTRICAL PARAMETERS OF ISOLATED ASTRIC-MUCOSA, Curr. Ther. Res.-Clin. Exp., 1990, 48, 1, 20-29 ANTAGONIST \N Tclin 406 406 Homo sapiens 189214 4945 607 Gastrin/cholecystokinin type B receptor GPCR P32239 CCKBR GASR_HUMAN 8.80000000000000071 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3551 \N AGONIST \N Tclin \N \N Homo sapiens 189216 5021 3658 globotriaosylceramide (GL-3) Metabolite \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000369/WC500053612.pdf http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000369/WC500053612.pdf HYDROLYTIC ENZYME \N \N 407 407 \N 189217 1394 366 Trace amine-associated receptor 1 GPCR Q96RJ0 TAAR1 TAAR1_HUMAN 5.52870845794677734 \N EC50 (S) enantiomer activation of hTAAR1 in RD-HGA16 cells SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/22037049 http://www.ncbi.nlm.nih.gov/pubmed/22037049 AGONIST \N Tclin 409 409 Homo sapiens 189219 195 366 Trace amine-associated receptor 1 GPCR Q96RJ0 TAAR1 TAAR1_HUMAN 6.22184896469116211 \N EC50 (S) enantiomer activation of hTAAR1 in RD-HGA16 cells SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/22037049 \N AGONIST \N Tclin 409 \N Homo sapiens 189221 2105 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 6.46999979019165039 \N Ki \N SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/20600305 http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/19385slr030,031,035_permax_lbl.pdf AGONIST \N Tclin 395 413 Homo sapiens 189187 5012 384 Neprilysin Enzyme P08473 MME NEP_HUMAN \N \N \N \N UNKNOWN \N 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207620Orig1s000lbl.pdf INHIBITOR \N Tclin \N 384 Homo sapiens 189188 5013 550 Dipeptidyl peptidase 4 Enzyme P27487 DPP4 DPP4_HUMAN 8.39793968200683594 \N IC50 \N SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/21186796 http://www.ncbi.nlm.nih.gov/pubmed/26115728 INHIBITOR \N Tclin 386 387 Homo sapiens 189190 2697 632 Catechol O-methyltransferase Enzyme P21964 COMT COMT_HUMAN 9.56863594055175781 \N Ki \N SCIENTIFIC LITERATURE = 1 CHEMBL http://www.ncbi.nlm.nih.gov/pubmed/7703232 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1324 INHIBITOR \N Tclin 389 \N Homo sapiens 189192 1018 632 Catechol O-methyltransferase Enzyme P21964 COMT COMT_HUMAN 9.52287864685058594 \N Ki \N SCIENTIFIC LITERATURE = 1 CHEMBL http://www.ncbi.nlm.nih.gov/pubmed/7703232 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL953 INHIBITOR \N Tclin 389 \N Homo sapiens 189193 1431 344 Farnesyl pyrophosphate synthase Enzyme P14324 FDPS FPPS_HUMAN 7.52287864685058594 \N IC50 inhibition of human recombinant FPP synthase SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/11160603 http://www.ncbi.nlm.nih.gov/pubmed/11160603 INHIBITOR \N Tclin 390 390 Homo sapiens 189194 5014 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 9.52287864685058594 \N Ki \N SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/24947465 http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205422s000lbl.pdf AGONIST \N Tclin 391 392 Homo sapiens 189195 5014 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 8.95860767364501953 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/24947465 \N AGONIST \N Tclin 391 \N Homo sapiens 189196 5014 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 9.92081832885742188 \N Ki \N SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/24947465 http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205422s000lbl.pdf AGONIST \N Tclin 391 392 Homo sapiens 189198 5014 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 9.32790184020996094 \N Ki \N SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/24947465 http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205422s000lbl.pdf ANTAGONIST \N Tclin 391 392 Homo sapiens 189199 5014 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 8.72124671936035156 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/24947465 \N ANTAGONIST \N Tclin 391 \N Homo sapiens 189200 5014 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN 9.76955127716064453 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/24947465 \N ANTAGONIST \N Tclin 391 \N Homo sapiens 189201 5014 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 9.22914791107177734 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/24947465 \N ANTAGONIST \N Tclin 391 \N Homo sapiens 189202 5014 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 7.72124624252319336 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/24947465 \N ANTAGONIST \N Tclin 391 \N Homo sapiens 189204 5014 105 5-hydroxytryptamine receptor 7 GPCR P34969 HTR7 5HT7R_HUMAN 8.43179798126220703 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/24947465 \N ANTAGONIST \N Tclin 391 \N Homo sapiens 189205 5014 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 8.58502674102783203 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/24947465 \N ANTAGONIST \N Tclin 391 \N Homo sapiens 189206 5015 2710 Growth hormone receptor GPCR P10912 GHR GHR_HUMAN \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021106s036lbl.pdf ANTAGONIST \N Tclin \N 393 Homo sapiens 189118 1293 719 Dihydropyrimidine dehydrogenase [NADP(+)] Enzyme Q12882 DPYD DPYD_HUMAN 6.63827228546142578 \N Ki Mechanism of Action SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/3114201 http://www.ncbi.nlm.nih.gov/pubmed/21668582 INHIBITOR \N Tclin 280 279 Homo sapiens 189119 2002 3650 Uridine 5'-monophosphate synthase Enzyme P11172 UMPS UMPS_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/8862723 http://www.ncbi.nlm.nih.gov/pubmed/8862723 INHIBITOR \N Tclin 281 281 Homo sapiens 189120 4172 2926 Hepatitis C virus serine protease, NS3/NS4A Enzyme A3EZI9|D2K2A8 NS3|NS4A A3EZI9_9HEPC|D2K2A8_9HEPC 8.95860767364501953 \N Ki Inhibition of HCV 1a NS3/4A protease CHEMBL = 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218394 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218394 INHIBITOR \N \N \N \N Hepatitis C virus 189121 4220 652 Protein P Polyprotein Q9IF40 P Q9IF40_HBV 5.88605642318725586 \N EC50 first strand synthesis DRUG LABEL = 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022011s013lbl.pdf INHIBITOR \N \N 8 290 Hepatitis B virus 189122 237 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/8723169 http://www.ncbi.nlm.nih.gov/pubmed/8723169 AGONIST \N Tclin 291 291 Homo sapiens 189123 4988 3651 Cell membrane Cell membrane \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206333Orig1s000lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206333Orig1s000lbl.pdf OTHER \N \N 294 294 \N 189124 2484 3261 Taste receptor type 2 member 46 GPCR P59540 TAS2R46 T2R46_HUMAN 6.3665313720703125 \N EC50 calcium imaging in ransfected human embryonic kidney (HEK)-293T SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/20022913 \N AGONIST \N Tbio 276 \N Homo sapiens 189125 4989 3404 glucocerebroside Metabolite \N \N \N \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022575s012lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022575s012lbl.pdf HYDROLYTIC ENZYME \N \N 295 295 \N 189126 4990 3518 Tubulin beta Tumour-associated antigen P04350|P07437|P68371|Q13509|Q13885|Q3ZCM7|Q9BUF5|Q9BVA1|Q9H4B7 TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8 TBB1_HUMAN|TBB2A_HUMAN|TBB2B_HUMAN|TBB3_HUMAN|TBB4A_HUMAN|TBB4B_HUMAN|TBB5_HUMAN|TBB6_HUMAN|TBB8_HUMAN \N \N \N microtubule destabilizing agent maytansine derivative DRUG LABEL \N 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125427s033lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125427s033lbl.pdf INHIBITOR \N Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin 296 296 Homo sapiens 189127 4990 546 Receptor tyrosine-protein kinase erbB-2 Kinase P04626 ERBB2 ERBB2_HUMAN \N \N \N binding to sub-domain IV of the HER2 receptor DRUG LABEL \N 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125427s033lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125427s033lbl.pdf ANTIBODY BINDING \N Tclin 296 296 Homo sapiens 189128 4991 3648 Granulocyte colony-stimulating factor receptor Membrane receptor Q99062 CSF3R CSF3R_HUMAN \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002556/WC500148380.pdf http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002556/WC500148380.pdf ACTIVATOR \N Tclin 299 299 Homo sapiens 189129 4993 2752 Potassium-transporting ATPase Transporter P20648|P51164 ATP4A|ATP4B ATP4A_HUMAN|ATP4B_HUMAN 8 \N Ki [14C]TAK-438 binding SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/21828261 http://www.ncbi.nlm.nih.gov/pubmed/21828261 INHIBITOR \N Tclin|Tclin 301 301 Homo sapiens 189130 4994 3652 uric acid Metabolite \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/103946s5083lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/103946s5083lbl.pdf OXIDATIVE ENZYME \N \N 302 302 \N 180664 4973 619 Histone deacetylase 3 Enzyme O15379 HDAC3 HDAC3_HUMAN 7.17392539978027344 \N IC50 HDAC enzyme inhibition assay using BSA substrate SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/22080169 http://www.ncbi.nlm.nih.gov/pubmed/22080169 INHIBITOR \N Tclin 243 243 Homo sapiens 189131 81 2857 Muscarinic acetylcholine receptor GPCR P08172|P08173|P08912|P11229|P20309 CHRM1|CHRM2|CHRM3|CHRM4|CHRM5 ACM1_HUMAN|ACM2_HUMAN|ACM3_HUMAN|ACM4_HUMAN|ACM5_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/1696381 http://www.ncbi.nlm.nih.gov/pubmed/1696381 AGONIST \N Tclin|Tclin|Tclin|Tclin|Tclin 307 307 Homo sapiens 189132 6 236 Voltage-dependent L-type calcium channel subunit alpha-1D Ion channel Q01668 CACNA1D CAC1D_HUMAN 8.40000000000000036 \N IC50 Recombinant Cav1.3 calcium channel complexes expressed in tsA-cells IUPHAR = 1 IUPHAR \N \N GATING INHIBITOR \N Tclin \N \N Homo sapiens 189133 4918 3653 glycosaminoglycans Metabolite \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125151s0184lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125151s0184lbl.pdf HYDROLYTIC ENZYME \N \N 321 321 \N 189136 4995 3397 Erythropoietin receptor Membrane receptor P19235 EPOR EPOR_HUMAN 11.1500000000000004 \N IC50 Assay performed using recombinant human EPO IUPHAR = 1 DRUG LABEL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4921 http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/103234s5323lbl.pdf AGONIST \N Tclin \N 322 Homo sapiens 189138 1112 189 DNA topoisomerase 2-alpha Enzyme P11388 TOP2A TOP2A_HUMAN 7.29999999999999982 \N IC50 Note: enzyme subunit is not specified in the referenced article IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6815 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL44657 INHIBITOR \N Tclin \N \N Homo sapiens 189139 4996 2683 Thrombopoietin receptor Membrane receptor P40238 MPL TPOR_HUMAN \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125268s141lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125268s141lbl.pdf AGONIST \N Tclin 323 323 Homo sapiens 189140 4997 3653 glycosaminoglycans Metabolite \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125058s220lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125058s220lbl.pdf HYDROLYTIC ENZYME \N \N 324 324 \N 189141 4999 3653 glycosaminoglycans Metabolite \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125460s000lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125460s000lbl.pdf HYDROLYTIC ENZYME \N \N 326 326 \N 189142 5001 74 Mu-type opioid receptor GPCR P35372 OPRM1 OPRM_HUMAN 8.76955127716064453 \N Ki Recombinantly expressed human mu OR SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/22671931 http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206940s000lbl.pdf AGONIST \N Tclin 328 331 Homo sapiens 189143 5001 176 Kappa-type opioid receptor GPCR P41145 OPRK1 OPRK_HUMAN 7.25963735580444336 \N Ki Recombinantly expressed human kappa OR SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/22671931 \N AGONIST \N Tclin 328 \N Homo sapiens 189145 5001 249 Delta-type opioid receptor GPCR P41143 OPRD1 OPRD_HUMAN 8.88605690002441406 \N Ki equivalent to DPDPE in human SK-N-BE cells SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/22671931 http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206940s000lbl.pdf ANTAGONIST \N Tclin 328 331 Homo sapiens 189146 1819 6 DNA DNA \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022572s003lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022572s003lbl.pdf OTHER \N \N 329 329 \N 189147 5002 620 Insulin receptor Kinase P06213 INSR INSR_HUMAN \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020563s124lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020563s124lbl.pdf AGONIST \N Tclin 330 330 Homo sapiens 189148 5003 620 Insulin receptor Kinase P06213 INSR INSR_HUMAN \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018780s150lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018780s150lbl.pdf AGONIST \N Tclin 332 332 Homo sapiens 189112 2063 56 Prostaglandin G/H synthase 2 Enzyme P35354 PTGS2 PGH2_HUMAN 8.30103015899658203 \N IC50 recombinant human cyclooxygenase SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/10794682 http://www.ncbi.nlm.nih.gov/pubmed/10794682 INHIBITOR \N Tclin 271 271 Homo sapiens 189113 2063 66 Prostaglandin G/H synthase 1 Enzyme P23219 PTGS1 PGH1_HUMAN 3.85387206077575684 \N IC50 recombinant human cyclooxygenase SCIENTIFIC LITERATURE = \N \N \N \N INHIBITOR \N Tclin \N \N Homo sapiens 189114 4189 237 Progesterone receptor Nuclear hormone receptor P06401 PGR PRGR_HUMAN 7.66354036331176758 \N IC50 human recombinant PR-B isoform in Sf9 cells SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/18060946 http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021945s005lbl.pdf AGONIST \N Tclin 272 273 Homo sapiens 189115 4986 3648 Granulocyte colony-stimulating factor receptor Membrane receptor Q99062 CSF3R CSF3R_HUMAN \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/125031s082lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/125031s082lbl.pdf ACTIVATOR \N Tclin 274 274 Homo sapiens 189116 4987 3648 Granulocyte colony-stimulating factor receptor Membrane receptor Q99062 CSF3R CSF3R_HUMAN \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103353s5184lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103353s5184lbl.pdf ACTIVATOR \N Tclin 275 275 Homo sapiens 189117 1193 3250 Taste receptor type 2 member 14 GPCR Q9NYV8 TAS2R14 T2R14_HUMAN 6.86327934265136719 \N EC50 calcium imaging in ransfected human embryonic kidney (HEK)-293T SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/20022913 \N AGONIST \N Tbio 276 \N Homo sapiens 180685 4976 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/016466s046lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/016466s046lbl.pdf AGONIST \N Tclin 254 254 Homo sapiens 180689 4112 445 Potassium voltage-gated channel subfamily A member 5 Ion channel P22460 KCNA5 KCNA5_HUMAN 5.62999999999999989 \N IC50 Inhibition of human Kv1.5 channel expressed in HEK293 cells by whole cell patch clamp assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL184412 \N \N \N Tclin \N \N Homo sapiens 180690 4112 94 Potassium voltage-gated channel subfamily H member 2 Ion channel Q12809 KCNH2 KCNH2_HUMAN 6.5 \N IC50 Inhibition of human ERG CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL184412 \N \N \N Tclin \N \N Homo sapiens 180691 1948 2827 Soluble guanylate cyclase Enzyme O75343|P33402|Q02108|Q02153 GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3 GCYA2_HUMAN|GCYA3_HUMAN|GCYB1_HUMAN|GCYB2_HUMAN \N \N \N Mechanism of Action; CHEMBL2111348; PROTEIN COMPLEX GROUP CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200689 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200689 ACTIVATOR \N Tclin|Tclin|Tclin|Tclin \N \N Homo sapiens 180692 1344 3412 Voltage-gated potassium channel Ion channel O43525|O43526|O95259|P16389|P17658|P22001|P22459|P22460|P48547|P51787|P56696|Q03721|Q09470|Q12809|Q14003|Q14721|Q16322|Q6PIU1|Q8NCM2|Q8TAE7|Q8TDN1|Q8TDN2|Q92953|Q96KK3|Q96L42|Q96PR1|Q96RP8|Q9BQ31|Q9H252|Q9H3M0|Q9NR82|Q9NS40|Q9NSA2|Q9NZV8|Q9UIX4|Q9UJ96|Q9UK17|Q9ULD8|Q9ULS6|Q9UQ05 KCNA1|KCNA10|KCNA2|KCNA3|KCNA4|KCNA5|KCNA6|KCNA7|KCNB1|KCNB2|KCNC1|KCNC2|KCNC3|KCNC4|KCND1|KCND2|KCND3|KCNF1|KCNG1|KCNG2|KCNG3|KCNG4|KCNH1|KCNH2|KCNH3|KCNH4|KCNH5|KCNH6|KCNH7|KCNH8|KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5|KCNS1|KCNS2|KCNS3|KCNV1|KCNV2 KCA10_HUMAN|KCNA1_HUMAN|KCNA2_HUMAN|KCNA3_HUMAN|KCNA4_HUMAN|KCNA5_HUMAN|KCNA6_HUMAN|KCNA7_HUMAN|KCNB1_HUMAN|KCNB2_HUMAN|KCNC1_HUMAN|KCNC2_HUMAN|KCNC3_HUMAN|KCNC4_HUMAN|KCND1_HUMAN|KCND2_HUMAN|KCND3_HUMAN|KCNF1_HUMAN|KCNG1_HUMAN|KCNG2_HUMAN|KCNG3_HUMAN|KCNG4_HUMAN|KCNH1_HUMAN|KCNH2_HUMAN|KCNH3_HUMAN|KCNH4_HUMAN|KCNH5_HUMAN|KCNH6_HUMAN|KCNH7_HUMAN|KCNH8_HUMAN|KCNQ1_HUMAN|KCNQ2_HUMAN|KCNQ3_HUMAN|KCNQ4_HUMAN|KCNQ5_HUMAN|KCNS1_HUMAN|KCNS2_HUMAN|KCNS3_HUMAN|KCNV1_HUMAN|KCNV2_HUMAN \N \N \N Mechanism of Action; CHEMBL2362996; PROTEIN FAMILY CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL821 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL821 BLOCKER \N Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin \N \N Homo sapiens 180693 1319 1537 Sodium- and chloride-dependent glycine transporter 1 Transporter P48067 SLC6A9 SC6A9_HUMAN 4.5 \N IC50 Inhibition of GlyT1 (unknown origin) assessed as inhibition of [14C]glycine uptake CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL773 \N \N \N Tchem \N \N Homo sapiens 180694 1319 1372 Glutamate receptor ionotropic, NMDA 1 Ion channel P35439 Grin1 NMDZ1_RAT 6.59999999999999964 \N IC50 In vitro inhibitory activity to inhibit [3H]glycine binding to NMDA receptor CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL773 \N \N \N \N \N \N Rattus norvegicus 180695 1319 2779 Glutamate NMDA receptor Ion channel P35439|Q00959|Q00960|Q00961|Q62645|Q8VHN2|Q9R1M7 Grin1|Grin2a|Grin2b|Grin2c|Grin2d|Grin3a|Grin3b NMD3A_RAT|NMD3B_RAT|NMDE1_RAT|NMDE2_RAT|NMDE3_RAT|NMDE4_RAT|NMDZ1_RAT 6.76999999999999957 \N Ki Affinity for the glycine binding site of NMDA receptor by inhibition of [3H]5,7-dichlorokynurenic acid ([3H]DCKA) binding to rat brain synaptic membrane CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL773 \N \N \N \N \N \N Rattus norvegicus 180696 58 3413 Urease Enzyme P07374 \N UREA_CANEN 4.75999999999999979 \N IC50 Inhibition of jack bean urease CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL734 \N \N \N \N \N \N Canavalia ensiformis 180697 58 161 Carbonic anhydrase 2 Enzyme P00918 CA2 CAH2_HUMAN 4.33000000000000007 \N IC50 Inhibitory activity against carbonic anhydrase II CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL734 \N \N \N Tclin \N \N Homo sapiens 180698 58 2747 Bacterial urease Enzyme Q03282|Q03283|Q03284 ureA|ureB|ureC URE1_ECOLX|URE2_ECOLX|URE3_ECOLX \N \N \N Mechanism of Action; CHEMBL2364683; PROTEIN COMPLEX CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL734 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL734 INHIBITOR \N \N \N \N Escherichia coli 180699 1399 398 Carbonic anhydrase 5A, mitochondrial Enzyme P35218 CA5A CAH5A_HUMAN 4.50999999999999979 \N Ki Inhibition of human CA5a CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL467 \N \N \N Tclin \N \N Homo sapiens 180700 1399 319 Carbonic anhydrase 9 Enzyme Q16790 CA9 CAH9_HUMAN 4.63999999999999968 \N Ki Inhibition of human CA9 CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL467 \N \N \N Tclin \N \N Homo sapiens 180701 1399 161 Carbonic anhydrase 2 Enzyme P00918 CA2 CAH2_HUMAN 4.54999999999999982 \N Ki Inhibition of human CA2 CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL467 \N \N \N Tclin \N \N Homo sapiens 180702 1233 2889 Alcohol dehydrogenase Enzyme P00327|P00328 \N ADH1E_HORSE|ADH1S_HORSE 7.88999999999999968 \N Kd Inhibition of horse liver alcohol dehydrogenase using ethanol as substrate assessed as dissociation constant by spectrophotometric titration in presence of 1 mM NAD+ CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1308 \N \N \N \N \N \N Equus caballus 180703 1233 2743 Alcohol dehydrogenase Enzyme P00325|P00326|P07327 ADH1A|ADH1B|ADH1C ADH1A_HUMAN|ADH1B_HUMAN|ADH1G_HUMAN \N \N \N Mechanism of Action; CHEMBL2363044; PROTEIN COMPLEX GROUP CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1308 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1308 INHIBITOR \N Tclin|Tclin|Tclin \N \N Homo sapiens 180706 759 1372 Glutamate receptor ionotropic, NMDA 1 Ion channel P35439 Grin1 NMDZ1_RAT 5.12999999999999989 \N IC50 In vitro inhibitory activity to inhibit [3H]glycine binding to NMDA receptor CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL771 \N \N \N \N \N \N Rattus norvegicus 180707 759 1839 Glutamate receptor ionotropic, NMDA 2C Ion channel Q00961 Grin2c NMDE3_RAT 4.74000000000000021 \N EC50 Compound was evaluated for in vitro inhibition of [3H]TCP at NMDA receptor. CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL771 \N \N \N \N \N \N Rattus norvegicus 180657 342 187 Voltage-dependent L-type calcium channel subunit alpha-1C Ion channel Q13936 CACNA1C CAC1C_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/1281221 http://www.ncbi.nlm.nih.gov/pubmed/1281221 BLOCKER \N Tclin 240 240 Homo sapiens 180658 342 236 Voltage-dependent L-type calcium channel subunit alpha-1D Ion channel Q01668 CACNA1D CAC1D_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/1281221 http://www.ncbi.nlm.nih.gov/pubmed/1281221 BLOCKER \N Tclin 240 240 Homo sapiens 180659 4177 215 Voltage-dependent calcium channel subunit alpha-2/delta-1 Ion channel P54289 CACNA2D1 CA2D1_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/21651903 http://www.ncbi.nlm.nih.gov/pubmed/21651903 MODULATOR \N Tclin 60 60 Homo sapiens 180660 4177 1030 Voltage-dependent calcium channel subunit alpha-2/delta-2 Ion channel Q9NY47 CACNA2D2 CA2D2_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/21651903 http://www.ncbi.nlm.nih.gov/pubmed/21651903 MODULATOR \N Tclin 60 60 Homo sapiens 180661 4483 2484 Proteasome subunit beta type-5 Enzyme P28074 PSMB5 PSB5_HUMAN 8.22184848785400391 \N IC50 fluorogenic peptide substrate hydrolysis SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/17616698 http://www.ncbi.nlm.nih.gov/pubmed/17616698 INHIBITOR \N Tclin 242 242 Homo sapiens 180662 4973 606 Histone deacetylase 1 Enzyme Q13547 HDAC1 HDAC1_HUMAN 7.02227640151977539 \N IC50 HDAC enzyme inhibition assay using BSA substrate SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/22080169 http://www.ncbi.nlm.nih.gov/pubmed/22080169 INHIBITOR \N Tclin 243 243 Homo sapiens 180663 4973 598 Histone deacetylase 2 Enzyme Q92769 HDAC2 HDAC2_HUMAN 6.79587984085083008 \N IC50 HDAC enzyme inhibition assay using BSA substrate SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/22080169 http://www.ncbi.nlm.nih.gov/pubmed/22080169 INHIBITOR \N Tclin 243 243 Homo sapiens 134526 269 6 DNA DNA \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/18506437 OTHER \N \N \N 447 \N 180665 4973 917 Histone deacetylase 10 Enzyme Q969S8 HDAC10 HDA10_HUMAN 7.10790538787841797 \N IC50 HDAC enzyme inhibition assay using BSA substrate SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/22080169 http://www.ncbi.nlm.nih.gov/pubmed/22080169 INHIBITOR \N Tclin 243 243 Homo sapiens 180666 4973 717 Histone deacetylase 8 Enzyme Q9BY41 HDAC8 HDAC8_HUMAN 6.13489580154418945 \N IC50 HDAC enzyme inhibition assay using BSA substrate SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/22080169 \N INHIBITOR \N Tclin 243 \N Homo sapiens 180667 4973 2307 Histone deacetylase 11 Enzyme Q96DB2 HDAC11 HDA11_HUMAN 6.36451625823974609 \N IC50 HDAC enzyme inhibition assay using BSA substrate SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/22080169 \N INHIBITOR \N Tclin 243 \N Homo sapiens 180669 939 3518 Tubulin beta Tumour-associated antigen P04350|P07437|P68371|Q13509|Q13885|Q3ZCM7|Q9BUF5|Q9BVA1|Q9H4B7 TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8 TBB1_HUMAN|TBB2A_HUMAN|TBB2B_HUMAN|TBB3_HUMAN|TBB4A_HUMAN|TBB4B_HUMAN|TBB5_HUMAN|TBB6_HUMAN|TBB8_HUMAN 6.69899988174438477 \N ID50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL92 INHIBITOR \N Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin \N \N Homo sapiens 180670 2044 3518 Tubulin beta Tumour-associated antigen P04350|P07437|P68371|Q13509|Q13885|Q3ZCM7|Q9BUF5|Q9BVA1|Q9H4B7 TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8 TBB1_HUMAN|TBB2A_HUMAN|TBB2B_HUMAN|TBB3_HUMAN|TBB4A_HUMAN|TBB4B_HUMAN|TBB5_HUMAN|TBB6_HUMAN|TBB8_HUMAN 8.05000000000000071 \N EC50 \N IUPHAR = 1 SCIENTIFIC LITERATURE http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2770 http://www.ncbi.nlm.nih.gov/pubmed/11309480 INHIBITOR \N Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin 244 244 Homo sapiens 180672 4964 3518 Tubulin beta Tumour-associated antigen P04350|P07437|P68371|Q13509|Q13885|Q3ZCM7|Q9BUF5|Q9BVA1|Q9H4B7 TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8 TBB1_HUMAN|TBB2A_HUMAN|TBB2B_HUMAN|TBB3_HUMAN|TBB4A_HUMAN|TBB4B_HUMAN|TBB5_HUMAN|TBB6_HUMAN|TBB8_HUMAN \N \N \N microtubule disrupting agent auristatin E DRUG LABEL \N 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125388_S056S078lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125388_S056S078lbl.pdf INHIBITOR \N Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin 226 226 Homo sapiens 180674 4171 3518 Tubulin beta Tumour-associated antigen P04350|P07437|P68371|Q13509|Q13885|Q3ZCM7|Q9BUF5|Q9BVA1|Q9H4B7 TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8 TBB1_HUMAN|TBB2A_HUMAN|TBB2B_HUMAN|TBB3_HUMAN|TBB4A_HUMAN|TBB4B_HUMAN|TBB5_HUMAN|TBB6_HUMAN|TBB8_HUMAN 8.22999954223632812 \N IC50 \N IUPHAR = 1 SCIENTIFIC LITERATURE http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6813 http://www.ncbi.nlm.nih.gov/pubmed/19010832 INHIBITOR \N Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin \N 245 Homo sapiens 180675 2823 3518 Tubulin beta Tumour-associated antigen P04350|P07437|P68371|Q13509|Q13885|Q3ZCM7|Q9BUF5|Q9BVA1|Q9H4B7 TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8 TBB1_HUMAN|TBB2A_HUMAN|TBB2B_HUMAN|TBB3_HUMAN|TBB4A_HUMAN|TBB4B_HUMAN|TBB5_HUMAN|TBB6_HUMAN|TBB8_HUMAN 9 \N IC50 \N IUPHAR = 1 SCIENTIFIC LITERATURE http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6851 http://www.ncbi.nlm.nih.gov/pubmed/19010832 INHIBITOR \N Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin \N 245 Homo sapiens 180676 2827 3518 Tubulin beta Tumour-associated antigen P04350|P07437|P68371|Q13509|Q13885|Q3ZCM7|Q9BUF5|Q9BVA1|Q9H4B7 TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8 TBB1_HUMAN|TBB2A_HUMAN|TBB2B_HUMAN|TBB3_HUMAN|TBB4A_HUMAN|TBB4B_HUMAN|TBB5_HUMAN|TBB6_HUMAN|TBB8_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/19010832 http://www.ncbi.nlm.nih.gov/pubmed/19010832 INHIBITOR \N Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin 245 245 Homo sapiens 180677 2825 3518 Tubulin beta Tumour-associated antigen P04350|P07437|P68371|Q13509|Q13885|Q3ZCM7|Q9BUF5|Q9BVA1|Q9H4B7 TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8 TBB1_HUMAN|TBB2A_HUMAN|TBB2B_HUMAN|TBB3_HUMAN|TBB4A_HUMAN|TBB4B_HUMAN|TBB5_HUMAN|TBB6_HUMAN|TBB8_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/19010832 http://www.ncbi.nlm.nih.gov/pubmed/19010832 INHIBITOR \N Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin 245 245 Homo sapiens 180678 1517 3518 Tubulin beta Tumour-associated antigen P04350|P07437|P68371|Q13509|Q13885|Q3ZCM7|Q9BUF5|Q9BVA1|Q9H4B7 TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8 TBB1_HUMAN|TBB2A_HUMAN|TBB2B_HUMAN|TBB3_HUMAN|TBB4A_HUMAN|TBB4B_HUMAN|TBB5_HUMAN|TBB6_HUMAN|TBB8_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/19010832 http://www.ncbi.nlm.nih.gov/pubmed/19010832 INHIBITOR \N Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin 245 245 Homo sapiens 180679 3644 3518 Tubulin beta Tumour-associated antigen P04350|P07437|P68371|Q13509|Q13885|Q3ZCM7|Q9BUF5|Q9BVA1|Q9H4B7 TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8 TBB1_HUMAN|TBB2A_HUMAN|TBB2B_HUMAN|TBB3_HUMAN|TBB4A_HUMAN|TBB4B_HUMAN|TBB5_HUMAN|TBB6_HUMAN|TBB8_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/19010832 http://www.ncbi.nlm.nih.gov/pubmed/19010832 INHIBITOR \N Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin 245 245 Homo sapiens 180680 3880 269 Voltage-dependent T-type calcium channel subunit alpha-1H Ion channel O95180 CACNA1H CAC1H_HUMAN 6.84314823150634766 \N IC50 HEK-293 cells stably expressing hCav3.2 T-type Ca2+ channels SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/21466810 \N BLOCKER \N Tclin 246 \N Homo sapiens 180681 992 269 Voltage-dependent T-type calcium channel subunit alpha-1H Ion channel O95180 CACNA1H CAC1H_HUMAN 6.62105751037597656 \N IC50 HEK-293 cells stably expressing hCav3.2 T-type Ca2+ channels SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/21466810 \N BLOCKER \N Tclin 246 \N Homo sapiens 172501 4941 2322 Cyclin-dependent kinase 4 Kinase P11802 CDK4 CDK4_HUMAN 7.95860719680786133 \N IC50 Cdk4/cyclin D1 SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/15542782 http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207103s000lbl.pdf INHIBITOR \N Tclin 171 170 Homo sapiens 172502 4941 1950 Cyclin-dependent kinase 6 Kinase Q00534 CDK6 CDK6_HUMAN 7.82390880584716797 \N IC50 Cdk6/cyclin D2 SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/15542782 http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207103s000lbl.pdf INHIBITOR \N Tclin 171 170 Homo sapiens 172503 4941 2327 Dual specificity tyrosine-phosphorylation-regulated kinase 1A Kinase Q13627 DYRK1A DYR1A_HUMAN 5.69896984100341797 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/15542782 \N INHIBITOR \N Tchem 171 \N Homo sapiens 172505 4941 2283 Ribosomal protein S6 kinase alpha-1 Kinase Q15418 RPS6KA1 KS6A1_HUMAN 5.09690999984741211 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/15542782 \N INHIBITOR \N Tchem 171 \N Homo sapiens 172506 4942 541 Vascular endothelial growth factor receptor 1 Kinase P17948 FLT1 VGFR1_HUMAN 7.6575775146484375 \N IC50 in vitro kinase activity at 1uM ATP SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/17943726 http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206947s000lbl.pdf INHIBITOR \N Tclin 173 172 Homo sapiens 172507 4942 542 Vascular endothelial growth factor receptor 2 Kinase P35968 KDR VGFR2_HUMAN 8.39793968200683594 \N IC50 in vitro kinase activity at 1uM ATP SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/17943726 http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206947s000lbl.pdf INHIBITOR \N Tclin 173 172 Homo sapiens 172508 4942 543 Vascular endothelial growth factor receptor 3 Kinase P35916 FLT4 VGFR3_HUMAN 8.28399658203125 \N IC50 in vitro kinase activity at 1uM ATP SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/17943726 http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206947s000lbl.pdf INHIBITOR \N Tclin 173 172 Homo sapiens 172509 4942 759 Fibroblast growth factor receptor 1 Kinase P11362 FGFR1 FGFR1_HUMAN 7.33724212646484375 \N IC50 in vitro kinase activity at 1uM ATP SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/17943726 http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206947s000lbl.pdf INHIBITOR \N Tclin 173 172 Homo sapiens 172510 4942 545 Platelet-derived growth factor receptor alpha Kinase P16234 PDGFRA PGFRA_HUMAN 7.29242992401123047 \N IC50 in vitro kinase activity at 1uM ATP SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/17943726 http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206947s000lbl.pdf INHIBITOR \N Tclin 173 172 Homo sapiens 172511 4942 381 Platelet-derived growth factor receptor beta Kinase P09619 PDGFRB PGFRB_HUMAN 7.408935546875 \N IC50 in vitro kinase activity at 1uM ATP SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/17943726 \N INHIBITOR \N Tclin 173 \N Homo sapiens 172512 4942 383 Mast/stem cell growth factor receptor Kit Kinase P10721 KIT KIT_HUMAN 7 \N IC50 in vitro kinase activity at 1uM ATP SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/17943726 http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206947s000lbl.pdf INHIBITOR \N Tclin 173 172 Homo sapiens 172513 4942 387 Epidermal growth factor receptor Kinase P00533 EGFR EGFR_HUMAN 5.18708658218383789 \N IC50 in vitro kinase activity at 1uM ATP SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/17943726 \N INHIBITOR \N Tclin 173 \N Homo sapiens 172514 4942 540 Proto-oncogene tyrosine-protein kinase receptor Ret Kinase P07949 RET RET_HUMAN 8.82000000000000028 \N Ki Inhibition of RET (unknown origin) CHEMBL = 1 DRUG LABEL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289601 http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206947s000lbl.pdf INHIBITOR \N Tclin \N 172 Homo sapiens 170515 2166 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 7.01999998092651367 \N EC50 calcium response in CHO cells SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/24558448 \N AGONIST \N Tclin 117 \N Homo sapiens 170517 2166 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 6.94999980926513672 \N EC50 calcium response in CHO cells SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/24558448 \N AGONIST \N Tclin 117 \N Homo sapiens 170520 2166 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 6.96999979019165039 \N EC50 calcium response in CHO cells SCIENTIFIC LITERATURE = 1 IUPHAR http://www.ncbi.nlm.nih.gov/pubmed/24558448 http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=305 AGONIST \N Tclin 117 \N Homo sapiens 170522 2166 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 7.15000009536743164 \N EC50 calcium response in CHO cells SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/24558448 \N AGONIST \N Tclin 117 \N Homo sapiens 170524 2166 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 7 \N EC50 calcium response in CHO cells SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/24558448 \N AGONIST \N Tclin 117 \N Homo sapiens 170527 4920 3393 Pseudomonas aeruginosa Bacteria \N \N \N 5.29927825927734375 \N MIC90 Pseudomonas aeruginosa ATCC 27853 ciprofloxacin susceptible at pH 5.8-6.2 SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/21709094 http://www.ncbi.nlm.nih.gov/pubmed/21709094 MINIMUM INHIBITORY CONCENTRATION \N \N 121 121 \N 170528 4920 25 Staphylococcus aureus subsp. aureus Bacteria \N \N \N 6.50339841842651367 \N MIC90 methicillin-resistant S. aureus [MRSA] ATCC 33591 ciprofloxacin susceptible at pH 5.8-6.2 SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/21709094 http://www.ncbi.nlm.nih.gov/pubmed/21709094 MINIMUM INHIBITORY CONCENTRATION \N \N 121 121 \N 170529 1859 526 Inosine-5'-monophosphate dehydrogenase 2 Enzyme P12268 IMPDH2 IMDH2_HUMAN 8.15490150451660156 \N Ki \N SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/10878285 http://www.ncbi.nlm.nih.gov/pubmed/10878285 INHIBITOR \N Tclin 124 124 Homo sapiens 170531 1859 282 Inosine-5'-monophosphate dehydrogenase 1 Enzyme P20839 IMPDH1 IMDH1_HUMAN 7.48148584365844727 \N Ki \N SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/10878285 http://www.ncbi.nlm.nih.gov/pubmed/10878285 INHIBITOR \N Tclin 124 124 Homo sapiens 170532 4921 286 Amine oxidase [flavin-containing] B Enzyme P27338 MAOB AOFB_HUMAN 6.34678745269775391 \N Ki human recombinant MAO B SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/17915852 http://www.ncbi.nlm.nih.gov/pubmed/17030736 INHIBITOR \N Tclin 125 126 Homo sapiens 170534 4923 3394 Programmed cell death protein 1 Membrane receptor Q15116 PDCD1 PDCD1_HUMAN 9.14000000000000057 \N Kd \N IUPHAR = 1 SCIENTIFIC LITERATURE http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7335 http://www.ncbi.nlm.nih.gov/pubmed/24872026 ANTIBODY BINDING \N Tclin 129 129 Homo sapiens 170536 4302 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 9.68999958038330078 \N Ki \N SCIENTIFIC LITERATURE = 1 CHEMBL http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002430/WC500133771.pdf https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201027 ANTAGONIST \N Tclin 130 \N Homo sapiens 170538 4302 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 9.25 \N Ki \N SCIENTIFIC LITERATURE = 1 IUPHAR http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002430/WC500133771.pdf http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7459 ANTAGONIST \N Tclin 130 \N Homo sapiens 170539 4302 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 9.64000034332275391 \N Ki \N SCIENTIFIC LITERATURE = 1 CHEMBL http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002430/WC500133771.pdf https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201027 ANTAGONIST \N Tclin 130 \N Homo sapiens 170540 4302 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 9.06000041961669922 \N Ki \N SCIENTIFIC LITERATURE = 1 IUPHAR http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002430/WC500133771.pdf http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7459 ANTAGONIST \N Tclin 130 \N Homo sapiens 134541 4168 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 9.00261402130126953 \N Ki Mechanism of Action DRUG LABEL = 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/200603s015lbl.pdf ANTAGONIST \N Tclin \N 180 Homo sapiens 170542 4302 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 8.90999984741210938 \N Ki \N SCIENTIFIC LITERATURE = 1 IUPHAR http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002430/WC500133771.pdf http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7459 ANTAGONIST \N Tclin 130 \N Homo sapiens 170543 4342 57 Transient receptor potential cation channel subfamily V member 1 Ion channel Q8NER1 TRPV1 TRPV1_HUMAN 7.71000003814697266 \N EC50 increases in intracellular (HEK-293 cells) Ca2+ using Fluo-3 dye SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/14599363 http://www.ncbi.nlm.nih.gov/pubmed/25171227 OPENER \N Tclin 131 340 Homo sapiens 169805 4915 2939 B-lymphocyte antigen CD19 Surface antigen P15391 CD19 CD19_HUMAN 9 \N Kd Binding of the single-chain Fv portion of blinatumomab to CD19. IUPHAR = 1 DRUG LABEL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7384 http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125557lbl.pdf ANTIBODY BINDING \N Tclin \N 102 Homo sapiens 169806 4915 2940 T-cell surface glycoprotein CD3 Surface antigen P04234|P07766|P09693 CD3D|CD3E|CD3G CD3D_HUMAN|CD3E_HUMAN|CD3G_HUMAN 7 \N Kd Binding of the single-chain Fv portion of blinatumomab to CD3. IUPHAR = 1 DRUG LABEL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7384 http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125557lbl.pdf ANTIBODY BINDING \N Tclin|Tclin|Tclin \N 102 Homo sapiens 169807 2368 55 Beta-2 adrenergic receptor GPCR P07550 ADRB2 ADRB2_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/10364735 AGONIST \N Tclin \N 103 Homo sapiens 169793 1101 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/4396765 http://www.ncbi.nlm.nih.gov/pubmed/4396765 AGONIST \N Tclin 89 89 Homo sapiens 169794 4824 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/4396765 http://www.ncbi.nlm.nih.gov/pubmed/4396765 AGONIST \N Tclin 89 89 Homo sapiens 169795 648 343 Cysteinyl leukotriene receptor 1 GPCR Q9Y271 CYSLTR1 CLTR1_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/23859232 ANTAGONIST \N Tclin \N 90 Homo sapiens 169796 2237 343 Cysteinyl leukotriene receptor 1 GPCR Q9Y271 CYSLTR1 CLTR1_HUMAN 10 \N IC50 \N IUPHAR = 1 SCIENTIFIC LITERATURE http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3634 http://www.ncbi.nlm.nih.gov/pubmed/23859232 ANTAGONIST \N Tclin \N 90 Homo sapiens 169798 2847 1648 Vitamin K epoxide reductase complex subunit 1-like protein 1 Enzyme Q8N0U8 VKORC1L1 VKORL_HUMAN 4.28399658203125 \N Ki \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/23928358 \N \N \N Tbio 91 \N Homo sapiens 169800 4516 2685 Adrenocorticotropic hormone receptor GPCR Q01718 MC2R ACTHR_HUMAN 8.26760578155517578 \N Ki 125I-ACTH binding in OS3 cells expressing hMC2R wild type SCIENTIFIC LITERATURE = 1 CHEMBL http://www.ncbi.nlm.nih.gov/pubmed/17877367 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103784 AGONIST \N Tclin 92 \N Homo sapiens 169801 4821 2685 Adrenocorticotropic hormone receptor GPCR Q01718 MC2R ACTHR_HUMAN 8.0087738037109375 \N Ki 125I-ACTH binding in OS3 cells expressing hMC2R wild type SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/17877367 http://www.ncbi.nlm.nih.gov/pubmed/17877367 AGONIST \N Tclin 92 92 Homo sapiens 169802 1384 30 Ryanodine receptor 2 Ion channel Q92736 RYR2 RYR2_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/23319593 http://www.ncbi.nlm.nih.gov/pubmed/23319593 BLOCKER \N Tclin 93 93 Homo sapiens 169803 1384 31 Ryanodine receptor 2 Ion channel B0LPN4 Ryr2 RYR2_RAT 7.15181064605712891 \N IC50 sarcoplasmic reticulum diastolic Ca2+ leakage SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/23319593 \N \N \N \N 93 \N Rattus norvegicus 169804 4156 11 reactive chemical species Reactive chemical species \N \N \N \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/19466525 http://www.ncbi.nlm.nih.gov/pubmed/19466525 OTHER \N \N 94 94 \N 169782 323 61 Sodium channel protein type 5 subunit alpha Ion channel Q14524 SCN5A SCN5A_HUMAN 3.49484992027282715 \N ED50 \N SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/19661462 http://www.ncbi.nlm.nih.gov/pubmed/12173241 BLOCKER \N Tclin 4 517 Homo sapiens 169783 323 137 Sodium channel protein type 1 subunit alpha Ion channel P35498 SCN1A SCN1A_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/12173241 BLOCKER \N Tclin \N 517 Homo sapiens 169785 323 138 Sodium channel protein type 2 subunit alpha Ion channel Q99250 SCN2A SCN2A_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/12173241 BLOCKER \N Tclin \N 517 Homo sapiens 169786 323 139 Sodium channel protein type 3 subunit alpha Ion channel Q9NY46 SCN3A SCN3A_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/12173241 BLOCKER \N Tclin \N 517 Homo sapiens 169787 323 140 Sodium channel protein type 4 subunit alpha Ion channel P35499 SCN4A SCN4A_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/12173241 BLOCKER \N Tclin \N 517 Homo sapiens 169788 323 473 Sodium channel protein type 7 subunit alpha Ion channel Q01118 SCN7A SCN7A_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/12173241 BLOCKER \N Tclin \N 517 Homo sapiens 169789 323 141 Sodium channel protein type 8 subunit alpha Ion channel Q9UQD0 SCN8A SCN8A_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/12173241 BLOCKER \N Tclin \N 517 Homo sapiens 169790 323 142 Sodium channel protein type 9 subunit alpha Ion channel Q15858 SCN9A SCN9A_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/12173241 BLOCKER \N Tclin \N 517 Homo sapiens 169791 323 472 Sodium channel protein type 10 subunit alpha Ion channel Q9Y5Y9 SCN10A SCNAA_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/12173241 BLOCKER \N Tclin \N 517 Homo sapiens 169792 323 175 Sodium channel protein type 11 subunit alpha Ion channel Q9UI33 SCN11A SCNBA_HUMAN \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/12173241 BLOCKER \N Tclin \N 517 Homo sapiens 134540 990 35 Ornithine decarboxylase Enzyme Q9TZZ6 \N Q9TZZ6_TRYBG \N \N \N Mechanism of Action DRUG LABEL \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/3924048 INHIBITOR \N \N \N 284 Trypanosoma brucei gambiense 28205 1436 55 Beta-2 adrenergic receptor GPCR P07550 ADRB2 ADRB2_HUMAN \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N Tclin \N \N Homo sapiens 134542 4168 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 9.32790184020996094 \N Ki Mechanism of Action DRUG LABEL = 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/200603s015lbl.pdf ANTAGONIST \N Tclin \N 180 Homo sapiens 134543 4168 105 5-hydroxytryptamine receptor 7 GPCR P34969 HTR7 5HT7R_HUMAN 9.30539512634277344 \N Ki \N DRUG LABEL = \N \N \N \N ANTAGONIST \N Tclin \N \N Homo sapiens 134544 4168 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 7.96657609939575195 \N Ki antagonist with moderate affinity DRUG LABEL = \N \N \N \N \N \N Tclin \N \N Homo sapiens 134545 4168 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 8.19517898559570312 \N Ki partial agonist DRUG LABEL = \N \N \N \N \N \N Tclin \N \N Homo sapiens 134546 4168 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 7.39040565490722656 \N Ki antagonist DRUG LABEL = \N \N \N \N \N \N Tclin \N \N Homo sapiens 134547 4885 1700 Glucagon-like peptide 1 receptor GPCR P43220 GLP1R GLP1R_HUMAN \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/125469Orig1s000Lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/125469Orig1s000Lbl.pdf AGONIST \N Tclin 252 252 Homo sapiens 134548 1770 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/011757s103lbl.pdf AGONIST \N Tclin \N 181 Homo sapiens 134549 302 6 DNA DNA \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022249Orig1s019lbl.pdf OTHER \N \N \N 286 \N 134550 43 56 Prostaglandin G/H synthase 2 Enzyme P35354 PTGS2 PGH2_HUMAN \N \N \N Mechanism of Action DRUG LABEL \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/11556519 INHIBITOR \N Tclin \N 429 Homo sapiens 134551 1751 241 Dihydrofolate reductase Enzyme P00374 DHFR DYR_HUMAN 8.91999999999999993 \N Ki \N IUPHAR = 1 DRUG LABEL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4815 http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205776s000lbl.pdf INHIBITOR \N Tclin \N 185 Homo sapiens 134552 2782 55 Beta-2 adrenergic receptor GPCR P07550 ADRB2 ADRB2_HUMAN \N \N \N Mechanism of Action DRUG LABEL \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/15212190 AGONIST \N Tclin \N 99 Homo sapiens 134553 1987 2849 Phosphodiesterase 3 Enzyme Q13370|Q14432 PDE3A|PDE3B PDE3A_HUMAN|PDE3B_HUMAN \N \N \N Mechanism of Action DRUG LABEL \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/9726653 INHIBITOR \N Tclin|Tclin \N 288 Homo sapiens 134554 4886 481 Pancreatic triacylglycerol lipase Enzyme P16233 PNLIP LIPP_HUMAN 8.22548294067382812 \N IC50 \N SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/18500680 http://www.ncbi.nlm.nih.gov/pubmed/18500680 INHIBITOR \N Tclin 5 5 Homo sapiens 134559 4888 304 Xanthine dehydrogenase/oxidase Enzyme P47989 XDH XDH_HUMAN 8.27572441101074219 \N IC50 \N SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/19783139 http://www.ncbi.nlm.nih.gov/pubmed/19783139 INHIBITOR \N Tclin 7 7 Homo sapiens 134560 4890 51 Sodium/glucose cotransporter 2 Transporter P31639 SLC5A2 SC5A2_HUMAN 8.13194370269775391 \N IC50 \N SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/22139434 http://www.ncbi.nlm.nih.gov/pubmed/22139434 INHIBITOR \N Tclin 8 8 Homo sapiens 134561 4890 2059 Sodium/glucose cotransporter 1 Transporter P13866 SLC5A1 SC5A1_HUMAN 5.72676706314086914 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/22139434 \N \N \N Tclin 8 \N Homo sapiens 134562 4891 51 Sodium/glucose cotransporter 2 Transporter P31639 SLC5A2 SC5A2_HUMAN 8.64589118957519531 \N IC50 \N SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/20302302 http://www.ncbi.nlm.nih.gov/pubmed/20302302 INHIBITOR \N Tclin 9 9 Homo sapiens 134563 4891 2059 Sodium/glucose cotransporter 1 Transporter P13866 SLC5A1 SC5A1_HUMAN 5.39902687072753906 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/20302302 \N \N \N Tclin 9 \N Homo sapiens 134564 4892 51 Sodium/glucose cotransporter 2 Transporter P31639 SLC5A2 SC5A2_HUMAN 8.53760242462158203 \N IC50 \N SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/22889351 http://www.ncbi.nlm.nih.gov/pubmed/22889351 INHIBITOR \N Tclin 10 10 Homo sapiens 134565 4892 2059 Sodium/glucose cotransporter 1 Transporter P13866 SLC5A1 SC5A1_HUMAN 5.07345199584960938 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/22889351 \N \N \N Tclin 10 \N Homo sapiens 134566 4893 700 Thymidine phosphorylase Enzyme P19971 TYMP TYPH_HUMAN 7.69896984100341797 \N IC50 spectrophotometric assay; 5-nitro-2'-deoxyuridine substrate SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/12519058 http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207981s000lbl.pdf INHIBITOR \N Tclin 11 442 Homo sapiens 134567 4895 550 Dipeptidyl peptidase 4 Enzyme P27487 DPP4 DPP4_HUMAN 9.43179798126220703 \N IC50 \N SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/22959556 http://www.ncbi.nlm.nih.gov/pubmed/22959556 INHIBITOR \N Tclin 12 12 Homo sapiens 134568 4895 844 Dipeptidyl peptidase 8 Enzyme Q6V1X1 DPP8 DPP8_HUMAN 6.58502674102783203 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/22959556 \N \N \N Tchem 12 \N Homo sapiens 134569 4895 880 Dipeptidyl peptidase 9 Enzyme Q86TI2 DPP9 DPP9_HUMAN 6.26760625839233398 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/22959556 \N \N \N Tchem 12 \N Homo sapiens 134570 4896 550 Dipeptidyl peptidase 4 Enzyme P27487 DPP4 DPP4_HUMAN 8.42021656036376953 \N IC50 \N SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/22019046 http://www.ncbi.nlm.nih.gov/pubmed/22019046 INHIBITOR \N Tclin 13 13 Homo sapiens 134571 4896 844 Dipeptidyl peptidase 8 Enzyme Q6V1X1 DPP8 DPP8_HUMAN 7.16749095916748047 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/22019046 \N \N \N Tchem 13 \N Homo sapiens 134572 4896 880 Dipeptidyl peptidase 9 Enzyme Q86TI2 DPP9 DPP9_HUMAN 7.22184896469116211 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/22019046 \N \N \N Tchem 13 \N Homo sapiens 134521 24 8 glutamine Amino acid \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020572s016,020573s015lbl.pdf OTHER \N \N \N 427 \N 134522 4797 5 heme iron Inorganic material \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/201444s000lbl.pdf OTHER \N \N \N 518 \N 134523 30 6 DNA DNA \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/09048slr037_methoxsalen_lbl.pdf CROSS-LINKING AGENT \N \N \N 428 \N 134524 141 6 DNA DNA \N \N \N \N \N \N Mechanism of Action SCIENTIFIC LITERATURE \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/7763301 OTHER \N \N \N 519 \N 134525 156 11 reactive chemical species Reactive chemical species \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020221s024lbl.pdf OTHER \N \N \N 563 \N 134527 269 7 RNA RNA \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/18506437 OTHER \N \N \N 447 \N 134528 512 6 DNA DNA \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020637s026lbl.pdf OTHER \N \N \N 282 \N 134529 347 9 homocysteine Unnatural amino acid \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020576s010lbl.pdf OTHER \N \N \N 505 \N 134530 438 6 DNA DNA \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020954s014lbl.pdf OTHER \N \N \N 564 \N 134532 636 10 trivalent metal Inorganic material \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21022s004lbl.pdf CHELATING AGENT \N \N \N 367 \N 134533 4133 6 DNA DNA \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020452s005lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020452s005lbl.pdf CROSS-LINKING AGENT \N \N 561 561 \N 134534 774 6 DNA DNA \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050682s029s030lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050682s029s030lbl.pdf OTHER \N \N 562 562 \N 134537 2081 3 copper Inorganic material \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19853s012,014lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19853s012,014lbl.pdf CHELATING AGENT \N \N 397 397 \N 126959 4622 36 Heat-stable enterotoxin receptor Enzyme P25092 GUCY2C GUC2C_HUMAN 8.90657806396484375 \N Ki competitive radioligand binding assay with [125I]-STa SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/20863829 http://www.ncbi.nlm.nih.gov/pubmed/20863829 AGONIST \N Tclin 14 14 Homo sapiens 126960 4678 25 Staphylococcus aureus subsp. aureus Bacteria \N \N \N 7.46935081481933594 \N MIC as determined by broth microdilution with 0.002% polysorbate-80 during oritavancin dissolution and dilution and in the final assay DRUG LABEL = 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206334s000lbl.pdf MINIMUM INHIBITORY CONCENTRATION \N \N \N 289 \N 126961 4678 23 Streptococcus pneumoniae Bacteria \N \N \N 8.90071487426757812 \N MIC as determined by broth microdilution with 0.002% polysorbate-80 during oritavancin dissolution and dilution and in the final assay DRUG LABEL = 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206334s000lbl.pdf MINIMUM INHIBITORY CONCENTRATION \N \N \N 289 \N 126962 4678 24 Enterococcus faecalis ATCC 29212 Bacteria \N \N \N 8.01990127563476562 \N MIC as determined by broth microdilution with 0.002% polysorbate-80 during oritavancin dissolution and dilution and in the final assay DRUG LABEL = 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206334s000lbl.pdf MINIMUM INHIBITORY CONCENTRATION \N \N \N 289 \N 126964 4881 38 Orexin receptor type 1 GPCR O43613 HCRTR1 OX1R_HUMAN 9.25963687896728516 \N Ki radioligand-displacement binding assay SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/20565075 http://www.ncbi.nlm.nih.gov/pubmed/20565075 ANTAGONIST \N Tclin 15 15 Homo sapiens 126965 4881 2577 Orexin receptor type 2 GPCR O43614 HCRTR2 OX2R_HUMAN 9.45593166351318359 \N Ki radioligand-displacement binding assay SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/20565075 http://www.ncbi.nlm.nih.gov/pubmed/20565075 ANTAGONIST \N Tclin 15 15 Homo sapiens 126966 2616 2576 Protein cereblon Cytosolic other Q96SW2 CRBN CRBN_HUMAN 6.39297389984130859 \N EC50 competitive titration of thalidomide with human DDB1-human CRBN (50 nM) and Cy5-thalidomide (20 nM) SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/25043012 http://www.ncbi.nlm.nih.gov/pubmed/26131937 MODULATOR \N Tclin 16 383 Homo sapiens 126967 3317 2576 Protein cereblon Cytosolic other Q96SW2 CRBN CRBN_HUMAN 6.5273900032043457 \N EC50 competitive titration of thalidomide with human DDB1-human CRBN (50 nM) and Cy5-thalidomide (20 nM) SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/25043012 http://www.ncbi.nlm.nih.gov/pubmed/26131937 MODULATOR \N Tclin 16 383 Homo sapiens 126968 4746 2576 Protein cereblon Cytosolic other Q96SW2 CRBN CRBN_HUMAN 6.57708215713500977 \N EC50 competitive titration of thalidomide with human DDB1-human CRBN (50 nM) and Cy5-thalidomide (20 nM) SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/25043012 http://www.ncbi.nlm.nih.gov/pubmed/26131937 MODULATOR \N Tclin 16 383 Homo sapiens 97500 4873 25 Staphylococcus aureus subsp. aureus Bacteria \N \N \N 5.95454883575439453 \N MIC MIC for S. aureus ATCC 29213 SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/21502615 http://www.ncbi.nlm.nih.gov/pubmed/21502615 MINIMUM INHIBITORY CONCENTRATION \N \N 17 17 \N 97501 4874 27 Trichophyton rubrum Fungi \N \N \N 6.44515609741210938 \N MIC 80% inhibition SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/11302816 http://www.ncbi.nlm.nih.gov/pubmed/11302816 MINIMUM INHIBITORY CONCENTRATION \N \N 18 18 \N 97502 4874 26 Trichophyton mentagrophytes Fungi \N \N \N 6.14412593841552734 \N MIC 80% inhibition SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/11302816 http://www.ncbi.nlm.nih.gov/pubmed/11302816 MINIMUM INHIBITORY CONCENTRATION \N \N 18 18 \N 97503 4875 2544 Genome polyprotein Polyprotein P27958 \N POLG_HCVH 10.301030158996582 \N EC50 \N SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/20410884 http://www.ncbi.nlm.nih.gov/pubmed/20410884 INHIBITOR \N \N 19 19 Hepatitis C virus genotype 1a (isolate H) 97504 4875 2536 Genome polyprotein Polyprotein P26663 \N POLG_HCVBK 11.0457572937011719 \N EC50 \N SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/20410884 http://www.ncbi.nlm.nih.gov/pubmed/20410884 INHIBITOR \N \N 19 19 Hepatitis C virus genotype 1b (isolate BK) 97493 4382 129 Beta-3 adrenergic receptor GPCR P13945 ADRB3 ADRB3_HUMAN 7.64975214004516602 \N EC50 cAMP accumulation in CHO cells expressing human beta-3 adrenergic receptor SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/17293563 http://www.ncbi.nlm.nih.gov/pubmed/17293563 AGONIST \N Tclin 20 20 Homo sapiens 97495 4866 609 Insulin-like growth factor 1 receptor Kinase P08069 IGF1R IGF1R_HUMAN 8.09691047668457031 \N IC50 in vitro enzymatic activity SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/23742252 \N \N \N Tclin 21 \N Homo sapiens 97496 4866 620 Insulin receptor Kinase P06213 INSR INSR_HUMAN 8.15490150451660156 \N IC50 in vitro enzymatic activity SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/23742252 \N AGONIST \N Tclin 21 \N Homo sapiens 97497 4866 925 Testis-specific serine/threonine-protein kinase 1 Kinase Q9BXA7 TSSK1B TSSK1_HUMAN 7.63827228546142578 \N IC50 in vitro enzymatic activity SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/23742252 \N \N \N Tchem 21 \N Homo sapiens 162409 1820 443 Cytochrome P450 11B1, mitochondrial Enzyme P15538 CYP11B1 C11B1_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1670 INHIBITOR \N Tclin \N \N Homo sapiens 97498 4866 847 ALK tyrosine kinase receptor Kinase Q9UM73 ALK ALK_HUMAN 9.69896984100341797 \N IC50 in vitro enzymatic activity SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/23742252 http://www.ncbi.nlm.nih.gov/pubmed/23742252 INHIBITOR \N Tclin 21 21 Homo sapiens 97499 4870 43 Proteinase-activated receptor 1 GPCR P25116 F2R PAR1_HUMAN 8.09151458740234375 \N Ki antagonist SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/18447380 http://www.ncbi.nlm.nih.gov/pubmed/18447380 ANTAGONIST \N Tclin 22 22 Homo sapiens 97488 4833 550 Dipeptidyl peptidase 4 Enzyme P27487 DPP4 DPP4_HUMAN 7.79587984085083008 \N IC50 fluorometric assay with Gly-Pro-AMC substrate SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://professional.diabetes.org/Content/Posters/2008/p502-P.pdf http://professional.diabetes.org/Content/Posters/2008/p502-P.pdf INHIBITOR \N Tclin 95 95 Homo sapiens 97489 4833 880 Dipeptidyl peptidase 9 Enzyme Q86TI2 DPP9 DPP9_HUMAN 4.32790231704711914 \N IC50 fluorometric assay with Gly-Pro-AMC substrate SCIENTIFIC LITERATURE = \N \N http://professional.diabetes.org/Content/Posters/2008/p502-P.pdf \N \N \N Tchem 95 \N Homo sapiens 97490 4834 524 Ceramide glucosyltransferase Enzyme Q16739 UGCG CEGT_HUMAN 6.82681369781494141 \N IC50 inhibition of GlcCer synthesis in disrupted wild-type MDCK cell preparations SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/22058426 http://www.ncbi.nlm.nih.gov/pubmed/22058426 INHIBITOR \N Tclin 23 23 Homo sapiens 97491 4864 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 7.95078182220458984 \N Ki radioligand binding in HEK-293 cells SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/23499664 http://www.ncbi.nlm.nih.gov/pubmed/23499664 INHIBITOR \N Tclin 24 24 Homo sapiens 97492 4864 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 7.03526926040649414 \N Ki radioligand binding in HEK-293 cells SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/23499664 http://www.ncbi.nlm.nih.gov/pubmed/23499664 INHIBITOR \N Tclin 24 24 Homo sapiens 97481 4829 559 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Enzyme Q08499 PDE4D PDE4D_HUMAN 7.1307682991027832 \N IC50 PDE4 enzyme isolated from U937 cells SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/19256507 http://www.ncbi.nlm.nih.gov/pubmed/19256507 INHIBITOR \N Tclin 25 25 Homo sapiens 97483 4830 2059 Sodium/glucose cotransporter 1 Transporter P13866 SLC5A1 SC5A1_HUMAN 5.08092212677001953 \N IC50 uptake of [14C] alpha-methyl glucopyranoside SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/21985634 \N \N \N Tclin 26 \N Homo sapiens 97484 4830 44 Sodium/glucose cotransporter 4 Transporter Q2M3M2 SLC5A9 SC5A9_HUMAN 4.95860719680786133 \N IC50 uptake of [14C] alpha-methyl glucopyranoside SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/21985634 \N \N \N Tdark 26 \N Homo sapiens 97485 4830 45 Sodium/glucose cotransporter 5 Transporter A0PJK1 SLC5A10 SC5AA_HUMAN 5.95860719680786133 \N IC50 uptake of [14C] mannose SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/21985634 \N \N \N Tdark 26 \N Homo sapiens 97486 4830 2432 Sodium/myo-inositol cotransporter 2 Transporter Q8WWX8 SLC5A11 SC5AB_HUMAN 5.69896984100341797 \N IC50 uptake of [14C] myo-inositol SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/21985634 \N \N \N Tchem 26 \N Homo sapiens 97487 4830 51 Sodium/glucose cotransporter 2 Transporter P31639 SLC5A2 SC5A2_HUMAN 7.2441253662109375 \N Kd [3H]-empagliflozin kinetic binding experiment SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/21985634 http://www.ncbi.nlm.nih.gov/pubmed/21985634 INHIBITOR \N Tclin 26 26 Homo sapiens 97477 2054 2729 Potassium-transporting ATPase Enzyme P18597|P27112 ATP4A|ATP4B ATP4A_RABIT|ATP4B_RABIT 6 \N IC50 [14C]AP accumulation as an indicator of acid secretion in rabbit isolated fundic glands SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/2164086 \N \N \N \N 27 \N Oryctolagus cuniculus 97478 1990 2729 Potassium-transporting ATPase Enzyme P18597|P27112 ATP4A|ATP4B ATP4A_RABIT|ATP4B_RABIT 6.15490198135375977 \N IC50 [14C]AP accumulation as an indicator of acid secretion in rabbit isolated fundic glands SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/2164086 \N \N \N \N 27 \N Oryctolagus cuniculus 97479 2716 529 Prostaglandin F2-alpha receptor GPCR P43088 PTGFR PF2R_HUMAN 7.28399658203125 \N Ki inhibition of [3H]AL-5848 binding to prostaglandin FP receptor SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/10454045 http://www.ncbi.nlm.nih.gov/pubmed/10454045 AGONIST \N Tclin 28 28 Homo sapiens 97480 2716 340 Prostaglandin E2 receptor EP3 subtype GPCR P43115 PTGER3 PE2R3_HUMAN 5.45580768585205078 \N Ki inhibition of [3H]AL-5848 binding to prostaglandin EP3 receptor SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/10454045 \N \N \N Tclin 28 \N Homo sapiens 97474 4820 378 Melatonin receptor type 1A GPCR P48039 MTNR1A MTR1A_HUMAN 9.44999980926513672 \N Ki \N SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/22640220 http://www.ncbi.nlm.nih.gov/pubmed/22640220 AGONIST \N Tclin 29 29 Homo sapiens 97475 4820 379 Melatonin receptor type 1B GPCR P49286 MTNR1B MTR1B_HUMAN 9.80000019073486328 \N Ki \N SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/22640220 http://www.ncbi.nlm.nih.gov/pubmed/22640220 AGONIST \N Tclin 29 29 Homo sapiens 97466 4814 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN 7.32999992370605469 \N Ki competitive binding experiments against [3H]CGP 12177 in the presence of 5'-guanylyl-imidodiphosphate SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/20371707 \N \N \N Tclin 30 \N Homo sapiens 97467 4814 55 Beta-2 adrenergic receptor GPCR P07550 ADRB2 ADRB2_HUMAN 9.14000034332275391 \N Ki competitive binding experiments against [3H]CGP 12177 in the presence of 5'-guanylyl-imidodiphosphate SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/20371707 http://www.ncbi.nlm.nih.gov/pubmed/20371707 ANTAGONIST \N Tclin 30 30 Homo sapiens 97468 4814 129 Beta-3 adrenergic receptor GPCR P13945 ADRB3 ADRB3_HUMAN 5.26000022888183594 \N Ki competitive binding experiments against [3H]CGP 12177 in the presence of 5'-guanylyl-imidodiphosphate SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/20371707 \N \N \N Tclin 30 \N Homo sapiens 97469 4815 1700 Glucagon-like peptide 1 receptor GPCR P43220 GLP1R GLP1R_HUMAN 8.84466361999511719 \N IC50 CHO cells transfected with the human GLP-1 receptor binding affinity SCIENTIFIC LITERATURE = 1 IUPHAR http://www.ncbi.nlm.nih.gov/pubmed/18417092 http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7387 AGONIST \N Tclin 31 \N Homo sapiens 97471 4816 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 10.2218484878540039 \N Ki radioligand binding assays in CHO cells expressing human M1, M2, or M3 receptors in a scintillation proximity assay with 0.5 nM [3H]-N-methyl scopolamine as the ligand SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/19317446 http://www.ncbi.nlm.nih.gov/pubmed/19317446 ANTAGONIST \N Tclin 32 32 Homo sapiens 97472 4816 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 9.82390880584716797 \N Ki radioligand binding assays in CHO cells expressing human M1, M2, or M3 receptors in a scintillation proximity assay with 0.5 nM [3H]-N-methyl scopolamine as the ligand SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/19317446 \N \N \N Tclin 32 \N Homo sapiens 97473 4816 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 9.79588031768798828 \N Ki radioligand binding assays in CHO cells expressing human M1, M2, or M3 receptors in a scintillation proximity assay with 0.5 nM [3H]-N-methyl scopolamine as the ligand SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/19317446 \N \N \N Tclin 32 \N Homo sapiens 93397 4806 171 5-hydroxytryptamine receptor 3A Ion channel P46098 HTR3A 5HT3A_HUMAN 8.43179798126220703 \N Ki antagonist SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/22171087 http://www.ncbi.nlm.nih.gov/pubmed/21486038 ANTAGONIST \N Tclin 33 138 Homo sapiens 93398 4806 105 5-hydroxytryptamine receptor 7 GPCR P34969 HTR7 5HT7R_HUMAN 7.72124624252319336 \N Ki antagonist SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/22171087 http://www.ncbi.nlm.nih.gov/pubmed/21486038 ANTAGONIST \N Tclin 33 138 Homo sapiens 93399 4806 130 5-hydroxytryptamine receptor 1B GPCR P28222 HTR1B 5HT1B_HUMAN 7.48148584365844727 \N Ki partial agonist SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/22171087 http://www.ncbi.nlm.nih.gov/pubmed/21486038 AGONIST \N Tclin 33 138 Homo sapiens 93400 4806 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 7.82390880584716797 \N Ki agonist SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/22171087 http://www.ncbi.nlm.nih.gov/pubmed/21486038 AGONIST \N Tclin 33 138 Homo sapiens 93401 4806 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 8.79588031768798828 \N Ki inhibitor SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/22171087 http://www.ncbi.nlm.nih.gov/pubmed/21486038 INHIBITOR \N Tclin 33 138 Homo sapiens 93402 4806 1777 5-hydroxytryptamine receptor 7 GPCR P32305 Htr7 5HT7R_RAT 6.69896984100341797 \N Ki antagonist SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/22171087 \N \N \N \N 33 \N Rattus norvegicus 93403 4807 46 Guanylate cyclase soluble subunit beta-1 Enzyme Q02153 GUCY1B3 GCYB1_HUMAN 7.52287864685058594 \N MEC minimal effective concentration to achieve threefold stimulation of cGMP formation in a recombinant sGC-overexpressing cell line SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/19263460 http://www.ncbi.nlm.nih.gov/pubmed/19263460 POSITIVE ALLOSTERIC MODULATOR \N Tclin 34 34 Homo sapiens 93404 4807 831 cAMP-specific 3',5'-cyclic phosphodiesterase 7B Enzyme Q9NP56 PDE7B PDE7B_HUMAN 5.53760194778442383 \N IC50 radioligand binding SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/19263460 \N \N \N Tclin 34 \N Homo sapiens 93405 4808 1791 Acetylcholinesterase Enzyme P37136 Ache ACES_RAT 6.56863641738891602 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/11256231 \N \N \N \N 35 \N Rattus norvegicus 93406 4808 1774 Butyrylcholinesterase; Protein Bche Enzyme Q9JKC1 Bche Q9JKC1_RAT 6.6575775146484375 \N IC50 \N SCIENTIFIC LITERATURE = \N \N http://www.ncbi.nlm.nih.gov/pubmed/11256231 \N \N \N \N 35 \N Rattus norvegicus 93407 4809 457 Endothelin-1 receptor GPCR P25101 EDNRA EDNRA_HUMAN 9.30103015899658203 \N IC50 IC50 value as determined in binding assays using membranes of Chinese hamster ovary (CHO) cells containing recombinant ETA SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/22862294 http://www.ncbi.nlm.nih.gov/pubmed/22862294 ANTAGONIST \N Tclin 36 36 Homo sapiens 93408 4809 458 Endothelin B receptor GPCR P24530 EDNRB EDNRB_HUMAN 6.40782308578491211 \N IC50 IC50 value as determined in binding assays using membranes of Chinese hamster ovary (CHO) cells containing recombinant ETB SCIENTIFIC LITERATURE = 1 SCIENTIFIC LITERATURE http://www.ncbi.nlm.nih.gov/pubmed/22862294 http://www.ncbi.nlm.nih.gov/pubmed/22862294 ANTAGONIST \N Tclin 36 36 Homo sapiens 93389 4305 411 cGMP-specific 3',5'-cyclic phosphodiesterase Enzyme O76074 PDE5A PDE5A_HUMAN 8.28399658203125 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1963681 INHIBITOR \N Tclin \N \N Homo sapiens 93390 4305 770 Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' Enzyme P51160 PDE6C PDE6C_HUMAN 6.20065927505493164 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28187 4283 74 Mu-type opioid receptor GPCR P35372 OPRM1 OPRM_HUMAN 7.01772880554199219 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201776 AGONIST \N Tclin \N \N Homo sapiens 28188 4283 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 6.31875896453857422 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201776 INHIBITOR \N Tclin \N \N Homo sapiens 28189 4713 52 Tyrosine-protein kinase JAK3 Kinase P52333 JAK3 JAK3_HUMAN 8.48148632049560547 \N IC50 \N WOMBAT-PK = \N \N \N \N INHIBITOR \N Tclin \N \N Homo sapiens 28190 4647 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 8.34679985046386719 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201064 AGONIST \N Tclin \N \N Homo sapiens 28191 4715 542 Vascular endothelial growth factor receptor 2 Kinase P35968 KDR VGFR2_HUMAN 10.4559316635131836 \N IC50 \N WOMBAT-PK = 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203756lbl.pdf INHIBITOR \N Tclin \N 560 Homo sapiens 28192 4715 744 Hepatocyte growth factor receptor Kinase P08581 MET MET_HUMAN 8.88605690002441406 \N IC50 \N WOMBAT-PK = 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203756lbl.pdf INHIBITOR \N Tclin \N 560 Homo sapiens 28193 4715 540 Proto-oncogene tyrosine-protein kinase receptor Ret Kinase P07949 RET RET_HUMAN 8.28399658203125 \N IC50 \N WOMBAT-PK = 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203756lbl.pdf INHIBITOR \N Tclin \N 560 Homo sapiens 28194 4715 735 Angiopoietin-1 receptor Kinase Q02763 TEK TIE2_HUMAN 7.84466409683227539 \N IC50 \N WOMBAT-PK = 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203756lbl.pdf INHIBITOR \N Tclin \N 560 Homo sapiens 28195 4715 539 Receptor-type tyrosine-protein kinase FLT3 Kinase P36888 FLT3 FLT3_HUMAN 7.94692134857177734 \N IC50 \N WOMBAT-PK = 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203756lbl.pdf INHIBITOR \N Tclin \N 560 Homo sapiens 28196 4715 383 Mast/stem cell growth factor receptor Kit Kinase P10721 KIT KIT_HUMAN 8.33724212646484375 \N IC50 \N WOMBAT-PK = 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203756lbl.pdf INHIBITOR \N Tclin \N 560 Homo sapiens 28197 4715 53 Macrophage-stimulating protein receptor Kinase Q04912 MST1R RON_HUMAN 6.90657854080200195 \N IC50 \N WOMBAT-PK = \N \N \N \N INHIBITOR \N Tchem \N \N Homo sapiens 28198 4621 209 Thymidylate synthase Enzyme P04818 TYMS TYSY_HUMAN \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N Tclin \N \N Homo sapiens 28204 1436 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N Tclin \N \N Homo sapiens 28206 4716 382 Tyrosine-protein kinase ABL1 Kinase P00519 ABL1 ABL1_HUMAN 9.43179798126220703 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1171837 INHIBITOR \N Tclin \N \N Homo sapiens 28207 4716 727 Tyrosine-protein kinase CSK Kinase P41240 CSK CSK_HUMAN 8.26760578155517578 \N IC50 \N WOMBAT-PK = \N \N \N \N INHIBITOR \N Tchem \N \N Homo sapiens 28208 4716 745 Tyrosine-protein kinase Lyn Kinase P07948 LYN LYN_HUMAN 9.61978912353515625 \N IC50 \N WOMBAT-PK = \N \N \N \N INHIBITOR \N Tclin \N \N Homo sapiens 28209 4716 383 Mast/stem cell growth factor receptor Kit Kinase P10721 KIT KIT_HUMAN 7.90309000015258789 \N IC50 \N WOMBAT-PK = \N \N \N \N INHIBITOR \N Tclin \N \N Homo sapiens 28210 4716 542 Vascular endothelial growth factor receptor 2 Kinase P35968 KDR VGFR2_HUMAN 8.82390880584716797 \N IC50 \N WOMBAT-PK = \N \N \N \N INHIBITOR \N Tclin \N \N Homo sapiens 28211 4716 759 Fibroblast growth factor receptor 1 Kinase P11362 FGFR1 FGFR1_HUMAN 8.6575775146484375 \N IC50 \N WOMBAT-PK = \N \N \N \N INHIBITOR \N Tclin \N \N Homo sapiens 28212 4716 545 Platelet-derived growth factor receptor alpha Kinase P16234 PDGFRA PGFRA_HUMAN 8.95860767364501953 \N IC50 \N WOMBAT-PK = \N \N \N \N INHIBITOR \N Tclin \N \N Homo sapiens 28214 4744 1047 Cystic fibrosis transmembrane conductance regulator Ion channel P13569 CFTR CFTR_HUMAN 5.15490198135375977 \N IC50 \N WOMBAT-PK = 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202292s000lbl.pdf INHIBITOR \N Tclin \N 236 Homo sapiens 28215 4744 1705 Anoctamin-1 Ion channel Q5XXA6 ANO1 ANO1_HUMAN 5.18708658218383789 \N IC50 \N WOMBAT-PK = 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202292s000lbl.pdf INHIBITOR \N Tclin \N 236 Homo sapiens 2978 85 71 DNA polymerase catalytic subunit Enzyme P09252 \N DPOL_VZVD \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Varicella-zoster virus (strain Dumas) 2979 85 72 Thymidine kinase Kinase Q9QNF7 TK KITH_HHV1 \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Human herpesvirus 1 2980 85 73 Thymidine kinase Kinase P04407 TK KITH_HHV23 \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Human herpesvirus 2 (strain 333) 2981 85 2053 Thymidine kinase Kinase P09250 \N KITH_VZVD \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Varicella-zoster virus (strain Dumas) 3046 192 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 3048 198 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 3119 492 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 3121 525 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 3124 530 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 3125 539 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 3126 542 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 3127 543 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 3128 544 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 3129 547 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 3130 550 153 Beta-lactamase Enzyme P00808 penP BLAC_BACLI \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Bacillus licheniformis 3131 550 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 3132 556 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 3133 563 153 Beta-lactamase Enzyme P00808 penP BLAC_BACLI \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Bacillus licheniformis 3134 563 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 3136 565 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 3137 571 124 Penicillin-binding protein 3 Enzyme P42971 pbpC PBPC_BACSU \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Bacillus subtilis (strain 168) 3138 574 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 3139 575 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 3140 576 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 3189 678 122 50S ribosomal protein L10 Ribosomal protein P15825 rpl10 RL10_HALMA \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Haloarcula marismortui (strain ATCC 43049 / DSM 3752 / JCM 8966 / VKM B-1809) 3197 720 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 162330 3424 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 8.75999999999999979 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL560 MODULATOR \N Tclin \N \N Homo sapiens 162331 842 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 6.45840000000000014 \N D2 \N WOMBAT-PK = \N \N \N \N AGONIST \N Tclin \N \N Homo sapiens 162332 437 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 7.31880000000000042 \N Ki \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 162334 2572 168 Beta-lactamase TEM Enzyme P62593 bla; blaT-3; blaT-4; BLAT_ECOLX 6.60210000000000008 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404 INHIBITOR \N \N \N \N Escherichia coli 162335 669 168 Beta-lactamase TEM Enzyme P62593 bla; blaT-3; blaT-4; BLAT_ECOLX 10.1870999999999992 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL777 INHIBITOR \N \N \N \N Escherichia coli 162336 640 227 Dipeptidase 1 Enzyme P16444 DPEP1 DPEP1_HUMAN 6.95859999999999967 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL766 INHIBITOR \N Tclin \N \N Homo sapiens 162337 3862 427 Retinoic acid receptor gamma Nuclear hormone receptor P13631 RARG RARG_HUMAN 7.12999999999999989 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL705 AGONIST \N Tclin \N \N Homo sapiens 162339 2722 427 Retinoic acid receptor gamma Nuclear hormone receptor P13631 RARG RARG_HUMAN 6.70000000000000018 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38 AGONIST \N Tclin \N \N Homo sapiens 162341 2808 2800 Neuronal acetylcholine receptor; alpha4/beta2 Ion channel P17787|P43681 CHRNA4|CHRNB2 ACHA4_HUMAN|ACHB2_HUMAN 9.39789999999999992 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1396 AGONIST \N Tclin|Tclin \N \N Homo sapiens 162342 2752 2801 Neuronal acetylcholine receptor; alpha3/beta4 Ion channel P30926|P32297 CHRNA3|CHRNB4 ACHA3_HUMAN|ACHB4_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1245 ANTAGONIST \N Tclin|Tclin \N \N Homo sapiens 162343 1920 2800 Neuronal acetylcholine receptor; alpha4/beta2 Ion channel P17787|P43681 CHRNA4|CHRNB2 ACHA4_HUMAN|ACHB2_HUMAN 8.5600000000000005 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3 AGONIST \N Tclin|Tclin \N \N Homo sapiens 162345 1646 2801 Neuronal acetylcholine receptor; alpha3/beta4 Ion channel P30926|P32297 CHRNA3|CHRNB4 ACHA3_HUMAN|ACHB4_HUMAN 6.2218 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267936 NEGATIVE ALLOSTERIC MODULATOR \N Tclin|Tclin \N \N Homo sapiens 162349 489 2736 Neuronal acetylcholine receptor; alpha2/beta4 Ion channel P30926|Q15822 CHRNA2|CHRNB4 ACHA2_HUMAN|ACHB4_HUMAN 4.30980000000000008 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N Tchem|Tclin \N \N Homo sapiens 162352 1648 2501 Penicillin-binding protein 2 Enzyme P0AD65 mrdA PBP2_ECOLI 7.03530000000000033 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL530 INHIBITOR \N \N \N \N Escherichia coli (strain K12) 162353 564 2501 Penicillin-binding protein 2 Enzyme P0AD65 mrdA PBP2_ECOLI 6.21250000000000036 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL161 INHIBITOR \N \N \N \N Escherichia coli (strain K12) 162354 112 2497 Protein farnesyltransferase subunit beta Enzyme P49356 FNTB FNTB_HUMAN 7.30100000000000016 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N \N \N \N Homo sapiens 162355 4802 1729 Dual specificity mitogen-activated protein kinase kinase 2 Kinase P36507 MAP2K2 MP2K2_HUMAN 9.0362120000000008 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103875 INHIBITOR \N Tclin \N \N Homo sapiens 162357 4802 1728 Dual specificity mitogen-activated protein kinase kinase 1 Kinase Q02750 MAP2K1 MP2K1_HUMAN 8.74472699999999925 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103875 INHIBITOR \N Tclin \N \N Homo sapiens 162359 4758 51 Sodium/glucose cotransporter 2 Transporter P31639 SLC5A2 SC5A2_HUMAN 8.65757750000000037 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2048484 INHIBITOR \N Tclin \N \N Homo sapiens 162360 4721 1704 Microsomal triglyceride transfer protein large subunit Cytosolic other P55157 MTTP MTP_HUMAN 8.09690999999999939 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL354541 INHIBITOR \N Tclin \N \N Homo sapiens 162361 4164 1700 Glucagon-like peptide 1 receptor GPCR P43220 GLP1R GLP1R_HUMAN 10.1999999999999993 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201866 AGONIST \N Tclin \N \N Homo sapiens 162362 1851 1418 Penicillin-binding protein 1B Enzyme P02919 mrcB PBPB_ECOLI 4.63719999999999999 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL74632 INHIBITOR \N \N \N \N Escherichia coli (strain K12) 162363 564 1418 Penicillin-binding protein 1B Enzyme P02919 mrcB PBPB_ECOLI 5.74399999999999977 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL161 INHIBITOR \N \N \N \N Escherichia coli (strain K12) 162364 279 1418 Penicillin-binding protein 1B Enzyme P02919 mrcB PBPB_ECOLI 4.31669999999999998 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL158 INHIBITOR \N \N \N \N Escherichia coli (strain K12) 162365 1851 1417 Penicillin-binding protein 1A Enzyme P02918 mrcA PBPA_ECOLI 6.71640000000000015 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL74632 INHIBITOR \N \N \N \N Escherichia coli (strain K12) 162366 564 1417 Penicillin-binding protein 1A Enzyme P02918 mrcA PBPA_ECOLI 6.51349999999999962 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL161 INHIBITOR \N \N \N \N Escherichia coli (strain K12) 162367 546 1417 Penicillin-binding protein 1A Enzyme P02918 mrcA PBPA_ECOLI 6.51229999999999976 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1010 INHIBITOR \N \N \N \N Escherichia coli (strain K12) 162368 279 1417 Penicillin-binding protein 1A Enzyme P02918 mrcA PBPA_ECOLI 5.31669999999999998 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL158 INHIBITOR \N \N \N \N Escherichia coli (strain K12) 162369 1944 1247 4-hydroxyphenylpyruvate dioxygenase Enzyme P32754 HPD HPPD_HUMAN 7.39799999999999969 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1337 INHIBITOR \N Tclin \N \N Homo sapiens 162373 780 624 Ryanodine receptor 1 Ion channel P21817 RYR1 RYR1_HUMAN 6.75699999999999967 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL928 ANTAGONIST \N Tclin \N \N Homo sapiens 162375 2448 550 Dipeptidyl peptidase 4 Enzyme P27487 DPP4 DPP4_HUMAN 7.77400000000000002 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1422 INHIBITOR \N Tclin \N \N Homo sapiens 162378 2544 540 Proto-oncogene tyrosine-protein kinase receptor Ret Kinase P07949 RET RET_HUMAN 8.80000000000000071 \N IC50 \N IUPHAR = 1 DRUG LABEL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5713 http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021938s027lbl.pdf INHIBITOR \N Tclin \N 159 Homo sapiens 162379 4801 538 Serine/threonine-protein kinase B-raf Kinase P15056 BRAF BRAF_HUMAN 9.15490149999999936 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2028663 INHIBITOR \N Tclin \N \N Homo sapiens 162385 371 529 Prostaglandin F2-alpha receptor GPCR P43088 PTGFR PF2R_HUMAN 5.29999999999999982 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200963 AGONIST \N Tclin \N \N Homo sapiens 3290 866 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 3352 961 122 50S ribosomal protein L10 Ribosomal protein P15825 rpl10 RL10_HALMA \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Haloarcula marismortui (strain ATCC 43049 / DSM 3752 / JCM 8966 / VKM B-1809) 3354 1013 195 DNA gyrase subunit A Enzyme P43700 gyrA GYRA_HAEIN \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) 3358 1073 196 Probable arabinosyltransferase A Enzyme P9WNL8 embA EMBA_MYCTO \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) 3359 1073 197 Probable arabinosyltransferase B Enzyme P9WNL6 embB EMBB_MYCTO \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) 3360 1073 198 Probable arabinosyltransferase C Enzyme P9WNL5 embC EMBC_MYCTU \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) 3410 1277 70 DNA polymerase catalytic subunit Enzyme P04293 \N DPOL_HHV11 \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL182 INHIBITOR \N \N \N \N Human herpesvirus 1 (strain 17) 3411 1277 72 Thymidine kinase Kinase Q9QNF7 TK KITH_HHV1 \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Human herpesvirus 1 3467 1497 229 Catalase-peroxidase Enzyme P9WIE4 katG KATG_MYCTO \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) 162407 4337 457 Endothelin-1 receptor GPCR P25101 EDNRA EDNRA_HUMAN 9.65000000000000036 \N Ki \N WOMBAT-PK = 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022081s033lbl.pdf ANTAGONIST \N Tclin \N 611 Homo sapiens 3468 1497 230 Enoyl-[acyl-carrier-protein] reductase [NADH] Enzyme P9WGR1 inhA INHA_MYCTU \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL64 INHIBITOR \N \N \N \N Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) 3505 1582 122 50S ribosomal protein L10 Ribosomal protein P15825 rpl10 RL10_HALMA \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Haloarcula marismortui (strain ATCC 43049 / DSM 3752 / JCM 8966 / VKM B-1809) 3508 1603 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 3528 1744 240 Beta-lactam-inducible penicillin-binding protein Enzyme P07944 pbp PBP_STAAU \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Staphylococcus aureus 3558 1795 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 3573 1869 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 3618 1981 256 DNA gyrase subunit B Enzyme P0AES7 gyrB GYRB_ECO57 \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Escherichia coli O157:H7 3624 2006 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 3682 2187 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 3692 2268 557 Solute carrier family 22 member 8 Transporter Q8TCC7 SLC22A8 S22A8_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL897 INHIBITOR \N Tclin \N \N Homo sapiens 3717 2328 274 Cyclopropane mycolic acid synthase 1 Enzyme P9WPB6 cmaA1 CMAS1_MYCTO \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) 3718 2328 275 Amidase; Nicotinamidase; Nicotinamidase/pyrazinamidase; Pyrazinamidase; Pyrazinamidase/nicotinamidase; Pyrazinamidase/nicotinamidase PncA Enzyme Q50575 pncA Q50575_MYCTX \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Mycobacterium tuberculosis 3737 2383 283 Matrix protein 2 Ion channel P21430 M M2_I60A0 \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Influenza A virus (strain A/Ann Arbor/6/1960 H2N2) 3756 2416 285 Salicylic acid-binding protein 2 Enzyme Q6RYA0 SABP2 SABP2_TOBAC \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Nicotiana tabacum 3771 2481 287 30S ribosomal protein S12 Ribosomal protein P9WH62 rpsL RS12_MYCTO \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) 3774 2500 288 Dihydroorotate dehydrogenase (quinone), mitochondrial Enzyme Q08210 \N PYRD_PLAF7 \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Plasmodium falciparum (isolate 3D7) 3775 2514 289 Bifunctional protein FolC Enzyme P08192 folC FOLC_ECOLI \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Escherichia coli (strain K12) 3778 2529 288 Dihydroorotate dehydrogenase (quinone), mitochondrial Enzyme Q08210 \N PYRD_PLAF7 \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Plasmodium falciparum (isolate 3D7) 3818 2611 193 30S ribosomal protein S4 Ribosomal protein P0A7V8 rpsD RS4_ECOLI \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Escherichia coli (strain K12) 3819 2611 194 30S ribosomal protein S9 Ribosomal protein P0A7X3 rpsI RS9_ECOLI \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Escherichia coli (strain K12) 3825 2656 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 3962 536 225 Penicillin-binding protein 1 Enzyme A1KS91 ponA A1KS91_NEIMF \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Neisseria meningitidis serogroup C / serotype 2a (strain ATCC 700532 / DSM 15464 / FAM18) 3963 536 124 Penicillin-binding protein 3 Enzyme P42971 pbpC PBPC_BACSU \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Bacillus subtilis (strain 168) 3964 548 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 3965 562 308 Penicillin-binding protein Enzyme Q1J5W5 \N Q1J5W5_STRPF \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Streptococcus pyogenes serotype M4 (strain MGAS10750) 3966 562 309 Penicillin-binding protein 3 Enzyme Q60FU1 pbp3 Q60FU1_HAEIF \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Haemophilus influenzae 3968 2410 122 50S ribosomal protein L10 Ribosomal protein P15825 rpl10 RL10_HALMA \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Haloarcula marismortui (strain ATCC 43049 / DSM 3752 / JCM 8966 / VKM B-1809) 3970 521 310 Peptidoglycan synthase FtsI Enzyme P0AD68 ftsI FTSI_ECOLI \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Escherichia coli (strain K12) 162386 2632 526 Inosine-5'-monophosphate dehydrogenase 2 Enzyme P12268 IMPDH2 IMDH2_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL727 INHIBITOR \N Tclin \N \N Homo sapiens 162387 1807 524 Ceramide glucosyltransferase Enzyme Q16739 UGCG CEGT_HUMAN 5.12999999999999989 \N Ki \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4841 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1029 INHIBITOR \N Tclin \N \N Homo sapiens 162388 119 509 Renin Enzyme P00797 REN RENI_HUMAN 9.22000000000000064 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1639 INHIBITOR \N Tclin \N \N Homo sapiens 162389 391 508 Proteasome subunit alpha type-1 Enzyme P25786 PSMA1 PSA1_HUMAN 9.20759999999999934 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325041 INHIBITOR \N Tclin \N \N Homo sapiens 162390 39 495 Maltase-glucoamylase, intestinal Enzyme O43451 MGAM MGA_HUMAN 5.69679999999999964 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1566 INHIBITOR \N Tclin \N \N Homo sapiens 162392 138 494 Prostaglandin E2 receptor EP4 subtype GPCR P35408 PTGER4 PE2R4_HUMAN 8.80000000000000071 \N EC50 \N WOMBAT-PK = \N \N \N \N AGONIST \N Tclin \N \N Homo sapiens 162394 138 493 Prostaglandin E2 receptor EP2 subtype GPCR P43116 PTGER2 PE2R2_HUMAN 8 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL495 AGONIST \N Tclin \N \N Homo sapiens 162395 156 491 Alkaline phosphatase, tissue-nonspecific isozyme Enzyme P05186 ALPL PPBT_HUMAN \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N Tchem \N \N Homo sapiens 162397 1996 481 Pancreatic triacylglycerol lipase Enzyme P16233 PNLIP LIPP_HUMAN 8.90000000000000036 \N IC50 \N IUPHAR = 1 DRUG LABEL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5277 http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020766s035lbl.pdf INHIBITOR \N Tclin \N 502 Homo sapiens 162398 1283 480 UMP-CMP kinase Kinase P30085 CMPK1 KCY_HUMAN \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N Tbio \N \N Homo sapiens 162399 2620 474 cAMP-specific 3',5'-cyclic phosphodiesterase 4A Enzyme P27815 PDE4A PDE4A_HUMAN 4.11000000000000032 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190 INHIBITOR \N Tclin \N \N Homo sapiens 162402 2403 472 Sodium channel protein type 10 subunit alpha Ion channel Q9Y5Y9 SCN10A SCNAA_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1077896 BLOCKER \N Tclin \N \N Homo sapiens 162404 1999 472 Sodium channel protein type 10 subunit alpha Ion channel Q9Y5Y9 SCN10A SCNAA_HUMAN 5.20070000000000032 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL900 BLOCKER \N Tclin \N \N Homo sapiens 162405 4337 458 Endothelin B receptor GPCR P24530 EDNRB EDNRB_HUMAN 6.98000000000000043 \N Ki \N WOMBAT-PK = \N \N \N \N ANTAGONIST \N Tclin \N \N Homo sapiens 162411 2840 429 Vitamin D3 receptor Nuclear hormone receptor P11473 VDR VDR_HUMAN 9.67999999999999972 \N EC50 Agonist activity at human VDR expressed in HEK293 cells by luciferase reporter gene assay CHEMBL = 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1042 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1042 AGONIST \N Tclin \N \N Homo sapiens 162412 2838 429 Vitamin D3 receptor Nuclear hormone receptor P11473 VDR VDR_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1536 AGONIST \N Tclin \N \N Homo sapiens 162413 2066 429 Vitamin D3 receptor Nuclear hormone receptor P11473 VDR VDR_HUMAN 8.69999999999999929 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200622 AGONIST \N Tclin \N \N Homo sapiens 162414 466 429 Vitamin D3 receptor Nuclear hormone receptor P11473 VDR VDR_HUMAN 8.40000000000000036 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL846 AGONIST \N Tclin \N \N Homo sapiens 162415 3862 426 Retinoic acid receptor beta Nuclear hormone receptor P10826 RARB RARB_HUMAN 7.29999999999999982 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL705 AGONIST \N Tclin \N \N Homo sapiens 162416 2722 426 Retinoic acid receptor beta Nuclear hormone receptor P10826 RARB RARB_HUMAN 6.70000000000000018 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38 AGONIST \N Tclin \N \N Homo sapiens 162417 3862 415 Retinoic acid receptor RXR-gamma Nuclear hormone receptor P48443 RXRG RXRG_HUMAN 6.66000000000000014 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL705 AGONIST \N Tclin \N \N Homo sapiens 162419 3862 414 Retinoic acid receptor RXR-beta Nuclear hormone receptor P28702 RXRB RXRB_HUMAN 6.70000000000000018 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL705 AGONIST \N Tclin \N \N Homo sapiens 162421 3862 413 Retinoic acid receptor RXR-alpha Nuclear hormone receptor P19793 RXRA RXRA_HUMAN 6.5 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL705 AGONIST \N Tclin \N \N Homo sapiens 162423 2809 411 cGMP-specific 3',5'-cyclic phosphodiesterase Enzyme O76074 PDE5A PDE5A_HUMAN 9.15489999999999959 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1339 INHIBITOR \N Tclin \N \N Homo sapiens 162424 2441 411 cGMP-specific 3',5'-cyclic phosphodiesterase Enzyme O76074 PDE5A PDE5A_HUMAN 9 \N IC50 \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4743 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL192 INHIBITOR \N Tclin \N \N Homo sapiens 162431 2352 403 Gag-Pol polyprotein Polyprotein P03367 gag-pol POL_HV1BR 7.52289999999999992 \N IC50 \N WOMBAT-PK = \N \N \N \N INHIBITOR \N \N \N \N Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI) 162432 864 400 Carbonic anhydrase 7 Enzyme P43166 CA7 CAH7_HUMAN 7.57680000000000042 \N Ki \N WOMBAT-PK = \N \N \N \N INHIBITOR \N Tclin \N \N Homo sapiens 162433 864 399 Carbonic anhydrase 5B, mitochondrial Enzyme Q9Y2D0 CA5B CAH5B_HUMAN 7.6778000000000004 \N Ki \N WOMBAT-PK = \N \N \N \N INHIBITOR \N Tclin \N \N Homo sapiens 162434 2767 395 Peroxisome proliferator-activated receptor gamma Nuclear hormone receptor P37231 PPARG PPARG_HUMAN 6.26999999999999957 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408 AGONIST \N Tclin \N \N Homo sapiens 162436 2405 395 Peroxisome proliferator-activated receptor gamma Nuclear hormone receptor P37231 PPARG PPARG_HUMAN 7.04000000000000004 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL121 AGONIST \N Tclin \N \N Homo sapiens 162437 2179 395 Peroxisome proliferator-activated receptor gamma Nuclear hormone receptor P37231 PPARG PPARG_HUMAN 6.23000000000000043 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL595 AGONIST \N Tclin \N \N Homo sapiens 162438 4110 392 Vasopressin V2 receptor GPCR P30518 AVPR2 V2R_HUMAN 9 \N Ki \N WOMBAT-PK = 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022275s014lbl.pdf ANTAGONIST \N Tclin \N 127 Homo sapiens 162439 2707 388 DNA topoisomerase I, mitochondrial Enzyme Q969P6 TOP1MT TOP1M_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL84 INHIBITOR \N Tclin \N \N Homo sapiens 162441 1045 387 Epidermal growth factor receptor Kinase P00533 EGFR EGFR_HUMAN 9.22000000000000064 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553 INHIBITOR \N Tclin \N \N Homo sapiens 162442 939 387 Epidermal growth factor receptor Kinase P00533 EGFR EGFR_HUMAN 9.08619999999999983 \N Kd \N WOMBAT-PK = \N \N \N \N INHIBITOR \N Tclin \N \N Homo sapiens 162443 475 385 Type-1 angiotensin II receptor GPCR P30556 AGTR1 AGTR1_HUMAN \N \N \N \N UNKNOWN \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1014 ANTAGONIST \N Tclin \N \N Homo sapiens 162445 60 384 Neprilysin Enzyme P08473 MME NEP_HUMAN 9 \N IC50 Inhibition of human NEP-mediated amyloid beta hydrolysis CHEMBL = 1 KEGG DRUG https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL10247 http://www.kegg.jp/entry/D08464 INHIBITOR \N Tclin \N \N Homo sapiens 162447 785 382 Tyrosine-protein kinase ABL1 Kinase P00519 ABL1 ABL1_HUMAN 9.59999999999999964 \N IC50 \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5678 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421 INHIBITOR \N Tclin \N \N Homo sapiens 162449 2355 379 Melatonin receptor type 1B GPCR P49286 MTNR1B MTR1B_HUMAN 10.3900000000000006 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1218 AGONIST \N Tclin \N \N Homo sapiens 162451 2355 378 Melatonin receptor type 1A GPCR P48039 MTNR1A MTR1A_HUMAN 10.9000000000000004 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1218 AGONIST \N Tclin \N \N Homo sapiens 162452 2852 376 Prothrombin Enzyme P00734 F2 THRB_HUMAN 6.43179999999999996 \N Ki \N WOMBAT-PK = 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/10102460 INHIBITOR \N Tclin \N 399 Homo sapiens 162453 239 376 Prothrombin Enzyme P00734 F2 THRB_HUMAN 7.39794000000000018 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1166 INHIBITOR \N Tclin \N \N Homo sapiens 162455 2308 357 Thyroid peroxidase Enzyme P07202 TPO PERT_HUMAN 5.05999999999999961 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1518 INHIBITOR \N Tclin \N \N Homo sapiens 162456 1745 357 Thyroid peroxidase Enzyme P07202 TPO PERT_HUMAN 5.57000000000000028 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1515 INHIBITOR \N Tclin \N \N Homo sapiens 162457 2525 353 Arachidonate 5-lipoxygenase Enzyme P09917 ALOX5 LOX5_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL421 INHIBITOR \N Tclin \N \N Homo sapiens 162458 1650 353 Arachidonate 5-lipoxygenase Enzyme P09917 ALOX5 LOX5_HUMAN 4.33000000000000007 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL509 INHIBITOR \N Tclin \N \N Homo sapiens 162459 2968 342 Gonadotropin-releasing hormone receptor GPCR P30968 GNRHR GNRHR_HUMAN 9.02500000000000036 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200554 AGONIST \N Tclin \N \N Homo sapiens 4896 1010 416 Envelope glycoprotein Viral envelope protein Q53I07 gp41 Q53I07_9HIV1 \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Human immunodeficiency virus 1 162460 1868 342 Gonadotropin-releasing hormone receptor GPCR P30968 GNRHR GNRHR_HUMAN 9.69899999999999984 \N Kd \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200671 AGONIST \N Tclin \N \N Homo sapiens 162461 1559 342 Gonadotropin-releasing hormone receptor GPCR P30968 GNRHR GNRHR_HUMAN 9.52289999999999992 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200775 AGONIST \N Tclin \N \N Homo sapiens 162463 1422 341 Prostacyclin receptor GPCR P43119 PTGIR PI2R_HUMAN 7.75 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL494 AGONIST \N Tclin \N \N Homo sapiens 162464 1034 341 Prostacyclin receptor GPCR P43119 PTGIR PI2R_HUMAN 7.79999999999999982 \N Ki \N IUPHAR = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL962 AGONIST \N Tclin \N \N Homo sapiens 162465 138 340 Prostaglandin E2 receptor EP3 subtype GPCR P43115 PTGER3 PE2R3_HUMAN 9 \N EC50 \N WOMBAT-PK = \N \N \N \N AGONIST \N Tclin \N \N Homo sapiens 162466 928 338 Aldehyde dehydrogenase, mitochondrial Enzyme P05091 ALDH2 ALDH2_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL964 INHIBITOR \N Tclin \N \N Homo sapiens 162469 864 330 Carbonic anhydrase 12 Enzyme O43570 CA12 CAH12_HUMAN 7.30100000000000016 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17 INHIBITOR \N Tclin \N \N Homo sapiens 162471 2657 327 P2Y purinoceptor 12 GPCR Q9H244 P2RY12 P2Y12_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL833 ANTAGONIST \N Tclin \N \N Homo sapiens 162472 708 327 P2Y purinoceptor 12 GPCR Q9H244 P2RY12 P2Y12_HUMAN 6.90000000000000036 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1771 ANTAGONIST \N Tclin \N \N Homo sapiens 162473 2098 326 Adenosine deaminase Enzyme P00813 ADA ADA_HUMAN 10.8000000000000007 \N IC50 \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4805 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1580 INHIBITOR \N Tclin \N \N Homo sapiens 162475 2606 325 Aromatase Enzyme P11511 CYP19A1 CP19A_HUMAN 4.45999999999999996 \N Ki \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7303 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1571 INHIBITOR \N Tclin \N \N Homo sapiens 162476 1556 325 Aromatase Enzyme P11511 CYP19A1 CP19A_HUMAN 8.22000000000000064 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1444 INHIBITOR \N Tclin \N \N Homo sapiens 162478 1122 325 Aromatase Enzyme P11511 CYP19A1 CP19A_HUMAN 5.69249999999999989 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200374 INHIBITOR \N Tclin \N \N Homo sapiens 162479 210 325 Aromatase Enzyme P11511 CYP19A1 CP19A_HUMAN 6.2218 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1399 INHIBITOR \N Tclin \N \N Homo sapiens 162480 164 325 Aromatase Enzyme P11511 CYP19A1 CP19A_HUMAN 5.11000000000000032 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL488 INHIBITOR \N Tclin \N \N Homo sapiens 162483 1189 322 DNA polymerase alpha catalytic subunit Enzyme P09884 POLA1 DPOLA_HUMAN \N \N \N \N WOMBAT-PK \N 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020038s033lbl.pdf INHIBITOR \N Tclin \N 565 Homo sapiens 162485 691 322 DNA polymerase alpha catalytic subunit Enzyme P09884 POLA1 DPOLA_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1750 INHIBITOR \N Tclin \N \N Homo sapiens 162486 2609 320 Synaptic vesicular amine transporter Transporter Q05940 SLC18A2 VMAT2_HUMAN 7 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL117785 INHIBITOR \N Tclin \N \N Homo sapiens 162487 2370 320 Synaptic vesicular amine transporter Transporter Q05940 SLC18A2 VMAT2_HUMAN 7.90000000000000036 \N Ki \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4823 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL772 INHIBITOR \N Tclin \N \N Homo sapiens 162488 864 319 Carbonic anhydrase 9 Enzyme Q16790 CA9 CAH9_HUMAN 7.30100000000000016 \N Ki \N WOMBAT-PK = \N \N \N \N INHIBITOR \N Tclin \N \N Homo sapiens 162490 1140 315 Glutamate receptor ionotropic, NMDA 2B Ion channel Q13224 GRIN2B NMDE2_HUMAN 4.28399999999999981 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1094 ANTAGONIST \N Tclin \N \N Homo sapiens 162491 2704 314 Aldose reductase Enzyme P15121 AKR1B1 ALDR_HUMAN 8.5085999999999995 \N IC50 \N WOMBAT-PK = 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/6422042 INHIBITOR \N Tclin \N 347 Homo sapiens 162492 1021 314 Aldose reductase Enzyme P15121 AKR1B1 ALDR_HUMAN 7.6778000000000004 \N IC50 \N WOMBAT-PK = 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/3025043 INHIBITOR \N Tclin \N 566 Homo sapiens 162493 1851 310 Peptidoglycan synthase FtsI Enzyme P0AD68 ftsI FTSI_ECOLI 5.93829999999999991 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL74632 INHIBITOR \N \N \N \N Escherichia coli (strain K12) 162494 564 310 Peptidoglycan synthase FtsI Enzyme P0AD68 ftsI FTSI_ECOLI 6.14189999999999969 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL161 INHIBITOR \N \N \N \N Escherichia coli (strain K12) 162495 546 310 Peptidoglycan synthase FtsI Enzyme P0AD68 ftsI FTSI_ECOLI 6.24350000000000005 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1010 INHIBITOR \N \N \N \N Escherichia coli (strain K12) 162496 279 310 Peptidoglycan synthase FtsI Enzyme P0AD68 ftsI FTSI_ECOLI 5.73580000000000023 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL158 INHIBITOR \N \N \N \N Escherichia coli (strain K12) 162498 1137 304 Xanthine dehydrogenase/oxidase Enzyme P47989 XDH XDH_HUMAN 9.22000000000000064 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1164729 INHIBITOR \N Tclin \N \N Homo sapiens 162499 4112 302 Potassium voltage-gated channel subfamily KQT member 2 Ion channel O43526 KCNQ2 KCNQ2_HUMAN 8 \N IC50 \N WOMBAT-PK = \N \N \N \N BLOCKER \N Tclin \N \N Homo sapiens 162502 989 299 Gag-Pol polyprotein Polyprotein P03369 gag-pol POL_HV1A2 8.30000000000000071 \N IC50 \N WOMBAT-PK = \N \N \N \N INHIBITOR \N \N \N \N Human immunodeficiency virus type 1 group M subtype B (isolate ARV2/SF2) 162503 799 299 Gag-Pol polyprotein Polyprotein P03369 gag-pol POL_HV1A2 6.5 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N \N \N \N Human immunodeficiency virus type 1 group M subtype B (isolate ARV2/SF2) 162504 2847 298 Vitamin K epoxide reductase complex subunit 1 Enzyme Q9BQB6 VKORC1 VKOR1_HUMAN 7 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1464 INHIBITOR \N Tclin \N \N Homo sapiens 162506 2130 298 Vitamin K epoxide reductase complex subunit 1 Enzyme Q9BQB6 VKORC1 VKOR1_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL711 INHIBITOR \N Tclin \N \N Homo sapiens 162508 2351 294 Estrogen receptor beta Nuclear hormone receptor Q92731 ESR2 ESR2_HUMAN 8 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL81 MODULATOR \N Tclin \N \N Homo sapiens 4897 1893 403 Gag-Pol polyprotein Polyprotein P03367 gag-pol POL_HV1BR \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI) 162509 1255 294 Estrogen receptor beta Nuclear hormone receptor Q92731 ESR2 ESR2_HUMAN 8.74000000000000021 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1358 ANTAGONIST \N Tclin \N \N Homo sapiens 162510 128 290 5-hydroxytryptamine receptor 1F GPCR P30939 HTR1F 5HT1F_HUMAN 7.20000000000000018 \N Ki \N WOMBAT-PK = \N \N \N \N AGONIST \N Tclin \N \N Homo sapiens 162511 2632 282 Inosine-5'-monophosphate dehydrogenase 1 Enzyme P20839 IMPDH1 IMDH1_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL727 INHIBITOR \N Tclin \N \N Homo sapiens 162512 2373 282 Inosine-5'-monophosphate dehydrogenase 1 Enzyme P20839 IMPDH1 IMDH1_HUMAN 6 \N IC50 In vitro inhibition of IMPDH (isoform not specified, human and mouse assayed) IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6842 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1643 INHIBITOR \N Tclin \N \N Homo sapiens 162513 790 271 DNA (cytosine-5)-methyltransferase 1 Enzyme P26358 DNMT1 DNMT1_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201129 INHIBITOR \N Tclin \N \N Homo sapiens 162515 1797 269 Voltage-dependent T-type calcium channel subunit alpha-1H Ion channel O95180 CACNA1H CAC1H_HUMAN 6.60210000000000008 \N IC50 \N WOMBAT-PK = 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/18974361 BLOCKER \N Tclin \N 239 Homo sapiens 162516 342 269 Voltage-dependent T-type calcium channel subunit alpha-1H Ion channel O95180 CACNA1H CAC1H_HUMAN 5.14869999999999983 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1008 BLOCKER \N Tclin \N \N Homo sapiens 162523 1980 260 Somatostatin receptor type 5 GPCR P35346 SSTR5 SSR5_HUMAN 8.52289999999999992 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1680 AGONIST \N Tclin \N \N Homo sapiens 162524 1980 259 Somatostatin receptor type 3 GPCR P32745 SSTR3 SSR3_HUMAN 8.30000000000000071 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1680 AGONIST \N Tclin \N \N Homo sapiens 162525 1980 258 Somatostatin receptor type 2 GPCR P30874 SSTR2 SSR2_HUMAN 10.6989999999999998 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1680 AGONIST \N Tclin \N \N Homo sapiens 162526 2551 251 Acetylcholinesterase Enzyme P22303 ACHE ACES_HUMAN 7.13999999999999968 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL95 INHIBITOR \N Tclin \N \N Homo sapiens 162529 1897 251 Acetylcholinesterase Enzyme P22303 ACHE ACES_HUMAN 7.58999999999999986 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54126 INHIBITOR \N Tclin \N \N Homo sapiens 162531 946 251 Acetylcholinesterase Enzyme P22303 ACHE ACES_HUMAN 7.79999999999999982 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502 INHIBITOR \N Tclin \N \N Homo sapiens 162532 1878 249 Delta-type opioid receptor GPCR P41143 OPRD1 OPRD_HUMAN 7.26999999999999957 \N Ki \N WOMBAT-PK = \N \N \N \N ANTAGONIST \N Tclin \N \N Homo sapiens 162534 1874 249 Delta-type opioid receptor GPCR P41143 OPRD1 OPRD_HUMAN 6 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL895 AGONIST \N Tclin \N \N Homo sapiens 162535 1765 249 Delta-type opioid receptor GPCR P41143 OPRD1 OPRD_HUMAN 7.99000000000000021 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19019 ANTAGONIST \N Tclin \N \N Homo sapiens 162540 434 249 Delta-type opioid receptor GPCR P41143 OPRD1 OPRD_HUMAN 8.07000000000000028 \N Ki \N WOMBAT-PK = \N \N \N \N ANTAGONIST \N Tclin \N \N Homo sapiens 162542 1782 245 5-hydroxytryptamine receptor 4 GPCR Q13639 HTR4 5HT4R_HUMAN 6 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86 AGONIST \N Tclin \N \N Homo sapiens 162543 2073 241 Dihydrofolate reductase Enzyme P00374 DHFR DYR_HUMAN 5.18050000000000033 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225072 INHIBITOR \N Tclin \N \N Homo sapiens 162544 2445 238 3-hydroxy-3-methylglutaryl-coenzyme A reductase Enzyme P04035 HMGCR HMDH_HUMAN 7.76999999999999957 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1064 INHIBITOR \N Tclin \N \N Homo sapiens 162546 2214 238 3-hydroxy-3-methylglutaryl-coenzyme A reductase Enzyme P04035 HMGCR HMDH_HUMAN 8.16750000000000043 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201753 INHIBITOR \N Tclin \N \N Homo sapiens 162547 1612 238 3-hydroxy-3-methylglutaryl-coenzyme A reductase Enzyme P04035 HMGCR HMDH_HUMAN 7.66999999999999993 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL503 INHIBITOR \N Tclin \N \N Homo sapiens 162548 577 238 3-hydroxy-3-methylglutaryl-coenzyme A reductase Enzyme P04035 HMGCR HMDH_HUMAN 8 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1477 INHIBITOR \N Tclin \N \N Homo sapiens 162549 257 238 3-hydroxy-3-methylglutaryl-coenzyme A reductase Enzyme P04035 HMGCR HMDH_HUMAN 8 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1487 INHIBITOR \N Tclin \N \N Homo sapiens 162550 2279 237 Progesterone receptor Nuclear hormone receptor P06401 PGR PRGR_HUMAN 9.87609999999999921 \N ED50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL103 AGONIST \N Tclin \N \N Homo sapiens 162551 1968 237 Progesterone receptor Nuclear hormone receptor P06401 PGR PRGR_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200934 AGONIST \N Tclin \N \N Homo sapiens 162552 1963 237 Progesterone receptor Nuclear hormone receptor P06401 PGR PRGR_HUMAN 11.2596000000000007 \N ED50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1162 AGONIST \N Tclin \N \N Homo sapiens 162553 1962 237 Progesterone receptor Nuclear hormone receptor P06401 PGR PRGR_HUMAN 11.2596000000000007 \N ED50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1162 AGONIST \N Tclin \N \N Homo sapiens 162554 1959 237 Progesterone receptor Nuclear hormone receptor P06401 PGR PRGR_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200807 AGONIST \N Tclin \N \N Homo sapiens 162555 1805 237 Progesterone receptor Nuclear hormone receptor P06401 PGR PRGR_HUMAN 8.74000000000000021 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1276308 ANTAGONIST \N Tclin \N \N Homo sapiens 162557 1659 237 Progesterone receptor Nuclear hormone receptor P06401 PGR PRGR_HUMAN 9.58999999999999986 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL717 AGONIST \N Tclin \N \N Homo sapiens 162559 1572 237 Progesterone receptor Nuclear hormone receptor P06401 PGR PRGR_HUMAN 12.7958999999999996 \N ED50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1389 AGONIST \N Tclin \N \N Homo sapiens 162561 1225 237 Progesterone receptor Nuclear hormone receptor P06401 PGR PRGR_HUMAN 9.76999999999999957 \N EC50 \N WOMBAT-PK = \N \N \N \N AGONIST \N Tclin \N \N Homo sapiens 162562 1110 237 Progesterone receptor Nuclear hormone receptor P06401 PGR PRGR_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1531 AGONIST \N Tclin \N \N Homo sapiens 162563 1095 237 Progesterone receptor Nuclear hormone receptor P06401 PGR PRGR_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200624 AGONIST \N Tclin \N \N Homo sapiens 162564 968 237 Progesterone receptor Nuclear hormone receptor P06401 PGR PRGR_HUMAN 10.5 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1509 AGONIST \N Tclin \N \N Homo sapiens 162565 818 237 Progesterone receptor Nuclear hormone receptor P06401 PGR PRGR_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1533 AGONIST \N Tclin \N \N Homo sapiens 162566 779 237 Progesterone receptor Nuclear hormone receptor P06401 PGR PRGR_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1479 AGONIST \N Tclin \N \N Homo sapiens 162567 1922 236 Voltage-dependent L-type calcium channel subunit alpha-1D Ion channel Q01668 CACNA1D CAC1D_HUMAN 7.70000000000000018 \N IC50 Recombinant Cav1.3 calcium channel complexes expressed in tsA-cells IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2514 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193 GATING INHIBITOR \N Tclin \N \N Homo sapiens 162568 1511 236 Voltage-dependent L-type calcium channel subunit alpha-1D Ion channel Q01668 CACNA1D CAC1D_HUMAN 9.30000000000000071 \N IC50 Recombinant Cav1.3 calcium channel complexes expressed in tsA201-cells IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4488 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1648 GATING INHIBITOR \N Tclin \N \N Homo sapiens 162569 1142 236 Voltage-dependent L-type calcium channel subunit alpha-1D Ion channel Q01668 CACNA1D CAC1D_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1480 BLOCKER \N Tclin \N \N Homo sapiens 162570 674 236 Voltage-dependent L-type calcium channel subunit alpha-1D Ion channel Q01668 CACNA1D CAC1D_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237132 BLOCKER \N Tclin \N \N Homo sapiens 162571 183 236 Voltage-dependent L-type calcium channel subunit alpha-1D Ion channel Q01668 CACNA1D CAC1D_HUMAN 7 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1491 BLOCKER \N Tclin \N \N Homo sapiens 162572 3862 231 Retinoic acid receptor alpha Nuclear hormone receptor P10276 RARA RARA_HUMAN 6.51999999999999957 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL705 AGONIST \N Tclin \N \N Homo sapiens 162573 2722 231 Retinoic acid receptor alpha Nuclear hormone receptor P10276 RARA RARA_HUMAN 6.70000000000000018 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38 AGONIST \N Tclin \N \N Homo sapiens 162574 2255 215 Voltage-dependent calcium channel subunit alpha-2/delta-1 Ion channel P54289 CACNA2D1 CA2D1_HUMAN 7.09689999999999976 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1059 MODULATOR \N Tclin \N \N Homo sapiens 162575 1264 215 Voltage-dependent calcium channel subunit alpha-2/delta-1 Ion channel P54289 CACNA2D1 CA2D1_HUMAN 7.25999999999999979 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL940 MODULATOR \N Tclin \N \N Homo sapiens 162577 864 213 Carbonic anhydrase 1 Enzyme P00915 CA1 CAH1_HUMAN 8.30100000000000016 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17 INHIBITOR \N Tclin \N \N Homo sapiens 162578 2073 209 Thymidylate synthase Enzyme P04818 TYMS TYSY_HUMAN 6.46849999999999969 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225072 INHIBITOR \N Tclin \N \N Homo sapiens 162579 1283 209 Thymidylate synthase Enzyme P04818 TYMS TYSY_HUMAN \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N Tclin \N \N Homo sapiens 162580 480 209 Thymidylate synthase Enzyme P04818 TYMS TYSY_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1773 INHIBITOR \N Tclin \N \N Homo sapiens 162581 26 209 Thymidylate synthase Enzyme P04818 TYMS TYSY_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL185 INHIBITOR \N Tclin \N \N Homo sapiens 162582 3483 208 Lanosterol 14-alpha demethylase Enzyme P10613 ERG11 CP51_CANAL 9.39840000000000053 \N MIC \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1397 INHIBITOR \N \N \N \N Candida albicans (strain SC5314 / ATCC MYA-2876) 162583 2846 208 Lanosterol 14-alpha demethylase Enzyme P10613 ERG11 CP51_CANAL 8.73029999999999973 \N MIC \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL638 INHIBITOR \N \N \N \N Candida albicans (strain SC5314 / ATCC MYA-2876) 162584 1527 208 Lanosterol 14-alpha demethylase Enzyme P10613 ERG11 CP51_CANAL 7 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL157101 INHIBITOR \N \N \N \N Candida albicans (strain SC5314 / ATCC MYA-2876) 162585 1513 208 Lanosterol 14-alpha demethylase Enzyme P10613 ERG11 CP51_CANAL 9.24649999999999928 \N MIC \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1711 INHIBITOR \N \N \N \N Candida albicans (strain SC5314 / ATCC MYA-2876) 162586 1187 208 Lanosterol 14-alpha demethylase Enzyme P10613 ERG11 CP51_CANAL 6.69899999999999984 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL106 INHIBITOR \N \N \N \N Candida albicans (strain SC5314 / ATCC MYA-2876) 162588 973 207 3-oxo-5-alpha-steroid 4-dehydrogenase 1 Enzyme P18405 SRD5A1 S5A1_HUMAN 8.49000000000000021 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200969 INHIBITOR \N Tclin \N \N Homo sapiens 162590 1171 206 3-oxo-5-alpha-steroid 4-dehydrogenase 2 Enzyme P31213 SRD5A2 S5A2_HUMAN 8.25999999999999979 \N IC50 \N WOMBAT-PK = 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020788s024lbl.pdf INHIBITOR \N Tclin \N 107 Homo sapiens 162592 973 206 3-oxo-5-alpha-steroid 4-dehydrogenase 2 Enzyme P31213 SRD5A2 S5A2_HUMAN 9.19999999999999929 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200969 INHIBITOR \N Tclin \N \N Homo sapiens 162594 2751 204 Voltage-dependent T-type calcium channel subunit alpha-1G Ion channel O43497 CACNA1G CAC1G_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL695 BLOCKER \N Tclin \N \N Homo sapiens 162595 1087 204 Voltage-dependent T-type calcium channel subunit alpha-1G Ion channel O43497 CACNA1G CAC1G_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL696 BLOCKER \N Tclin \N \N Homo sapiens 162596 2607 203 Androgen receptor Nuclear hormone receptor P10275 AR ANDR_HUMAN 9.19999999999999929 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL386630 AGONIST \N Tclin \N \N Homo sapiens 162597 2033 203 Androgen receptor Nuclear hormone receptor P10275 AR ANDR_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200585 AGONIST \N Tclin \N \N Homo sapiens 162598 1882 203 Androgen receptor Nuclear hormone receptor P10275 AR ANDR_HUMAN 9.5 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200412 AGONIST \N Tclin \N \N Homo sapiens 4674 639 70 DNA polymerase catalytic subunit Enzyme P04293 \N DPOL_HHV11 \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL152 INHIBITOR \N \N \N \N Human herpesvirus 1 (strain 17) 162599 4749 202 Estrogen receptor Nuclear hormone receptor P03372 ESR1 ESR1_HUMAN 6.08249429999999958 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105395 MODULATOR \N Tclin \N \N Homo sapiens 162600 2709 202 Estrogen receptor Nuclear hormone receptor P03372 ESR1 ESR1_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1655 MODULATOR \N Tclin \N \N Homo sapiens 162601 1255 202 Estrogen receptor Nuclear hormone receptor P03372 ESR1 ESR1_HUMAN 9.61999999999999922 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1358 ANTAGONIST \N Tclin \N \N Homo sapiens 162602 1082 202 Estrogen receptor Nuclear hormone receptor P03372 ESR1 ESR1_HUMAN 9.83000000000000007 \N Kd \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL691 AGONIST \N Tclin \N \N Homo sapiens 162603 1057 202 Estrogen receptor Nuclear hormone receptor P03372 ESR1 ESR1_HUMAN 10.3000000000000007 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL135 AGONIST \N Tclin \N \N Homo sapiens 162605 1679 199 Glutamate receptor ionotropic, NMDA 3A Ion channel Q8TCU5 GRIN3A NMD3A_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL807 NEGATIVE ALLOSTERIC MODULATOR \N Tclin \N \N Homo sapiens 162607 842 199 Glutamate receptor ionotropic, NMDA 3A Ion channel Q8TCU5 GRIN3A NMD3A_HUMAN 5.69899999999999984 \N IC50 \N WOMBAT-PK = \N \N \N \N ANTAGONIST \N Tclin \N \N Homo sapiens 162609 2805 189 DNA topoisomerase 2-alpha Enzyme P11388 TOP2A TOP2A_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1096885 INHIBITOR \N Tclin \N \N Homo sapiens 162610 2590 189 DNA topoisomerase 2-alpha Enzyme P11388 TOP2A TOP2A_HUMAN \N \N \N Mechanism of Action; CHEMBL2094255; PROTEIN FAMILY WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL452231 INHIBITOR \N Tclin \N \N Homo sapiens 162611 1821 189 DNA topoisomerase 2-alpha Enzyme P11388 TOP2A TOP2A_HUMAN 5.95859999999999967 \N IC90 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58 INHIBITOR \N Tclin \N \N Homo sapiens 162612 1414 189 DNA topoisomerase 2-alpha Enzyme P11388 TOP2A TOP2A_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1117 INHIBITOR \N Tclin \N \N Homo sapiens 162616 786 189 DNA topoisomerase 2-alpha Enzyme P11388 TOP2A TOP2A_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL178 INHIBITOR \N Tclin \N \N Homo sapiens 162617 926 188 G protein-activated inward rectifier potassium channel 4 Ion channel P48544 KCNJ5 KCNJ5_HUMAN 4.92079999999999984 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N Tbio \N \N Homo sapiens 4395 2447 85 30S ribosomal protein S12 Cytosolic other P0A7S3 rpsL RS12_ECOLI \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Escherichia coli (strain K12) 4397 2082 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 4398 632 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 4399 1183 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 4400 524 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 4401 2083 119 Penicillin-binding protein 1A Enzyme Q8XJ01 pbpA PBPA_CLOPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Clostridium perfringens (strain 13 / Type A) 4402 2512 350 Dihydropteroate synthase Enzyme P0AC13 folP DHPS_ECOLI \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1191 INHIBITOR \N \N \N \N Escherichia coli (strain K12) 4403 2524 351 Dihydropteroate synthase type-1 Enzyme Q49184 sulI DHP1_MYCFO \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Mycobacterium fortuitum 4407 802 193 30S ribosomal protein S4 Ribosomal protein P0A7V8 rpsD RS4_ECOLI \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Escherichia coli (strain K12) 4408 802 194 30S ribosomal protein S9 Ribosomal protein P0A7X3 rpsI RS9_ECOLI \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Escherichia coli (strain K12) 4409 2041 193 30S ribosomal protein S4 Ribosomal protein P0A7V8 rpsD RS4_ECOLI \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Escherichia coli (strain K12) 4410 2041 194 30S ribosomal protein S9 Ribosomal protein P0A7X3 rpsI RS9_ECOLI \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Escherichia coli (strain K12) 4411 2468 85 30S ribosomal protein S12 Cytosolic other P0A7S3 rpsL RS12_ECOLI \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Escherichia coli (strain K12) 4412 2624 122 50S ribosomal protein L10 Ribosomal protein P15825 rpl10 RL10_HALMA \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Haloarcula marismortui (strain ATCC 43049 / DSM 3752 / JCM 8966 / VKM B-1809) 4428 1331 356 Tubulin beta chain Structural P10875 TUB2 TBB_CANAX \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Candida albicans 4454 2050 358 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase Kinase P9WNC6 folK HPPK_MYCTO \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) 4455 1083 229 Catalase-peroxidase Enzyme P9WIE4 katG KATG_MYCTO \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) 4495 1561 368 Acetylcholine receptor subunit alpha-type unc-63 Ion channel Q9N587 unc-63 ACH6_CAEEL \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Caenorhabditis elegans 4505 2241 370 Glutathione S-transferase class-mu 26 kDa isozyme Enzyme P08515 \N GST26_SCHJA \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Schistosoma japonicum 4543 365 222 Penicillin-binding protein 2 Enzyme Q9X6V3 pbpA Q9X6V3_PSEAI \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Pseudomonas aeruginosa 4544 365 223 Penicillin-binding protein 4 Enzyme Q5D1E9 \N Q5D1E9_STAAU \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Staphylococcus aureus 4545 365 224 D-ala-D-ala-carboxypeptidase; D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase family protein; Penicillin-binding protein 5 Enzyme Q9X6V7 dacA Q9X6V7_PSEAI \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Pseudomonas aeruginosa 4546 365 225 Penicillin-binding protein 1 Enzyme A1KS91 ponA A1KS91_NEIMF \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Neisseria meningitidis serogroup C / serotype 2a (strain ATCC 700532 / DSM 15464 / FAM18) 4547 365 226 D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase penicillin-binding protein 6 Enzyme Q7CHG0 dacC Q7CHG0_YERPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Yersinia pestis 4557 258 373 Ubiquinol-cytochrome-c reductase complex core protein I, mitochondrial Enzyme P43264 \N QCR1_EUGGR \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Euglena gracilis 4559 759 375 Alanine racemase Enzyme P9WQA8 alr ALR_MYCTO \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) 4619 783 389 Outer membrane porin protein OmpD Transporter Q57P83 ompD OMPD_SALCH \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Salmonella choleraesuis (strain SC-B67) 4623 1128 70 DNA polymerase catalytic subunit Enzyme P04293 \N DPOL_HHV11 \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL880 INHIBITOR \N \N \N \N Human herpesvirus 1 (strain 17) 4624 1128 71 DNA polymerase catalytic subunit Enzyme P09252 \N DPOL_VZVD \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Varicella-zoster virus (strain Dumas) 4651 2188 394 Gamma-aminobutyric acid receptor subunit beta Ion channel O18276 gab-1 GBRB_CAEEL \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Caenorhabditis elegans 4707 2798 70 DNA polymerase catalytic subunit Enzyme P04293 \N DPOL_HHV11 \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1349 INHIBITOR \N \N \N \N Human herpesvirus 1 (strain 17) 4712 1857 402 Isoleucine--tRNA ligase Enzyme P00956 ileS SYI_ECOLI \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Escherichia coli (strain K12) 162618 2815 187 Voltage-dependent L-type calcium channel subunit alpha-1C Ion channel Q13936 CACNA1C CAC1C_HUMAN 6 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1280 BLOCKER \N Tclin \N \N Homo sapiens 162619 1511 187 Voltage-dependent L-type calcium channel subunit alpha-1C Ion channel Q13936 CACNA1C CAC1C_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1648 BLOCKER \N Tclin \N \N Homo sapiens 162620 1142 187 Voltage-dependent L-type calcium channel subunit alpha-1C Ion channel Q13936 CACNA1C CAC1C_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1480 BLOCKER \N Tclin \N \N Homo sapiens 162621 897 187 Voltage-dependent L-type calcium channel subunit alpha-1C Ion channel Q13936 CACNA1C CAC1C_HUMAN 7.31880000000000042 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23 BLOCKER \N Tclin \N \N Homo sapiens 162622 674 187 Voltage-dependent L-type calcium channel subunit alpha-1C Ion channel Q13936 CACNA1C CAC1C_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237132 BLOCKER \N Tclin \N \N Homo sapiens 162623 183 187 Voltage-dependent L-type calcium channel subunit alpha-1C Ion channel Q13936 CACNA1C CAC1C_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1491 BLOCKER \N Tclin \N \N Homo sapiens 162624 2733 185 Solute carrier family 12 member 3 Transporter P55017 SLC12A3 S12A3_HUMAN 7 \N A2 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1054 INHIBITOR \N Tclin \N \N Homo sapiens 162625 2228 185 Solute carrier family 12 member 3 Transporter P55017 SLC12A3 S12A3_HUMAN 9.08999999999999986 \N A2 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1587 INHIBITOR \N Tclin \N \N Homo sapiens 162626 1433 185 Solute carrier family 12 member 3 Transporter P55017 SLC12A3 S12A3_HUMAN 7.54000000000000004 \N A2 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL406 INHIBITOR \N Tclin \N \N Homo sapiens 162627 1392 185 Solute carrier family 12 member 3 Transporter P55017 SLC12A3 S12A3_HUMAN 7.37000000000000011 \N A2 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1763 INHIBITOR \N Tclin \N \N Homo sapiens 162628 1385 185 Solute carrier family 12 member 3 Transporter P55017 SLC12A3 S12A3_HUMAN 7.00999999999999979 \N A2 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL435 INHIBITOR \N Tclin \N \N Homo sapiens 162629 609 185 Solute carrier family 12 member 3 Transporter P55017 SLC12A3 S12A3_HUMAN 5.42999999999999972 \N A2 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL842 INHIBITOR \N Tclin \N \N Homo sapiens 162630 332 185 Solute carrier family 12 member 3 Transporter P55017 SLC12A3 S12A3_HUMAN 8.16999999999999993 \N A2 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201039 INHIBITOR \N Tclin \N \N Homo sapiens 162631 305 185 Solute carrier family 12 member 3 Transporter P55017 SLC12A3 S12A3_HUMAN 8.30000000000000071 \N A2 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1684 INHIBITOR \N Tclin \N \N Homo sapiens 162632 824 184 Interleukin-4 Cytokine P05112 IL4 IL4_HUMAN 8.33000000000000007 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N Tbio \N \N Homo sapiens 162633 2475 183 Mineralocorticoid receptor Nuclear hormone receptor P08235 NR3C2 MCR_HUMAN 9.88439999999999941 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1393 ANTAGONIST \N Tclin \N \N Homo sapiens 162634 1032 183 Mineralocorticoid receptor Nuclear hormone receptor P08235 NR3C2 MCR_HUMAN 7 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1095097 ANTAGONIST \N Tclin \N \N Homo sapiens 162635 968 183 Mineralocorticoid receptor Nuclear hormone receptor P08235 NR3C2 MCR_HUMAN 10.5 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1509 ANTAGONIST \N Tclin \N \N Homo sapiens 162636 822 183 Mineralocorticoid receptor Nuclear hormone receptor P08235 NR3C2 MCR_HUMAN 11 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200592 AGONIST \N Tclin \N \N Homo sapiens 162637 897 182 Voltage-dependent calcium channel gamma-1 subunit Ion channel Q06432 CACNG1 CCG1_HUMAN 6.09999999999999964 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N Tbio \N \N Homo sapiens 162638 183 182 Voltage-dependent calcium channel gamma-1 subunit Ion channel Q06432 CACNG1 CCG1_HUMAN 7.20000000000000018 \N Ki \N WOMBAT-PK = \N \N \N \N \N \N Tbio \N \N Homo sapiens 162639 782 181 Dihydropteroate synthase 1 Enzyme P0C0X1 folP1 DHPS1_MYCLE 5.90000000000000036 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1043 INHIBITOR \N \N \N \N Mycobacterium leprae (strain TN) 162640 760 180 Peptidyl-prolyl cis-trans isomerase A Enzyme P62937 PPIA PPIA_HUMAN 8.04579999999999984 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL160 MODULATOR \N Tclin \N \N Homo sapiens 162641 760 179 Dihydroorotate dehydrogenase (quinone), mitochondrial Enzyme Q02127 DHODH PYRD_HUMAN 6.69899999999999984 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 162642 2552 178 Peptidyl-prolyl cis-trans isomerase FKBP1A Enzyme P62942 FKBP1A FKB1A_HUMAN 9.39799999999999969 \N Kd \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL269732 INHIBITOR \N Tclin \N \N Homo sapiens 162643 2446 178 Peptidyl-prolyl cis-trans isomerase FKBP1A Enzyme P62942 FKBP1A FKB1A_HUMAN 8.96000000000000085 \N Kd \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL413 INHIBITOR \N Tclin \N \N Homo sapiens 162644 2168 178 Peptidyl-prolyl cis-trans isomerase FKBP1A Enzyme P62942 FKBP1A FKB1A_HUMAN 9 \N Kd \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200686 INHIBITOR \N Tclin \N \N Homo sapiens 162645 1118 178 Peptidyl-prolyl cis-trans isomerase FKBP1A Enzyme P62942 FKBP1A FKB1A_HUMAN 8.2596399999999992 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1908360 INHIBITOR \N Tclin \N \N Homo sapiens 162646 760 178 Peptidyl-prolyl cis-trans isomerase FKBP1A Enzyme P62942 FKBP1A FKB1A_HUMAN 7.79589999999999961 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 162647 2034 176 Kappa-type opioid receptor GPCR P41145 OPRK1 OPRK_HUMAN 6.82969999999999988 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL963 AGONIST \N Tclin \N \N Homo sapiens 162648 1878 176 Kappa-type opioid receptor GPCR P41145 OPRK1 OPRK_HUMAN 8.5 \N Ki \N WOMBAT-PK = \N \N \N \N ANTAGONIST \N Tclin \N \N Homo sapiens 162649 1874 176 Kappa-type opioid receptor GPCR P41145 OPRK1 OPRK_HUMAN 8 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL895 AGONIST \N Tclin \N \N Homo sapiens 162650 1765 176 Kappa-type opioid receptor GPCR P41145 OPRK1 OPRK_HUMAN 8.92999999999999972 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19019 ANTAGONIST \N Tclin \N \N Homo sapiens 162652 847 176 Kappa-type opioid receptor GPCR P41145 OPRK1 OPRK_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1685 ANTAGONIST \N Tclin \N \N Homo sapiens 162655 434 176 Kappa-type opioid receptor GPCR P41145 OPRK1 OPRK_HUMAN 9.00999999999999979 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL511142 ANTAGONIST \N Tclin \N \N Homo sapiens 162657 3584 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN 9.08000000000000007 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL611 ANTAGONIST \N Tclin \N \N Homo sapiens 162659 2146 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN 6.90000000000000036 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1215 AGONIST \N Tclin \N \N Homo sapiens 162662 954 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN 9.09999999999999964 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL707 ANTAGONIST \N Tclin \N \N Homo sapiens 162663 429 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN \N \N \N \N WOMBAT-PK \N 1 KEGG DRUG \N http://www.kegg.jp/entry/D01887 ANTAGONIST \N Tclin \N \N Homo sapiens 162664 1992 171 5-hydroxytryptamine receptor 3A Ion channel P46098 HTR3A 5HT3A_HUMAN 7.79999999999999982 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46 ANTAGONIST \N Tclin \N \N Homo sapiens 162665 1782 171 5-hydroxytryptamine receptor 3A Ion channel P46098 HTR3A 5HT3A_HUMAN 6.69899999999999984 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86 ANTAGONIST \N Tclin \N \N Homo sapiens 162666 1329 171 5-hydroxytryptamine receptor 3A Ion channel P46098 HTR3A 5HT3A_HUMAN 8.69999999999999929 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL289469 ANTAGONIST \N Tclin \N \N Homo sapiens 162669 3584 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 9.19999999999999929 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL611 ANTAGONIST \N Tclin \N \N Homo sapiens 162671 2146 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 5.90000000000000036 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1215 AGONIST \N Tclin \N \N Homo sapiens 162672 1753 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 4.90000000000000036 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL524 AGONIST \N Tclin \N \N Homo sapiens 162673 954 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 8.84999999999999964 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL707 ANTAGONIST \N Tclin \N \N Homo sapiens 162675 228 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 7.18710000000000004 \N Ki \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 162676 659 166 DNA gyrase subunit A Enzyme P0AES4 gyrA GYRA_ECOLI 5.75 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8 INHIBITOR \N \N \N \N Escherichia coli (strain K12) 162678 659 164 DNA topoisomerase 4 subunit A Enzyme P0C1U9 parC PARC_STAAU 6 \N IC50 \N WOMBAT-PK = \N \N \N \N INHIBITOR \N \N \N \N Staphylococcus aureus 162679 864 161 Carbonic anhydrase 2 Enzyme P00918 CA2 CAH2_HUMAN 7.42020000000000035 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17 INHIBITOR \N Tclin \N \N Homo sapiens 162691 2865 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 7.29999999999999982 \N Ki \N WOMBAT-PK = \N \N \N \N ANTAGONIST \N Tchem \N \N Homo sapiens 162692 2402 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 6.07000000000000028 \N Ki \N WOMBAT-PK = \N \N \N \N AGONIST \N Tchem \N \N Homo sapiens 162693 2389 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 8 \N Ki \N WOMBAT-PK = \N \N \N \N ANTAGONIST \N Tchem \N \N Homo sapiens 162694 2172 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 8.74469999999999992 \N Ki \N WOMBAT-PK = \N \N \N \N ANTAGONIST \N Tchem \N \N Homo sapiens 162695 2105 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 7.25 \N Ki \N WOMBAT-PK = \N \N \N \N AGONIST \N Tchem \N \N Homo sapiens 162696 1982 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 8.79589999999999961 \N Ki \N WOMBAT-PK = \N \N \N \N ANTAGONIST \N Tchem \N \N Homo sapiens 162698 947 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 9 \N Ki \N WOMBAT-PK = \N \N \N \N AGONIST \N Tchem \N \N Homo sapiens 162699 722 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 7.51999999999999957 \N Ki \N WOMBAT-PK = \N \N \N \N ANTAGONIST \N Tchem \N \N Homo sapiens 162701 621 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 7.69000000000000039 \N Ki \N WOMBAT-PK = \N \N \N \N ANTAGONIST \N Tchem \N \N Homo sapiens 162703 437 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 7 \N Ki \N WOMBAT-PK = \N \N \N \N \N \N Tchem \N \N Homo sapiens 162704 242 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 6.65000000000000036 \N Ki \N WOMBAT-PK = \N \N \N \N \N \N Tchem \N \N Homo sapiens 162711 2099 149 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Enzyme Q07343 PDE4B PDE4B_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL628 INHIBITOR \N Tclin \N \N Homo sapiens 162712 976 149 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Enzyme Q07343 PDE4B PDE4B_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1752 INHIBITOR \N Tclin \N \N Homo sapiens 162714 463 148 Adenosine receptor A3 GPCR P0DMS8 ADORA3 AA3R_HUMAN 4.33000000000000007 \N Ki \N WOMBAT-PK = \N \N \N \N ANTAGONIST \N Tchem \N \N Homo sapiens 162716 463 147 Adenosine receptor A2b GPCR P29275 ADORA2B AA2BR_HUMAN 4.76999999999999957 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113 ANTAGONIST \N Tclin \N \N Homo sapiens 162718 90 147 Adenosine receptor A2b GPCR P29275 ADORA2B AA2BR_HUMAN 4.61979999999999968 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477 AGONIST \N Tclin \N \N Homo sapiens 162719 90 146 Adenosine receptor A1 GPCR P30542 ADORA1 AA1R_HUMAN 6.50860000000000039 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477 AGONIST \N Tclin \N \N Homo sapiens 162720 4501 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.49749999999999961 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201192 INHIBITOR \N Tclin \N \N Homo sapiens 162721 2440 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 6.02550000000000008 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1419 INHIBITOR \N Tclin \N \N Homo sapiens 162722 2133 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 6.88269999999999982 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200483 INHIBITOR \N Tclin \N \N Homo sapiens 162723 841 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 6.67999999999999972 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL612 RELEASING AGENT \N Tclin \N \N Homo sapiens 162727 435 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 6.28000000000000025 \N Kd \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL894 INHIBITOR \N Tclin \N \N Homo sapiens 4900 200 403 Gag-Pol polyprotein Polyprotein P03367 gag-pol POL_HV1BR \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI) 4914 1286 256 DNA gyrase subunit B Enzyme P0AES7 gyrB GYRB_ECO57 \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Escherichia coli O157:H7 4915 1286 257 DNA topoisomerase 4 subunit A Enzyme P72525 parC PARC_STRPN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL430 INHIBITOR \N \N \N \N Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4) 4925 692 419 Uncharacterized oxidoreductase CzcO-like Enzyme Q5L2G3 \N CZCO_GEOKA \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Geobacillus kaustophilus (strain HTA426) 4971 2478 299 Gag-Pol polyprotein Polyprotein P03369 gag-pol POL_HV1A2 \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Human immunodeficiency virus type 1 group M subtype B (isolate ARV2/SF2) 5017 2282 278 Bifunctional dihydrofolate reductase-thymidylate synthase Enzyme O02604 \N DRTS_PLAVI \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Plasmodium vivax 5018 2282 277 Bifunctional dihydrofolate reductase-thymidylate synthase Enzyme Q0IJY2 \N Q0IJY2_PLAMA \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Plasmodium malariae 5155 2599 208 Lanosterol 14-alpha demethylase Enzyme P10613 ERG11 CP51_CANAL \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1306 INHIBITOR \N \N \N \N Candida albicans (strain SC5314 / ATCC MYA-2876) 5176 1364 471 D-lactate dehydrogenase Enzyme P06149 dld DLD_ECOLI \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Escherichia coli (strain K12) 5275 533 478 Pencillin binding protein 2a; Penicillin binding protein 2'; Penicillin binding protein, PBP2; Penicillin-binding protein 2; Penicillin-binding protein 2'; Peptidase Unclassified O54286 mecA O54286_STAAU \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Staphylococcus aureus 5276 533 479 Penicillin-binding protein 3 Unclassified Q14TG6 pbp3 Q14TG6_HAEIF \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Haemophilus influenzae 5299 2434 208 Lanosterol 14-alpha demethylase Enzyme P10613 ERG11 CP51_CANAL \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200725 INHIBITOR \N \N \N \N Candida albicans (strain SC5314 / ATCC MYA-2876) 5303 2593 299 Gag-Pol polyprotein Polyprotein P03369 gag-pol POL_HV1A2 \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Human immunodeficiency virus type 1 group M subtype B (isolate ARV2/SF2) 5304 1243 484 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1 Enzyme Q836E5 murA1 MURA1_ENTFA \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Enterococcus faecalis (strain ATCC 700802 / V583) 5305 1243 485 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 2 Enzyme Q831A8 murA2 MURA2_ENTFA \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Enterococcus faecalis (strain ATCC 700802 / V583) 5310 534 487 Penicillin-binding protein Unclassified Q54906 dacA Q54906_STRPY \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Streptococcus pyogenes 5311 534 479 Penicillin-binding protein 3 Unclassified Q14TG6 pbp3 Q14TG6_HAEIF \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Haemophilus influenzae 5314 1896 489 Phenylalanine--tRNA ligase alpha subunit Enzyme P08312 pheS SYFA_ECOLI \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Escherichia coli (strain K12) 5315 1896 490 Phenylalanine--tRNA ligase beta subunit Enzyme P07395 pheT SYFB_ECOLI \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Escherichia coli (strain K12) 5316 1896 85 30S ribosomal protein S12 Cytosolic other P0A7S3 rpsL RS12_ECOLI \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Escherichia coli (strain K12) 5335 1358 492 Antithrombin-III Secreted P01008 SERPINC1 ANT3_HUMAN 7.84999999999999964 \N Kd Catalyses the inactivation of coagulation proteases by activatted antithrombin-III IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4214 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL526514 ACTIVATOR \N Tclin \N \N Homo sapiens 5404 103 499 Tubulin alpha chain Structural P50719 \N TBA_HAECO \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Haemonchus contortus 5414 1601 403 Gag-Pol polyprotein Polyprotein P03367 gag-pol POL_HV1BR \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI) 5417 2999 502 Acetylcholinesterase Enzyme O96529 ACHE O96529_MELIC \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Meloidogyne incognita 5426 2621 504 Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial Enzyme Q09508 sdha-1 SDHA_CAEEL \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Caenorhabditis elegans 5445 1709 222 Penicillin-binding protein 2 Enzyme Q9X6V3 pbpA Q9X6V3_PSEAI \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Pseudomonas aeruginosa 5446 1709 223 Penicillin-binding protein 4 Enzyme Q5D1E9 \N Q5D1E9_STAAU \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Staphylococcus aureus 5447 1709 224 D-ala-D-ala-carboxypeptidase; D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase family protein; Penicillin-binding protein 5 Enzyme Q9X6V7 dacA Q9X6V7_PSEAI \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Pseudomonas aeruginosa 5448 1709 225 Penicillin-binding protein 1 Enzyme A1KS91 ponA A1KS91_NEIMF \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Neisseria meningitidis serogroup C / serotype 2a (strain ATCC 700532 / DSM 15464 / FAM18) 5449 1709 226 D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase penicillin-binding protein 6 Enzyme Q7CHG0 dacC Q7CHG0_YERPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Yersinia pestis 5450 1046 222 Penicillin-binding protein 2 Enzyme Q9X6V3 pbpA Q9X6V3_PSEAI \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Pseudomonas aeruginosa 5451 1046 223 Penicillin-binding protein 4 Enzyme Q5D1E9 \N Q5D1E9_STAAU \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Staphylococcus aureus 5452 1046 224 D-ala-D-ala-carboxypeptidase; D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase family protein; Penicillin-binding protein 5 Enzyme Q9X6V7 dacA Q9X6V7_PSEAI \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Pseudomonas aeruginosa 5453 1046 225 Penicillin-binding protein 1 Enzyme A1KS91 ponA A1KS91_NEIMF \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Neisseria meningitidis serogroup C / serotype 2a (strain ATCC 700532 / DSM 15464 / FAM18) 5454 1046 226 D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase penicillin-binding protein 6 Enzyme Q7CHG0 dacC Q7CHG0_YERPE \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Yersinia pestis 162728 138 143 Prostaglandin E2 receptor EP1 subtype GPCR P34995 PTGER1 PE2R1_HUMAN 6.79999999999999982 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL495 AGONIST \N Tclin \N \N Homo sapiens 162729 2403 142 Sodium channel protein type 9 subunit alpha Ion channel Q15858 SCN9A SCN9A_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1077896 BLOCKER \N Tclin \N \N Homo sapiens 162730 1999 142 Sodium channel protein type 9 subunit alpha Ion channel Q15858 SCN9A SCN9A_HUMAN 4.76449999999999996 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL900 BLOCKER \N Tclin \N \N Homo sapiens 162731 1700 142 Sodium channel protein type 9 subunit alpha Ion channel Q15858 SCN9A SCN9A_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1087 BLOCKER \N Tclin \N \N Homo sapiens 162732 2403 141 Sodium channel protein type 8 subunit alpha Ion channel Q9UQD0 SCN8A SCN8A_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1077896 BLOCKER \N Tclin \N \N Homo sapiens 162733 1700 141 Sodium channel protein type 8 subunit alpha Ion channel Q9UQD0 SCN8A SCN8A_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1087 BLOCKER \N Tclin \N \N Homo sapiens 162734 2403 140 Sodium channel protein type 4 subunit alpha Ion channel P35499 SCN4A SCN4A_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1077896 BLOCKER \N Tclin \N \N Homo sapiens 162735 1999 140 Sodium channel protein type 4 subunit alpha Ion channel P35499 SCN4A SCN4A_HUMAN 5.65760000000000041 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL900 BLOCKER \N Tclin \N \N Homo sapiens 162736 1794 140 Sodium channel protein type 4 subunit alpha Ion channel P35499 SCN4A SCN4A_HUMAN 4.37999999999999989 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL558 BLOCKER \N Tclin \N \N Homo sapiens 162738 1700 140 Sodium channel protein type 4 subunit alpha Ion channel P35499 SCN4A SCN4A_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1087 BLOCKER \N Tclin \N \N Homo sapiens 162739 1097 140 Sodium channel protein type 4 subunit alpha Ion channel P35499 SCN4A SCN4A_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL492 BLOCKER \N Tclin \N \N Homo sapiens 162740 432 140 Sodium channel protein type 4 subunit alpha Ion channel P35499 SCN4A SCN4A_HUMAN 6 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1098 BLOCKER \N Tclin \N \N Homo sapiens 162741 4 140 Sodium channel protein type 4 subunit alpha Ion channel P35499 SCN4A SCN4A_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200749 BLOCKER \N Tclin \N \N Homo sapiens 162742 2403 139 Sodium channel protein type 3 subunit alpha Ion channel Q9NY46 SCN3A SCN3A_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1077896 BLOCKER \N Tclin \N \N Homo sapiens 162744 1700 139 Sodium channel protein type 3 subunit alpha Ion channel Q9NY46 SCN3A SCN3A_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1087 BLOCKER \N Tclin \N \N Homo sapiens 162745 2403 138 Sodium channel protein type 2 subunit alpha Ion channel Q99250 SCN2A SCN2A_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1077896 BLOCKER \N Tclin \N \N Homo sapiens 162747 1700 138 Sodium channel protein type 2 subunit alpha Ion channel Q99250 SCN2A SCN2A_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1087 BLOCKER \N Tclin \N \N Homo sapiens 162748 2872 137 Sodium channel protein type 1 subunit alpha Ion channel P35498 SCN1A SCN1A_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750 BLOCKER \N Tclin \N \N Homo sapiens 162749 2403 137 Sodium channel protein type 1 subunit alpha Ion channel P35498 SCN1A SCN1A_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1077896 BLOCKER \N Tclin \N \N Homo sapiens 162750 2114 137 Sodium channel protein type 1 subunit alpha Ion channel P35498 SCN1A SCN1A_HUMAN \N \N \N \N WOMBAT-PK \N \N \N \N \N BLOCKER \N Tclin \N \N Homo sapiens 162751 1999 137 Sodium channel protein type 1 subunit alpha Ion channel P35498 SCN1A SCN1A_HUMAN 4.88940000000000019 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL900 BLOCKER \N Tclin \N \N Homo sapiens 162752 1700 137 Sodium channel protein type 1 subunit alpha Ion channel P35498 SCN1A SCN1A_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1087 BLOCKER \N Tclin \N \N Homo sapiens 162755 427 136 Sodium/potassium-transporting ATPase subunit alpha-1 Transporter P05023 ATP1A1 AT1A1_HUMAN 7.51999999999999957 \N Kd \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 162756 2708 135 Solute carrier family 12 member 1 Transporter Q13621 SLC12A1 S12A1_HUMAN 6.40000000000000036 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1148 INHIBITOR \N Tclin \N \N Homo sapiens 162757 1258 135 Solute carrier family 12 member 1 Transporter Q13621 SLC12A1 S12A1_HUMAN 6.20000000000000018 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL35 INHIBITOR \N Tclin \N \N Homo sapiens 162758 1071 135 Solute carrier family 12 member 1 Transporter Q13621 SLC12A1 S12A1_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL456 INHIBITOR \N Tclin \N \N Homo sapiens 162760 427 135 Solute carrier family 12 member 1 Transporter Q13621 SLC12A1 S12A1_HUMAN 7.59999999999999964 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1072 INHIBITOR \N Tclin \N \N Homo sapiens 162761 419 134 Interferon gamma Cytokine P01579 IFNG IFNG_HUMAN 9.5 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 162762 824 133 Interleukin-5 Cytokine P05113 IL5 IL5_HUMAN 8.45599999999999952 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 162763 419 133 Interleukin-5 Cytokine P05113 IL5 IL5_HUMAN 9.91999999999999993 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 162764 2695 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 5.42999999999999972 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL770 ANTAGONIST \N Tclin \N \N Homo sapiens 162765 2683 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1079 AGONIST \N Tclin \N \N Homo sapiens 162766 1343 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 5.67999999999999972 \N EC50 \N WOMBAT-PK = \N \N \N \N AGONIST \N Tclin \N \N Homo sapiens 162767 922 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200833 AGONIST \N Tclin \N \N Homo sapiens 162768 704 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 6.70000000000000018 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134 AGONIST \N Tclin \N \N Homo sapiens 162769 395 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 8.46850000000000058 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL844 AGONIST \N Tclin \N \N Homo sapiens 162770 2869 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 8.90000000000000036 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1185 AGONIST \N Tclin \N \N Homo sapiens 162771 2393 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 7.90000000000000036 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL905 AGONIST \N Tclin \N \N Homo sapiens 162773 1884 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 8.79589999999999961 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1278 AGONIST \N Tclin \N \N Homo sapiens 162774 403 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 8 \N Ki \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 162775 128 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 7.5 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1505 AGONIST \N Tclin \N \N Homo sapiens 162776 2869 130 5-hydroxytryptamine receptor 1B GPCR P28222 HTR1B 5HT1B_HUMAN 7.70000000000000018 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1185 AGONIST \N Tclin \N \N Homo sapiens 27126 2875 112 Histamine H4 receptor GPCR Q9H3N8 HRH4 HRH4_HUMAN 5.70399332046508789 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 162777 2393 130 5-hydroxytryptamine receptor 1B GPCR P28222 HTR1B 5HT1B_HUMAN 6.90000000000000036 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL905 AGONIST \N Tclin \N \N Homo sapiens 162779 128 130 5-hydroxytryptamine receptor 1B GPCR P28222 HTR1B 5HT1B_HUMAN 8 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1505 AGONIST \N Tclin \N \N Homo sapiens 162780 1499 129 Beta-3 adrenergic receptor GPCR P13945 ADRB3 ADRB3_HUMAN 8.5 \N EC50 \N WOMBAT-PK = \N \N \N \N AGONIST \N Tclin \N \N Homo sapiens 162781 2726 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 9.30000000000000071 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1504 AGONIST \N Tclin \N \N Homo sapiens 162782 2253 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 8 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL635 AGONIST \N Tclin \N \N Homo sapiens 162783 2245 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 7.79999999999999982 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL131 AGONIST \N Tclin \N \N Homo sapiens 162784 1805 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 9 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1276308 ANTAGONIST \N Tclin \N \N Homo sapiens 162785 1768 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 8.5 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL650 AGONIST \N Tclin \N \N Homo sapiens 5582 104 499 Tubulin alpha chain Structural P50719 \N TBA_HAECO \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Haemonchus contortus 5626 1019 530 Protein P Polyprotein P17394 P DPOL_HBVB1 \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Hepatitis B virus genotype B1 subtype adw (isolate Japan/pJDW233/1988) 5707 1798 551 Beta-1,3-glucan synthase Unclassified Q5AIC4 GSC1 Q5AIC4_CANAL \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Candida albicans (strain SC5314 / ATCC MYA-2876) 5729 2449 256 DNA gyrase subunit B Enzyme P0AES7 gyrB GYRB_ECO57 \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Escherichia coli O157:H7 5730 2449 257 DNA topoisomerase 4 subunit A Enzyme P72525 parC PARC_STRPN \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4) 5838 1242 208 Lanosterol 14-alpha demethylase Enzyme P10613 ERG11 CP51_CANAL \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Candida albicans (strain SC5314 / ATCC MYA-2876) 5851 1240 403 Gag-Pol polyprotein Polyprotein P03367 gag-pol POL_HV1BR \N \N \N \N WOMBAT-PK \N \N \N \N \N \N \N \N \N \N Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI) 162786 1388 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 8.5 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL389621 AGONIST \N Tclin \N \N Homo sapiens 162787 1225 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 10.7400000000000002 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1473 AGONIST \N Tclin \N \N Homo sapiens 162788 1201 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 9.09999999999999964 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1512 AGONIST \N Tclin \N \N Homo sapiens 162789 824 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 8.88000000000000078 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467 AGONIST \N Tclin \N \N Homo sapiens 162791 734 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 6.01999999999999957 \N Kd \N WOMBAT-PK = 1 KEGG DRUG \N http://www.kegg.jp/entry/D00973 AGONIST \N Tclin \N \N Homo sapiens 162792 633 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 7.42999999999999972 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2040682 AGONIST \N Tclin \N \N Homo sapiens 162793 419 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 10.3000000000000007 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1370 AGONIST \N Tclin \N \N Homo sapiens 162794 348 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 8.07000000000000028 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL632 AGONIST \N Tclin \N \N Homo sapiens 162796 342 126 Voltage-dependent P/Q-type calcium channel subunit alpha-1A Ion channel O00555 CACNA1A CAC1A_HUMAN 6.59999999999999964 \N Ki \N WOMBAT-PK = \N \N \N \N BLOCKER \N Tchem \N \N Homo sapiens 162797 2712 125 Angiotensin-converting enzyme Enzyme P12821 ACE ACE_HUMAN 8.11999999999999922 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1519 INHIBITOR \N Tclin \N \N Homo sapiens 162800 2356 125 Angiotensin-converting enzyme Enzyme P12821 ACE ACE_HUMAN 8.34179999999999922 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1168 INHIBITOR \N Tclin \N \N Homo sapiens 162802 1587 125 Angiotensin-converting enzyme Enzyme P12821 ACE ACE_HUMAN 8.91999999999999993 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237 INHIBITOR \N Tclin \N \N Homo sapiens 162806 641 125 Angiotensin-converting enzyme Enzyme P12821 ACE ACE_HUMAN 8.69999999999999929 \N IC50 \N WOMBAT-PK = 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/2419701 INHIBITOR \N Tclin \N 211 Homo sapiens 162808 484 125 Angiotensin-converting enzyme Enzyme P12821 ACE ACE_HUMAN 8.69999999999999929 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1560 INHIBITOR \N Tclin \N \N Homo sapiens 162809 299 125 Angiotensin-converting enzyme Enzyme P12821 ACE ACE_HUMAN 6.50999999999999979 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL838 INHIBITOR \N Tclin \N \N Homo sapiens 162813 2620 121 cGMP-inhibited 3',5'-cyclic phosphodiesterase A Enzyme Q14432 PDE3A PDE3A_HUMAN 3.85000000000000009 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190 INHIBITOR \N Tclin \N \N Homo sapiens 162814 644 121 cGMP-inhibited 3',5'-cyclic phosphodiesterase A Enzyme Q14432 PDE3A PDE3A_HUMAN 6.70000000000000018 \N IC50 \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7148 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL799 INHIBITOR \N Tclin \N \N Homo sapiens 162815 201 121 cGMP-inhibited 3',5'-cyclic phosphodiesterase A Enzyme Q14432 PDE3A PDE3A_HUMAN 4.78000000000000025 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12856 INHIBITOR \N Tclin \N \N Homo sapiens 162816 488 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 8.09689999999999976 \N EC50 \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 162817 333 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 8.55279999999999951 \N Ki \N WOMBAT-PK = \N \N \N \N ANTAGONIST \N Tclin \N \N Homo sapiens 162818 260 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 9.28999999999999915 \N Ki \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 162819 916 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 6.95080000000000009 \N Ki \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 162820 333 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 8.95860000000000056 \N Ki \N WOMBAT-PK = \N \N \N \N ANTAGONIST \N Tclin \N \N Homo sapiens 162821 260 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 9.39000000000000057 \N Ki \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 162822 4191 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 6.27059999999999995 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201764 ANTAGONIST \N Tclin \N \N Homo sapiens 162823 2776 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1888176 ANTAGONIST \N Tclin \N \N Homo sapiens 162824 2677 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 11.0999999999999996 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1182657 ANTAGONIST \N Tclin \N \N Homo sapiens 162825 1475 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 9.29240000000000066 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1464005 ANTAGONIST \N Tclin \N \N Homo sapiens 162826 1402 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 9.80000000000000071 \N Ki \N WOMBAT-PK = 1 KEGG DRUG \N http://www.kegg.jp/entry/D00147 ANTAGONIST \N Tclin \N \N Homo sapiens 162827 722 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 7.59109999999999996 \N Ki \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 162828 584 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 7.31880000000000042 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL168815 AGONIST \N Tclin \N \N Homo sapiens 162829 488 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 8.69899999999999984 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14 AGONIST \N Tclin \N \N Homo sapiens 162830 333 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 8.95860000000000056 \N Ki \N WOMBAT-PK = \N \N \N \N ANTAGONIST \N Tclin \N \N Homo sapiens 162831 260 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 9.5 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL517712 ANTAGONIST \N Tclin \N \N Homo sapiens 162832 4191 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 6.4009999999999998 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201764 ANTAGONIST \N Tclin \N \N Homo sapiens 162833 1402 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 9.30000000000000071 \N Ki \N WOMBAT-PK = 1 KEGG DRUG \N http://www.kegg.jp/entry/D00147 ANTAGONIST \N Tclin \N \N Homo sapiens 162834 916 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 6.92079999999999984 \N Ki \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 162835 488 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 7.92079999999999984 \N EC50 \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 162836 333 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 8.85389999999999944 \N Ki \N WOMBAT-PK = \N \N \N \N ANTAGONIST \N Tclin \N \N Homo sapiens 162837 260 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 8.97000000000000064 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL517712 ANTAGONIST \N Tclin \N \N Homo sapiens 162838 2424 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 9 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL569713 ANTAGONIST \N Tclin \N \N Homo sapiens 162839 2039 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200906 ANTAGONIST \N Tclin \N \N Homo sapiens 162840 1402 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 9 \N Ki \N WOMBAT-PK = 1 KEGG DRUG \N http://www.kegg.jp/entry/D00147 ANTAGONIST \N Tclin \N \N Homo sapiens 162841 1086 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1206 ANTAGONIST \N Tclin \N \N Homo sapiens 162842 916 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 7 \N Ki \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 162843 763 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200828 ANTAGONIST \N Tclin \N \N Homo sapiens 162844 584 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 7.63830000000000009 \N EC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL168815 AGONIST \N Tclin \N \N Homo sapiens 162845 333 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 9.63640000000000008 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200383 ANTAGONIST \N Tclin \N \N Homo sapiens 162846 260 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 9.3100000000000005 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL517712 ANTAGONIST \N Tclin \N \N Homo sapiens 162847 621 112 Histamine H4 receptor GPCR Q9H3N8 HRH4 HRH4_HUMAN 6.87000000000000011 \N Ki \N WOMBAT-PK = \N \N \N \N \N \N Tchem \N \N Homo sapiens 162849 2358 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 6.86000000000000032 \N Kd \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1790041 ANTAGONIST \N Tclin \N \N Homo sapiens 162850 1955 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 6.91999999999999993 \N Kd \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3183075 ANTAGONIST \N Tclin \N \N Homo sapiens 162851 1129 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 7.92999999999999972 \N Kd \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL902 ANTAGONIST \N Tclin \N \N Homo sapiens 162852 645 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 6.13999999999999968 \N Kd \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL30 ANTAGONIST \N Tclin \N \N Homo sapiens 162853 357 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200949 AGONIST \N Tclin \N \N Homo sapiens 162855 2298 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN \N \N \N \N WOMBAT-PK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL252103 ANTAGONIST \N Tclin \N \N Homo sapiens 162856 2286 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 9.61979999999999968 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL643 ANTAGONIST \N Tclin \N \N Homo sapiens 162857 1999 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 7.95859999999999967 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL900 ANTAGONIST \N Tclin \N \N Homo sapiens 162858 1986 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 8.2840000000000007 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1719 ANTAGONIST \N Tclin \N \N Homo sapiens 162859 1605 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 6.96999999999999975 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL998 ANTAGONIST \N Tclin \N \N Homo sapiens 162861 1566 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 7.95000000000000018 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201190 ANTAGONIST \N Tclin \N \N Homo sapiens 162863 1564 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 7.27899999999999991 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237102 ANTAGONIST \N Tclin \N \N Homo sapiens 162864 1530 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 9.5085999999999995 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL534 ANTAGONIST \N Tclin \N \N Homo sapiens 162865 1400 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 8.69899999999999984 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL896 ANTAGONIST \N Tclin \N \N Homo sapiens 162866 1170 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 8 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL914 ANTAGONIST \N Tclin \N \N Homo sapiens 162867 1027 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 8.90000000000000036 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1106 ANTAGONIST \N Tclin \N \N Homo sapiens 162868 956 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 9.75 \N Ki \N WOMBAT-PK = 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022036lbl.pdf ANTAGONIST \N Tclin \N 136 Homo sapiens 162869 920 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 8.07569999999999943 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1492 ANTAGONIST \N Tclin \N \N Homo sapiens 162870 916 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 7.80999999999999961 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL657 ANTAGONIST \N Tclin \N \N Homo sapiens 162872 814 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 9.40000000000000036 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1172 ANTAGONIST \N Tclin \N \N Homo sapiens 162873 812 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 7.12000000000000011 \N Ki \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 162874 765 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 10.2218 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL516 ANTAGONIST \N Tclin \N \N Homo sapiens 162875 722 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 9.19999999999999929 \N Ki \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 162876 671 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 8.58500000000000085 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1626 ANTAGONIST \N Tclin \N \N Homo sapiens 162877 621 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 8.19999999999999929 \N Ki \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 162878 616 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 8.15000000000000036 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL505 ANTAGONIST \N Tclin \N \N Homo sapiens 162880 581 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 7.91000000000000014 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1000 ANTAGONIST \N Tclin \N \N Homo sapiens 162882 404 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 8.88610000000000078 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200967 ANTAGONIST \N Tclin \N \N Homo sapiens 162883 271 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 8.16750000000000043 \N Ki \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL639 ANTAGONIST \N Tclin \N \N Homo sapiens 162884 82 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 7.16000000000000014 \N IC50 \N WOMBAT-PK = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1224 ANTAGONIST \N Tclin \N \N Homo sapiens 162886 2105 109 D(1B) dopamine receptor GPCR P21918 DRD5 DRD5_HUMAN 6.75999999999999979 \N Ki \N WOMBAT-PK = \N \N \N \N AGONIST \N Tchem \N \N Homo sapiens 162887 947 109 D(1B) dopamine receptor GPCR P21918 DRD5 DRD5_HUMAN 9 \N Ki \N WOMBAT-PK = \N \N \N \N AGONIST \N Tchem \N \N Homo sapiens 162888 722 109 D(1B) dopamine receptor GPCR P21918 DRD5 DRD5_HUMAN 6.59410000000000007 \N Ki \N WOMBAT-PK = \N \N \N \N \N \N Tchem \N \N Homo sapiens 162889 2865 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 8.14000000000000057 \N Ki \N WOMBAT-PK = \N \N \N \N ANTAGONIST \N Tclin \N \N Homo sapiens 162890 2637 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 7.29999999999999982 \N IC50 \N WOMBAT-PK = \N \N \N \N ANTAGONIST \N Tclin \N \N Homo sapiens 162892 2402 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 7.42999999999999972 \N Ki \N WOMBAT-PK = \N \N \N \N AGONIST \N Tclin \N \N Homo sapiens 162893 2389 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 8.07000000000000028 \N Ki \N WOMBAT-PK = \N \N \N \N ANTAGONIST \N Tclin \N \N Homo sapiens 180708 759 2779 Glutamate NMDA receptor Ion channel P35439|Q00959|Q00960|Q00961|Q62645|Q8VHN2|Q9R1M7 Grin1|Grin2a|Grin2b|Grin2c|Grin2d|Grin3a|Grin3b NMD3A_RAT|NMD3B_RAT|NMDE1_RAT|NMDE2_RAT|NMDE3_RAT|NMDE4_RAT|NMDZ1_RAT 5.63999999999999968 \N IC50 In vitro inhibition of [3H]glycine at NMDA receptor CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL771 \N \N \N \N \N \N Rattus norvegicus 180709 759 1344 D-alanine--D-alanine ligase Enzyme P9WP31 ddl DDL_MYCTU \N \N \N Mechanism of Action; CHEMBL2030; SINGLE PROTEIN CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL771 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL771 INHIBITOR \N \N \N \N Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) 180710 759 1345 Alanine racemase Enzyme P9WQA9 alr ALR_MYCTU \N \N \N Mechanism of Action; CHEMBL2031; SINGLE PROTEIN CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL771 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL771 INHIBITOR \N \N \N \N Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) 180711 3097 1772 Acetylcholine receptor subunit delta Ion channel P02718 chrnd ACHD_TORCA 4.37999999999999989 \N Ki Binding affinity towards rat forebrain nicotinic acetylcholine receptor using [3H]EB as radioligand CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL920 \N \N \N \N \N \N Torpedo californica 180712 3097 2728 Neuronal acetylcholine receptor; alpha4/beta4 Ion channel P09483|P12392 Chrna4|Chrnb4 ACHA4_RAT|ACHB4_RAT 4.46999999999999975 \N Ki Binding affinity towards rat Nicotinic acetylcholine receptor alpha4-beta4 expressed in HEK293 cells using [3H]EB as radioligand CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL920 \N \N \N \N \N \N Rattus norvegicus 180713 3097 2727 Neuronal acetylcholine receptor; alpha4/beta2 Ion channel P09483|P12390 Chrna4|Chrnb2 ACHA4_RAT|ACHB2_RAT 4.42999999999999972 \N Ki Binding affinity towards rat Nicotinic acetylcholine receptor alpha4-beta2 expressed in HEK293 cells using [3H]EB as radioligand CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL920 \N \N \N \N \N \N Rattus norvegicus 180714 3097 3519 Creatine transporter Unclassified P28570 Slc6a8 SC6A8_RAT 4.37999999999999989 \N Ki Inhibition of [3H]-choline brain uptake was determined by in situ brain perfusion studies in male rats CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL920 \N \N \N \N \N \N Rattus norvegicus 27127 2875 106 Alpha-1A adrenergic receptor GPCR P35348 ADRA1A ADA1A_HUMAN 8.15490150451660156 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27128 2875 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.44117164611816406 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 180715 3097 2725 Neuronal acetylcholine receptor; alpha3/beta2 Ion channel P04757|P12390 Chrna3|Chrnb2 ACHA3_RAT|ACHB2_RAT 4.42999999999999972 \N Ki Binding affinity towards rat Nicotinic acetylcholine receptor alpha3-beta2 expressed in HEK293 cells using [3H]EB as radioligand CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL920 \N \N \N \N \N \N Rattus norvegicus 180716 3097 2726 Neuronal acetylcholine receptor; alpha3/beta4 Ion channel P04757|P12392 Chrna3|Chrnb4 ACHA3_RAT|ACHB4_RAT 4.32000000000000028 \N Ki Binding affinity towards rat Nicotinic acetylcholine receptor alpha3-beta4 expressed in HEK293 cells using [3H]EB as radioligand CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL920 \N \N \N \N \N \N Rattus norvegicus 180717 3097 2724 Neuronal acetylcholine receptor; alpha2/beta2 Ion channel P12389|P12390 Chrna2|Chrnb2 ACHA2_RAT|ACHB2_RAT 4.74000000000000021 \N Ki Binding affinity towards rat nicotinic acetylcholine receptor alpha2-beta2 expressed in HEK293 cells using [3H]EB as radioligand CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL920 \N \N \N \N \N \N Rattus norvegicus 180718 3097 1961 High affinity choline transporter 1 Unclassified Q8BGY9 Slc5a7 SC5A7_MOUSE 5.79999999999999982 \N IC50 In vitro ability to inhibit the transport of [3H]choline in to high affinity choline transport system HAChT CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL920 \N \N \N \N \N \N Mus musculus 180719 3524 751 Carbonic anhydrase 14 Enzyme Q9ULX7 CA14 CAH14_HUMAN 4.96999999999999975 \N Ki Inhibition of human carbonic anhydrase 14 by stopped-flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24147 \N \N \N Tclin \N \N Homo sapiens 180720 3524 398 Carbonic anhydrase 5A, mitochondrial Enzyme P35218 CA5A CAH5A_HUMAN 5.05999999999999961 \N Ki Inhibition of human carbonic anhydrase 5A by stopped-flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24147 \N \N \N Tclin \N \N Homo sapiens 180721 3524 1746 Carbonic anhydrase 13 Enzyme Q9D6N1 Ca13 CAH13_MOUSE 4.20000000000000018 \N Ki Inhibition of mouse carbonic anhydrase 13 by stopped-flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24147 \N \N \N \N \N \N Mus musculus 180722 3524 319 Carbonic anhydrase 9 Enzyme Q16790 CA9 CAH9_HUMAN 4.16000000000000014 \N Ki Inhibition of human carbonic anhydrase 9 catalytic domain by stopped-flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24147 \N \N \N Tclin \N \N Homo sapiens 180723 3524 330 Carbonic anhydrase 12 Enzyme O43570 CA12 CAH12_HUMAN 5.12000000000000011 \N Ki Inhibition of human carbonic anhydrase 12 catalytic domain by stopped-flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24147 \N \N \N Tclin \N \N Homo sapiens 180724 3524 2436 Carbonic anhydrase Unclassified Q2PCB5 ca Q2PCB5_DICLA 5.19000000000000039 \N Ki Inhibition of Dicentrarchus labrax CA using 4-nitrophenylacetate substrate by esterase assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24147 \N \N \N \N \N \N Dicentrarchus labrax 180725 3524 399 Carbonic anhydrase 5B, mitochondrial Enzyme Q9Y2D0 CA5B CAH5B_HUMAN 5.15000000000000036 \N Ki Inhibition of human carbonic anhydrase 5B by stopped-flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24147 \N \N \N Tclin \N \N Homo sapiens 180726 3524 1784 Prostaglandin G/H synthase 1 Enzyme P05979 PTGS1 PGH1_SHEEP 4.05999999999999961 \N Kd Binding affinity to COX1 in sheep seminal vesicle CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24147 \N \N \N \N \N \N Ovis aries 180727 3524 161 Carbonic anhydrase 2 Enzyme P00918 CA2 CAH2_HUMAN 5.11000000000000032 \N Ki Inhibition of human carbonic anhydrase 2 by stopped-flow CO2 hydrase assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24147 \N \N \N Tclin \N \N Homo sapiens 180728 3282 751 Carbonic anhydrase 14 Enzyme Q9ULX7 CA14 CAH14_HUMAN 4.37999999999999989 \N Ki Inhibition of human carbonic anhydrase 14 by stopped-flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL537 \N \N \N Tclin \N \N Homo sapiens 180729 3282 220 Carbonic anhydrase 4 Enzyme P22748 CA4 CAH4_HUMAN 4.96999999999999975 \N Ki Inhibition of human carbonic anhydrase 4 by stopped-flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL537 \N \N \N Tclin \N \N Homo sapiens 180730 3282 213 Carbonic anhydrase 1 Enzyme P00915 CA1 CAH1_HUMAN 4.96999999999999975 \N Ki Inhibition of human carbonic anhydrase 1 by stopped-flow CO2 hydrase assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL537 \N \N \N Tclin \N \N Homo sapiens 180731 3282 398 Carbonic anhydrase 5A, mitochondrial Enzyme P35218 CA5A CAH5A_HUMAN 4.84999999999999964 \N Ki Inhibition of human carbonic anhydrase 5A by stopped-flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL537 \N \N \N Tclin \N \N Homo sapiens 180732 3282 1746 Carbonic anhydrase 13 Enzyme Q9D6N1 Ca13 CAH13_MOUSE 4.12999999999999989 \N Ki Inhibition of mouse carbonic anhydrase 13 by stopped-flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL537 \N \N \N \N \N \N Mus musculus 180733 3282 319 Carbonic anhydrase 9 Enzyme Q16790 CA9 CAH9_HUMAN 4.49000000000000021 \N Ki Inhibition of human carbonic anhydrase 9 catalytic domain by stopped-flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL537 \N \N \N Tclin \N \N Homo sapiens 180734 3282 330 Carbonic anhydrase 12 Enzyme O43570 CA12 CAH12_HUMAN 5.11000000000000032 \N Ki Inhibition of human carbonic anhydrase 12 catalytic domain by stopped-flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL537 \N \N \N Tclin \N \N Homo sapiens 180735 3282 2073 Carbonic anhydrase 15 Enzyme Q99N23 Ca15 CAH15_MOUSE 4.96999999999999975 \N Ki Inhibition of mouse recombinant carbonic anhydrase 15 by stopped-flow CO2 hydrase assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL537 \N \N \N \N \N \N Mus musculus 180736 3282 2436 Carbonic anhydrase Unclassified Q2PCB5 ca Q2PCB5_DICLA 5.23000000000000043 \N Ki Inhibition of Dicentrarchus labrax CA using 4-nitrophenylacetate substrate by esterase assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL537 \N \N \N \N \N \N Dicentrarchus labrax 180737 3282 399 Carbonic anhydrase 5B, mitochondrial Enzyme Q9Y2D0 CA5B CAH5B_HUMAN 4.90000000000000036 \N Ki Inhibition of human carbonic anhydrase 5B by stopped-flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL537 \N \N \N Tclin \N \N Homo sapiens 180738 3282 2031 Polyphenol oxidase 2 Enzyme O42713 PPO2 PPO2_AGABI 5.00999999999999979 \N IC50 Inhibition of mushroom tyrosinase activity after 20 mins CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL537 \N \N \N \N \N \N Agaricus bisporus 180739 3282 682 Carbonic anhydrase 3 Enzyme P07451 CA3 CAH3_HUMAN 5.08999999999999986 \N Ki Inhibition of human carbonic anhydrase 3 by stopped-flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL537 \N \N \N Tclin \N \N Homo sapiens 180740 3282 161 Carbonic anhydrase 2 Enzyme P00918 CA2 CAH2_HUMAN 7.04999999999999982 \N Ki Inhibition of human carbonic anhydrase 2 by stopped-flow CO2 hydrase assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL537 \N \N \N Tclin \N \N Homo sapiens 180741 1375 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 4.29999999999999982 \N Ki Displacement of [125I]iodoaminopotentidine from human histamine H2 receptor expressed in CHO cells CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90 \N \N \N Tclin \N \N Homo sapiens 180742 1375 1747 Histamine H2 receptor GPCR P47747 HRH2 HRH2_CAVPO 6 \N EC50 Agonist activity at guinea pig atrium histamine H2 receptor assessed as potentiation of histamine-induced response after 30 mins CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90 \N \N \N \N \N \N Cavia porcellus 180743 1375 112 Histamine H4 receptor GPCR Q9H3N8 HRH4 HRH4_HUMAN 8.09999999999999964 \N Ki Displacement of [3H]-histamine from human histamine H4 receptor expressed in Sf9 cells coexpressing RGS19, Galphai2, Gbeta1gamma2 CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90 \N \N \N Tchem \N \N Homo sapiens 180744 1375 788 Histamine H3 receptor GPCR Q9Y5N1 HRH3 HRH3_HUMAN 8.27999999999999936 \N Ki Displacement of [3H[N-alpha-methylhistamine form human recombinant histamine H3 receptor expressed in CHO cells after 1 hr by liquid scintillation counting CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90 \N \N \N Tclin \N \N Homo sapiens 180745 1375 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 4.09999999999999964 \N Ki Displacement of [3H]mepyramine from human wild-type histamine H1 receptor expressed in COS-7 cells by liquid scintillation counting CHEMBL = 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90 AGONIST \N Tclin \N \N Homo sapiens 180746 1375 2402 Histamine H4 receptor GPCR Q91ZY2 Hrh4 HRH4_MOUSE 7.09999999999999964 \N Ki Binding affinity to mouse histamine H4 receptor expressed in human SK-N-MC cells by radioligand displacement assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90 \N \N \N \N \N \N Mus musculus 180747 1375 2154 Histamine H3 receptor GPCR P58406 Hrh3 HRH3_MOUSE 7.16999999999999993 \N Ki Displacement of 3-([1,1,1-3H]methyl)-2-(4-{[3-(1-pyrrolidinyl)propyl]oxy}phenyl)-4(3H)-quinazolinone from mouse histamine H3 receptor expressed in HEK293 cells CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90 \N \N \N \N \N \N Mus musculus 180748 1375 2403 Histamine H4 receptor GPCR Q91ZY1 Hrh4 HRH4_RAT 7.20000000000000018 \N Ki Binding affinity to rat histamine H4 receptor expressed in human SK-N-MC cells by radioligand displacement assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90 \N \N \N \N \N \N Rattus norvegicus 180749 1745 3520 Dopamine beta-hydroxylase Unclassified P15101 DBH DOPO_BOVIN 4.34999999999999964 \N Ki Compound was evaluated for the inhibition of Dopamine beta hydroxylase at pH 4.5 CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1515 \N \N \N \N \N \N Bos taurus 180750 1745 2599 Lactoperoxidase Enzyme P80025 LPO PERL_BOVIN 5.08000000000000007 \N IC50 Inhibition of Bos taurus (bovine) milk lactoperoxidase-catalyzed iodination of L-tyrosine substrate by reverse phase HPLC analysis CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1515 \N \N \N \N \N \N Bos taurus 180751 1745 3415 Lactoperoxidase Enzyme P22079 LPO PERL_HUMAN 4.92999999999999972 \N IC50 Inhibition of lactoperoxidase-catalyzed iodination of L-tyrosine assessed as 3,5-diiodo-L-tyrosine formation by HPLC CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1515 \N \N \N Tbio \N \N Homo sapiens 180752 3229 930 Egl nine homolog 1 Enzyme Q9GZT9 EGLN1 EGLN1_HUMAN 4.71999999999999975 \N IC50 Inhibition of 2-oxoglutarate-dependent human recombinant HIF PHD2 preincubated for 1 hr CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL503160 \N \N \N Tclin \N \N Homo sapiens 180753 2487 930 Egl nine homolog 1 Enzyme Q9GZT9 EGLN1 EGLN1_HUMAN 5.51999999999999957 \N IC50 Inhibition of 2-oxoglutarate-dependent human recombinant HIF PHD2 preincubated for 1 hr CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL576 \N \N \N Tclin \N \N Homo sapiens 180754 1906 3417 NAD-dependent deacetylase sirtuin 3 Enzyme Q9NTG7 SIRT3 SIR3_HUMAN 4.84999999999999964 \N IC50 Inhibition of human recombinant SIRT3 after 60 mins by fluorimetric analysis CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1140 \N \N \N Tchem \N \N Homo sapiens 180755 1906 1976 Fatty-acid amide hydrolase 1 Enzyme P97612 Faah FAAH1_RAT 5.48000000000000043 \N IC50 Inhibition of Wistar rat brain FAAH CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1140 \N \N \N \N \N \N Rattus norvegicus 180756 1906 842 NAD-dependent protein deacetylase sirtuin-2 Enzyme Q8IXJ6 SIRT2 SIR2_HUMAN 5.91999999999999993 \N IC50 Inhibition of recombinant SIRT2 using ZMAL substrate after 4 hrs by homogeneous fluorescence assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1140 \N \N \N Tchem \N \N Homo sapiens 180757 1906 3418 NAD-dependent protein deacylase sirtuin-5, mitochondrial Enzyme Q9NXA8 SIRT5 SIR5_HUMAN 4.33000000000000007 \N IC50 Inhibition of SIRT5 using ZK(suc)A substrate after 1 hr by homogeneous fluorescence assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1140 \N \N \N Tbio \N \N Homo sapiens 180758 1906 3416 NAD-dependent deacetylase HST2 Enzyme P53686 HST2 HST2_YEAST 4.04000000000000004 \N IC50 Inhibition of yeast Hst2 by fluorimetric assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1140 \N \N \N \N \N \N Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 180759 1906 3521 Putative silent information regulator 2 Unclassified Q8I6E4 SIR2RP1 Q8I6E4_LEIIN 4.40000000000000036 \N IC50 Inhibition of Leishmania infantum SIR2RP1 CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1140 \N \N \N \N \N \N Leishmania infantum 180760 1906 826 NAD-dependent protein deacetylase sirtuin-1 Enzyme Q96EB6 SIRT1 SIR1_HUMAN 4.29999999999999982 \N IC50 Inhibition of recombinant SIRT1 using ZMAL substrate after 4 hrs by homogeneous fluorescence assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1140 \N \N \N Tchem \N \N Homo sapiens 180761 2835 2052 Hydroxycarboxylic acid receptor 2 GPCR Q9EP66 Hcar2 HCAR2_MOUSE 6.84999999999999964 \N IC50 Displacement of [3H]niacin from mouse GPR109A CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL573 \N \N \N \N \N \N Mus musculus 180762 2835 1982 Hydroxycarboxylic acid receptor 2 GPCR Q80Z39 Hcar2 HCAR2_RAT 7.48000000000000043 \N Ki Inhibition of [3H]-nicotinic acid (20 nM) binding to nicotinic acid receptor in rat spleen membrane. CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL573 \N \N \N \N \N \N Rattus norvegicus 180763 2835 361 Hydroxycarboxylic acid receptor 2 GPCR Q8TDS4 HCAR2 HCAR2_HUMAN 7.29999999999999982 \N Ki Displacement of [3H]nicotinic acid from human GPR109a receptor expressed in CHO cells CHEMBL = 1 SCIENTIFIC LITERATURE https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL573 http://www.ncbi.nlm.nih.gov/pubmed/17705685 AGONIST \N Tclin \N 501 Homo sapiens 180764 2328 2636 3-oxoacyl-ACP synthase; Fatty acid synthase Fas; Probable fatty acid synthase Fas (Fatty acid synthetase) Enzyme P95029 fas P95029_MYCTU \N \N \N Mechanism of Action; CHEMBL2011; SINGLE PROTEIN CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL614 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL614 INHIBITOR \N \N \N \N Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) 180765 1334 213 Carbonic anhydrase 1 Enzyme P00915 CA1 CAH1_HUMAN 4.21999999999999975 \N Ki Inhibition of human erythrocyte CA1 esterase activity using 4-nitrophenyl acetate substrate CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL13766 \N \N \N Tclin \N \N Homo sapiens 180766 1334 161 Carbonic anhydrase 2 Enzyme P00918 CA2 CAH2_HUMAN 5.53000000000000025 \N Ki Inhibition of human erythrocyte CA2 esterase activity using 4-nitrophenyl acetate substrate CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL13766 \N \N \N Tclin \N \N Homo sapiens 27130 2875 284 5-hydroxytryptamine receptor 5A GPCR P47898 HTR5A 5HT5A_HUMAN 7.53760194778442383 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 180767 1241 70 DNA polymerase catalytic subunit Enzyme P04293 \N DPOL_HHV11 4.12999999999999989 \N IC50 Inhibition of HSV-1 DNA polymerase in HSV-1 C42 plaque reduction assay CHEMBL = 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL666 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL666 INHIBITOR \N \N \N \N Human herpesvirus 1 (strain 17) 180768 1241 1743 Reverse transcriptase/RNaseH Enzyme Q72547 pol Q72547_9HIV1 5.69000000000000039 \N IC50 Inhibitory activity against HIV-1 reverse transcriptase CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL666 \N \N \N \N \N \N Human immunodeficiency virus 1 180769 1241 212 DNA polymerase catalytic subunit Enzyme P08546 UL54 DPOL_HCMVA 5.59999999999999964 \N IC50 Inhibition of human cytomegalovirus DNA polymerase (95 uL) activity in a solution containing 6.4 mM HEPES (pH 7.5), incubation for 12 minutes at 26 degrees C CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL666 \N \N \N \N \N \N Human cytomegalovirus (strain AD169) 27018 4137 112 Histamine H4 receptor GPCR Q9H3N8 HRH4 HRH4_HUMAN 5.06058073043823242 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27020 4137 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 5.61726284027099609 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27021 4137 284 5-hydroxytryptamine receptor 5A GPCR P47898 HTR5A 5HT5A_HUMAN 6.55611133575439453 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27022 4137 340 Prostaglandin E2 receptor EP3 subtype GPCR P43115 PTGER3 PE2R3_HUMAN 5 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27023 4137 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 7.20859003067016602 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27024 4137 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 9.04575729370117188 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27025 4137 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN 9.15490150451660156 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27026 4137 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 8.25103759765625 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27027 4137 105 5-hydroxytryptamine receptor 7 GPCR P34969 HTR7 5HT7R_HUMAN 8.56863594055175781 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27028 4137 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.42980766296386719 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27029 4137 339 5-hydroxytryptamine receptor 1E GPCR P28566 HTR1E 5HT1E_HUMAN 5.99139976501464844 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27030 4137 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 7.31875896453857422 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27031 4137 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 8.95860767364501953 \N Ki \N PDSP = 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021999s029lbl.pdf ANTAGONIST \N Tclin \N 306 Homo sapiens 27032 4137 130 5-hydroxytryptamine receptor 1B GPCR P28222 HTR1B 5HT1B_HUMAN 7.63827228546142578 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27033 4137 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 7.72124624252319336 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27034 4137 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 6.91649723052978516 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27035 4137 109 D(1B) dopamine receptor GPCR P21918 DRD5 DRD5_HUMAN 7.53760194778442383 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27036 4137 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 7.26520013809204102 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27037 4137 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 7.38684558868408203 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27038 4137 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 8.19520282745361328 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27039 4137 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 7.6354985237121582 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27040 4137 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 8.47002887725830078 \N Ki \N PDSP = 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021999s029lbl.pdf ANTAGONIST \N Tclin \N 306 Homo sapiens 27041 4137 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 7.92539024353027344 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27042 4137 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 6.21767902374267578 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27047 3912 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 8.66487693786621094 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27048 3912 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 9.37236404418945312 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27049 3912 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 9.39793968200683594 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27051 3658 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 6.8899998664855957 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27052 3658 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 5.98000001907348633 \N Ki \N PDSP = 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/20030735 AGONIST \N Tclin \N 269 Homo sapiens 27053 3658 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 7.82000017166137695 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27056 3652 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 6.40000009536743164 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27057 3652 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN 5.80000019073486328 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27066 3652 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 6 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27072 3620 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 6.55999994277954102 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27073 3620 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.8600001335144043 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27074 3620 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 7.5 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27079 3584 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 5.44977188110351562 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27102 3369 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 6.3899998664855957 \N Ki \N PDSP = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL761 AGONIST \N Tclin \N \N Homo sapiens 27103 3369 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.3899998664855957 \N Ki \N PDSP = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL761 AGONIST \N Tclin \N \N Homo sapiens 27104 3369 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 7.67999982833862305 \N Ki \N PDSP = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL761 AGONIST \N Tclin \N \N Homo sapiens 27120 3294 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 5.30998134613037109 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27123 3294 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 5.07998085021972656 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27124 3294 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 5.4800410270690918 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27125 2875 55 Beta-2 adrenergic receptor GPCR P07550 ADRB2 ADRB2_HUMAN 5.63827228546142578 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27131 2875 171 5-hydroxytryptamine receptor 3A Ion channel P46098 HTR3A 5HT3A_HUMAN 6.32605791091918945 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27133 2875 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN 8.30103015899658203 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27136 2875 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 6.82102298736572266 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27142 2875 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 6.30103015899658203 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27143 2875 109 D(1B) dopamine receptor GPCR P21918 DRD5 DRD5_HUMAN 6.60554838180541992 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 180774 2153 882 Beta-secretase 1 Enzyme P56817 BACE1 BACE1_HUMAN 4.44000000000000039 \N IC50 Inhibition of human recombinant BACE1 after 60 mins by FRET assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL473159 \N \N \N Tchem \N \N Homo sapiens 180775 3508 751 Carbonic anhydrase 14 Enzyme Q9ULX7 CA14 CAH14_HUMAN 5.54000000000000004 \N Ki Inhibition of human recombinant carbonic anhydrase 14 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356238 \N \N \N Tclin \N \N Homo sapiens 180776 3508 220 Carbonic anhydrase 4 Enzyme P22748 CA4 CAH4_HUMAN 5.20999999999999996 \N Ki Inhibition of human recombinant carbonic anhydrase 4 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356238 \N \N \N Tclin \N \N Homo sapiens 180777 3508 400 Carbonic anhydrase 7 Enzyme P43166 CA7 CAH7_HUMAN 5.11000000000000032 \N Ki Inhibition of human recombinant carbonic anhydrase 7 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356238 \N \N \N Tclin \N \N Homo sapiens 180778 3508 398 Carbonic anhydrase 5A, mitochondrial Enzyme P35218 CA5A CAH5A_HUMAN 5.29000000000000004 \N Ki Inhibition of human recombinant carbonic anhydrase 5A preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356238 \N \N \N Tclin \N \N Homo sapiens 180779 3508 319 Carbonic anhydrase 9 Enzyme Q16790 CA9 CAH9_HUMAN 5.75999999999999979 \N Ki Inhibition of human recombinant carbonic anhydrase 9 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356238 \N \N \N Tclin \N \N Homo sapiens 180780 3508 330 Carbonic anhydrase 12 Enzyme O43570 CA12 CAH12_HUMAN 5.26999999999999957 \N Ki Inhibition of human recombinant carbonic anhydrase 12 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356238 \N \N \N Tclin \N \N Homo sapiens 180781 3508 690 Carbonic anhydrase 6 Enzyme P23280 CA6 CAH6_HUMAN 5.62000000000000011 \N Ki Inhibition of human recombinant carbonic anhydrase 6 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356238 \N \N \N Tclin \N \N Homo sapiens 180782 3508 2055 Carbonic anhydrase 13 Enzyme Q8N1Q1 CA13 CAH13_HUMAN 5.37999999999999989 \N Ki Inhibition of human recombinant carbonic anhydrase 13 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356238 \N \N \N Tclin \N \N Homo sapiens 180783 3508 399 Carbonic anhydrase 5B, mitochondrial Enzyme Q9Y2D0 CA5B CAH5B_HUMAN 5.45000000000000018 \N Ki Inhibition of human recombinant carbonic anhydrase 5B preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356238 \N \N \N Tclin \N \N Homo sapiens 180784 3508 682 Carbonic anhydrase 3 Enzyme P07451 CA3 CAH3_HUMAN 5.79000000000000004 \N Ki Inhibition of human recombinant carbonic anhydrase 3 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356238 \N \N \N Tclin \N \N Homo sapiens 180785 1188 602 Thymidylate synthase Enzyme P0CS13 TMP1 TYSY_CRYNB \N \N \N Mechanism of Action; CHEMBL4665; SINGLE PROTEIN CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1463 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1463 INHIBITOR \N \N \N \N Cryptococcus neoformans var. neoformans serotype D (strain B-3501A) 180786 2819 3522 Gamma-amino-N-butyrate transaminase Unclassified P50554 Abat GABT_RAT 4.37999999999999989 \N IC50 Inhibition of Rattus norvegicus (rat) brain gamma-amino butyrate aminotransferase using gamma-amino butyrate as substrate assessed as decrease in NADPH generation after 30 min by spectrophotometric analysis CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL89598 \N \N \N \N \N \N Rattus norvegicus 180787 2819 318 4-aminobutyrate aminotransferase, mitochondrial Enzyme P80404 ABAT GABT_HUMAN \N \N \N Mechanism of Action; CHEMBL2044; SINGLE PROTEIN CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL89598 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL89598 INHIBITOR \N Tclin \N \N Homo sapiens 180788 1725 550 Dipeptidyl peptidase 4 Enzyme P27487 DPP4 DPP4_HUMAN 4.54000000000000004 \N IC50 Inhibition of DPP4 CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1431 \N \N \N Tclin \N \N Homo sapiens 180789 1725 2815 Mitochondrial complex I (NADH dehydrogenase) Enzyme O00217|O00483|O14561|O15239|O43181|O43674|O43676|O43677|O43678|O43920|O75251|O75306|O75380|O75438|O75489|O95139|O95167|O95168|O95169|O95178|O95182|O95298|O95299|O96000|P03886|P03891|P03897|P03901|P03905|P03915|P03923|P17568|P19404|P28331|P49821|P51970|P56181|P56556|Q16718|Q16795|Q86Y39|Q8N183|Q9BU61|Q9NRX3|Q9NX14|Q9P032|Q9P0J0|Q9UI09|Q9Y375|Q9Y6M9 MT-ND1|MT-ND2|MT-ND3|MT-ND4|MT-ND4L|MT-ND5|MT-ND6|NDUFA1|NDUFA10|NDUFA11|NDUFA12|NDUFA13|NDUFA2|NDUFA3|NDUFA4|NDUFA4L2|NDUFA5|NDUFA6|NDUFA7|NDUFA8|NDUFA9|NDUFAB1|NDUFAF1|NDUFAF2|NDUFAF3|NDUFAF4|NDUFB1|NDUFB10|NDUFB11|NDUFB2|NDUFB3|NDUFB4|NDUFB5|NDUFB6|NDUFB7|NDUFB8|NDUFB9|NDUFC1|NDUFC2|NDUFS1|NDUFS2|NDUFS3|NDUFS4|NDUFS5|NDUFS6|NDUFS7|NDUFS8|NDUFV1|NDUFV2|NDUFV3 ACPM_HUMAN|CIA30_HUMAN|MIMIT_HUMAN|NDUA1_HUMAN|NDUA2_HUMAN|NDUA3_HUMAN|NDUA4_HUMAN|NDUA5_HUMAN|NDUA6_HUMAN|NDUA7_HUMAN|NDUA8_HUMAN|NDUA9_HUMAN|NDUAA_HUMAN|NDUAB_HUMAN|NDUAC_HUMAN|NDUAD_HUMAN|NDUB1_HUMAN|NDUB2_HUMAN|NDUB3_HUMAN|NDUB4_HUMAN|NDUB5_HUMAN|NDUB6_HUMAN|NDUB7_HUMAN|NDUB8_HUMAN|NDUB9_HUMAN|NDUBA_HUMAN|NDUBB_HUMAN|NDUC1_HUMAN|NDUC2_HUMAN|NDUF3_HUMAN|NDUF4_HUMAN|NDUS1_HUMAN|NDUS2_HUMAN|NDUS3_HUMAN|NDUS4_HUMAN|NDUS5_HUMAN|NDUS6_HUMAN|NDUS7_HUMAN|NDUS8_HUMAN|NDUV1_HUMAN|NDUV2_HUMAN|NDUV3_HUMAN|NU1M_HUMAN|NU2M_HUMAN|NU3M_HUMAN|NU4LM_HUMAN|NU4M_HUMAN|NU5M_HUMAN|NU6M_HUMAN|NUA4L_HUMAN \N \N \N Mechanism of Action; CHEMBL2363065; PROTEIN COMPLEX CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1431 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1431 INHIBITOR \N Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin \N \N Homo sapiens 27182 2865 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN 5.59006690979003906 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 180790 26 1790 Thymidylate synthase Enzyme P07607 Tyms TYSY_MOUSE 7.70000000000000018 \N IC50 Inhibition of thymidylate synthase in mouse L1210 cells assessed as inhibition of tritium release from [5-3H]deoxyuridine after preincubation for 24 hrs by liquid scintillation counting CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL185 \N \N \N \N \N \N Mus musculus 180791 26 3523 Uracil phosphoribosyltransferase Unclassified P0A8F0 upp UPP_ECOLI 4.88999999999999968 \N Ki Inhibition of Escherichia coli K-12 MTCC 1302 UPRT activity by spectrophotometry CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL185 \N \N \N \N \N \N Escherichia coli (strain K12) 180792 163 334 Plasminogen Enzyme P00747 PLG PLMN_HUMAN 4.40000000000000036 \N IC50 Binding affinity to full length Glu-plasminogen in human plasma assessed as inhibition of interaction with fibrin in presence of tPA CHEMBL = 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1046 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1046 INHIBITOR \N Tclin \N \N Homo sapiens 180793 1550 2779 Glutamate NMDA receptor Ion channel P35439|Q00959|Q00960|Q00961|Q62645|Q8VHN2|Q9R1M7 Grin1|Grin2a|Grin2b|Grin2c|Grin2d|Grin3a|Grin3b NMD3A_RAT|NMD3B_RAT|NMDE1_RAT|NMDE2_RAT|NMDE3_RAT|NMDE4_RAT|NMDZ1_RAT 5.79000000000000004 \N IC50 Compound was evaluated for the inhibition of [3H]-CGS-19,755 binding at N-methyl-D-aspartate glutamate receptor CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL274323 \N \N \N \N \N \N Rattus norvegicus 180794 2715 1626 Cationic trypsin Enzyme P00760 \N TRY1_BOVIN 4.87999999999999989 \N Ki Binding affinity against bovine trypsin CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1179 \N \N \N \N \N \N Bos taurus 180795 2715 2614 Lysine-specific histone demethylase 1A Enzyme O60341 KDM1A KDM1A_HUMAN 4.59999999999999964 \N Ki Inhibition of human recombinant His-tagged full length LSD1 expressed in Escherichia coli BL21 (DE3) assessed as inactivation constant preincubated for 20 mins with substrate measured after 30 mins by AmplexRed based fluorescence quenching assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1179 \N \N \N Tchem \N \N Homo sapiens 180796 2715 286 Amine oxidase [flavin-containing] B Enzyme P27338 MAOB AOFB_HUMAN 7.48000000000000043 \N IC50 Compound was evaluated for inhibition of Microbial tyramine oxidase; irreversible CHEMBL = 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1179 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1179 INHIBITOR \N Tclin \N \N Homo sapiens 180797 89 3419 Phosphatidylinositol 4-kinase, PI4K Kinase P42356|Q8TCG2|Q9BTU6|Q9UBF8 PI4K2A|PI4K2B|PI4KA|PI4KB P4K2A_HUMAN|P4K2B_HUMAN|PI4KA_HUMAN|PI4KB_HUMAN 4.07000000000000028 \N Ki Binding affinity (Ki) against human phosphatidylinositol 4-kinase CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL226345 \N \N \N Tbio|Tbio|Tchem|Tchem \N \N Homo sapiens 180798 89 304 Xanthine dehydrogenase/oxidase Enzyme P47989 XDH XDH_HUMAN 4.95999999999999996 \N IC50 Inhibition of human xanthine oxidase CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL226345 \N \N \N Tclin \N \N Homo sapiens 180799 1562 366 Trace amine-associated receptor 1 GPCR Q96RJ0 TAAR1 TAAR1_HUMAN 6.59999999999999964 \N EC50 Activation of human TAAR1 expressed in human HEK293T cells assessed as cAMP accumulation after 10 mins by BRET assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19393 \N \N \N Tclin \N \N Homo sapiens 180800 1562 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 4.33000000000000007 \N Ki Binding affinity towards sigma opioid receptor in guinea pig cerebral homogenate using [3H]DTG as radioligand CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19393 \N \N \N Tclin \N \N Homo sapiens 180801 1562 2470 Trace amine-associated receptor 1 GPCR Q923Y9 Taar1 TAAR1_RAT 7.46999999999999975 \N EC50 Activation of rat wild type TAAR1 expressed in HEK293 cells assessed as stimulation of cAMP production after 1 hr by chemiluminescent assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19393 \N \N \N \N \N \N Rattus norvegicus 180802 1562 2471 Trace amine-associated receptor 1 GPCR Q923Y8 Taar1 TAAR1_MOUSE 7.19000000000000039 \N EC50 Activation of mouse TAAR1 expressed in human HEK293 cells assessed as accumulation of cAMP after 15 mins CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19393 \N \N \N \N \N \N Mus musculus 180803 1562 2846 Serotonin (5-HT) receptor GPCR P08909|P14842|P19327|P28564|P28565|P30940|P30994|P31388|P32305|P35364|P35365|P35563|Q62758|Q9JJ16 Htr1a|Htr1b|Htr1d|Htr1f|Htr2a|Htr2b|Htr2c|Htr3a|Htr3b|Htr4|Htr5a|Htr5b|Htr6|Htr7 5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT|5HT2A_RAT|5HT2B_RAT|5HT2C_RAT|5HT3A_RAT|5HT3B_RAT|5HT4R_RAT|5HT5A_RAT|5HT5B_RAT|5HT6R_RAT|5HT7R_RAT 5.16000000000000014 \N Kd Affinity against 5-hydroxytryptamine receptors in rat fundus model CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19393 \N \N \N \N \N \N Rattus norvegicus 180804 1562 2469 Trace amine-associated receptor 1 GPCR Q8HZ64 TAAR1 TAAR1_MACMU 5.73000000000000043 \N EC50 Activation of rhesus monkey TAAR1 expressed in RD-HGA16 cells co-expressing Gq protein assessed as cAMP accumulation by fluorescence plate reader CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19393 \N \N \N \N \N \N Macaca mulatta 180805 841 1754 Sodium-dependent dopamine transporter Transporter P23977 Slc6a3 SC6A3_RAT 5.30999999999999961 \N IC50 Inhibition of dopamine transporter-mediated [3H]dopamine uptake in Wistar rat striatal synaptosomes by liquid scintillation spectrometry CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL612 \N \N \N \N \N \N Rattus norvegicus 180806 841 313 Amine oxidase [flavin-containing] A Enzyme P21397 MAOA AOFA_HUMAN 4.83999999999999986 \N Ki Inhibition of human recombinant MAOA by spectrophotometrically CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL612 \N \N \N Tclin \N \N Homo sapiens 180807 841 2470 Trace amine-associated receptor 1 GPCR Q923Y9 Taar1 TAAR1_RAT 7.25 \N EC50 Activation of rat wild type TAAR1 expressed in HEK293 cells assessed as stimulation of cAMP production after 1 hr by chemiluminescent assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL612 \N \N \N \N \N \N Rattus norvegicus 180808 841 2471 Trace amine-associated receptor 1 GPCR Q923Y8 Taar1 TAAR1_MOUSE 8.69999999999999929 \N EC50 Activation of mouse TAAR1 expressed in human HEK293 cells assessed as accumulation of cAMP after 15 mins CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL612 \N \N \N \N \N \N Mus musculus 180809 841 2846 Serotonin (5-HT) receptor GPCR P08909|P14842|P19327|P28564|P28565|P30940|P30994|P31388|P32305|P35364|P35365|P35563|Q62758|Q9JJ16 Htr1a|Htr1b|Htr1d|Htr1f|Htr2a|Htr2b|Htr2c|Htr3a|Htr3b|Htr4|Htr5a|Htr5b|Htr6|Htr7 5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT|5HT2A_RAT|5HT2B_RAT|5HT2C_RAT|5HT3A_RAT|5HT3B_RAT|5HT4R_RAT|5HT5A_RAT|5HT5B_RAT|5HT6R_RAT|5HT7R_RAT 5.34999999999999964 \N Kd Affinity against 5-hydroxytryptamine receptors in rat fundus model CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL612 \N \N \N \N \N \N Rattus norvegicus 180810 841 2469 Trace amine-associated receptor 1 GPCR Q8HZ64 TAAR1 TAAR1_MACMU 6 \N EC50 Activation of rhesus monkey TAAR1 expressed in RD-HGA16 cells co-expressing Gq protein assessed as cAMP accumulation by fluorescence plate reader CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL612 \N \N \N \N \N \N Macaca mulatta 180811 841 1817 Amine oxidase [flavin-containing] A Enzyme P21396 Maoa AOFA_RAT 4.91000000000000014 \N Ki Inhibition of MAOA in rat brain mitochondrial suspension CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL612 \N \N \N \N \N \N Rattus norvegicus 180812 841 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.24000000000000021 \N Ki Inhibition of [3H]5-HT uptake at human SERT expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL612 \N \N \N Tclin \N \N Homo sapiens 180813 841 320 Synaptic vesicular amine transporter Transporter Q05940 SLC18A2 VMAT2_HUMAN \N \N \N Mechanism of Action; CHEMBL1893; SINGLE PROTEIN CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL612 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL612 INHIBITOR \N Tclin \N \N Homo sapiens 180814 195 2847 Serotonin 1 (5-HT1) receptor GPCR P19327|P28564|P28565|P30940 Htr1a|Htr1b|Htr1d|Htr1f 5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT 5.12000000000000011 \N Ki Evaluated for binding affinity towards rat cortical membranes at 5-hydroxytryptamine 1 receptor binding site by using [3H]-5-HT as a radioligand. CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405 \N \N \N \N \N \N Rattus norvegicus 180815 195 1754 Sodium-dependent dopamine transporter Transporter P23977 Slc6a3 SC6A3_RAT 6.01999999999999957 \N IC50 Inhibition of [3H]dopamine uptake at dopamine transporter expressed in rat striatal homogenate after 5 mins by scintillation counting analysis CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405 \N \N \N \N \N \N Rattus norvegicus 180816 195 1842 Sodium-dependent serotonin transporter Transporter Q60857 Slc6a4 SC6A4_MOUSE 4.34999999999999964 \N IC50 Inhibition of 5-HT transporter in NMRI albino mouse brain assessed as [3H]5-HT accumulation in hypothalamus after 5 mins CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405 \N \N \N \N \N \N Mus musculus 180817 195 2092 Transporter Transporter Q63380 NET Q63380_RAT 6.70000000000000018 \N IC50 Inhibition of [3H]norepinephrine uptake at NET expressed in rat hypothalamic homogenate containing synaptosomes after 5 mins by scintillation counting analysis CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405 \N \N \N \N \N \N Rattus norvegicus 180818 195 1835 5-hydroxytryptamine receptor 2B GPCR P30994 Htr2b 5HT2B_RAT 5.26999999999999957 \N Kd Affinity against serotonergic receptor in the isolated rat stomach fundus CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405 \N \N \N \N \N \N Rattus norvegicus 180819 195 2860 Serotonin 2 (5-HT2) receptor GPCR P08909|P14842|P30994 Htr2a|Htr2b|Htr2c 5HT2A_RAT|5HT2B_RAT|5HT2C_RAT 4.37000000000000011 \N Ki Binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 (5-HT2) receptor using [3H]KET as a radioligand CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405 \N \N \N \N \N \N Rattus norvegicus 180820 195 2846 Serotonin (5-HT) receptor GPCR P08909|P14842|P19327|P28564|P28565|P30940|P30994|P31388|P32305|P35364|P35365|P35563|Q62758|Q9JJ16 Htr1a|Htr1b|Htr1d|Htr1f|Htr2a|Htr2b|Htr2c|Htr3a|Htr3b|Htr4|Htr5a|Htr5b|Htr6|Htr7 5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT|5HT2A_RAT|5HT2B_RAT|5HT2C_RAT|5HT3A_RAT|5HT3B_RAT|5HT4R_RAT|5HT5A_RAT|5HT5B_RAT|5HT6R_RAT|5HT7R_RAT 5.26999999999999957 \N Kd Affinity against 5-hydroxytryptamine receptors in rat fundus model CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405 \N \N \N \N \N \N Rattus norvegicus 180821 195 1817 Amine oxidase [flavin-containing] A Enzyme P21396 Maoa AOFA_RAT 4.91000000000000014 \N Ki Inhibition of MAOA in rat brain mitochondria CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405 \N \N \N \N \N \N Rattus norvegicus 180822 195 1830 Sodium-dependent noradrenaline transporter Transporter O55192 Slc6a2 SC6A2_MOUSE 6 \N IC50 Inhibition of noradrenaline transporter in NMRI albino mouse brain assessed as [3H]NA accumulation in hypothalamus after 5 mins CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405 \N \N \N \N \N \N Mus musculus 180823 195 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN \N \N \N Mechanism of Action; CHEMBL222; SINGLE PROTEIN CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405 RELEASING AGENT \N Tclin \N \N Homo sapiens 180824 124 1650 Xanthine dehydrogenase/oxidase Enzyme P80457 XDH XDH_BOVIN 6 \N Ki Mixed-type inhibition of bovine milk xanthine oxidase using xanthine as substrate by Lineweaver-Burk plot analysis CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1467 \N \N \N \N \N \N Bos taurus 180825 124 2295 Xanthine dehydrogenase/oxidase Enzyme P22985 Xdh XDH_RAT 6.12000000000000011 \N IC50 Inhibition of rat liver xanthine oxidase by spectrophotometry CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1467 \N \N \N \N \N \N Rattus norvegicus 180826 124 304 Xanthine dehydrogenase/oxidase Enzyme P47989 XDH XDH_HUMAN 5.15000000000000036 \N Ki Inhibitory activity against Xanthine Oxidase CHEMBL = 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1467 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1467 INHIBITOR \N Tclin \N \N Homo sapiens 180827 2123 753 Membrane primary amine oxidase Enzyme Q16853 AOC3 AOC3_HUMAN 7.70000000000000018 \N IC50 Inhibition of human recombinant VAP-1 expressed in CHO cells after 30 mins by coupled colorimetric method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1089 \N \N \N Tchem \N \N Homo sapiens 180828 2123 2614 Lysine-specific histone demethylase 1A Enzyme O60341 KDM1A KDM1A_HUMAN 4.75 \N Ki Inhibition of LSD1 CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1089 \N \N \N Tchem \N \N Homo sapiens 180829 2123 1817 Amine oxidase [flavin-containing] A Enzyme P21396 Maoa AOFA_RAT 7.51999999999999957 \N IC50 In vitro ability to inhibit Monoamine oxidase A activity in rat whole brain in vitro CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1089 \N \N \N \N \N \N Rattus norvegicus 180830 2123 1816 Amine oxidase [flavin-containing] B Enzyme P19643 Maob AOFB_RAT 7.12000000000000011 \N IC50 In vitro ability to inhibit Monoamine oxidase B activity in rat whole brain in vitro CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1089 \N \N \N \N \N \N Rattus norvegicus 180831 346 1966 Histamine H3 receptor GPCR Q9QYN8 Hrh3 HRH3_RAT 5.69000000000000039 \N Ki Binding affinity to rat histamine H3 receptor CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24441 \N \N \N \N \N \N Rattus norvegicus 180832 2049 1791 Acetylcholinesterase Enzyme P37136 Ache ACES_RAT 7.45000000000000018 \N IC50 Inhibition of AChE activity in rat brain homogenate using acetylthiocholine as substrate by Ellman's method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL542 \N \N \N \N \N \N Rattus norvegicus 180833 2049 213 Carbonic anhydrase 1 Enzyme P00915 CA1 CAH1_HUMAN 5.08000000000000007 \N Ki Inhibition of human cytosolic carbonic anhydrase 1 by stopped flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL542 \N \N \N Tclin \N \N Homo sapiens 180834 2049 2292 Dihydropteroate synthase Enzyme Q81VW8 folP Q81VW8_BACAN 5.25 \N Kd Binding affinity to Bacillus anthracis DHPS expressed in Escherichia coli BL21 (DE3) after 30 mins by isothermal titration calorimetry CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL542 \N \N \N \N \N \N Bacillus anthracis 180835 2049 161 Carbonic anhydrase 2 Enzyme P00918 CA2 CAH2_HUMAN 5.08999999999999986 \N Ki Inhibition of human cytosolic carbonic anhydrase 2 by stopped flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL542 \N \N \N Tclin \N \N Homo sapiens 27184 2815 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 6.85387182235717773 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 180836 1497 2593 Dihydrofolate reductase Enzyme P9WNX1 folA DYR_MYCTU 9 \N Ki Inhibition of Mycobacterium tuberculosis dihydrofolate reductase CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL64 \N \N \N \N \N \N Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) 180837 2231 251 Acetylcholinesterase Enzyme P22303 ACHE ACES_HUMAN 4.58999999999999986 \N Kd Binding affinity to sarin-inhibited hemoglobin free human erythrocyte ghost acetylcholinesterase using acetylthiocholineiodide as substrate measured up to 1 hr by Ellman method CHEMBL = 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL748 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL748 ACTIVATOR \N Tclin \N \N Homo sapiens 180838 2784 171 5-hydroxytryptamine receptor 3A Ion channel P46098 HTR3A 5HT3A_HUMAN 4.58999999999999986 \N EC50 Activity at SER3 receptor expressed in HEK293 cells assessed as increase in calcium by calcium imaging assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11608 \N \N \N Tclin \N \N Homo sapiens 180839 2784 2615 TyR1 GPCR H9TVJ1 \N H9TVJ1_9NEOP 6.42999999999999972 \N EC50 Agonist activity at Chilo suppressalis (rice stem borer) tyramine receptor TyR1 expressed in HEK293 cells assessed as reduction in forskolin-induced cAMP accumulation incubated for 20 min CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11608 \N \N \N \N \N \N Chilo suppressalis 180840 2784 2846 Serotonin (5-HT) receptor GPCR P08909|P14842|P19327|P28564|P28565|P30940|P30994|P31388|P32305|P35364|P35365|P35563|Q62758|Q9JJ16 Htr1a|Htr1b|Htr1d|Htr1f|Htr2a|Htr2b|Htr2c|Htr3a|Htr3b|Htr4|Htr5a|Htr5b|Htr6|Htr7 5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT|5HT2A_RAT|5HT2B_RAT|5HT2C_RAT|5HT3A_RAT|5HT3B_RAT|5HT4R_RAT|5HT5A_RAT|5HT5B_RAT|5HT6R_RAT|5HT7R_RAT 5.07000000000000028 \N Kd Affinity against 5-hydroxytryptamine receptors in rat fundus model CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11608 \N \N \N \N \N \N Rattus norvegicus 180841 2784 882 Beta-secretase 1 Enzyme P56817 BACE1 BACE1_HUMAN 2.70000000000000018 \N Kd Binding affinity to BACE1 by surface plasmon resonance method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11608 \N \N \N Tchem \N \N Homo sapiens 180842 1243 486 UDP-N-acetylglucosamine 1-carboxyvinyltransferase Enzyme P0A749 murA MURA_ECOLI 7 \N IC50 Inhibition of Escherichia coli MurA expressed in Escherichia coli BL21(lambdaDE3) using UNAG and PEP as substrate incubated for 10 mins prior to PEP addition measured after 60 mins by spectrophotometric analysis CHEMBL = 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1757 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1757 INHIBITOR \N \N \N \N Escherichia coli (strain K12) 180843 1243 3524 UDP-N-acetylglucosamine 1-carboxyvinyltransferase Unclassified Q9HVW7 murA MURA_PSEAE 4.98000000000000043 \N IC50 Inhibition of Pseudomonas aeruginosa PAO1293 MurA in presence of UNAG CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1757 \N \N \N \N \N \N Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228) 180844 2416 751 Carbonic anhydrase 14 Enzyme Q9ULX7 CA14 CAH14_HUMAN 4.29999999999999982 \N Ki Inhibition of human carbonic anhydrase 14 by stopped-flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL424 \N \N \N Tclin \N \N Homo sapiens 180845 2416 220 Carbonic anhydrase 4 Enzyme P22748 CA4 CAH4_HUMAN 4.95000000000000018 \N Ki Inhibition of human carbonic anhydrase 4 by stopped-flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL424 \N \N \N Tclin \N \N Homo sapiens 180846 2416 213 Carbonic anhydrase 1 Enzyme P00915 CA1 CAH1_HUMAN 5 \N Ki Inhibition of human carbonic anhydrase 1 by stopped-flow CO2 hydrase assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL424 \N \N \N Tclin \N \N Homo sapiens 180847 2416 400 Carbonic anhydrase 7 Enzyme P43166 CA7 CAH7_HUMAN 4.08999999999999986 \N Ki Inhibition of human carbonic anhydrase 7 by stopped-flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL424 \N \N \N Tclin \N \N Homo sapiens 180848 2416 1746 Carbonic anhydrase 13 Enzyme Q9D6N1 Ca13 CAH13_MOUSE 4.16999999999999993 \N Ki Inhibition of mouse carbonic anhydrase 13 by stopped-flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL424 \N \N \N \N \N \N Mus musculus 180849 2416 319 Carbonic anhydrase 9 Enzyme Q16790 CA9 CAH9_HUMAN 4.09999999999999964 \N Ki Inhibition of human carbonic anhydrase 9 catalytic domain by stopped-flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL424 \N \N \N Tclin \N \N Homo sapiens 180850 2416 330 Carbonic anhydrase 12 Enzyme O43570 CA12 CAH12_HUMAN 5.05999999999999961 \N Ki Inhibition of human carbonic anhydrase 12 catalytic domain by stopped-flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL424 \N \N \N Tclin \N \N Homo sapiens 180851 2416 2073 Carbonic anhydrase 15 Enzyme Q99N23 Ca15 CAH15_MOUSE 5.13999999999999968 \N Ki Inhibition of mouse recombinant carbonic anhydrase 15 by stopped-flow CO2 hydrase assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL424 \N \N \N \N \N \N Mus musculus 180852 2416 690 Carbonic anhydrase 6 Enzyme P23280 CA6 CAH6_HUMAN 4.91999999999999993 \N Ki Inhibition of human carbonic anhydrase 6 by stopped-flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL424 \N \N \N Tclin \N \N Homo sapiens 180853 2416 2031 Polyphenol oxidase 2 Enzyme O42713 PPO2 PPO2_AGABI 4 \N IC50 Inhibition of mushroom tyrosinase after 10 mins CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL424 \N \N \N \N \N \N Agaricus bisporus 180854 2416 2079 Solute carrier family 22 member 20 Transporter Q80UJ1 Slc22a20 S22AK_MOUSE 4.36000000000000032 \N Ki Inhibition of mouse Oat6-mediated [3H]ES uptake in Xenopus oocytes after 1 hr CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL424 \N \N \N \N \N \N Mus musculus 180855 2416 161 Carbonic anhydrase 2 Enzyme P00918 CA2 CAH2_HUMAN 5.15000000000000036 \N Ki Inhibition of human carbonic anhydrase 2 by stopped-flow CO2 hydrase assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL424 \N \N \N Tclin \N \N Homo sapiens 180856 3977 2567 D-amino-acid oxidase Enzyme P14920 DAO OXDA_HUMAN 5.70000000000000018 \N IC50 Inhibition of human recombinant DAAO expressed in HEK293 cell lysate assessed as D-Serine conversion to H2O2 after 20 mins by spectrophotometric analysis CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL287556 \N \N \N Tchem \N \N Homo sapiens 180857 3977 3525 D-amino-acid oxidase Unclassified P00371 DAO OXDA_PIG 4.67999999999999972 \N Ki Competitive inhibition of pig kidney DAAO using D-Alanine as substrate by Michaelis-Menten plot analysis CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL287556 \N \N \N \N \N \N Sus scrofa 180858 3977 3526 Tyrosinase Unclassified P11344 Tyr TYRO_MOUSE 4.20999999999999996 \N IC50 Inhibition of catecholase activity of tyrosinase in mouse B16 cells assessed as dopachrome formation CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL287556 \N \N \N \N \N \N Mus musculus 180859 3977 2031 Polyphenol oxidase 2 Enzyme O42713 PPO2 PPO2_AGABI 4.65000000000000036 \N Ki Inhibition of mashroom tyrosinase CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL287556 \N \N \N \N \N \N Agaricus bisporus 180860 3977 432 Tyrosinase Enzyme P14679 TYR TYRO_HUMAN 5.12999999999999989 \N IC50 Inhibition of Tyrosinase CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL287556 \N \N \N Tclin \N \N Homo sapiens 27186 2813 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 5.55408477783203125 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 180861 2803 1707 Aldose reductase Enzyme P07943 Akr1b1 ALDR_RAT 4.25 \N IC50 Inhibition of Fischer-344 rat kidney ALR1 using D,L-glyceraldehyde as substrate by spectrophotometry CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL109 \N \N \N \N \N \N Rattus norvegicus 180862 2803 633 Alcohol dehydrogenase [NADP(+)] Enzyme P14550 AKR1A1 AK1A1_HUMAN 4.29999999999999982 \N IC50 Inhibition of AK1A1 CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL109 \N \N \N Tchem \N \N Homo sapiens 180863 2803 973 Alcohol dehydrogenase [NADP(+)] Enzyme P50578 AKR1A1 AK1A1_PIG 4.04999999999999982 \N IC50 Selectivity ratio measured as the IC50 ratio of aldehyde/aldose reductase values CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL109 \N \N \N \N \N \N Sus scrofa 180864 2803 1788 Alcohol dehydrogenase [NADP(+)] Enzyme P51635 Akr1a1 AK1A1_RAT 4.29999999999999982 \N IC50 Inhibition of rat kidney aldehyde reductase at 0.1 mM after 20 mins by spectrometric analysis CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL109 \N \N \N \N \N \N Rattus norvegicus 180865 2803 598 Histone deacetylase 2 Enzyme Q92769 HDAC2 HDAC2_HUMAN 4.20999999999999996 \N IC50 Inhibition of human recombinant HDAC2 CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL109 \N \N \N Tclin \N \N Homo sapiens 180866 2803 569 Succinate-semialdehyde dehydrogenase, mitochondrial Enzyme P51649 ALDH5A1 SSDH_HUMAN \N \N \N Mechanism of Action; CHEMBL1911; SINGLE PROTEIN CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL109 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL109 INHIBITOR \N Tclin \N \N Homo sapiens 180867 3290 567 72 kDa type IV collagenase Enzyme P08253 MMP2 MMP2_HUMAN 3.89000000000000012 \N IC50 Inhibition of human recombinant MMP2 after 30 mins CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL310555 \N \N \N Tchem \N \N Homo sapiens 180868 3290 987 Methionine aminopeptidase 2 Enzyme P50579 METAP2 MAP2_HUMAN 5.69000000000000039 \N IC50 Inhibition of human methionine aminopeptidase 2 CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL310555 \N \N \N Tchem \N \N Homo sapiens 180869 3290 2309 Methionine aminopeptidase 1 Enzyme P53582 METAP1 MAP11_HUMAN 4.66999999999999993 \N IC50 Inhibition of human MetAP1 CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL310555 \N \N \N Tchem \N \N Homo sapiens 180870 3290 1912 Catechol O-methyltransferase Enzyme P22734 Comt COMT_RAT 4.66999999999999993 \N IC50 Inhibition of Sprague-Dawley rat liver COMT after 10 mins using 0.05 uCi [14CH3]-SAM as substrate CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL310555 \N \N \N \N \N \N Rattus norvegicus 180871 3474 2074 Solute carrier family 22 member 6 Transporter Q8VC69 Slc22a6 S22A6_MOUSE 6.38999999999999968 \N Ki Inhibition of mouse Oat1-mediated [3H]PAH uptake in Xenopus oocytes after 1 hr CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1157 \N \N \N \N \N \N Mus musculus 180872 738 213 Carbonic anhydrase 1 Enzyme P00915 CA1 CAH1_HUMAN 5.50999999999999979 \N Ki Inhibition of human carbonic anhydrase 1 by stopped flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466 \N \N \N Tclin \N \N Homo sapiens 180873 738 220 Carbonic anhydrase 4 Enzyme P22748 CA4 CAH4_HUMAN 5.16999999999999993 \N Ki Inhibition of human carbonic anhydrase 4 by stopped flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466 \N \N \N Tclin \N \N Homo sapiens 180874 738 398 Carbonic anhydrase 5A, mitochondrial Enzyme P35218 CA5A CAH5A_HUMAN 5.03000000000000025 \N Ki Inhibition of human carbonic anhydrase 5A by stopped flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466 \N \N \N Tclin \N \N Homo sapiens 180875 738 399 Carbonic anhydrase 5B, mitochondrial Enzyme Q9Y2D0 CA5B CAH5B_HUMAN 5.28000000000000025 \N Ki Inhibition of human carbonic anhydrase 5B by stopped flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466 \N \N \N Tclin \N \N Homo sapiens 180876 738 1817 Amine oxidase [flavin-containing] A Enzyme P21396 Maoa AOFA_RAT 4.38999999999999968 \N IC50 Inhibitory effect on monoamine oxidase A, SD on IC50 values < 10% CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466 \N \N \N \N \N \N Rattus norvegicus 180877 738 1816 Amine oxidase [flavin-containing] B Enzyme P19643 Maob AOFB_RAT 4.91999999999999993 \N IC50 Inhibitory effect on Monoamine oxidase B, SD on IC50 values < 10% CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466 \N \N \N \N \N \N Rattus norvegicus 180878 738 161 Carbonic anhydrase 2 Enzyme P00918 CA2 CAH2_HUMAN 5.04000000000000004 \N Ki Inhibition of full length human CA2 cytosolic isoform by stopped-flow CO2 hydration method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466 \N \N \N Tclin \N \N Homo sapiens 180879 738 682 Carbonic anhydrase 3 Enzyme P07451 CA3 CAH3_HUMAN 5.25 \N Ki Inhibition of human carbonic anhydrase 3 by stopped flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466 \N \N \N Tclin \N \N Homo sapiens 180880 738 751 Carbonic anhydrase 14 Enzyme Q9ULX7 CA14 CAH14_HUMAN 7.32000000000000028 \N Ki Inhibition of human carbonic anhydrase 14 by stopped flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466 \N \N \N Tclin \N \N Homo sapiens 180881 738 400 Carbonic anhydrase 7 Enzyme P43166 CA7 CAH7_HUMAN 5.48000000000000043 \N Ki Inhibition of human carbonic anhydrase 7 by stopped flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466 \N \N \N Tclin \N \N Homo sapiens 180882 738 1746 Carbonic anhydrase 13 Enzyme Q9D6N1 Ca13 CAH13_MOUSE 5.04000000000000004 \N Ki Inhibition of mouse carbonic anhydrase 13 by stopped flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466 \N \N \N \N \N \N Mus musculus 180883 738 330 Carbonic anhydrase 12 Enzyme O43570 CA12 CAH12_HUMAN 5.04999999999999982 \N Ki Inhibition of human carbonic anhydrase 12 by stopped flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466 \N \N \N Tclin \N \N Homo sapiens 180884 738 319 Carbonic anhydrase 9 Enzyme Q16790 CA9 CAH9_HUMAN 5.04000000000000004 \N Ki Inhibition of human carbonic anhydrase 9 by stopped flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466 \N \N \N Tclin \N \N Homo sapiens 180885 738 2073 Carbonic anhydrase 15 Enzyme Q99N23 Ca15 CAH15_MOUSE 4.40000000000000036 \N Ki Inhibition of mouse carbonic anhydrase 15 by stopped flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466 \N \N \N \N \N \N Mus musculus 180886 738 690 Carbonic anhydrase 6 Enzyme P23280 CA6 CAH6_HUMAN 5.70000000000000018 \N Ki Inhibition of human carbonic anhydrase 6 by stopped flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466 \N \N \N Tclin \N \N Homo sapiens 180887 1622 152 Glutathione reductase, mitochondrial Enzyme P00390 GSR GSHR_HUMAN 4.25999999999999979 \N Ki Competitive inhibition of human erythrocyte Glutathione reductase using GSSG substrate by Lineweaver-Burk plot analysis CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8085 \N \N \N Tclin \N \N Homo sapiens 180888 65 2728 Neuronal acetylcholine receptor; alpha4/beta4 Ion channel P09483|P12392 Chrna4|Chrnb4 ACHA4_RAT|ACHB4_RAT 7.24000000000000021 \N Ki Displacement of [3H]epibatidine from rat recombinant alpha4beta4 nAChR expressed in HEK293 cells after 4 hrs by scintillation counting analysis CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667 \N \N \N \N \N \N Rattus norvegicus 180889 65 1772 Acetylcholine receptor subunit delta Ion channel P02718 chrnd ACHD_TORCA 7.37000000000000011 \N Ki Binding affinity towards rat forebrain nicotinic acetylcholine receptor using [3H]EB as radioligand CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667 \N \N \N \N \N \N Torpedo californica 180890 65 252 Neuronal acetylcholine receptor subunit alpha-7 Ion channel P36544 CHRNA7 ACHA7_HUMAN 5.09999999999999964 \N Ki Displacement of [3H]-MLA from human alpha7 nAChR expressed in human SH-SY5Y cells after 1.5 hrs by liquid scintillation counting CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667 \N \N \N Tchem \N \N Homo sapiens 180891 65 1783 Neuronal acetylcholine receptor subunit alpha-7 Ion channel Q05941 Chrna7 ACHA7_RAT 5.45000000000000018 \N Ki Displacement of [3H]alpha-bungaro-toxine from nicotinic alpha-7 receptor in rat brain CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667 \N \N \N \N \N \N Rattus norvegicus 180892 65 2727 Neuronal acetylcholine receptor; alpha4/beta2 Ion channel P09483|P12390 Chrna4|Chrnb2 ACHA4_RAT|ACHB2_RAT 8.11999999999999922 \N Ki Displacement of [3H]-cytisine from Alpha4-beta2 Nicotinic acetylcholine receptor of rat brain homogenates CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667 \N \N \N \N \N \N Rattus norvegicus 180893 65 3527 Nicotinic acetylcholine receptor alpha8 subunit Unclassified H6TY12 \N H6TY12_PERAM 4.94000000000000039 \N EC50 Agonist activity at Periplaneta americana (American cockroach) nAChR in terminal abdominal ganglion assessed as assessed as inward current by tight-seal whole cell patch clamp method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667 \N \N \N \N \N \N Periplaneta americana 180894 65 2838 Muscarinic acetylcholine receptor GPCR P08482|P08483|P08485|P08911|P10980 Chrm1|Chrm2|Chrm3|Chrm4|Chrm5 ACM1_RAT|ACM2_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT 7.91999999999999993 \N IC50 Compound was tested in vitro for its binding affinity to muscarinic acetylcholine receptor from rat cortical homogenates using [3H]OXO-M as radioligand CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667 \N \N \N \N \N \N Rattus norvegicus 180895 65 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 6.66000000000000014 \N EC50 Activation of M3-ACh receptor-FLASH/CFP expressed in HEK293 cells assessed as FRET signal CHEMBL = 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667 AGONIST \N Tclin \N \N Homo sapiens 180896 65 2800 Neuronal acetylcholine receptor; alpha4/beta2 Ion channel P17787|P43681 CHRNA4|CHRNB2 ACHA4_HUMAN|ACHB2_HUMAN 5.79999999999999982 \N EC50 Partial agonist activity at human 2:3 alpha4beta2 nAChR expressed in Xenopus laevis oocytes after 1 min by two electrode voltage clamp technique CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667 \N \N \N Tclin|Tclin \N \N Homo sapiens 180897 65 956 Acetylcholine-binding protein Unclassified P58154 \N ACHP_LYMST 5.5 \N Ki Displacement of [125I]alpha-bungarotoxin from Lymnaea stagnalis His-tagged AchBP CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667 \N \N \N \N \N \N Lymnaea stagnalis 180898 65 2725 Neuronal acetylcholine receptor; alpha3/beta2 Ion channel P04757|P12390 Chrna3|Chrnb2 ACHA3_RAT|ACHB2_RAT 7.38999999999999968 \N Ki Binding affinity towards rat Nicotinic acetylcholine receptor alpha3-beta2 expressed in HEK293 cells using [3H]EB as radioligand CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667 \N \N \N \N \N \N Rattus norvegicus 180899 65 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 6.09999999999999964 \N EC50 Activation of M5-ACh receptor-FLASH/CFP expressed in HEK293 cells assessed as FRET signal CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667 \N \N \N Tclin \N \N Homo sapiens 180900 65 2726 Neuronal acetylcholine receptor; alpha3/beta4 Ion channel P04757|P12392 Chrna3|Chrnb4 ACHA3_RAT|ACHB4_RAT 6.20999999999999996 \N Ki Displacement of [3H]epibatidine from rat alpha3beta4 nAChR expressed in HEK292 cells after 3 hrs CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667 \N \N \N \N \N \N Rattus norvegicus 180901 65 2724 Neuronal acetylcholine receptor; alpha2/beta2 Ion channel P12389|P12390 Chrna2|Chrnb2 ACHA2_RAT|ACHB2_RAT 7.95999999999999996 \N Ki Binding affinity towards rat nicotinic acetylcholine receptor alpha2-beta2 expressed in HEK293 cells using [3H]EB as radioligand CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667 \N \N \N \N \N \N Rattus norvegicus 180902 65 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 6.11000000000000032 \N EC50 Activation of M1-ACh receptor-FLASH/CFP expressed in HEK293 cells assessed as FRET signal CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667 \N \N \N Tclin \N \N Homo sapiens 180903 2738 220 Carbonic anhydrase 4 Enzyme P22748 CA4 CAH4_HUMAN 4.45999999999999996 \N Ki Inhibition of human carbonic anhydrase 4 by stopped flow CO2 hydration method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL609 \N \N \N Tclin \N \N Homo sapiens 180904 2738 213 Carbonic anhydrase 1 Enzyme P00915 CA1 CAH1_HUMAN 4 \N Ki Inhibition of human carbonic anhydrase 1 by stopped flow CO2 hydration method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL609 \N \N \N Tclin \N \N Homo sapiens 180905 2738 398 Carbonic anhydrase 5A, mitochondrial Enzyme P35218 CA5A CAH5A_HUMAN 4.41999999999999993 \N Ki Inhibition of human carbonic anhydrase 5A by stopped flow CO2 hydration method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL609 \N \N \N Tclin \N \N Homo sapiens 180906 2738 399 Carbonic anhydrase 5B, mitochondrial Enzyme Q9Y2D0 CA5B CAH5B_HUMAN 4.30999999999999961 \N Ki Inhibition of human carbonic anhydrase 5B by stopped flow CO2 hydration method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL609 \N \N \N Tclin \N \N Homo sapiens 180907 2738 682 Carbonic anhydrase 3 Enzyme P07451 CA3 CAH3_HUMAN 4.32000000000000028 \N Ki Inhibition of human carbonic anhydrase 3 by stopped flow CO2 hydration method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL609 \N \N \N Tclin \N \N Homo sapiens 180908 2738 161 Carbonic anhydrase 2 Enzyme P00918 CA2 CAH2_HUMAN 4.19000000000000039 \N Ki Inhibition of human carbonic anhydrase 2 by stopped flow CO2 hydration method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL609 \N \N \N Tclin \N \N Homo sapiens 180909 2738 751 Carbonic anhydrase 14 Enzyme Q9ULX7 CA14 CAH14_HUMAN 4.91999999999999993 \N Ki Inhibition of human carbonic anhydrase 14 by stopped flow CO2 hydration method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL609 \N \N \N Tclin \N \N Homo sapiens 180910 2738 400 Carbonic anhydrase 7 Enzyme P43166 CA7 CAH7_HUMAN 4.34999999999999964 \N Ki Inhibition of human carbonic anhydrase 7 by stopped flow CO2 hydration method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL609 \N \N \N Tclin \N \N Homo sapiens 180911 2738 1746 Carbonic anhydrase 13 Enzyme Q9D6N1 Ca13 CAH13_MOUSE 4.28000000000000025 \N Ki Inhibition of mouse carbonic anhydrase 13 by stopped flow CO2 hydration method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL609 \N \N \N \N \N \N Mus musculus 180912 2738 330 Carbonic anhydrase 12 Enzyme O43570 CA12 CAH12_HUMAN 4.24000000000000021 \N Ki Inhibition of human carbonic anhydrase 12 by stopped flow CO2 hydration method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL609 \N \N \N Tclin \N \N Homo sapiens 27188 2813 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 5.69810247421264648 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 180913 2738 319 Carbonic anhydrase 9 Enzyme Q16790 CA9 CAH9_HUMAN 4.41000000000000014 \N Ki Inhibition of human carbonic anhydrase 9 by stopped flow CO2 hydration method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL609 \N \N \N Tclin \N \N Homo sapiens 180914 2738 2073 Carbonic anhydrase 15 Enzyme Q99N23 Ca15 CAH15_MOUSE 4.23000000000000043 \N Ki Inhibition of mouse carbonic anhydrase 15 by stopped flow CO2 hydration method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL609 \N \N \N \N \N \N Mus musculus 180915 2738 690 Carbonic anhydrase 6 Enzyme P23280 CA6 CAH6_HUMAN 4.37000000000000011 \N Ki Inhibition of human carbonic anhydrase 6 by stopped flow CO2 hydration method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL609 \N \N \N Tclin \N \N Homo sapiens 180916 3995 1026 Gamma-butyrobetaine dioxygenase Enzyme O75936 BBOX1 BODG_HUMAN 4.79999999999999982 \N Ki Inhibition of BBOX (unknown origin) CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104708 \N \N \N Tchem \N \N Homo sapiens 180917 488 1773 Acetylcholinesterase Enzyme P21836 Ache ACES_MOUSE 8.09999999999999964 \N Ki Compound was evaluated for the binding affinity by displacing [3H]oxotremorine from mouse cerebral cortex tissue. CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14 \N \N \N \N \N \N Mus musculus 180918 488 1772 Acetylcholine receptor subunit delta Ion channel P02718 chrnd ACHD_TORCA 6.34999999999999964 \N Ki Binding affinity towards rat forebrain nicotinic acetylcholine receptor using [3H]EB as radioligand CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14 \N \N \N \N \N \N Torpedo californica 180919 488 2728 Neuronal acetylcholine receptor; alpha4/beta4 Ion channel P09483|P12392 Chrna4|Chrnb4 ACHA4_RAT|ACHB4_RAT 5.88999999999999968 \N Ki Binding affinity towards rat Nicotinic acetylcholine receptor alpha4-beta4 expressed in HEK293 cells using [3H]EB as radioligand CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14 \N \N \N \N \N \N Rattus norvegicus 180920 488 252 Neuronal acetylcholine receptor subunit alpha-7 Ion channel P36544 CHRNA7 ACHA7_HUMAN 4.17999999999999972 \N Ki Binding affinity to alpha7 nAChR (unknown origin) CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14 \N \N \N Tchem \N \N Homo sapiens 180921 488 1744 Muscarinic acetylcholine receptor M2 GPCR P10980 Chrm2 ACM2_RAT 8.40000000000000036 \N Ki Binding affinity at [3H]CD radiolabeled muscarinic M2 receptor in rat cortex. CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14 \N \N \N \N \N \N Rattus norvegicus 180922 488 2727 Neuronal acetylcholine receptor; alpha4/beta2 Ion channel P09483|P12390 Chrna4|Chrnb2 ACHA4_RAT|ACHB2_RAT 6.23000000000000043 \N Ki Binding affinity towards rat Nicotinic acetylcholine receptor alpha4-beta2 expressed in HEK293 cells using [3H]EB as radioligand CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14 \N \N \N \N \N \N Rattus norvegicus 180923 488 2290 Muscarinic acetylcholine receptor GPCR Q8VH26 GPM3 Q8VH26_CAVPO 4.74000000000000021 \N Kd Dissociation constant for complex with muscarinic acetylcholine receptor M3 of guinea pig ileum CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14 \N \N \N \N \N \N Cavia porcellus 180924 488 1997 Muscarinic acetylcholine receptor M4 GPCR P08485 Chrm4 ACM4_RAT 5.58999999999999986 \N Ki Inhibition of binding of [3H]quinuclidinyl benzilate to Muscarinic acetylcholine receptor M4 in rat cerebral cortical membranes CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14 \N \N \N \N \N \N Rattus norvegicus 180925 488 2838 Muscarinic acetylcholine receptor GPCR P08482|P08483|P08485|P08911|P10980 Chrm1|Chrm2|Chrm3|Chrm4|Chrm5 ACM1_RAT|ACM2_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT 8.89000000000000057 \N Ki In vitro binding affinity for muscarinic receptor by displacing [3H]oxotremorine-M binding on rat brain homogenate. CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14 \N \N \N \N \N \N Rattus norvegicus 180926 488 1809 Muscarinic acetylcholine receptor M2 GPCR Q9ERZ4 Chrm2 ACM2_MOUSE 8.09999999999999964 \N Ki Ability to displace [3H]oxotremorine ([3H]OXO-M) from mouse cerebral cortex CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14 \N \N \N \N \N \N Mus musculus 180927 488 2583 Acetylcholine receptor subunit alpha Ion channel P02710 CHRNA1 ACHA_TORCA 5.12000000000000011 \N IC50 Displacement of [3H]alpha-BGT from nAChR in Torpedo nobiliana electric organs CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14 \N \N \N \N \N \N Torpedo californica 180928 488 2800 Neuronal acetylcholine receptor; alpha4/beta2 Ion channel P17787|P43681 CHRNA4|CHRNB2 ACHA4_HUMAN|ACHB2_HUMAN 6.12000000000000011 \N Ki Binding affinity to alpha4beta2 nAChR (unknown origin) CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14 \N \N \N Tclin|Tclin \N \N Homo sapiens 180929 488 2725 Neuronal acetylcholine receptor; alpha3/beta2 Ion channel P04757|P12390 Chrna3|Chrnb2 ACHA3_RAT|ACHB2_RAT 5.95999999999999996 \N Ki Binding affinity towards rat Nicotinic acetylcholine receptor alpha3-beta2 expressed in HEK293 cells using [3H]EB as radioligand CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14 \N \N \N \N \N \N Rattus norvegicus 180930 488 1808 Muscarinic acetylcholine receptor M1 GPCR P12657 Chrm1 ACM1_MOUSE 7.70000000000000018 \N Ki Binding affinity (low) of [3H](R)-QNB binding to Muscarinic acetylcholine receptor M1 expressed in A9 L cell line in the absence of 300 uM GTP-gamma-S CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14 \N \N \N \N \N \N Mus musculus 180931 488 2726 Neuronal acetylcholine receptor; alpha3/beta4 Ion channel P04757|P12392 Chrna3|Chrnb4 ACHA3_RAT|ACHB4_RAT 5.32000000000000028 \N Ki Binding affinity towards rat Nicotinic acetylcholine receptor alpha3-beta4 expressed in HEK293 cells using [3H]EB as radioligand CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14 \N \N \N \N \N \N Rattus norvegicus 180932 488 2724 Neuronal acetylcholine receptor; alpha2/beta2 Ion channel P12389|P12390 Chrna2|Chrnb2 ACHA2_RAT|ACHB2_RAT 6.67999999999999972 \N Ki Binding affinity towards rat nicotinic acetylcholine receptor alpha2-beta2 expressed in HEK293 cells using [3H]EB as radioligand CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14 \N \N \N \N \N \N Rattus norvegicus 180933 488 1745 Muscarinic acetylcholine receptor M1 GPCR P08482 Chrm1 ACM1_RAT 7.50999999999999979 \N Ki Affinity versus [3H]oxotremorine M (agonist) binding to Muscarinic acetylcholine receptor M1 in Rat Cerebral Cortical Membranes, (Kd=0.75 nM) CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14 \N \N \N \N \N \N Rattus norvegicus 180934 3347 3528 S-ribosylhomocysteine lyase Unclassified O34667 luxS LUXS_BACSU 4.20999999999999996 \N Ki Inhibition of cobalt substituted Bacillus subtilis LuxS CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42336 \N \N \N \N \N \N Bacillus subtilis (strain 168) 180935 2081 1941 Succinyl-diaminopimelate desuccinylase Enzyme P44514 dapE DAPE_HAEIN 4.29999999999999982 \N IC50 Inhibition of Haemophilus influenzae recombinant DapE CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1430 \N \N \N \N \N \N Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) 180936 1732 366 Trace amine-associated receptor 1 GPCR Q96RJ0 TAAR1 TAAR1_HUMAN 5.88999999999999968 \N EC50 Activation of human TAAR1 expressed in human HEK293T cells assessed as cAMP accumulation after 10 mins by BRET assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200952 \N AGONIST \N Tclin \N \N Homo sapiens 27189 2813 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 5.65169525146484375 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 180937 1732 2470 Trace amine-associated receptor 1 GPCR Q923Y9 Taar1 TAAR1_RAT 6.87999999999999989 \N EC50 Activation of rat wild type TAAR1 expressed in HEK293 cells assessed as stimulation of cAMP production after 1 hr by chemiluminescent assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200952 \N \N \N \N \N \N Rattus norvegicus 180938 1732 2471 Trace amine-associated receptor 1 GPCR Q923Y8 Taar1 TAAR1_MOUSE 7.15000000000000036 \N EC50 Activation of mouse TAAR1 expressed in human HEK293 cells assessed as accumulation of cAMP after 15 mins CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200952 \N \N \N \N \N \N Mus musculus 180939 1732 2469 Trace amine-associated receptor 1 GPCR Q8HZ64 TAAR1 TAAR1_MACMU 5.28000000000000025 \N EC50 Activation of rhesus monkey TAAR1 expressed in RD-HGA16 cells co-expressing Gq protein assessed as cAMP accumulation by fluorescence plate reader CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200952 \N \N \N \N \N \N Macaca mulatta 180940 1732 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 5.08000000000000007 \N Ki Binding affinity towards sigma opioid receptor in guinea pig cerebral homogenate using [3H]DTG as radioligand CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200952 \N \N \N Tclin \N \N Homo sapiens 180941 1732 2286 Synaptic vesicular amine transporter Transporter Q01827 Slc18a2 VMAT2_RAT 5.61000000000000032 \N Ki Inhibition of VMAT2-mediated [3H]-dopamine uptake in rat striata isolated synaptic vesicles by liquid scintillation spectroscopy CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200952 \N \N \N \N \N \N Rattus norvegicus 180942 931 40 Carbonic anhydrase 1; GH09688p Enzyme Q9V396 CAH1 Q9V396_DROME 5.62999999999999989 \N Ki Inhibition of Drosophila melanogaster recombinant carbonic anhydrase-1 expressed in Escherichia coli BL21 (DE3) preincubated for 15 mins by CO2 hydration stopped-flow assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL961 \N \N \N \N \N \N Drosophila melanogaster 180943 931 220 Carbonic anhydrase 4 Enzyme P22748 CA4 CAH4_HUMAN 5.19000000000000039 \N Ki Inhibition of human recombinant carbonic anhydrase 4-catalyzed CO2 hydration by stopped flow assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL961 \N \N \N Tclin \N \N Homo sapiens 180944 931 213 Carbonic anhydrase 1 Enzyme P00915 CA1 CAH1_HUMAN 6.09999999999999964 \N Ki Inhibition of human recombinant carbonic anhydrase 1-catalyzed CO2 hydration by stopped flow assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL961 \N \N \N Tclin \N \N Homo sapiens 180945 931 39 Carbonic anhydrase 2, isoform A; LD26647p Enzyme Q9VTU8 CAH2 Q9VTU8_DROME 6.17999999999999972 \N Ki Inhibition of Drosophila melanogaster recombinant carbonic anhydrase-2 expressed in Escherichia coli BL21 (DE3) preincubated for 15 mins by CO2 hydration stopped-flow assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL961 \N \N \N \N \N \N Drosophila melanogaster 180946 931 161 Carbonic anhydrase 2 Enzyme P00918 CA2 CAH2_HUMAN 5.50999999999999979 \N Ki Inhibition of human recombinant carbonic anhydrase 2-catalyzed CO2 hydration by stopped flow assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL961 \N \N \N Tclin \N \N Homo sapiens 180947 931 1746 Carbonic anhydrase 13 Enzyme Q9D6N1 Ca13 CAH13_MOUSE 4.25 \N Ki Inhibition of mouse recombinant carbonic anhydrase 13-catalyzed CO2 hydration by stopped flow assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL961 \N \N \N \N \N \N Mus musculus 180948 931 330 Carbonic anhydrase 12 Enzyme O43570 CA12 CAH12_HUMAN 5.95999999999999996 \N Ki Inhibition of human CA12 pre-incubated for 15 mins by stopped-flow CO2 hydration method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL961 \N \N \N Tclin \N \N Homo sapiens 180949 931 319 Carbonic anhydrase 9 Enzyme Q16790 CA9 CAH9_HUMAN 5.84999999999999964 \N Ki Inhibition of human CA9 pre-incubated for 15 mins by stopped-flow CO2 hydration method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL961 \N \N \N Tclin \N \N Homo sapiens 180950 52 220 Carbonic anhydrase 4 Enzyme P22748 CA4 CAH4_HUMAN 4.94000000000000039 \N Ki Inhibition of human carbonic anhydrase 4 by stopped-flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112 \N \N \N Tclin \N \N Homo sapiens 180951 52 213 Carbonic anhydrase 1 Enzyme P00915 CA1 CAH1_HUMAN 5 \N Ki Inhibition of human carbonic anhydrase 1 by stopped-flow CO2 hydrase assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112 \N \N \N Tclin \N \N Homo sapiens 180952 52 900 Arachidonate 5-lipoxygenase-activating protein Cytosolic other P20292 ALOX5AP AL5AP_HUMAN 4.36000000000000032 \N IC50 Inhibition of FLAP CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112 \N \N \N Tchem \N \N Homo sapiens 180953 52 682 Carbonic anhydrase 3 Enzyme P07451 CA3 CAH3_HUMAN 5.15000000000000036 \N Ki Inhibition of human carbonic anhydrase 3 by stopped-flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112 \N \N \N Tclin \N \N Homo sapiens 180954 52 161 Carbonic anhydrase 2 Enzyme P00918 CA2 CAH2_HUMAN 5.20999999999999996 \N Ki Inhibition of human carbonic anhydrase 2 by stopped-flow CO2 hydrase assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112 \N \N \N Tclin \N \N Homo sapiens 27146 2875 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 7.13667726516723633 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27147 2875 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 7.01575851440429688 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27148 2875 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 8.27257728576660156 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27150 2875 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 7.74472761154174805 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27151 2875 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.68590784072875977 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27152 2875 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 6.58502674102783203 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27154 2875 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN 5.39361858367919922 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27156 2875 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 6.85387182235717773 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27159 2865 284 5-hydroxytryptamine receptor 5A GPCR P47898 HTR5A 5HT5A_HUMAN 6.53610706329345703 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27160 2865 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 7.56495237350463867 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27162 2865 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN 8.04575729370117188 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27171 2865 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 5.4559321403503418 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27172 2865 109 D(1B) dopamine receptor GPCR P21918 DRD5 DRD5_HUMAN 6.81815624237060547 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27175 2865 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 5 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27176 2865 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 7.11350917816162109 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27177 2865 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 7.31875896453857422 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27190 2799 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 5.73565435409545898 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27191 2774 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 8.46000003814697266 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27192 2758 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.42250823974609375 \N Ki \N PDSP = 1 IUPHAR \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7317 INHIBITOR \N Tclin \N \N Homo sapiens 27193 2758 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 8.85387229919433594 \N Ki \N PDSP = \N \N \N \N ANTAGONIST \N Tclin \N \N Homo sapiens 27194 2758 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 6.82681369781494141 \N Ki \N PDSP = 1 IUPHAR \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7317 INHIBITOR \N Tclin \N \N Homo sapiens 27195 2742 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 8.39793968200683594 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27196 2742 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 8.55284214019775391 \N Ki \N PDSP = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL570 ANTAGONIST \N Tclin \N \N Homo sapiens 27197 2740 106 Alpha-1A adrenergic receptor GPCR P35348 ADRA1A ADA1A_HUMAN 7.61978864669799805 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27198 2740 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 6.84883451461791992 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27199 2740 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 9.25084495544433594 \N Ki \N PDSP = \N \N \N \N ANTAGONIST \N Tclin \N \N Homo sapiens 27201 2740 105 5-hydroxytryptamine receptor 7 GPCR P34969 HTR7 5HT7R_HUMAN 6.53640556335449219 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27204 2740 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 7.3772435188293457 \N Ki \N PDSP = \N \N \N \N ANTAGONIST \N Tchem \N \N Homo sapiens 27205 2740 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 5.99956607818603516 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27206 2740 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 6.40726804733276367 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27207 2740 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.78621673583984375 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27208 2740 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 8.84096813201904297 \N Ki \N PDSP = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL422 ANTAGONIST \N Tclin \N \N Homo sapiens 27209 2740 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.18462133407592773 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27210 2740 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 6.02227640151977539 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27211 2729 305 Platelet-activating factor receptor GPCR P25105 PTAFR PTAFR_HUMAN 5.87948751449584961 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27220 2717 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 6.97469425201416016 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27221 2717 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 5.48280429840087891 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27224 2717 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 6.80966806411743164 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27231 2651 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 6.75586557388305664 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27232 2651 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 7.85387182235717773 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27233 2651 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 7.07726478576660156 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27234 2639 106 Alpha-1A adrenergic receptor GPCR P35348 ADRA1A ADA1A_HUMAN 7.9397130012512207 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27235 2639 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 6.68110227584838867 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27236 2639 284 5-hydroxytryptamine receptor 5A GPCR P47898 HTR5A 5HT5A_HUMAN 6.44249296188354492 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27237 2639 171 5-hydroxytryptamine receptor 3A Ion channel P46098 HTR3A 5HT3A_HUMAN 5.72978734970092773 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27238 2639 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 9.41195392608642578 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27239 2639 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN 7.4559321403503418 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27241 2639 105 5-hydroxytryptamine receptor 7 GPCR P34969 HTR7 5HT7R_HUMAN 7.81678867340087891 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27242 2639 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.4113922119140625 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27243 2639 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 5.86813449859619141 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27245 2639 130 5-hydroxytryptamine receptor 1B GPCR P28222 HTR1B 5HT1B_HUMAN 6.82102298736572266 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27246 2639 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 6.18111467361450195 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27247 2639 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 6.38615798950195312 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27248 2639 109 D(1B) dopamine receptor GPCR P21918 DRD5 DRD5_HUMAN 6.58335971832275391 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27249 2639 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 6.69250392913818359 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27250 2639 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 7.29242992401123047 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27251 2639 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 5.39794015884399414 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27252 2639 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 7.28441476821899414 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27253 2639 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 7.30016326904296875 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27254 2639 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 9.34678745269775391 \N Ki \N PDSP = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201 ANTAGONIST \N Tclin \N \N Homo sapiens 27255 2639 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 5.58502674102783203 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27256 2639 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 7.09718179702758789 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27257 2639 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 5.31753158569335938 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27258 2639 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 6.38700437545776367 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27259 2639 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 5.81247949600219727 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27260 2639 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 5.6777806282043457 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27261 2637 112 Histamine H4 receptor GPCR Q9H3N8 HRH4 HRH4_HUMAN 5.61978864669799805 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27263 2637 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.77365779876708984 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27265 2637 284 5-hydroxytryptamine receptor 5A GPCR P47898 HTR5A 5HT5A_HUMAN 6.43889856338500977 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27267 2637 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN 8.61978912353515625 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27270 2637 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.89997434616088867 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27271 2637 339 5-hydroxytryptamine receptor 1E GPCR P28566 HTR1E 5HT1E_HUMAN 6.71219825744628906 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27274 2637 130 5-hydroxytryptamine receptor 1B GPCR P28222 HTR1B 5HT1B_HUMAN 6.96257352828979492 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27275 2637 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 6.23732137680053711 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27276 2637 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 6.86646127700805664 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27278 2637 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 7.97881078720092773 \N Ki \N PDSP = \N \N \N \N ANTAGONIST \N Tchem \N \N Homo sapiens 27280 2637 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 7.59522008895874023 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27281 2637 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 7.125518798828125 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27282 2637 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.46641874313354492 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27284 2637 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 8.56863594055175781 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27285 2637 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.87240982055664062 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27286 2637 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 7.88605642318725586 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27288 2637 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 8.04575729370117188 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27289 2637 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 7.85387182235717773 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27290 2635 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 8.92081832885742188 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27291 2635 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 9.34678745269775391 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27295 2605 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 8.08696269989013672 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27298 2558 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 7.48148584365844727 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27299 2558 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN 5.40999984741210938 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27300 2558 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 5.90000009536743164 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27301 2558 109 D(1B) dopamine receptor GPCR P21918 DRD5 DRD5_HUMAN 5.46000003814697266 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27302 2558 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 6.48000001907348633 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27303 2558 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 6.69500017166137695 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27304 2558 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.69000005722045898 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27305 2558 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 6.30946779251098633 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27306 2558 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.91499996185302734 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27307 2558 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 5.76999998092651367 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27315 2541 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 8.42021656036376953 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27316 2541 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 8.57133388519287109 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27320 2532 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 9.15490150451660156 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27321 2532 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 9.61092472076416016 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27324 2491 249 Delta-type opioid receptor GPCR P41143 OPRD1 OPRD_HUMAN 7.30103015899658203 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27329 2470 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 6.3222198486328125 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27331 2470 290 5-hydroxytryptamine receptor 1F GPCR P30939 HTR1F 5HT1F_HUMAN 8.40011692047119141 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27332 2470 339 5-hydroxytryptamine receptor 1E GPCR P28566 HTR1E 5HT1E_HUMAN 5.29662275314331055 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27379 2436 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 5.88605642318725586 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27380 2436 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 6.12781429290771484 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27381 2436 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 5.72124624252319336 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27382 2436 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 5.85387182235717773 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27383 2436 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 5.6777806282043457 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27384 2435 106 Alpha-1A adrenergic receptor GPCR P35348 ADRA1A ADA1A_HUMAN 8.74472713470458984 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27388 2435 105 5-hydroxytryptamine receptor 7 GPCR P34969 HTR7 5HT7R_HUMAN 7.55284214019775391 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27396 2435 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 5.56992483139038086 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27397 2435 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 6.34678745269775391 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27398 2435 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.34678745269775391 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27400 2435 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.19381999969482422 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27405 2402 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 5.42000007629394531 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27407 2402 105 5-hydroxytryptamine receptor 7 GPCR P34969 HTR7 5HT7R_HUMAN 5.82000017166137695 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27408 2402 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 5.8600001335144043 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27410 2402 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 5.92000007629394531 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27413 2402 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 5.73000001907348633 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27415 2397 493 Prostaglandin E2 receptor EP2 subtype GPCR P43116 PTGER2 PE2R2_HUMAN 7.46590709686279297 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27430 2389 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 6.92081880569458008 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27431 2389 109 D(1B) dopamine receptor GPCR P21918 DRD5 DRD5_HUMAN 7.02268600463867188 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27434 2389 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 5 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27440 2389 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 5.53760194778442383 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27441 2389 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 5.43179845809936523 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27444 2337 284 5-hydroxytryptamine receptor 5A GPCR P47898 HTR5A 5HT5A_HUMAN 5.50584554672241211 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27446 2337 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN 7.408935546875 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27448 2337 105 5-hydroxytryptamine receptor 7 GPCR P34969 HTR7 5HT7R_HUMAN 6.51201391220092773 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27453 2337 130 5-hydroxytryptamine receptor 1B GPCR P28222 HTR1B 5HT1B_HUMAN 5.82165718078613281 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27455 2337 109 D(1B) dopamine receptor GPCR P21918 DRD5 DRD5_HUMAN 5.79005575180053711 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27458 2337 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 5.79547643661499023 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27460 2337 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.12691211700439453 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27463 2337 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 5.4400935173034668 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 180955 52 751 Carbonic anhydrase 14 Enzyme Q9ULX7 CA14 CAH14_HUMAN 4.96999999999999975 \N Ki Inhibition of human carbonic anhydrase 14 by stopped-flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112 \N \N \N Tclin \N \N Homo sapiens 180956 52 400 Carbonic anhydrase 7 Enzyme P43166 CA7 CAH7_HUMAN 5.04000000000000004 \N Ki Inhibition of human carbonic anhydrase 7 by stopped-flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112 \N \N \N Tclin \N \N Homo sapiens 180957 52 1746 Carbonic anhydrase 13 Enzyme Q9D6N1 Ca13 CAH13_MOUSE 4.51999999999999957 \N Ki Inhibition of mouse carbonic anhydrase 13 by stopped-flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112 \N \N \N \N \N \N Mus musculus 180958 52 319 Carbonic anhydrase 9 Enzyme Q16790 CA9 CAH9_HUMAN 4.15000000000000036 \N Ki Inhibition of human carbonic anhydrase 9 catalytic domain by stopped-flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112 \N \N \N Tclin \N \N Homo sapiens 180959 52 330 Carbonic anhydrase 12 Enzyme O43570 CA12 CAH12_HUMAN 5.38999999999999968 \N Ki Inhibition of human carbonic anhydrase 12 catalytic domain by stopped-flow CO2 hydration assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112 \N \N \N Tclin \N \N Homo sapiens 180960 52 2073 Carbonic anhydrase 15 Enzyme Q99N23 Ca15 CAH15_MOUSE 5.03000000000000025 \N Ki Inhibition of mouse recombinant carbonic anhydrase 15 by stopped-flow CO2 hydrase assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112 \N \N \N \N \N \N Mus musculus 180961 52 2937 Myoglobin Unclassified P02144 MB MYG_HUMAN 5.63999999999999968 \N IC50 Inhibition of myoglobin (unknown origin)-mediated arachidonic acid oxidation using [14C]AA as substrate after 3 hrs by GC/NICI/MS analysis CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112 \N \N \N Tbio \N \N Homo sapiens 180962 2149 1732 Alpha-1A adrenergic receptor GPCR P43140 Adra1a ADA1A_RAT 5.00999999999999979 \N Ki Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61006 \N \N \N \N \N \N Rattus norvegicus 180963 2149 2000 Alpha-1B adrenergic receptor GPCR P18841 ADRA1B ADA1B_MESAU 5.01999999999999957 \N Ki Binding affinity to Cricetinae (hamster) alpha1B adrenoreceptor by radioligand displacement assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61006 \N \N \N \N \N \N Mesocricetus auratus 180964 2149 1734 Alpha-1D adrenergic receptor GPCR P23944 Adra1d ADA1D_RAT 5.07000000000000028 \N Ki Binding affinity to Rattus norvegicus (rat) alpha1D adrenoreceptor by radioligand displacement assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61006 \N \N \N \N \N \N Rattus norvegicus 180965 2149 106 Alpha-1A adrenergic receptor GPCR P35348 ADRA1A ADA1A_HUMAN \N \N \N Mechanism of Action; CHEMBL229; SINGLE PROTEIN CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61006 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61006 AGONIST \N Tclin \N \N Homo sapiens 180967 1394 2470 Trace amine-associated receptor 1 GPCR Q923Y9 Taar1 TAAR1_RAT 7.29999999999999982 \N EC50 Activation of rat TAAR1 expressed in HEK293 cells assessed as accumulation of [3H]cAMP after 1 hr by competitive binding assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1546 \N \N \N \N \N \N Rattus norvegicus 180968 1394 882 Beta-secretase 1 Enzyme P56817 BACE1 BACE1_HUMAN 3.10000000000000009 \N Kd Binding affinity to BACE1 by surface plasmon resonance method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1546 \N \N \N Tchem \N \N Homo sapiens 180970 144 3529 Matrix protein 2 Unclassified Q20MD5 M2 Q20MD5_9INFA 4.79999999999999982 \N IC50 Inhibition of Influenza A virus (A/Udorn/72) wild type matrix protein 2 expressed in xenopus oocytes after 2 mins by two-electrode voltage clamp assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL660 \N \N \N \N \N \N Influenza A virus (A/udorn/1972(H3N2)) 180971 144 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 7.69000000000000039 \N Ki Binding affinity towards sigma receptor in guinea pig brain membrane was determined by using [3H]DTG as the radioligand CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL660 \N \N \N Tclin \N \N Homo sapiens 180972 144 2638 Matrix protein 2 Ion channel P63231 M M2_I72A2 4.79999999999999982 \N IC50 Inhibition of wild type Influenza A virus (A/udorn/72(H3N2)) M2 channel expressed in Xenopus oocyte plasma membrane incubated for 2 mins measured over 48 to 72 hrs by two-electrode voltage clamp method CHEMBL = 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL660 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL660 INHIBITOR \N \N \N \N Influenza A virus (strain A/Udorn/307/1972 H3N2) 180973 144 2494 Multidrug and toxin extrusion protein 1 Transporter Q96FL8 SLC47A1 S47A1_HUMAN 4.41999999999999993 \N IC50 Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL660 \N \N \N Tchem \N \N Homo sapiens 180975 1766 213 Carbonic anhydrase 1 Enzyme P00915 CA1 CAH1_HUMAN 5.58999999999999986 \N Ki Inhibition of human carbonic anhydrase 1 preincubated for 15 mins by CO2 hydration stopped-flow assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325372 \N \N \N Tclin \N \N Homo sapiens 27530 2181 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 7.4559321403503418 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 180976 1766 161 Carbonic anhydrase 2 Enzyme P00918 CA2 CAH2_HUMAN 5.46999999999999975 \N Ki Inhibition of human carbonic anhydrase 2 preincubated for 15 mins by CO2 hydration stopped-flow assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325372 \N \N \N Tclin \N \N Homo sapiens 180977 1766 751 Carbonic anhydrase 14 Enzyme Q9ULX7 CA14 CAH14_HUMAN 5.38999999999999968 \N Ki Inhibition of human carbonic anhydrase 14 preincubated for 15 mins by CO2 hydration stopped-flow assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325372 \N \N \N Tclin \N \N Homo sapiens 180978 1766 400 Carbonic anhydrase 7 Enzyme P43166 CA7 CAH7_HUMAN 6.11000000000000032 \N Ki Inhibition of human carbonic anhydrase 7 preincubated for 15 mins by CO2 hydration stopped-flow assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325372 \N \N \N Tclin \N \N Homo sapiens 180979 1766 319 Carbonic anhydrase 9 Enzyme Q16790 CA9 CAH9_HUMAN 5.25999999999999979 \N Ki Inhibition of human carbonic anhydrase 9 preincubated for 15 mins by CO2 hydration stopped-flow assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325372 \N \N \N Tclin \N \N Homo sapiens 180980 1766 330 Carbonic anhydrase 12 Enzyme O43570 CA12 CAH12_HUMAN 6.08999999999999986 \N Ki Inhibition of human carbonic anhydrase 12 preincubated for 15 mins by CO2 hydration stopped-flow assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325372 \N \N \N Tclin \N \N Homo sapiens 180981 1708 3530 Purine nucleoside phosphorylase Unclassified P9WP01 punA PUNA_MYCTU 4.09999999999999964 \N Kd Binding affinity to Mycobacterium tuberculosis purine nucleoside phosphorylase by spectrophotometric analysis CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1425 \N \N \N \N \N \N Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) 180982 470 1793 Acetylcholinesterase Enzyme O42275 ache ACES_ELEEL 4.29999999999999982 \N Ki Inhibition of Electrophorus electricus (electric eel) acetylcholinesterase (AChE) using acetylthiocholine iodide substrate by Ellman method based colorimetry CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL504760 \N \N \N \N \N \N Electrophorus electricus 180983 2050 424 Tyrosine-protein phosphatase non-receptor type 1 Enzyme P18031 PTPN1 PTN1_HUMAN 2.91999999999999993 \N Kd Dissociation constant for Protein-tyrosine phosphatase 1B CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1169 \N \N \N Tchem \N \N Homo sapiens 180984 2050 2891 Cyclooxygenase Enzyme P23219|P35354 PTGS1|PTGS2 PGH1_HUMAN|PGH2_HUMAN \N \N \N Mechanism of Action; CHEMBL2094253; PROTEIN FAMILY CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1169 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1169 INHIBITOR \N Tclin|Tclin \N \N Homo sapiens 180985 1710 353 Arachidonate 5-lipoxygenase Enzyme P09917 ALOX5 LOX5_HUMAN \N \N \N Mechanism of Action; CHEMBL215; SINGLE PROTEIN CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL704 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL704 INHIBITOR \N Tclin \N \N Homo sapiens 180986 3396 2615 TyR1 GPCR H9TVJ1 \N H9TVJ1_9NEOP 6.00999999999999979 \N EC50 Agonist activity at Chilo suppressalis (rice stem borer) tyramine receptor TyR1 expressed in HEK293 cells assessed as reduction in forskolin-induced cAMP accumulation incubated for 20 min CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53929 \N \N \N \N \N \N Chilo suppressalis 180987 3396 171 5-hydroxytryptamine receptor 3A Ion channel P46098 HTR3A 5HT3A_HUMAN 7.62000000000000011 \N EC50 Activity at SER3 receptor expressed in HEK293 cells assessed as increase in calcium by calcium imaging assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53929 \N \N \N Tclin \N \N Homo sapiens 180988 947 2851 Dopamine receptor GPCR P20288|Q95136 DRD1|DRD2 DRD1_BOVIN|DRD2_BOVIN 8.42999999999999972 \N IC50 Tested for binding to dopamine receptor using [3H]- ADTN as radioligand in calf caudate nucleus homogenates. CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59 \N \N \N \N \N \N Bos taurus 180989 947 1754 Sodium-dependent dopamine transporter Transporter P23977 Slc6a3 SC6A3_RAT 6.70000000000000018 \N IC50 Inhibition of dopamine transporter-mediated [3H]dopamine uptake in Wistar rat striatal synaptosomes by liquid scintillation spectrometry CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59 \N \N \N \N \N \N Rattus norvegicus 180990 947 2862 Adenylate cyclase Enzyme D4A3N4|P21932|P26769|P26770|P40146|Q03343|Q04400|Q8CFM9 Adcy1|Adcy2|Adcy3|Adcy4|Adcy5|Adcy6|Adcy8 ADCY2_RAT|ADCY3_RAT|ADCY4_RAT|ADCY5_RAT|ADCY6_RAT|ADCY8_RAT|D4A3N4_RAT|Q8CFM9_RAT 5.45999999999999996 \N EC50 Tested for ability to stimulate dopamine sensitive adenylate cyclase in rat caudate homogenate CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59 \N \N \N \N \N \N Rattus norvegicus 180991 947 1801 D(1A) dopamine receptor GPCR Q95136 DRD1 DRD1_BOVIN 8.15000000000000036 \N Ki Binding Affinity was tested on High Affinity Site of Bovine Dopamine receptor D1. Tested for ability to displace the radioligand [3H]-SCH- 23390 CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59 \N \N \N \N \N \N Bos taurus 180992 947 1803 Beta-1 adrenergic receptor GPCR P18090 Adrb1 ADRB1_RAT 5 \N Ki Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59 \N \N \N \N \N \N Rattus norvegicus 180993 947 1878 D(4) dopamine receptor GPCR P30729 Drd4 DRD4_RAT 8.61999999999999922 \N EC50 In vitro effective concentration tested on HEK293 cells co-transfected with rat Dopamine receptor D4 using FLIPR assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59 \N \N \N \N \N \N Rattus norvegicus 180994 947 55 Beta-2 adrenergic receptor GPCR P07550 ADRB2 ADRB2_HUMAN 4.19000000000000039 \N Kd Binding affinity to human adrenergic beta2 receptor CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59 \N \N \N Tclin \N \N Homo sapiens 180995 947 2852 Dopamine receptor GPCR P18901|P19020|P25115|P30729|P61169 Drd1|Drd2|Drd3|Drd4|Drd5 DRD1_RAT|DRD2_RAT|DRD3_RAT|DRD4_RAT|DRD5_RAT 5.26999999999999957 \N IC50 Tested for Dopamine receptor activity by the inhibition against spiroperidol binding to rat caudate tissue. CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59 \N \N \N \N \N \N Rattus norvegicus 180996 947 378 Melatonin receptor type 1A GPCR P48039 MTNR1A MTR1A_HUMAN 5.15000000000000036 \N Ki Displacement of 2-[125I]iodomelatonin from human Melatonin receptor type 1A expressed in CHO cells CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59 \N \N \N Tclin \N \N Homo sapiens 180997 947 379 Melatonin receptor type 1B GPCR P49286 MTNR1B MTR1B_HUMAN 5.04000000000000004 \N Ki Inhibition of 2-[125I]iodomelatonin binding to human Melatonin receptor type 1B expressed in CHO cells CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59 \N \N \N Tclin \N \N Homo sapiens 180998 947 2850 Adrenergic receptor alpha-2 GPCR P19328|P22086|P22909 Adra2a|Adra2b|Adra2c ADA2A_RAT|ADA2B_RAT|ADA2C_RAT 7.24000000000000021 \N Ki Binding of [3H]clonidine to alpha-2-adrenergic receptor of rat cerebral cortical membranes CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59 \N \N \N \N \N \N Rattus norvegicus 180999 947 2854 Adrenergic receptor alpha-1 GPCR P15823|P23944|P43140 Adra1a|Adra1b|Adra1d ADA1A_RAT|ADA1B_RAT|ADA1D_RAT 4.84999999999999964 \N Ki Binding of [3H]prazosin to alpha-1 adrenergic receptor of rat cerebral cortical membranes CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59 \N \N \N \N \N \N Rattus norvegicus 27531 2181 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 6.9397130012512207 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 181000 947 1814 D(2) dopamine receptor GPCR P20288 DRD2 DRD2_BOVIN 8.74000000000000021 \N Ki Binding Affinity on high Affinity Site of Bovine dopamine receptor D2. Tested for ability to displace the radioligand [3H]pramipexole was tested CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59 \N \N \N \N \N \N Bos taurus 181001 947 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.19000000000000039 \N Ki Displacement of [125I]RT155 binding in HEK cells expressing human DAT CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59 \N \N \N Tclin \N \N Homo sapiens 181002 947 1824 Beta-2 adrenergic receptor GPCR P54833 ADRB2 ADRB2_CANFA 4.29999999999999982 \N Ki Binding of [3H]dihydroalprenolol to beta-2 adrenergic receptor of rat cerebral cortical membranes CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59 \N \N \N \N \N \N Canis familiaris 181003 947 1810 D(1A) dopamine receptor GPCR P18901 Drd1 DRD1_RAT 6.82000000000000028 \N Ki Displacement of [3H]fenoldopam from Dopamine receptor D1 of rat striatum membranes CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59 \N \N \N \N \N \N Rattus norvegicus 181004 947 1748 D(2) dopamine receptor GPCR P61169 Drd2 DRD2_RAT 8.34999999999999964 \N Ki Displacement of [3H]-spiperone from rat dopamine D2S receptor expressed in rat C6 cells after 45 mins by scintillation counting analysis CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59 \N \N \N \N \N \N Rattus norvegicus 181005 947 1865 D(3) dopamine receptor GPCR P19020 Drd3 DRD3_RAT 7.95999999999999996 \N Ki Binding affinity which represents concentration giving half-maximal inhibition of [3H]7-OH-DPAT binding to Dopamine receptor D3 in rat tissue homogenate CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59 \N \N \N \N \N \N Rattus norvegicus 181006 947 2842 Opioid receptor GPCR P33533|P33535|P34975|Q9R0C9 Oprd1|Oprk1|Oprm1|Sigmar1 OPRD_RAT|OPRK_RAT|OPRM_RAT|SGMR1_RAT 5.51999999999999957 \N IC50 Ability to inhibit the specific binding of [3H]- dihydromorphine to opiate receptors in rat brain membrane preparation by 50% CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59 \N \N \N \N \N \N Rattus norvegicus 181007 3260 213 Carbonic anhydrase 1 Enzyme P00915 CA1 CAH1_HUMAN 5.37999999999999989 \N Ki Inhibition of human carbonic anhydrase 1 preincubated for 15 mins by CO2 hydration stopped-flow assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1461 \N \N \N Tclin \N \N Homo sapiens 181008 3260 161 Carbonic anhydrase 2 Enzyme P00918 CA2 CAH2_HUMAN 5.38999999999999968 \N Ki Inhibition of human carbonic anhydrase 2 preincubated for 15 mins by CO2 hydration stopped-flow assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1461 \N \N \N Tclin \N \N Homo sapiens 181009 3260 751 Carbonic anhydrase 14 Enzyme Q9ULX7 CA14 CAH14_HUMAN 4.16999999999999993 \N Ki Inhibition of human carbonic anhydrase 14 preincubated for 15 mins by CO2 hydration stopped-flow assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1461 \N \N \N Tclin \N \N Homo sapiens 181010 3260 400 Carbonic anhydrase 7 Enzyme P43166 CA7 CAH7_HUMAN 4.16999999999999993 \N Ki Inhibition of human carbonic anhydrase 7 preincubated for 15 mins by CO2 hydration stopped-flow assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1461 \N \N \N Tclin \N \N Homo sapiens 181011 3260 353 Arachidonate 5-lipoxygenase Enzyme P09917 ALOX5 LOX5_HUMAN 4.12000000000000011 \N IC50 Inhibition of human recombinant 5-lipoxygenase after 10 mins by fluorescence assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1461 \N \N \N Tclin \N \N Homo sapiens 181012 3260 319 Carbonic anhydrase 9 Enzyme Q16790 CA9 CAH9_HUMAN 5.17999999999999972 \N Ki Inhibition of human carbonic anhydrase 9 preincubated for 15 mins by CO2 hydration stopped-flow assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1461 \N \N \N Tclin \N \N Homo sapiens 181013 3260 330 Carbonic anhydrase 12 Enzyme O43570 CA12 CAH12_HUMAN 5.13999999999999968 \N Ki Inhibition of human carbonic anhydrase 12 preincubated for 15 mins by CO2 hydration stopped-flow assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1461 \N \N \N Tclin \N \N Homo sapiens 181027 2059 3421 Voltage-gated T-type calcium channel Ion channel O43497|O95180|Q9P0X4 CACNA1G|CACNA1H|CACNA1I CAC1G_HUMAN|CAC1H_HUMAN|CAC1I_HUMAN \N \N \N Mechanism of Action; CHEMBL2362995; PROTEIN FAMILY CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1100 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1100 BLOCKER \N Tclin|Tclin|Tclin \N \N Homo sapiens 181028 2713 334 Plasminogen Enzyme P00747 PLG PLMN_HUMAN 5.95999999999999996 \N Kd Binding affinity to human plasma full length Glu-plasminogen K1 domain by surface plasmon resonance analysis CHEMBL = 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL877 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL877 INHIBITOR \N Tclin \N \N Homo sapiens 181029 2664 1912 Catechol O-methyltransferase Enzyme P22734 Comt COMT_RAT 4.34999999999999964 \N IC50 Inhibition of Sprague-Dawley rat liver COMT after 10 mins using 0.05 uCi [14CH3]-SAM as substrate CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1410814 \N \N \N \N \N \N Rattus norvegicus 181030 2255 2030 Uncharacterized protein; Voltage-dependent calcium channel alpha-2 delta subunit Ion channel O77773 CACNA2D1 O77773_PIG 7.13999999999999968 \N IC50 Displacement of [3H]gabapentin from alpha-2delta calcium channel in pig brain membrane CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1059 \N \N \N \N \N \N Sus scrofa 181031 2065 2111 Aldehyde dehydrogenase, mitochondrial Enzyme P11884 Aldh2 ALDH2_RAT 5.25 \N IC50 Inhibition of Sprague-Dawley rat mitochondrial aldehyde dehydrogenase CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL673 \N \N \N \N \N \N Rattus norvegicus 181032 2065 1817 Amine oxidase [flavin-containing] A Enzyme P21396 Maoa AOFA_RAT 5.07000000000000028 \N Ki Inhibition of MAO-A in rat liver homogenate after 60 mins by Lineweaver-Burke plot CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL673 \N \N \N \N \N \N Rattus norvegicus 181033 2065 1816 Amine oxidase [flavin-containing] B Enzyme P19643 Maob AOFB_RAT 5.46999999999999975 \N Ki Inhibition of MAO-B in rat liver homogenate after 60 mins by Lineweaver-Burke plot CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL673 \N \N \N \N \N \N Rattus norvegicus 181034 2065 286 Amine oxidase [flavin-containing] B Enzyme P27338 MAOB AOFB_HUMAN 5.74000000000000021 \N Ki Inhibition constant against human recombinant Monoamine oxidase-B CHEMBL = 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL673 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL673 INHIBITOR \N Tclin \N \N Homo sapiens 181035 2065 313 Amine oxidase [flavin-containing] A Enzyme P21397 MAOA AOFA_HUMAN 5.46999999999999975 \N IC50 Inhibition of MAOA (unknown origin) using kynuramine as substrate after 1 hr by fluorescence assay CHEMBL = 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL673 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL673 INHIBITOR \N Tclin \N \N Homo sapiens 181036 1384 2077 Cholinesterase Enzyme P81908 BCHE CHLE_HORSE 5.71999999999999975 \N Ki Inhibition of Equus caballus (horse) serum butyrylcholinesterase (BChE) assessed as inhibition of BTCh hydrolysis by Ellman method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL276832 \N \N \N \N \N \N Equus caballus 181037 1384 1793 Acetylcholinesterase Enzyme O42275 ache ACES_ELEEL 5.15000000000000036 \N Ki Inhibition of Electrophorus electricus (electric eel) acetylcholinesterase (AChE) assessed as inhibition of ATCh hydrolysis by Ellman method CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL276832 \N \N \N \N \N \N Electrophorus electricus 181038 2695 366 Trace amine-associated receptor 1 GPCR Q96RJ0 TAAR1 TAAR1_HUMAN 5.79000000000000004 \N Ki Displacement of (S)-4-(2,4-difluorophenyl-3-tritio) -4,5-dihydro-2-oxazolamine from human TAAR1 receptor expressed in HEK293 cells after 90 mins by beta counting analysis CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL770 \N \N \N Tclin \N \N Homo sapiens 181039 2695 2850 Adrenergic receptor alpha-2 GPCR P19328|P22086|P22909 Adra2a|Adra2b|Adra2c ADA2A_RAT|ADA2B_RAT|ADA2C_RAT 6.74000000000000021 \N Ki Displacement of [3H]clonidine from Alpha-2 adrenergic receptor of rat brain membranes CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL770 \N \N \N \N \N \N Rattus norvegicus 181040 2695 2854 Adrenergic receptor alpha-1 GPCR P15823|P23944|P43140 Adra1a|Adra1b|Adra1d ADA1A_RAT|ADA1B_RAT|ADA1D_RAT 5.67999999999999972 \N IC50 Inhibition of specific [3H]-prazosin binding (0.2 nM) to rat brain membranes alpha1 adrenoceptor; 2.1*10e-6 CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL770 \N \N \N \N \N \N Rattus norvegicus 181042 1726 1744 Muscarinic acetylcholine receptor M2 GPCR P10980 Chrm2 ACM2_RAT 7.23000000000000043 \N Ki Inhibition of binding of [3H]quinuclidinyl benzilate to Muscarinic acetylcholine receptor M2 in rat cerebral cortical membranes CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL978 \N \N \N \N \N \N Rattus norvegicus 181043 1726 1997 Muscarinic acetylcholine receptor M4 GPCR P08485 Chrm4 ACM4_RAT 5.79999999999999982 \N Ki Inhibition of binding of [3H]quinuclidinyl benzilate to Muscarinic acetylcholine receptor M4 in rat cerebral cortical membranes CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL978 \N \N \N \N \N \N Rattus norvegicus 181044 1726 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 7.23000000000000043 \N Ki Inhibition of binding of [3H]quinuclidinyl benzilate to muscarinic receptors in membranes of CHO cells transfected with Muscarinic acetylcholine receptor M2 CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL978 \N \N \N Tclin \N \N Homo sapiens 181045 1726 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 5.79999999999999982 \N Ki Inhibition of binding of [3H]quinuclidinyl benzilate to muscarinic receptors in membranes of CHO cells transfected with Muscarinic acetylcholine receptor M4 CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL978 \N \N \N Tclin \N \N Homo sapiens 181046 1726 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN \N \N \N Mechanism of Action; CHEMBL245; SINGLE PROTEIN CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL978 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL978 AGONIST \N Tclin \N \N Homo sapiens 181047 358 2290 Muscarinic acetylcholine receptor GPCR Q8VH26 GPM3 Q8VH26_CAVPO 4.90000000000000036 \N Kd Binding affinity to muscarinic M3 receptor in guinea-pig ileum CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1482 \N \N \N \N \N \N Cavia porcellus 181048 358 3531 Muscarinic receptor 2 Unclassified Q8VH27 GPM2 Q8VH27_CAVPO 6 \N EC50 Agonist activity at muscarinic M3 receptor in albino guinea pig ileum assessed as stimulation of electrically-induced response CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1482 \N \N \N \N \N \N Cavia porcellus 181049 1670 238 3-hydroxy-3-methylglutaryl-coenzyme A reductase Enzyme P04035 HMGCR HMDH_HUMAN 7.62999999999999989 \N Ki Inhibitory constant against HMG-CoA reductase CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50444 \N \N \N Tclin \N \N Homo sapiens 181050 513 2001 Carnitine O-palmitoyltransferase 1, muscle isoform Enzyme Q63704 Cpt1b CPT1B_RAT 4 \N Ki Tested against neonatal rat cardiac myocyte carnitine palmitoyltransferase 1 CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1149 \N \N \N \N \N \N Rattus norvegicus 181051 513 3532 Carnitine palmitoyltransferase 2 Unclassified P18886 Cpt2 CPT2_RAT 4 \N Ki Tested against neonatal rat cardiac myocyte carnitine palmitoyltransferase 2 CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1149 \N \N \N \N \N \N Rattus norvegicus 181052 1920 1779 Neuronal acetylcholine receptor subunit alpha-4 Ion channel P09483 Chrna4 ACHA4_RAT 9.02999999999999936 \N Ki Displacement of [3H]cytisine from alpha4beta2 nAChR in rat brain membrane CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3 \N \N \N \N \N \N Rattus norvegicus 181053 1920 2605 Neuronal acetylcholine receptor subunit alpha-4 Ion channel O70174 Chrna4 ACHA4_MOUSE 8.15000000000000036 \N IC50 Inhibition of [3H]nicotine binding to alpha4 nicotinic acetylcholine receptor in Mus musculus (mouse) M10 cells co-expressing beta2 nicotinic acetylcholine receptor subunits CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3 \N \N \N \N \N \N Mus musculus 181054 1920 2762 Neuronal acetylcholine receptor Ion channel P04757|P09483|P12389|P12390|P12391|P12392|P20420|P25108|P25109|P43143|P43144|Q05941|Q9JLB5 Chrna1|Chrna10|Chrna2|Chrna3|Chrna4|Chrna5|Chrna6|Chrna7|Chrna9|Chrnb1|Chrnb2|Chrnb3|Chrnb4 ACH10_RAT|ACHA2_RAT|ACHA3_RAT|ACHA4_RAT|ACHA5_RAT|ACHA6_RAT|ACHA7_RAT|ACHA9_RAT|ACHA_RAT|ACHB2_RAT|ACHB3_RAT|ACHB4_RAT|ACHB_RAT 11 \N Kd Ability to enhance the binding of (+/-)-[3H]nicotine to the rat brain P2 fraction at binding site 2 CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3 \N \N \N \N \N \N Rattus norvegicus 181055 1920 1909 Neuronal acetylcholine receptor subunit alpha-9 Ion channel P43144 Chrna9 ACHA9_RAT 8.30000000000000071 \N Kd The compound was tested for the inhibition of binding of [3H]epibatidine to central nicotinic acetylcholine receptor (nAChR) in rat brain. CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3 \N \N \N \N \N \N Rattus norvegicus 181056 1920 1989 Neuronal acetylcholine receptor subunit beta-4 Ion channel P12392 Chrnb4 ACHB4_RAT 7.13999999999999968 \N Ki Binding affinity to Nicotinic acetylcholine receptor alpha3-beta4 using +/-[3H]epibatidine as radioligand in pig adrenal gland CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3 \N \N \N \N \N \N Rattus norvegicus 181057 1920 2156 Neuronal acetylcholine receptor subunit alpha-2 Ion channel P12389 Chrna2 ACHA2_RAT 7.91999999999999993 \N Ki Displacement of [3H]epibatidine from rat alpha2beta2 nicotinic receptor expressed in human HEK293 cells by liquid scintillation counting CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3 \N \N \N \N \N \N Rattus norvegicus 181058 1920 2819 Acetylcholine receptor; alpha1/beta1/delta/gamma Ion channel P02708|P07510|P11230|Q07001 CHRNA1|CHRNB1|CHRND|CHRNG ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN|ACHG_HUMAN 5.83000000000000007 \N Ki Binding affinity to alpha-1-beta-gamma-delta nicotinic receptor CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3 \N \N \N Tclin|Tclin|Tclin|Tclin \N \N Homo sapiens 181059 1920 2725 Neuronal acetylcholine receptor; alpha3/beta2 Ion channel P04757|P12390 Chrna3|Chrnb2 ACHA3_RAT|ACHB2_RAT 9 \N Ki Affinity for Nicotinic acetylcholine receptor alpha4-beta2 tested by analogue-induced inhibition of [3H]NIC binding to rat striatal membranes CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3 \N \N \N \N \N \N Rattus norvegicus 181060 1920 2726 Neuronal acetylcholine receptor; alpha3/beta4 Ion channel P04757|P12392 Chrna3|Chrnb4 ACHA3_RAT|ACHB4_RAT 6.70000000000000018 \N Ki Displacement of [3H]epibatidine from recombinant rat alpha-3-beta-4 nAChr in HEK293 cell line CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3 \N \N \N \N \N \N Rattus norvegicus 27532 2181 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.06550168991088867 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 181061 1920 2724 Neuronal acetylcholine receptor; alpha2/beta2 Ion channel P12389|P12390 Chrna2|Chrnb2 ACHA2_RAT|ACHB2_RAT 8.25999999999999979 \N Ki Displacement of [3H]epibatidine from rat nAChR alpha2beta2 CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3 \N \N \N \N \N \N Rattus norvegicus 181062 1920 2821 Neuronal acetylcholine receptor; alpha2/beta4 Ion channel P12389|P12392 Chrna2|Chrnb4 ACHA2_RAT|ACHB4_RAT 7.15000000000000036 \N Ki Displacement of [3H]epibatidine from rat nAChR alpha2beta4 CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3 \N \N \N \N \N \N Rattus norvegicus 181063 1920 2602 Nicotinic acetylcholine receptor alpha 5 subunit Ion channel A9XFY4 nAChRalpha5 A9XFY4_MUSDO 5.61000000000000032 \N Ki Displacement of [3H]alpha-bungarotoxin from nAChR in Musca domestica (house fly) head membrane after 60 min by scintillation counting CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3 \N \N \N \N \N \N Musca domestica 181064 1920 1772 Acetylcholine receptor subunit delta Ion channel P02718 chrnd ACHD_TORCA 9 \N Ki Bindind affinity values obtained by measuring the displacement of radioligand [3H](-)-cytisine from a preparation of whole rat brain CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3 \N \N \N \N \N \N Torpedo californica 181065 1920 2728 Neuronal acetylcholine receptor; alpha4/beta4 Ion channel P09483|P12392 Chrna4|Chrnb4 ACHA4_RAT|ACHB4_RAT 8.25999999999999979 \N Ki Displacement of [3H]epibatidine from rat alpha2beta2 nACHR CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3 \N \N \N \N \N \N Rattus norvegicus 181066 1920 2727 Neuronal acetylcholine receptor; alpha4/beta2 Ion channel P09483|P12390 Chrna4|Chrnb2 ACHA4_RAT|ACHB2_RAT 9.40000000000000036 \N Kd GRAC: rat AChR-alpha4-beta2 radioligand CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3 \N \N \N \N \N \N Rattus norvegicus 181067 1920 1783 Neuronal acetylcholine receptor subunit alpha-7 Ion channel Q05941 Chrna7 ACHA7_RAT 6.88999999999999968 \N Ki Binding affinity to subtype Nicotinic acetylcholine receptor alpha-7 using [125I]-alpha-BTX as radioligand in rat brain CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3 \N \N \N \N \N \N Rattus norvegicus 181068 1920 1895 Neuronal acetylcholine receptor subunit alpha-7 Ion channel P49582 Chrna7 ACHA7_MOUSE 6.61000000000000032 \N Ki Displacement of [125I]-alpha-Btx from alpha7 nAChR in mouse hippocampal membranes CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3 \N \N \N \N \N \N Mus musculus 181069 1920 2822 Acetylcholine receptor Ion channel P02710|P02712|P02714|P02718 CHRNA1|CHRNB1|CHRNG|chrnd ACHA_TORCA|ACHB_TORCA|ACHD_TORCA|ACHG_TORCA 5.20000000000000018 \N Ki Inhibition of [125I]alpha-bungarotoxin binding to nicotinic acetylcholine receptor alpha1 beta gamma delta of electroplax CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3 \N \N \N \N \N \N Torpedo californica 181070 1920 2107 Neuronal acetylcholine receptor subunit alpha-3 Ion channel P04757 Chrna3 ACHA3_RAT 7.33000000000000007 \N Ki Displacement of [3H]epibatidine from rat alpha3beta2 nicotinic receptor expressed in human HEK293 cells by liquid scintillation counting CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3 \N \N \N \N \N \N Rattus norvegicus 181071 1920 2603 Acetylcholine receptor subunit beta-like 2 Ion channel P25162 nAChRbeta2 ACH4_DROME 5.57000000000000028 \N Ki Binding affinity to Drosophila brain nicotinic acetylcholine receptor assessed as [3H]IMI binding by radioligand binding assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3 \N \N \N \N \N \N Drosophila melanogaster 181072 1920 2838 Muscarinic acetylcholine receptor GPCR P08482|P08483|P08485|P08911|P10980 Chrm1|Chrm2|Chrm3|Chrm4|Chrm5 ACM1_RAT|ACM2_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT 4.54999999999999982 \N IC50 Inhibitory concentration required for in vitro binding affinity to cholinergic central muscarinic receptor on rat brain cortex by using [3H]OXO-M CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3 \N \N \N \N \N \N Rattus norvegicus 181073 1920 2818 Serotonin 3 (5-HT3) receptor Ion channel A5X5Y0|O95264|P46098|Q70Z44|Q8WXA8 HTR3A|HTR3B|HTR3C|HTR3D|HTR3E 5HT3A_HUMAN|5HT3B_HUMAN|5HT3C_HUMAN|5HT3D_HUMAN|5HT3E_HUMAN 4.15000000000000036 \N Ki In vitro Binding affinity towards 5-hydroxytryptamine 3 receptor was determined CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3 \N \N \N Tchem|Tchem|Tchem|Tchem|Tclin \N \N Homo sapiens 181074 1920 3383 Acetylcholine receptor subunit alpha Ion channel P02708 CHRNA1 ACHA_HUMAN 4.67999999999999972 \N IC50 Inhibition of [3H]alpha-BGT binding to alpha1 nicotinic acetylcholine receptor in Homo sapiens (human) TE671 cells co-expressing gammaalpha1deltabeta1 nicotinic acetylcholine receptor subunits CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3 \N \N \N Tclin \N \N Homo sapiens 181075 1920 2601 Lycopene cyclase Enzyme P21687 crtY CRTY_PANAN 5.32000000000000028 \N IC50 Inhibition of Pantoea ananatis lycopene cyclase CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3 \N \N \N \N \N \N Pantoea ananas 181076 1920 2583 Acetylcholine receptor subunit alpha Ion channel P02710 CHRNA1 ACHA_TORCA 4.63999999999999968 \N IC50 Displacement of [3H]alpha-BGT from nAChR in Torpedo nobiliana electric organs CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3 \N \N \N \N \N \N Torpedo californica 181077 1920 2473 Soluble acetylcholine receptor Unclassified Q8WSF8 \N Q8WSF8_APLCA 7.51999999999999957 \N Ki Binding affinity to salt water mollusc Aplysia californica AChBP Y55W mutant assessed as [3H]acetamiprid binding by radioligand binding assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3 \N \N \N \N \N \N Aplysia californica 181078 1920 2604 Neuronal acetylcholine receptor subunit alpha-4 Ion channel P09482 CHRNA4 ACHA4_CHICK 8.72000000000000064 \N Ki Binding affinity to recombinant Gallus gallus (chicken) alpha4beta2 nicotinic acetylcholine receptor assessed as [3H]NIC binding by radioligand binding assay CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3 \N \N \N \N \N \N Gallus gallus 181079 1920 956 Acetylcholine-binding protein Unclassified P58154 \N ACHP_LYMST 7.20000000000000018 \N Ki Displacement of [125I]alpha-bungarotoxin from Lymnaea stagnalis His-tagged AchBP CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3 \N \N \N \N \N \N Lymnaea stagnalis 181080 2676 1710 Angiotensin-converting enzyme Enzyme P12822 ACE ACE_RABIT 5.71999999999999975 \N IC50 Inhibition of the activity of rabbit lung Angiotensin I converting enzyme CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1314 \N \N \N \N \N \N Oryctolagus cuniculus 181081 24 717 Histone deacetylase 8 Enzyme Q9BY41 HDAC8 HDAC8_HUMAN 4.03000000000000025 \N IC50 Inhibition of human recombinant HDAC8 CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1044 \N \N \N Tclin \N \N Homo sapiens 181082 24 606 Histone deacetylase 1 Enzyme Q13547 HDAC1 HDAC1_HUMAN 4.19000000000000039 \N IC50 Inhibition of human recombinant HDAC1 CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1044 \N \N \N Tclin \N \N Homo sapiens 181083 24 598 Histone deacetylase 2 Enzyme Q92769 HDAC2 HDAC2_HUMAN 4.19000000000000039 \N IC50 Inhibition of human recombinant HDAC2 CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1044 \N \N \N Tclin \N \N Homo sapiens 181105 1960 2867 Adrenergic receptor alpha GPCR P15823|P19328|P22086|P22909|P23944|P43140 Adra1a|Adra1b|Adra1d|Adra2a|Adra2b|Adra2c ADA1A_RAT|ADA1B_RAT|ADA1D_RAT|ADA2A_RAT|ADA2B_RAT|ADA2C_RAT 7.79999999999999982 \N IC50 Binding affinity against Alpha adrenergic receptor using [3H]dihydroergocryptine radioligand in rat brain homogenate CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437 \N \N \N \N \N \N Rattus norvegicus 181084 1754 3533 GABA-A receptor; anion channel Ion channel O00591|O14764|P14867|P18505|P18507|P28472|P31644|P34903|P47869|P47870|P48169|P78334|Q16445|Q8N1C3|Q99928|Q9UN88 GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ GBRA1_HUMAN|GBRA2_HUMAN|GBRA3_HUMAN|GBRA4_HUMAN|GBRA5_HUMAN|GBRA6_HUMAN|GBRB1_HUMAN|GBRB2_HUMAN|GBRB3_HUMAN|GBRD_HUMAN|GBRE_HUMAN|GBRG1_HUMAN|GBRG2_HUMAN|GBRG3_HUMAN|GBRP_HUMAN|GBRT_HUMAN \N \N \N Mechanism of Action; CHEMBL2093872; PROTEIN COMPLEX GROUP CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1341 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1341 POSITIVE MODULATOR \N Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin \N \N Homo sapiens 181085 2326 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN \N \N \N Mechanism of Action; CHEMBL222; SINGLE PROTEIN CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1590 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1590 RELEASING AGENT \N Tclin \N \N Homo sapiens 181086 988 1799 Acetylcholinesterase Enzyme P23795 ACHE ACES_BOVIN 6.70000000000000018 \N Ki Binding affinity against Acetylcholinesterase of purified calf forebrain (CFB) CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1104 \N \N \N \N \N \N Bos taurus 181087 988 251 Acetylcholinesterase Enzyme P22303 ACHE ACES_HUMAN 8.78999999999999915 \N Ki Inhibition constant determined against Acetylcholinesterase (AChE) receptor. CHEMBL = 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1104 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1104 INHIBITOR \N Tclin \N \N Homo sapiens 181088 2632 304 Xanthine dehydrogenase/oxidase Enzyme P47989 XDH XDH_HUMAN 4.03000000000000025 \N IC50 Inhibition of human xanthine oxidase CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL727 \N \N \N Tclin \N \N Homo sapiens 181089 3577 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 4.20000000000000018 \N Ki Displacement of [3H]8-OH-DPAT from 5HT1A receptor by vacuum filtration CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL33720 \N \N \N Tclin \N \N Homo sapiens 181090 2146 2850 Adrenergic receptor alpha-2 GPCR P19328|P22086|P22909 Adra2a|Adra2b|Adra2c ADA2A_RAT|ADA2B_RAT|ADA2C_RAT 6.57000000000000028 \N Ki Displacement of [3H]clonidine from Alpha-2 adrenergic receptor of rat brain membranes CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1215 \N \N \N \N \N \N Rattus norvegicus 181091 2146 2855 Adrenergic receptor alpha-2 GPCR P08913|P18089|P18825 ADRA2A|ADRA2B|ADRA2C ADA2A_HUMAN|ADA2B_HUMAN|ADA2C_HUMAN 6.41000000000000014 \N Ki Compound was tested for its ability to displace [3H]clonidine form alpha-2 adrenergic receptor site in guinea pig cerebral cortical membranes. CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1215 \N \N \N Tclin|Tclin|Tclin \N \N Homo sapiens 181092 2146 1803 Beta-1 adrenergic receptor GPCR P18090 Adrb1 ADRB1_RAT 4.88999999999999968 \N Ki Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1215 \N \N \N \N \N \N Rattus norvegicus 181093 2146 2854 Adrenergic receptor alpha-1 GPCR P15823|P23944|P43140 Adra1a|Adra1b|Adra1d ADA1A_RAT|ADA1B_RAT|ADA1D_RAT 5.20999999999999996 \N Ki Displacement of [3H]WB-4101 from adrenergic alpha 1 receptor of rat cerebral cortical membranes CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1215 \N \N \N \N \N \N Rattus norvegicus 181094 811 2746 Glycine receptor (alpha-1/beta) Ion channel P23415|P48167 GLRA1|GLRB GLRA1_HUMAN|GLRB_HUMAN \N \N \N Mechanism of Action; CHEMBL2363052; PROTEIN COMPLEX CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733 POSITIVE MODULATOR \N Tclin|Tclin \N \N Homo sapiens 181095 811 3533 GABA-A receptor; anion channel Ion channel O00591|O14764|P14867|P18505|P18507|P28472|P31644|P34903|P47869|P47870|P48169|P78334|Q16445|Q8N1C3|Q99928|Q9UN88 GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ GBRA1_HUMAN|GBRA2_HUMAN|GBRA3_HUMAN|GBRA4_HUMAN|GBRA5_HUMAN|GBRA6_HUMAN|GBRB1_HUMAN|GBRB2_HUMAN|GBRB3_HUMAN|GBRD_HUMAN|GBRE_HUMAN|GBRG1_HUMAN|GBRG2_HUMAN|GBRG3_HUMAN|GBRP_HUMAN|GBRT_HUMAN \N \N \N Mechanism of Action; CHEMBL2093872; PROTEIN COMPLEX GROUP CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733 POSITIVE ALLOSTERIC MODULATOR \N Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin \N \N Homo sapiens 181096 811 1680 Potassium channel subfamily K member 10 Ion channel P57789 KCNK10 KCNKA_HUMAN \N \N \N Mechanism of Action; CHEMBL2331041; SINGLE PROTEIN CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733 OPENER \N Tclin \N \N Homo sapiens 181097 811 1692 Potassium channel subfamily K member 18 Ion channel Q7Z418 KCNK18 KCNKI_HUMAN \N \N \N Mechanism of Action; CHEMBL2331042; SINGLE PROTEIN CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733 OPENER \N Tclin \N \N Homo sapiens 181098 811 641 Potassium channel subfamily K member 3 Ion channel O14649 KCNK3 KCNK3_HUMAN \N \N \N Mechanism of Action; CHEMBL2321613; SINGLE PROTEIN CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733 OPENER \N Tclin \N \N Homo sapiens 181099 811 642 Potassium channel subfamily K member 9 Ion channel Q9NPC2 KCNK9 KCNK9_HUMAN \N \N \N Mechanism of Action; CHEMBL2321614; SINGLE PROTEIN CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733 OPENER \N Tclin \N \N Homo sapiens 181100 811 397 Potassium channel subfamily K member 2 Ion channel O95069 KCNK2 KCNK2_HUMAN \N \N \N Mechanism of Action; CHEMBL2321615; SINGLE PROTEIN CHEMBL \N 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733 OPENER \N Tclin \N \N Homo sapiens 181101 3607 161 Carbonic anhydrase 2 Enzyme P00918 CA2 CAH2_HUMAN 5.75 \N IC50 Inhibition of human recombinant carbonic anhydrase 2 assessed as activity of carbonic anhydrase 2 esterase activity against 4-nitrophenyl acetate CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL442687 \N \N \N Tclin \N \N Homo sapiens 181102 1960 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN 4.69000000000000039 \N Ki Displacement of [3H]prazosin from human adrenergic Alpha-1B receptor expressed in CHO cell membrane CHEMBL = 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437 AGONIST \N Tclin \N \N Homo sapiens 181103 1960 2850 Adrenergic receptor alpha-2 GPCR P19328|P22086|P22909 Adra2a|Adra2b|Adra2c ADA2A_RAT|ADA2B_RAT|ADA2C_RAT 8.32000000000000028 \N Ki Tested for binding affinity against alpha-2 adrenergic receptor in rat brain using [3H]- rauwolscine as radioligand CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437 \N \N \N \N \N \N Rattus norvegicus 181104 1960 1757 Beta-2 adrenergic receptor GPCR Q28044 ADRB2 ADRB2_BOVIN 5.21999999999999975 \N Ki Tested for binding affinity against beta-2 adrenergic receptor in bovine lung using [3H]DHA as radioligand CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437 \N \N \N \N \N \N Bos taurus 181106 1960 1824 Beta-2 adrenergic receptor GPCR P54833 ADRB2 ADRB2_CANFA 5.29999999999999982 \N Ki Binding of [3H]dihydroalprenolol to beta-2 adrenergic receptor of rat cerebral cortical membranes CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437 \N \N \N \N \N \N Canis familiaris 181107 1960 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 7.20000000000000018 \N Ki Binding affinity for human Alpha-2C adrenergic receptor CHEMBL = 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437 AGONIST \N Tclin \N \N Homo sapiens 181108 1960 2893 Adrenergic receptor beta GPCR P10608|P18090|P26255 Adrb1|Adrb2|Adrb3 ADRB1_RAT|ADRB2_RAT|ADRB3_RAT 6 \N IC50 Inhibitory concentration required for displacement of Beta adrenergic receptor specific ligand [3H]dihydroalprenolol from rat brain cerebral cortical membranes CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437 \N \N \N \N \N \N Rattus norvegicus 181110 1960 1740 Mu-type opioid receptor GPCR P33535 Oprm1 OPRM_RAT 4.84999999999999964 \N Ki Compound was evaluated for binding affinity towards mu-specific opiate receptor from combinatorial peptoid library CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437 \N \N \N \N \N \N Rattus norvegicus 181111 1960 1803 Beta-1 adrenergic receptor GPCR P18090 Adrb1 ADRB1_RAT 6.90000000000000036 \N Ki Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437 \N \N \N \N \N \N Rattus norvegicus 181112 1960 55 Beta-2 adrenergic receptor GPCR P07550 ADRB2 ADRB2_HUMAN 5.40000000000000036 \N Kd Binding affinity to human adrenergic beta2 receptor CHEMBL = 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437 AGONIST \N Tclin \N \N Homo sapiens 181113 1960 1733 Alpha-2B adrenergic receptor GPCR P19328 Adra2b ADA2B_RAT 7.11000000000000032 \N Ki Binding affinity for rat Alpha-2B adrenergic receptor CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437 \N \N \N \N \N \N Rattus norvegicus 181114 1960 2854 Adrenergic receptor alpha-1 GPCR P15823|P23944|P43140 Adra1a|Adra1b|Adra1d ADA1A_RAT|ADA1B_RAT|ADA1D_RAT 6.41000000000000014 \N Ki Binding affinity for alpha-1 adrenergic receptor in rat liver using [3H]prazosin. CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437 \N \N \N \N \N \N Rattus norvegicus 181115 1960 1880 Beta-2 adrenergic receptor GPCR P10608 Adrb2 ADRB2_RAT 5.37999999999999989 \N Ki Binding affinity against adrenergic beta 2 receptor versus 1 nM [3H]dihydroalprenolol in rat cerebral cerebellar membranes CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437 \N \N \N \N \N \N Rattus norvegicus 181116 1960 2110 Beta-1 adrenergic receptor GPCR B0FL73 ADRB1 B0FL73_CAVPO 6.40000000000000036 \N Ki Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437 \N \N \N \N \N \N Cavia porcellus 27464 2337 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 5.52432870864868164 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27466 2337 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 6.26600074768066406 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27467 2337 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 6.03693962097167969 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27469 2331 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 5.6999049186706543 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27470 2320 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.6777806282043457 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27473 2303 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 5.37789630889892578 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27474 2303 130 5-hydroxytryptamine receptor 1B GPCR P28222 HTR1B 5HT1B_HUMAN 6.19691276550292969 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27475 2303 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 5.3457179069519043 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27477 2303 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 6.91253423690795898 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27485 2276 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 7.90657854080200195 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27486 2276 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 8.33724212646484375 \N Ki \N PDSP = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1761 ANTAGONIST \N Tclin \N \N Homo sapiens 27487 2276 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 7.61978864669799805 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27488 2276 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 8.15490150451660156 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27489 2276 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 7.60205984115600586 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27496 2274 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 5.22914791107177734 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27497 2270 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 7.81247949600219727 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27498 2263 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 8.19381999969482422 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27499 2263 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 8.79588031768798828 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27500 2263 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 7.79860305786132812 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27501 2263 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 8.58502674102783203 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27502 2263 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 8.14999961853027344 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27507 2202 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN 5.21000003814697266 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27508 2202 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 6.65999984741210938 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27511 2202 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.53999996185302734 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27520 2193 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 9.55284214019775391 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27521 2193 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 9.69896984100341797 \N Ki \N PDSP = 1 IUPHAR \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7557 ANTAGONIST \N Tclin \N \N Homo sapiens 27522 2181 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 7.32422161102294922 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27523 2181 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 6.60205984115600586 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27525 2181 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6.64397430419921875 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27529 2181 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 6.53760194778442383 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27538 2176 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 5.20885467529296875 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27547 2172 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6.05848836898803711 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27549 2172 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 5.50863838195800781 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27551 2172 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 5.70885324478149414 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27555 2172 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 5.79778432846069336 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27557 2142 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 5.39794015884399414 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27558 2142 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 5.60926914215087891 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27562 2142 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 5.66735935211181641 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27563 2136 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 8.45593166351318359 \N Ki \N PDSP = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL753 ANTAGONIST \N Tclin \N \N Homo sapiens 27564 2132 112 Histamine H4 receptor GPCR Q9H3N8 HRH4 HRH4_HUMAN 5.37840843200683594 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27565 2123 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.07572078704833984 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27574 2113 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 5.73329782485961914 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27580 2111 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 6.82390880584716797 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27581 2111 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 7 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27582 2111 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 7.7044677734375 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27583 2111 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 7.52287864685058594 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27584 2111 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 7.22184896469116211 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27585 2080 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 5.68214559555053711 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27586 2032 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.8300023078918457 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27587 2032 339 5-hydroxytryptamine receptor 1E GPCR P28566 HTR1E 5HT1E_HUMAN 6.37889766693115234 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27589 2032 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 6.59001636505126953 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27595 1971 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.92081880569458008 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27609 1922 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 6.49485015869140625 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27616 1837 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 9.5 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27617 1837 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 8.13380336761474609 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27618 1837 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 9 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27619 1830 106 Alpha-1A adrenergic receptor GPCR P35348 ADRA1A ADA1A_HUMAN 5.58302688598632812 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27620 1830 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 5.99653959274291992 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27621 1830 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 7.42021656036376953 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27624 1830 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 5 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27626 1830 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 5.61978864669799805 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27627 1830 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 5 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27628 1830 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 6.76295900344848633 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27629 1830 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.25352144241333008 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27631 1830 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 5.9597935676574707 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27632 1830 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 5.42055940628051758 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27638 1816 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 5.38017654418945312 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27642 1796 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.02687215805053711 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27648 1796 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.39794015884399414 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27665 1767 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 6.06752634048461914 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27666 1767 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 5.61493015289306641 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27667 1767 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 5.25181198120117188 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27668 1752 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 9.236572265625 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27669 1732 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 7.61083412170410156 \N Ki \N PDSP = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200952 INHIBITOR \N Tclin \N \N Homo sapiens 27670 1732 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 5 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27671 1732 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 6.13312196731567383 \N Ki \N PDSP = \N \N \N \N INHIBITOR \N Tclin \N \N Homo sapiens 27672 1732 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 6.08953571319580078 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27673 1732 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.12819385528564453 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27674 1732 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 5.38279008865356445 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27678 1726 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 7.63827228546142578 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27679 1712 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 6.42021656036376953 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27680 1712 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 8.58502674102783203 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27681 1712 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 8.74352455139160156 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27682 1712 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6.80410051345825195 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27683 1712 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 8.12491512298583984 \N Ki \N PDSP = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1088 ANTAGONIST \N Tclin \N \N Homo sapiens 27684 1712 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 8.04095840454101562 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27685 1712 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 7.04575729370117188 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27686 1712 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 7.72445821762084961 \N Ki \N PDSP = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1088 ANTAGONIST \N Tclin \N \N Homo sapiens 27687 1712 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 8 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27688 1712 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 7.22184896469116211 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27689 1712 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 7.72124624252319336 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27690 1712 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 7.82390880584716797 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27691 1707 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 8.236572265625 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27694 1677 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 5.6777806282043457 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27696 1677 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 5.4685211181640625 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27699 1677 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 5.6575775146484375 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27700 1677 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 5.35654735565185547 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27701 1677 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 5.61978864669799805 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27706 1640 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 6.22184896469116211 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27709 1634 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.2365717887878418 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27710 1613 112 Histamine H4 receptor GPCR Q9H3N8 HRH4 HRH4_HUMAN 5.29688072204589844 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27711 1613 106 Alpha-1A adrenergic receptor GPCR P35348 ADRA1A ADA1A_HUMAN 7.50863838195800781 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27713 1613 284 5-hydroxytryptamine receptor 5A GPCR P47898 HTR5A 5HT5A_HUMAN 6.1101384162902832 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27714 1613 171 5-hydroxytryptamine receptor 3A Ion channel P46098 HTR3A 5HT3A_HUMAN 6.72124624252319336 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27716 1613 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN 7.27572393417358398 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27719 1613 339 5-hydroxytryptamine receptor 1E GPCR P28566 HTR1E 5HT1E_HUMAN 5.85418224334716797 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27722 1613 130 5-hydroxytryptamine receptor 1B GPCR P28222 HTR1B 5HT1B_HUMAN 6.41116809844970703 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27723 1613 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 5.45992088317871094 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27724 1613 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 6.68193674087524414 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27725 1613 109 D(1B) dopamine receptor GPCR P21918 DRD5 DRD5_HUMAN 7.12493896484375 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27727 1613 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 7.26760625839233398 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27728 1613 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 6.91364002227783203 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27729 1613 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 7.09718179702758789 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27730 1613 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.96738195419311523 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27733 1613 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.82131099700927734 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27734 1613 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 6.82947063446044922 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27735 1613 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 5.609771728515625 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27736 1613 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 6.08709239959716797 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27737 1613 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 6.37601327896118164 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27742 1592 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 5.69896984100341797 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27745 1592 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 5.33724212646484375 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27750 1524 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 8.7471466064453125 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27752 1524 290 5-hydroxytryptamine receptor 1F GPCR P30939 HTR1F 5HT1F_HUMAN 8.90308952331542969 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27759 1524 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.70114707946777344 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27762 1478 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.18508672714233398 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27763 1478 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 6.92081880569458008 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27764 1478 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.79048490524291992 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27765 1440 493 Prostaglandin E2 receptor EP2 subtype GPCR P43116 PTGER2 PE2R2_HUMAN 7.69055795669555664 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27766 1427 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.07058095932006836 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27774 1427 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 5.2365717887878418 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27777 1423 808 Fibroblast growth factor receptor 2 Kinase P21802 FGFR2 FGFR2_HUMAN 5 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27780 1423 759 Fibroblast growth factor receptor 1 Kinase P11362 FGFR1 FGFR1_HUMAN 5 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27781 1423 890 Ephrin type-B receptor 1 Kinase P54762 EPHB1 EPHB1_HUMAN 5 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27782 1423 922 Ephrin type-B receptor 4 Kinase P54760 EPHB4 EPHB4_HUMAN 5 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27784 1423 746 Cytoplasmic tyrosine-protein kinase BMX Kinase P51813 BMX BMX_HUMAN 5 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27797 1423 620 Insulin receptor Kinase P06213 INSR INSR_HUMAN 5 \N Ki \N PDSP = \N \N \N \N AGONIST \N Tclin \N \N Homo sapiens 27799 1423 712 Tyrosine-protein kinase JAK2 Kinase O60674 JAK2 JAK2_HUMAN 5 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27811 1353 284 5-hydroxytryptamine receptor 5A GPCR P47898 HTR5A 5HT5A_HUMAN 5.64839696884155273 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27814 1353 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN 8.09691047668457031 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27820 1353 130 5-hydroxytryptamine receptor 1B GPCR P28222 HTR1B 5HT1B_HUMAN 6.56863641738891602 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27822 1353 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 5.99869918823242188 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27826 1353 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 5 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27827 1353 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 6.25963735580444336 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27828 1353 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.31875896453857422 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27830 1353 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 5.94692134857177734 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27831 1353 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 6.1824345588684082 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27848 1222 55 Beta-2 adrenergic receptor GPCR P07550 ADRB2 ADRB2_HUMAN 6.29242992401123047 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27849 1222 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 8.408935546875 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27853 1222 130 5-hydroxytryptamine receptor 1B GPCR P28222 HTR1B 5HT1B_HUMAN 5.95078182220458984 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27854 1222 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 8.05551719665527344 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27855 1222 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 7.20760822296142578 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27856 1222 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 7.31875896453857422 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27857 1222 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 9.4364471435546875 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27858 1222 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.2441253662109375 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27860 1222 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN 6.22914791107177734 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27861 1214 106 Alpha-1A adrenergic receptor GPCR P35348 ADRA1A ADA1A_HUMAN 8.19045352935791016 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27862 1214 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 7.42021656036376953 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27863 1214 284 5-hydroxytryptamine receptor 5A GPCR P47898 HTR5A 5HT5A_HUMAN 6.83863210678100586 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27864 1214 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 9.61092472076416016 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27865 1214 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN 7.88605642318725586 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27866 1214 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 7.67954587936401367 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27867 1214 105 5-hydroxytryptamine receptor 7 GPCR P34969 HTR7 5HT7R_HUMAN 8.09691047668457031 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27868 1214 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.22548294067382812 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27869 1214 339 5-hydroxytryptamine receptor 1E GPCR P28566 HTR1E 5HT1E_HUMAN 6.26760625839233398 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27870 1214 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6.04777908325195312 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27871 1214 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 7.97890901565551758 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27872 1214 130 5-hydroxytryptamine receptor 1B GPCR P28222 HTR1B 5HT1B_HUMAN 6.47625350952148438 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27873 1214 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 6.47625350952148438 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27874 1214 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 6.25181198120117188 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27875 1214 109 D(1B) dopamine receptor GPCR P21918 DRD5 DRD5_HUMAN 7.88734531402587891 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27876 1214 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 7.44369745254516602 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27877 1214 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 7.6777806282043457 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27878 1214 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 5.84133625030517578 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27879 1214 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 7.53910493850708008 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27880 1214 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 7.08724784851074219 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27881 1214 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 9.26760578155517578 \N Ki \N PDSP = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200951 ANTAGONIST \N Tclin \N \N Homo sapiens 27882 1214 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 5.9605860710144043 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27883 1214 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.50300121307373047 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27884 1214 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 6.44733190536499023 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27885 1214 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 6.83654022216796875 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27886 1214 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 5.27400684356689453 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27887 1214 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 5.14490509033203125 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27896 1209 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 5.56863641738891602 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27897 1209 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 5.53760194778442383 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27898 1209 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 5.56863641738891602 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27901 1153 109 D(1B) dopamine receptor GPCR P21918 DRD5 DRD5_HUMAN 6.96040916442871094 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27903 1113 493 Prostaglandin E2 receptor EP2 subtype GPCR P43116 PTGER2 PE2R2_HUMAN 7.10237312316894531 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27904 1111 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 5.50863838195800781 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27905 1111 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 6.05061006546020508 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27906 1111 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 5.63827228546142578 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27907 1111 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 7.07058095932006836 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27924 966 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 9.07572078704833984 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27925 966 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 9.60206031799316406 \N Ki \N PDSP = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1108 ANTAGONIST \N Tclin \N \N Homo sapiens 27931 947 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 5.08365154266357422 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27943 832 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 5.04191398620605469 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 27945 832 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN 6.84771156311035156 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27946 832 105 5-hydroxytryptamine receptor 7 GPCR P34969 HTR7 5HT7R_HUMAN 5.25705337524414062 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27947 832 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 6.17587423324584961 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27948 832 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 5.79048490524291992 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27949 832 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 5.60730314254760742 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27950 832 130 5-hydroxytryptamine receptor 1B GPCR P28222 HTR1B 5HT1B_HUMAN 5.71964931488037109 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27951 832 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 5.89825296401977539 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27952 832 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 5.32585859298706055 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27953 832 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 6.70553398132324219 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27954 832 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.61978864669799805 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27955 832 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 5.7330632209777832 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27956 832 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.27490568161010742 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27957 832 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 6.0803990364074707 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27958 832 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN 6.00152921676635742 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27959 832 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 5.15598106384277344 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27960 832 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 5.57660102844238281 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27966 812 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 5.63126468658447266 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27969 812 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 5.19381999969482422 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27972 789 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 7.60205984115600586 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27981 765 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 5.88605642318725586 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27988 746 171 5-hydroxytryptamine receptor 3A Ion channel P46098 HTR3A 5HT3A_HUMAN 5.53120994567871094 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27989 746 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 8.60206031799316406 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27993 746 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 8.42021656036376953 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27994 746 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 7.49485015869140625 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27995 746 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 8.236572265625 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27996 746 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 7.88605642318725586 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27997 746 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 7.4559321403503418 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 27999 746 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 7.92081880569458008 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28000 746 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 7.37675094604492188 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28002 704 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN 6.5 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28009 701 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 7.41152048110961914 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28010 701 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 9.70335674285888672 \N Ki \N PDSP = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL415 INHIBITOR \N Tclin \N \N Homo sapiens 28011 701 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 7.18976736068725586 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28012 701 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 7.44977188110351562 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28013 701 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 6.65955591201782227 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28014 701 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 6.95031166076660156 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28015 701 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.27984046936035156 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28016 672 112 Histamine H4 receptor GPCR Q9H3N8 HRH4 HRH4_HUMAN 6.39555788040161133 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 28020 663 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 5.87527132034301758 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28024 621 284 5-hydroxytryptamine receptor 5A GPCR P47898 HTR5A 5HT5A_HUMAN 6.92811822891235352 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 28025 621 171 5-hydroxytryptamine receptor 3A Ion channel P46098 HTR3A 5HT3A_HUMAN 6.01010560989379883 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28027 621 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN 9.09151458740234375 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28031 621 339 5-hydroxytryptamine receptor 1E GPCR P28566 HTR1E 5HT1E_HUMAN 6.46344137191772461 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 28034 621 130 5-hydroxytryptamine receptor 1B GPCR P28222 HTR1B 5HT1B_HUMAN 5.82710552215576172 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28035 621 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 6.34486150741577148 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28036 621 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 6.75945091247558594 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28040 621 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 7.25091361999511719 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28044 621 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 7.60205984115600586 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28046 621 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 7.37675094604492188 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28048 621 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 7.39794015884399414 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28049 621 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 6.74573516845703125 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28050 619 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 7.98693752288818359 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28051 619 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 7.63827228546142578 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 28052 619 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 7.97930383682250977 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28054 616 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 5.16749095916748047 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28061 517 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 7.82390880584716797 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28062 517 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 8.06048107147216797 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28068 455 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.40450382232666016 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28069 455 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.86646127700805664 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28077 408 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 8.21752738952636719 \N Ki \N PDSP = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL811 ANTAGONIST \N Tclin \N \N Homo sapiens 28080 407 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 5.1463017463684082 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28082 407 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 5.1191864013671875 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28083 407 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 5.31875896453857422 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28084 407 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 5.76955127716064453 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28085 407 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 5.74472761154174805 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28096 374 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 8.20065975189208984 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28107 242 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.49248170852661133 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28109 242 284 5-hydroxytryptamine receptor 5A GPCR P47898 HTR5A 5HT5A_HUMAN 5.9064030647277832 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 28110 242 171 5-hydroxytryptamine receptor 3A Ion channel P46098 HTR3A 5HT3A_HUMAN 6.20204019546508789 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28111 242 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 9.44369792938232422 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28113 242 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN 7.4634709358215332 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28117 242 339 5-hydroxytryptamine receptor 1E GPCR P28566 HTR1E 5HT1E_HUMAN 5.09690999984741211 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 28122 242 109 D(1B) dopamine receptor GPCR P21918 DRD5 DRD5_HUMAN 5.6812129020690918 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 28124 242 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 6.06001663208007812 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28125 242 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 5.3300328254699707 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28126 242 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 7.42136096954345703 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28127 242 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.99139976501464844 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28129 242 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 5.16889858245849609 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28130 242 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 7.1307682991027832 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28131 242 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 5.63292407989501953 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28133 242 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN 6.85078096389770508 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28134 242 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 5.81801366806030273 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28135 242 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 5.45487833023071289 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28142 229 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 7.93839359283447266 \N Ki \N PDSP = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL647 AGONIST \N Tclin \N \N Homo sapiens 28144 195 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 6.93554210662841797 \N Ki \N PDSP = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405 RELEASING AGENT \N Tclin \N \N Homo sapiens 28145 195 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.75325536727905273 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28147 193 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 5.79587984085083008 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 28150 191 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 7.73362302780151367 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28154 191 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 7.79587984085083008 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28171 137 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 5.29242992401123047 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 28174 136 305 Platelet-activating factor receptor GPCR P25105 PTAFR PTAFR_HUMAN 5.45734691619873047 \N Ki \N PDSP = \N \N \N \N \N \N Tchem \N \N Homo sapiens 28176 105 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN 5.6126103401184082 \N Ki \N PDSP = \N \N \N \N \N \N Tclin \N \N Homo sapiens 22832 4135 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB01255 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201178 RELEASING AGENT \N Tclin \N \N Homo sapiens 22896 4123 1060 Chloride channel protein 2 Ion channel P51788 CLCN2 CLCN2_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB01046 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201134 OPENER \N Tclin \N \N Homo sapiens 26286 91 860 P2Y purinoceptor 2 GPCR P41231 P2RY2 P2RY2_HUMAN 7.09999999999999964 \N EC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1713 \N AGONIST \N Tclin \N \N Homo sapiens 180605 4947 29 Aspergillus fumigatus Fungi \N \N \N 5.22184896469116211 \N ED50 iv administration in rat immunosuppressed model ED50(umol/kg) measures on Day 14 SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/12482421 http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207500Orig1s000lbl.pdf MINIMUM INHIBITORY CONCENTRATION \N \N 195 196 \N 180606 4947 28 Candida albicans Fungi \N \N \N 5.82390880584716797 \N ED50 iv administration in rat model (C. albicans CY3003) ED50(umol/kg) measures on Day 14 SCIENTIFIC LITERATURE = 1 DRUG LABEL http://www.ncbi.nlm.nih.gov/pubmed/12482421 http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207500Orig1s000lbl.pdf MINIMUM INHIBITORY CONCENTRATION \N \N 195 196 \N 23149 3016 472 Sodium channel protein type 10 subunit alpha Ion channel Q9Y5Y9 SCN10A SCNAA_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00892 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200 BLOCKER \N Tclin \N \N Homo sapiens 23240 2801 70 DNA polymerase catalytic subunit Enzyme P04293 \N DPOL_HHV11 \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB01610 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200454 INHIBITOR \N \N \N \N Human herpesvirus 1 (strain 17) 23272 2746 934 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 Enzyme P26439 HSD3B2 3BHS2_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB01108 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200907 INHIBITOR \N Tclin \N \N Homo sapiens 23331 2706 137 Sodium channel protein type 1 subunit alpha Ion channel P35498 SCN1A SCN1A_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00273 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492 BLOCKER \N Tclin \N \N Homo sapiens 23395 2612 1430 Phenylalanine-4-hydroxylase Enzyme P00439 PAH PH4H_HUMAN 5.40000000000000036 \N Ki Binding affinity for human PAH. IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5276 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201774 ACTIVATOR \N Tclin \N \N Homo sapiens 23443 2529 350 Dihydropteroate synthase Enzyme P0AC13 folP DHPS_ECOLI \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00263 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL453 INHIBITOR \N \N \N \N Escherichia coli (strain K12) 23489 2474 125 Angiotensin-converting enzyme Enzyme P12821 ACE ACE_HUMAN 9.09999999999999964 \N IC50 Compound tested in vitro for inhibition of Angiotensin I converting enzyme CHEMBL = 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431 INHIBITOR \N Tclin \N \N Homo sapiens 23538 2439 200 Glycine receptor subunit alpha-1 Ion channel P23415 GLRA1 GLRA1_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB01236 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200694 POSITIVE MODULATOR \N Tclin \N \N Homo sapiens 23585 2377 1510 DNA-directed RNA polymerase subunit beta Enzyme P0A8V2 rpoB RPOB_ECOLI \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB01045 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL374478 INHIBITOR \N \N \N \N Escherichia coli (strain K12) 23609 2342 202 Estrogen receptor Nuclear hormone receptor P03372 ESR1 ESR1_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB04575 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201165 AGONIST \N Tclin \N \N Homo sapiens 23634 2294 472 Sodium channel protein type 10 subunit alpha Ion channel Q9Y5Y9 SCN10A SCNAA_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00807 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1196 BLOCKER \N Tclin \N \N Homo sapiens 23650 2282 1124 Bifunctional dihydrofolate reductase-thymidylate synthase Enzyme P13922 \N DRTS_PLAFK \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB01131 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1377 INHIBITOR \N \N \N \N Plasmodium falciparum 23662 2271 472 Sodium channel protein type 10 subunit alpha Ion channel Q9Y5Y9 SCN10A SCNAA_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00721 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL569 BLOCKER \N Tclin \N \N Homo sapiens 23669 2268 1529 Solute carrier family 22 member 11 Transporter Q9NSA0 SLC22A11 S22AB_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB01032 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL897 INHIBITOR \N Tclin \N \N Homo sapiens 23741 2123 286 Amine oxidase [flavin-containing] B Enzyme P27338 MAOB AOFB_HUMAN 7.82000000000000028 \N Ki \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7266 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1089 INHIBITOR \N Tclin \N \N Homo sapiens 23760 2099 411 cGMP-specific 3',5'-cyclic phosphodiesterase Enzyme O76074 PDE5A PDE5A_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00806 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL628 INHIBITOR \N Tclin \N \N Homo sapiens 23775 2079 70 DNA polymerase catalytic subunit Enzyme P04293 \N DPOL_HHV11 \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00299 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1540 INHIBITOR \N \N \N \N Human herpesvirus 1 (strain 17) 23807 2011 203 Androgen receptor Nuclear hormone receptor P10275 AR ANDR_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00621 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200436 AGONIST \N Tclin \N \N Homo sapiens 23848 1960 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 7.40000000000000036 \N Ki \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=505 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437 AGONIST \N Tclin \N \N Homo sapiens 23870 1943 1443 Pyruvate dehydrogenase [NADP(+)] Enzyme Q968X7 PFOR PNO_CRYPV \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00507 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1401 INHIBITOR \N \N \N \N Cryptosporidium parvum 23875 1925 1059 Chloride channel protein ClC-Ka Ion channel P51800 CLCNKA CLCKA_HUMAN 5 \N EC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2439 \N ACTIVATOR \N Tbio \N \N Homo sapiens 23922 1857 1581 Isoleucine--tRNA ligase Enzyme P41972 ileS SYI1_STAAU \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00410 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL719 INHIBITOR \N \N \N \N Staphylococcus aureus 23934 1832 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00764 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1161 AGONIST \N Tclin \N \N Homo sapiens 23975 1792 1630 Tyrosine 3-monooxygenase Enzyme P07101 TH TY3H_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00765 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200862 INHIBITOR \N Tclin \N \N Homo sapiens 23999 1754 200 Glycine receptor subunit alpha-1 Ion channel P23415 GLRA1 GLRA1_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB01028 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1341 AGONIST \N Tclin \N \N Homo sapiens 24011 1710 56 Prostaglandin G/H synthase 2 Enzyme P35354 PTGS2 PGH2_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00244 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL704 INHIBITOR \N Tclin \N \N Homo sapiens 33786 191 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 7.95860731500000007 \N Ki DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 24012 1709 1093 D-alanyl-D-alanine carboxypeptidase DacB Enzyme P24228 dacB DACB_ECOLI \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00760 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL127 INHIBITOR \N \N \N \N Escherichia coli (strain K12) 24015 1708 1467 Amidophosphoribosyltransferase Enzyme Q06203 PPAT PUR1_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB01033 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1425 INHIBITOR \N Tclin \N \N Homo sapiens 24031 1694 106 Alpha-1A adrenergic receptor GPCR P35348 ADRA1A ADA1A_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB01365 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200996 AGONIST \N Tclin \N \N Homo sapiens 24054 1667 237 Progesterone receptor Nuclear hormone receptor P06401 PGR PRGR_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00351 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201139 AGONIST \N Tclin \N \N Homo sapiens 24093 1611 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00873 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200865 AGONIST \N Tclin \N \N Homo sapiens 24203 1540 142 Sodium channel protein type 9 subunit alpha Ion channel Q15858 SCN9A SCN9A_HUMAN 4.76999999999999957 \N IC50 Inhibition of human Nav1.7 expressed in SHSY5Y cells assessed as reduction in blue fluorescent signal by VSP-FRET assay CHEMBL = 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741 BLOCKER \N Tclin \N \N Homo sapiens 24204 1540 141 Sodium channel protein type 8 subunit alpha Ion channel Q9UQD0 SCN8A SCN8A_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00555 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741 BLOCKER \N Tclin \N \N Homo sapiens 24206 1540 139 Sodium channel protein type 3 subunit alpha Ion channel Q9NY46 SCN3A SCN3A_HUMAN 4.76999999999999957 \N IC50 Inhibition of human Nav1.3 expressed in SHSY5Y cells assessed as reduction in blue fluorescent signal by VSP-FRET assay CHEMBL = 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741 BLOCKER \N Tclin \N \N Homo sapiens 24208 1540 137 Sodium channel protein type 1 subunit alpha Ion channel P35498 SCN1A SCN1A_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00555 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741 BLOCKER \N Tclin \N \N Homo sapiens 24224 1490 313 Amine oxidase [flavin-containing] A Enzyme P21397 MAOA AOFA_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB01247 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201168 INHIBITOR \N Tclin \N \N Homo sapiens 24225 1490 286 Amine oxidase [flavin-containing] B Enzyme P27338 MAOB AOFB_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB01247 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201168 INHIBITOR \N Tclin \N \N Homo sapiens 24226 1482 596 DNA topoisomerase 1 Enzyme P11387 TOP1 TOP1_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00762 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL481 INHIBITOR \N Tclin \N \N Homo sapiens 24235 1434 61 Sodium channel protein type 5 subunit alpha Ion channel Q14524 SCN5A SCN5A_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00192 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200341 BLOCKER \N Tclin \N \N Homo sapiens 24326 1339 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00226 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1037 SUBSTRATE \N Tclin \N \N Homo sapiens 180607 4948 3501 glycolipid disialoganglioside (GD2) Glycolipid \N \N \N \N \N \N Mechanism of Action DRUG LABEL \N 1 DRUG LABEL http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125516s000lbl.pdf http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125516s000lbl.pdf ANTIBODY BINDING \N \N 197 197 \N 24578 1247 61 Sodium channel protein type 5 subunit alpha Ion channel Q14524 SCN5A SCN5A_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00252 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL919 BLOCKER \N Tclin \N \N Homo sapiens 24647 1198 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200877 AGONIST \N Tclin \N \N Homo sapiens 24651 1191 183 Mineralocorticoid receptor Nuclear hormone receptor P08235 NR3C2 MCR_HUMAN 9.91999999999999993 \N IC50 \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2873 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201010 AGONIST \N Tclin \N \N Homo sapiens 24658 1188 1633 Thymidylate synthase Enzyme P12461 TMP1 TYSY_CANAL \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB01099 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1463 INHIBITOR \N \N \N \N Candida albicans (strain SC5314 / ATCC MYA-2876) 24662 1184 209 Thymidylate synthase Enzyme P04818 TYMS TYSY_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00322 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL917 INHIBITOR \N Tclin \N \N Homo sapiens 24678 1140 84 Glutamate receptor ionotropic, NMDA 2A Ion channel Q12879 GRIN2A NMDE1_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00949 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1094 ANTAGONIST \N Tclin \N \N Homo sapiens 24692 1116 415 Retinoic acid receptor RXR-gamma Nuclear hormone receptor P48443 RXRG RXRG_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00459 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL464 AGONIST \N Tclin \N \N Homo sapiens 24704 1083 230 Enoyl-[acyl-carrier-protein] reductase [NADH] Enzyme P9WGR1 inhA INHA_MYCTU \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00609 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1441 INHIBITOR \N \N \N \N Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) 24731 1046 1418 Penicillin-binding protein 1B Enzyme P02919 mrcB PBPB_ECOLI \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00303 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1232 INHIBITOR \N \N \N \N Escherichia coli (strain K12) 24732 1046 1417 Penicillin-binding protein 1A Enzyme P02918 mrcA PBPA_ECOLI \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00303 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1232 INHIBITOR \N \N \N \N Escherichia coli (strain K12) 24735 1046 1093 D-alanyl-D-alanine carboxypeptidase DacB Enzyme P24228 dacB DACB_ECOLI \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00303 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1232 INHIBITOR \N \N \N \N Escherichia coli (strain K12) 24778 975 237 Progesterone receptor Nuclear hormone receptor P06401 PGR PRGR_HUMAN 6.90000000000000036 \N Ki \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2878 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200853 AGONIST \N Tclin \N \N Homo sapiens 24779 974 472 Sodium channel protein type 10 subunit alpha Ion channel Q9Y5Y9 SCN10A SCNAA_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00645 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200478 BLOCKER \N Tclin \N \N Homo sapiens 34555 719 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 5.1558335900000003 \N Ki DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 24790 965 203 Androgen receptor Nuclear hormone receptor P10275 AR ANDR_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00858 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201048 AGONIST \N Tclin \N \N Homo sapiens 24823 915 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB13720 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200880 ANTAGONIST \N Tclin \N \N Homo sapiens 24871 870 202 Estrogen receptor Nuclear hormone receptor P03372 ESR1 ESR1_HUMAN 4.87999999999999989 \N EC50 PUBCHEM_BIOASSAY: Estrogen Receptor-alpha Coactivator Binding Potentiators Dose Response Confirmation. (Class of assay: confirmatory) [Related pubchem assays: 639 (Primary screen preceding this dose response confirmation assay.)] CHEMBL = 1 CHEMBL https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1018 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1018 AGONIST \N Tclin \N \N Homo sapiens 24883 859 472 Sodium channel protein type 10 subunit alpha Ion channel Q9Y5Y9 SCN10A SCNAA_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00527 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1086 BLOCKER \N Tclin \N \N Homo sapiens 24885 859 61 Sodium channel protein type 5 subunit alpha Ion channel Q14524 SCN5A SCN5A_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00527 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1086 BLOCKER \N Tclin \N \N Homo sapiens 24918 830 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00405 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200638 ANTAGONIST \N Tclin \N \N Homo sapiens 24940 801 251 Acetylcholinesterase Enzyme P22303 ACHE ACES_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00944 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200514 INHIBITOR \N Tclin \N \N Homo sapiens 25184 605 472 Sodium channel protein type 10 subunit alpha Ion channel Q9Y5Y9 SCN10A SCNAA_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB01161 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL944 BLOCKER \N Tclin \N \N Homo sapiens 25190 579 558 Cholecystokinin receptor type A GPCR P32238 CCKAR CCKAR_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00403 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200755 AGONIST \N Tclin \N \N Homo sapiens 25232 516 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB01038 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201328 ANTAGONIST \N Tclin \N \N Homo sapiens 25266 427 1519 Solute carrier family 12 member 2 Transporter P55011 SLC12A2 S12A2_HUMAN 5.59999999999999964 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4837 \N INHIBITOR \N Tclin \N \N Homo sapiens 25288 385 376 Prothrombin Enzyme P00734 F2 THRB_HUMAN 8.59999999999999964 \N Ki \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6470 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103749 INHIBITOR \N Tclin \N \N Homo sapiens 25316 359 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00217 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201260 SUBSTRATE \N Tclin \N \N Homo sapiens 25323 341 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB04890 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201758 ANTAGONIST \N Tclin \N \N Homo sapiens 25360 268 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00719 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL946 ANTAGONIST \N Tclin \N \N Homo sapiens 25401 223 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00517 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1578 ANTAGONIST \N Tclin \N \N Homo sapiens 25403 223 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00517 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1578 ANTAGONIST \N Tclin \N \N Homo sapiens 25404 222 627 Vitamin K-dependent gamma-carboxylase Enzyme P38435 GGCX VKGC_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB01125 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL712 INHIBITOR \N Tclin \N \N Homo sapiens 25413 209 121 cGMP-inhibited 3',5'-cyclic phosphodiesterase A Enzyme Q14432 PDE3A PDE3A_HUMAN 7.26999999999999957 \N IC50 \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7114 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL760 INHIBITOR \N Tclin \N \N Homo sapiens 25442 163 662 Tissue-type plasminogen activator Enzyme P00750 PLAT TPA_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00513 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1046 INHIBITOR \N Tclin \N \N Homo sapiens 25448 158 952 Acid-sensing ion channel 2 Ion channel Q16515 ASIC2 ASIC2_HUMAN 4.59999999999999964 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2421 \N BLOCKER \N Tbio \N \N Homo sapiens 25580 59 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB01063 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1085 ANTAGONIST \N Tclin \N \N Homo sapiens 25606 25 271 DNA (cytosine-5)-methyltransferase 1 Enzyme P26358 DNMT1 DNMT1_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL http://www.drugbank.ca/drugs/DB00928 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1489 INHIBITOR \N Tclin \N \N Homo sapiens 25609 13 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN \N \N \N \N DRUGBANK \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1367478 AGONIST \N Tclin \N \N Homo sapiens 25618 522 55 Beta-2 adrenergic receptor GPCR P07550 ADRB2 ADRB2_HUMAN 9.90000000000000036 \N Ki \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=551 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL723 ANTAGONIST \N Tclin \N \N Homo sapiens 25622 1895 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 9.30000000000000071 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=983 \N ANTAGONIST \N Tclin \N \N Homo sapiens 25624 35 342 Gonadotropin-releasing hormone receptor GPCR P30968 GNRHR GNRHR_HUMAN 9.49000000000000021 \N Ki \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1188 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1252 ANTAGONIST \N Tclin \N \N Homo sapiens 25628 460 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 9.19999999999999929 \N Ki \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201087 AGONIST \N Tclin \N \N Homo sapiens 25652 1775 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 8.90000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=134 \N ANTAGONIST \N Tclin \N \N Homo sapiens 25836 1422 527 Prostaglandin D2 receptor GPCR Q13258 PTGDR PD2R_HUMAN 6.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1895 \N AGONIST \N Tclin \N \N Homo sapiens 25656 433 55 Beta-2 adrenergic receptor GPCR P07550 ADRB2 ADRB2_HUMAN 9.09999999999999964 \N Ki \N IUPHAR = 1 IUPHAR http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=550 http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=550 ANTAGONIST \N Tclin \N \N Homo sapiens 25672 2032 106 Alpha-1A adrenergic receptor GPCR P35348 ADRA1A ADA1A_HUMAN 8.19999999999999929 \N Ki \N IUPHAR = 1 SCIENTIFIC LITERATURE http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=124 http://www.ncbi.nlm.nih.gov/pubmed/20030735 AGONIST \N Tclin \N 269 Homo sapiens 25677 945 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 8.40000000000000036 \N Ki \N IUPHAR = 1 IUPHAR http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=965 http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=965 ANTAGONIST \N Tclin \N \N Homo sapiens 25680 1588 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 8.30000000000000071 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=43 \N AGONIST \N Tclin \N \N Homo sapiens 25688 1613 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 8 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=205 \N ANTAGONIST \N Tclin \N \N Homo sapiens 25691 1211 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 8.96000000000000085 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=948 \N ANTAGONIST \N Tclin \N \N Homo sapiens 25699 1211 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 8.82000000000000028 \N Ki \N IUPHAR = 1 IUPHAR http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=948 http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=948 ANTAGONIST \N Tclin \N \N Homo sapiens 25722 433 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN 9 \N Ki \N IUPHAR = 1 IUPHAR http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=550 http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=550 ANTAGONIST \N Tclin \N \N Homo sapiens 25735 2637 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 7.29999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=100 \N ANTAGONIST \N Tclin \N \N Homo sapiens 25737 1775 105 5-hydroxytryptamine receptor 7 GPCR P34969 HTR7 5HT7R_HUMAN 7.79999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=134 \N ANTAGONIST \N Tclin \N \N Homo sapiens 25747 1865 55 Beta-2 adrenergic receptor GPCR P07550 ADRB2 ADRB2_HUMAN 8.59999999999999964 \N Ki \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=554 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL649 ANTAGONIST \N Tclin \N \N Homo sapiens 25751 1942 187 Voltage-dependent L-type calcium channel subunit alpha-1C Ion channel Q13936 CACNA1C CAC1C_HUMAN 7.09999999999999964 \N IC50 \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2524 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1726 GATING INHIBITOR \N Tclin \N \N Homo sapiens 25757 1211 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 8.40000000000000036 \N Ki Note that this assay uses the cis form of the compound, whereas the approved drug is a racemic mixture of cis and trans molecules. IUPHAR = 1 IUPHAR http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=948 http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=948 ANTAGONIST \N Tclin \N \N Homo sapiens 25770 433 129 Beta-3 adrenergic receptor GPCR P13945 ADRB3 ADRB3_HUMAN 7.29999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=550 \N ANTAGONIST \N Tclin \N \N Homo sapiens 25772 2202 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 6.90000000000000036 \N Ki \N IUPHAR = 1 SCIENTIFIC LITERATURE http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=49 http://www.ncbi.nlm.nih.gov/pubmed/20600305 AGONIST \N Tclin \N 395 Homo sapiens 25782 1775 130 5-hydroxytryptamine receptor 1B GPCR P28222 HTR1B 5HT1B_HUMAN 7.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=134 \N ANTAGONIST \N Tclin \N \N Homo sapiens 25791 913 527 Prostaglandin D2 receptor GPCR Q13258 PTGDR PD2R_HUMAN 7 \N Ki \N IUPHAR = \N \N \N \N AGONIST \N Tclin \N \N Homo sapiens 25792 1775 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 6.79999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=134 \N ANTAGONIST \N Tchem \N \N Homo sapiens 25793 1775 339 5-hydroxytryptamine receptor 1E GPCR P28566 HTR1E 5HT1E_HUMAN 6.79999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=134 \N ANTAGONIST \N Tchem \N \N Homo sapiens 25799 228 109 D(1B) dopamine receptor GPCR P21918 DRD5 DRD5_HUMAN 7.79999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=33 \N AGONIST \N Tchem \N \N Homo sapiens 25801 1942 236 Voltage-dependent L-type calcium channel subunit alpha-1D Ion channel Q01668 CACNA1D CAC1D_HUMAN \N \N \N \N UNKNOWN \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1726 BLOCKER \N Tclin \N \N Homo sapiens 25803 913 529 Prostaglandin F2-alpha receptor GPCR P43088 PTGFR PF2R_HUMAN 6.90000000000000036 \N Ki \N IUPHAR = \N \N \N \N AGONIST \N Tclin \N \N Homo sapiens 25804 2393 290 5-hydroxytryptamine receptor 1F GPCR P30939 HTR1F 5HT1F_HUMAN 6.79999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=51 \N AGONIST \N Tclin \N \N Homo sapiens 25813 1775 284 5-hydroxytryptamine receptor 5A GPCR P47898 HTR5A 5HT5A_HUMAN 7 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=134 \N ANTAGONIST \N Tchem \N \N Homo sapiens 25815 2032 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6.79999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=124 \N AGONIST \N Tclin \N \N Homo sapiens 25818 4120 1210 Metabotropic glutamate receptor 8 GPCR O00222 GRM8 GRM8_HUMAN 7.20000000000000018 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1411 \N AGONIST \N Tchem \N \N Homo sapiens 25821 1848 245 5-hydroxytryptamine receptor 4 GPCR Q13639 HTR4 5HT4R_HUMAN 6.90000000000000036 \N Ki \N IUPHAR = 1 SCIENTIFIC LITERATURE http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=242 http://www.ncbi.nlm.nih.gov/pubmed/8950316 AGONIST \N Tclin \N 268 Homo sapiens 25822 2543 105 5-hydroxytryptamine receptor 7 GPCR P34969 HTR7 5HT7R_HUMAN 6 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=54 \N ANTAGONIST \N Tclin \N \N Homo sapiens 25827 109 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 6.90000000000000036 \N Kd \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=341 \N ALLOSTERIC MODULATOR \N Tclin \N \N Homo sapiens 25828 3486 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN 6.79999999999999982 \N Ki \N IUPHAR = 1 IUPHAR http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=555 http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=555 ANTAGONIST \N Tclin \N \N Homo sapiens 93838 192 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 5.95999999999999996 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 25850 1937 236 Voltage-dependent L-type calcium channel subunit alpha-1D Ion channel Q01668 CACNA1D CAC1D_HUMAN \N \N \N \N UNKNOWN \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1428 BLOCKER \N Tclin \N \N Homo sapiens 25862 2032 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.20000000000000018 \N Ki \N IUPHAR = 1 SCIENTIFIC LITERATURE http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=124 http://www.ncbi.nlm.nih.gov/pubmed/20030735 AGONIST \N Tclin \N 269 Homo sapiens 25863 2470 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 6 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=99 \N ANTAGONIST \N Tclin \N \N Homo sapiens 25869 3396 366 Trace amine-associated receptor 1 GPCR Q96RJ0 TAAR1 TAAR1_HUMAN 5.79999999999999982 \N EC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2149 \N AGONIST \N Tclin \N \N Homo sapiens 25878 875 812 Steroid hormone receptor ERR2 Nuclear hormone receptor O95718 ESRRB ERR2_HUMAN 5.29999999999999982 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2801 \N ANTAGONIST \N Tchem \N \N Homo sapiens 25879 912 493 Prostaglandin E2 receptor EP2 subtype GPCR P43116 PTGER2 PE2R2_HUMAN 6 \N Ki \N IUPHAR = \N \N \N \N AGONIST \N Tclin \N \N Homo sapiens 25888 1310 1210 Metabotropic glutamate receptor 8 GPCR O00222 GRM8 GRM8_HUMAN 5.70000000000000018 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1369 \N AGONIST \N Tchem \N \N Homo sapiens 25893 2966 904 P2Y purinoceptor 11 GPCR Q96G91 P2RY11 P2Y11_HUMAN 6 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1728 \N ANTAGONIST \N Tbio \N \N Homo sapiens 25894 875 296 Estrogen-related receptor gamma Nuclear hormone receptor P62508 ESRRG ERR3_HUMAN 5.29999999999999982 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2801 \N ANTAGONIST \N Tchem \N \N Homo sapiens 25897 463 146 Adenosine receptor A1 GPCR P30542 ADORA1 AA1R_HUMAN 4.96999999999999975 \N Ki \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=407 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113 ANTAGONIST \N Tclin \N \N Homo sapiens 25898 1422 494 Prostaglandin E2 receptor EP4 subtype GPCR P35408 PTGER4 PE2R4_HUMAN 6.67999999999999972 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1895 \N AGONIST \N Tclin \N \N Homo sapiens 25899 65 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 5.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=294 \N AGONIST \N Tclin \N \N Homo sapiens 25902 3323 838 Free fatty acid receptor 1 GPCR O14842 FFAR1 FFAR1_HUMAN 5.70000000000000018 \N EC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1052 \N AGONIST \N Tchem \N \N Homo sapiens 25928 1368 202 Estrogen receptor Nuclear hormone receptor P03372 ESR1 ESR1_HUMAN 10.3000000000000007 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2823 \N ANTAGONIST \N Tclin \N \N Homo sapiens 25929 2293 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 10.1999999999999993 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=329 \N ANTAGONIST \N Tclin \N \N Homo sapiens 25933 2293 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 10 \N Ki \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=329 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1240 ANTAGONIST \N Tclin \N \N Homo sapiens 25942 2293 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 9.69999999999999929 \N Ki \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=329 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1240 ANTAGONIST \N Tclin \N \N Homo sapiens 25946 676 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 9.59999999999999964 \N Ki \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=366 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL620 ANTAGONIST \N Tclin \N \N Homo sapiens 25947 3165 393 Thromboxane A2 receptor GPCR P21731 TBXA2R TA2R_HUMAN 9.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1979 \N ANTAGONIST \N Tclin \N \N Homo sapiens 25950 2293 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 9.5 \N Ki \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=329 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1240 ANTAGONIST \N Tclin \N \N Homo sapiens 25954 522 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN 9.5 \N Ki \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=551 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL723 ANTAGONIST \N Tclin \N \N Homo sapiens 25959 522 129 Beta-3 adrenergic receptor GPCR P13945 ADRB3 ADRB3_HUMAN 9.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=551 \N ANTAGONIST \N Tclin \N \N Homo sapiens 25960 1947 187 Voltage-dependent L-type calcium channel subunit alpha-1C Ion channel Q13936 CACNA1C CAC1C_HUMAN \N \N \N \N UNKNOWN \N 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/17276408 BLOCKER \N Tclin \N 509 Homo sapiens 25969 2875 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 9.30000000000000071 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=103 \N ANTAGONIST \N Tclin \N \N Homo sapiens 25970 2878 843 Voltage-dependent N-type calcium channel subunit alpha-1B Ion channel Q00975 CACNA1B CAC1B_HUMAN \N \N \N \N UNKNOWN \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1795072 BLOCKER \N Tclin \N \N Homo sapiens 25974 2470 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN 9.19999999999999929 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=99 \N ANTAGONIST \N Tclin \N \N Homo sapiens 25980 460 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 9.09999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37 \N AGONIST \N Tclin \N \N Homo sapiens 26000 1371 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 8.90000000000000036 \N Ki \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=323 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201325 ANTAGONIST \N Tclin \N \N Homo sapiens 26001 2875 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 8.30000000000000071 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=103 \N ANTAGONIST \N Tchem \N \N Homo sapiens 26009 2875 105 5-hydroxytryptamine receptor 7 GPCR P34969 HTR7 5HT7R_HUMAN 8.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=103 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26014 746 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 8.80000000000000071 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=84 \N ANTAGONIST \N Tclin \N \N Homo sapiens 93906 258 179 Dihydroorotate dehydrogenase (quinone), mitochondrial Enzyme Q02127 DHODH PYRD_HUMAN 5.03000000000000025 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 26019 4151 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 8.69999999999999929 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=493 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26022 487 129 Beta-3 adrenergic receptor GPCR P13945 ADRB3 ADRB3_HUMAN 8.69999999999999929 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=569 \N AGONIST \N Tclin \N \N Homo sapiens 26028 1371 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN \N \N \N \N UNKNOWN \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201325 ANTAGONIST \N Tclin \N \N Homo sapiens 26030 2605 129 Beta-3 adrenergic receptor GPCR P13945 ADRB3 ADRB3_HUMAN 8.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=571 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26033 2646 93 Thyroid hormone receptor beta Nuclear hormone receptor P10828 THRB THB_HUMAN 8.51999999999999957 \N IC50 \N IUPHAR = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL559 AGONIST \N Tclin \N \N Homo sapiens 26040 2423 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 8.5 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=210 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26041 1371 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 8.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=323 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26053 2639 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 8.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=212 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26057 1371 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 8.30000000000000071 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=323 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26058 2865 130 5-hydroxytryptamine receptor 1B GPCR P28222 HTR1B 5HT1B_HUMAN 8.30000000000000071 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=59 \N AGONIST \N Tclin \N \N Homo sapiens 26067 2181 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 8.30000000000000071 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=92 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26072 1524 106 Alpha-1A adrenergic receptor GPCR P35348 ADRA1A ADA1A_HUMAN 8.19999999999999929 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=88 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26073 1524 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN 8.19999999999999929 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=88 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26077 2637 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 7.20000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=100 \N ANTAGONIST \N Tchem \N \N Homo sapiens 26083 1613 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 8.19999999999999929 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=205 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26085 3652 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 8.19999999999999929 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=57 \N AGONIST \N Tclin \N \N Homo sapiens 26086 1884 290 5-hydroxytryptamine receptor 1F GPCR P30939 HTR1F 5HT1F_HUMAN 8.19999999999999929 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=45 \N AGONIST \N Tclin \N \N Homo sapiens 26087 1775 290 5-hydroxytryptamine receptor 1F GPCR P30939 HTR1F 5HT1F_HUMAN 8.19999999999999929 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=134 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26088 460 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 8.19999999999999929 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37 \N AGONIST \N Tclin \N \N Homo sapiens 26092 1211 109 D(1B) dopamine receptor GPCR P21918 DRD5 DRD5_HUMAN 8.09999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=948 \N ANTAGONIST \N Tchem \N \N Homo sapiens 26094 2470 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 8.09999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=99 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26097 3639 860 P2Y purinoceptor 2 GPCR P41231 P2RY2 P2RY2_HUMAN 8.09999999999999964 \N EC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1734 \N AGONIST \N Tclin \N \N Homo sapiens 26101 460 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 8.09999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37 \N AGONIST \N Tclin \N \N Homo sapiens 26120 1222 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 8 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=85 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26122 460 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 7.90000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26129 1222 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 7.90000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=85 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26132 2740 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 7.90000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=214 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26133 746 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 7.90000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=84 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26138 1524 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 7.79999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=88 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26145 2600 1668 Potassium voltage-gated channel subfamily H member 1 Ion channel O95259 KCNH1 KCNH1_HUMAN 7.79999999999999982 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2608 \N BLOCKER \N Tclin \N \N Homo sapiens 26154 460 109 D(1B) dopamine receptor GPCR P21918 DRD5 DRD5_HUMAN 7.70000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37 \N AGONIST \N Tchem \N \N Homo sapiens 26155 4151 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN 7.70000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=493 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26156 460 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 7.70000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37 \N AGONIST \N Tclin \N \N Homo sapiens 26165 2637 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 7.70000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=100 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26166 460 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 7.70000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26170 1884 339 5-hydroxytryptamine receptor 1E GPCR P28566 HTR1E 5HT1E_HUMAN 7.70000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=45 \N AGONIST \N Tchem \N \N Homo sapiens 26174 3652 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 7.70000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=57 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26176 1371 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 7.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=323 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26194 1796 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 7.5 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=135 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26200 2172 270 Voltage-dependent T-type calcium channel subunit alpha-1I Ion channel Q9P0X4 CACNA1I CAC1I_HUMAN 7.5 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=90 \N BLOCKER \N Tclin \N \N Homo sapiens 26201 942 1668 Potassium voltage-gated channel subfamily H member 1 Ion channel O95259 KCNH1 KCNH1_HUMAN 7.5 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2604 \N BLOCKER \N Tclin \N \N Homo sapiens 26211 1796 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN 7.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=135 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26212 2389 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 7.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=96 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26213 2220 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 7.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=93 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26223 228 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 7.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=33 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26224 1310 1209 Metabotropic glutamate receptor 3 GPCR Q14832 GRM3 GRM3_HUMAN 7.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1369 \N AGONIST \N Tchem \N \N Homo sapiens 26228 2423 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 7.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=210 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26229 3652 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 7.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=57 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26232 1440 395 Peroxisome proliferator-activated receptor gamma Nuclear hormone receptor P37231 PPARG PPARG_HUMAN 7.37999999999999989 \N Kd \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1909 \N AGONIST \N Tclin \N \N Homo sapiens 26234 3652 130 5-hydroxytryptamine receptor 1B GPCR P28222 HTR1B 5HT1B_HUMAN 7.29999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=57 \N AGONIST \N Tclin \N \N Homo sapiens 26235 460 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 7.29999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37 \N AGONIST \N Tchem \N \N Homo sapiens 26237 191 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 7.29999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=201 \N ANTAGONIST \N Tchem \N \N Homo sapiens 26245 2639 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 7.29999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=212 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26249 2875 130 5-hydroxytryptamine receptor 1B GPCR P28222 HTR1B 5HT1B_HUMAN 7.20000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=103 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26251 1028 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN \N \N \N \N UNKNOWN \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679 AGONIST \N Tclin \N \N Homo sapiens 26252 3652 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 7.20000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=57 \N AGONIST \N Tclin \N \N Homo sapiens 26253 1222 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 7.20000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=85 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26257 746 105 5-hydroxytryptamine receptor 7 GPCR P34969 HTR7 5HT7R_HUMAN 7.20000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=84 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26262 228 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 7.20000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=33 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26263 2740 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 7.20000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=214 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26265 2202 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 7.20000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=49 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26268 2435 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 7.20000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=98 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26271 1649 60 Nuclear receptor subfamily 1 group I member 3 Nuclear hormone receptor Q14994 NR1I3 NR1I3_HUMAN 7.16000000000000014 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2757 \N ANTAGONIST \N Tchem \N \N Homo sapiens 26274 3536 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 7.09999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=306 \N AGONIST \N Tclin \N \N Homo sapiens 26277 2202 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 7.09999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=49 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26278 2637 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 7.09999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=100 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26283 460 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 7.09999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37 \N ANTAGONIST \N Tclin \N \N Homo sapiens 163346 956 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 7.28399999999999981 \N Ki \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 26304 228 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 7 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=33 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26310 228 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.90000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=33 \N AGONIST \N Tclin \N \N Homo sapiens 26313 3652 105 5-hydroxytryptamine receptor 7 GPCR P34969 HTR7 5HT7R_HUMAN 6.90000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=57 \N AGONIST \N Tclin \N \N Homo sapiens 26318 1865 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN 6.90000000000000036 \N Ki \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=554 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL649 ANTAGONIST \N Tclin \N \N Homo sapiens 26324 228 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 6.90000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=33 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26325 3652 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 6.90000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=57 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26326 228 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.90000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=33 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26334 2181 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 6.79999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=92 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26336 1937 187 Voltage-dependent L-type calcium channel subunit alpha-1C Ion channel Q13936 CACNA1C CAC1C_HUMAN \N \N \N \N UNKNOWN \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1428 BLOCKER \N Tclin \N \N Homo sapiens 26337 2393 339 5-hydroxytryptamine receptor 1E GPCR P28566 HTR1E 5HT1E_HUMAN 6.79999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=51 \N AGONIST \N Tchem \N \N Homo sapiens 26340 460 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 6.70000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37 \N AGONIST \N Tclin \N \N Homo sapiens 26341 1524 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 6.70000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=88 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26348 249 1668 Potassium voltage-gated channel subfamily H member 1 Ion channel O95259 KCNH1 KCNH1_HUMAN 6.70000000000000018 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2603 \N BLOCKER \N Tclin \N \N Homo sapiens 26349 868 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 6.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=355 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26350 2202 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 6.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=49 \N AGONIST \N Tclin \N \N Homo sapiens 26355 1353 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 6.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=86 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26358 99 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=198 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26359 2423 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=210 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26361 1153 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 6.5 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=939 \N AGONIST \N Tchem \N \N Homo sapiens 26362 2202 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 6.5 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=49 \N ANTAGONIST \N Tchem \N \N Homo sapiens 26363 460 106 Alpha-1A adrenergic receptor GPCR P35348 ADRA1A ADA1A_HUMAN 6.5 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26364 1028 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN \N \N \N \N UNKNOWN \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679 AGONIST \N Tclin \N \N Homo sapiens 26365 2032 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN 6.5 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=124 \N AGONIST \N Tclin \N \N Homo sapiens 26367 1817 340 Prostaglandin E2 receptor EP3 subtype GPCR P43115 PTGER3 PE2R3_HUMAN 8.09999999999999964 \N Ki \N IUPHAR = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL606 AGONIST \N Tclin \N \N Homo sapiens 26368 3652 290 5-hydroxytryptamine receptor 1F GPCR P30939 HTR1F 5HT1F_HUMAN 6.5 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=57 \N AGONIST \N Tclin \N \N Homo sapiens 26369 2172 438 Potassium voltage-gated channel subfamily A member 10 Ion channel Q16322 KCNA10 KCA10_HUMAN 6.5 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=90 \N BLOCKER \N Tclin \N \N Homo sapiens 26370 4110 390 Vasopressin V1a receptor GPCR P37288 AVPR1A V1AR_HUMAN 7.90000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2226 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26371 2875 339 5-hydroxytryptamine receptor 1E GPCR P28566 HTR1E 5HT1E_HUMAN 6.5 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=103 \N ANTAGONIST \N Tchem \N \N Homo sapiens 26373 1830 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 6.5 \N Ki \N IUPHAR = 1 IUPHAR http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=207 http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=207 ANTAGONIST \N Tclin \N \N Homo sapiens 26375 65 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 6.5 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=294 \N AGONIST \N Tclin \N \N Homo sapiens 26376 2032 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 6.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=124 \N AGONIST \N Tclin \N \N Homo sapiens 26377 2202 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 6.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=49 \N AGONIST \N Tclin \N \N Homo sapiens 26379 972 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 6.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=202 \N ANTAGONIST \N Tchem \N \N Homo sapiens 26384 912 228 Prostaglandin D2 receptor 2 GPCR Q9Y5Y4 PTGDR2 PD2R2_HUMAN 6.40000000000000036 \N Ki \N IUPHAR = \N \N \N \N AGONIST \N Tchem \N \N Homo sapiens 26388 4120 897 Metabotropic glutamate receptor 6 GPCR O15303 GRM6 GRM6_HUMAN 6.40000000000000036 \N EC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1411 \N AGONIST \N Tbio \N \N Homo sapiens 26390 2435 290 5-hydroxytryptamine receptor 1F GPCR P30939 HTR1F 5HT1F_HUMAN 6.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=98 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26392 2435 339 5-hydroxytryptamine receptor 1E GPCR P28566 HTR1E 5HT1E_HUMAN 6.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=98 \N ANTAGONIST \N Tchem \N \N Homo sapiens 26393 2740 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=214 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26394 460 130 5-hydroxytryptamine receptor 1B GPCR P28222 HTR1B 5HT1B_HUMAN 6.29999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37 \N AGONIST \N Tclin \N \N Homo sapiens 26397 746 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 6.29999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=84 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26399 3639 600 P2Y purinoceptor 4 GPCR P51582 P2RY4 P2RY4_HUMAN 6.29999999999999982 \N EC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1734 \N AGONIST \N Tchem \N \N Homo sapiens 26401 1865 129 Beta-3 adrenergic receptor GPCR P13945 ADRB3 ADRB3_HUMAN 6.29999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=554 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26404 1551 529 Prostaglandin F2-alpha receptor GPCR P43088 PTGFR PF2R_HUMAN 6.29999999999999982 \N Ki \N IUPHAR = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1050 AGONIST \N Tclin \N \N Homo sapiens 26406 972 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 6.29999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=202 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26409 2181 130 5-hydroxytryptamine receptor 1B GPCR P28222 HTR1B 5HT1B_HUMAN 6.20000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=92 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26420 1353 1668 Potassium voltage-gated channel subfamily H member 1 Ion channel O95259 KCNH1 KCNH1_HUMAN 6.20000000000000018 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=86 \N BLOCKER \N Tclin \N \N Homo sapiens 26421 1422 529 Prostaglandin F2-alpha receptor GPCR P43088 PTGFR PF2R_HUMAN 6.20000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1895 \N AGONIST \N Tclin \N \N Homo sapiens 26423 460 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6.20000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37 \N AGONIST \N Tclin \N \N Homo sapiens 26424 99 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6.20000000000000018 \N Ki \N IUPHAR = 1 DRUG LABEL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=198 http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000916/WC500038317.pdf ANTAGONIST \N Tclin \N 109 Homo sapiens 26425 719 60 Nuclear receptor subfamily 1 group I member 3 Nuclear hormone receptor Q14994 NR1I3 NR1I3_HUMAN 6.16000000000000014 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2330 \N ANTAGONIST \N Tchem \N \N Homo sapiens 26429 2202 106 Alpha-1A adrenergic receptor GPCR P35348 ADRA1A ADA1A_HUMAN 6.09999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=49 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26438 1947 150 Intermediate conductance calcium-activated potassium channel protein 4 Ion channel O15554 KCNN4 KCNN4_HUMAN 7.59999999999999964 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2334 \N BLOCKER \N Tchem \N \N Homo sapiens 26442 1222 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 6 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=85 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26445 1922 907 Voltage-dependent L-type calcium channel subunit alpha-1F Ion channel O60840 CACNA1F CAC1F_HUMAN 6 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2514 \N GATING INHIBITOR \N Tclin \N \N Homo sapiens 26446 1097 138 Sodium channel protein type 2 subunit alpha Ion channel Q99250 SCN2A SCN2A_HUMAN \N \N \N \N UNKNOWN \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL492 BLOCKER \N Tclin \N \N Homo sapiens 26447 3312 1671 Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 Ion channel O60741 HCN1 HCN1_HUMAN 5.70000000000000018 \N IC50 \N IUPHAR = 1 DRUG LABEL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2357 http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206143Orig1s000lbl.pdf BLOCKER \N Tclin \N 253 Homo sapiens 26449 972 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=202 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26451 3652 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 5.90000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=57 \N AGONIST \N Tchem \N \N Homo sapiens 26455 1422 493 Prostaglandin E2 receptor EP2 subtype GPCR P43116 PTGER2 PE2R2_HUMAN 5.70000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1895 \N AGONIST \N Tclin \N \N Homo sapiens 26456 2389 290 5-hydroxytryptamine receptor 1F GPCR P30939 HTR1F 5HT1F_HUMAN 5.90000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=96 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26458 2337 339 5-hydroxytryptamine receptor 1E GPCR P28566 HTR1E 5HT1E_HUMAN 5.90000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=50 \N AGONIST \N Tchem \N \N Homo sapiens 26459 2389 339 5-hydroxytryptamine receptor 1E GPCR P28566 HTR1E 5HT1E_HUMAN 5.90000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=96 \N ANTAGONIST \N Tchem \N \N Homo sapiens 26460 2202 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 5.90000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=49 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26461 109 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 5.79999999999999982 \N Kd \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=341 \N ALLOSTERIC MODULATOR \N Tclin \N \N Homo sapiens 26467 2346 1668 Potassium voltage-gated channel subfamily H member 1 Ion channel O95259 KCNH1 KCNH1_HUMAN 5.79999999999999982 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2342 \N BLOCKER \N Tclin \N \N Homo sapiens 34934 887 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 9.30891850799999965 \N Ki DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 26473 3643 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 5.70000000000000018 \N Kd \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=349 \N ALLOSTERIC MODULATOR \N Tclin \N \N Homo sapiens 26477 1830 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 5.70000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=207 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26478 2337 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 5.70000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=50 \N AGONIST \N Tclin \N \N Homo sapiens 26480 1427 1668 Potassium voltage-gated channel subfamily H member 1 Ion channel O95259 KCNH1 KCNH1_HUMAN 5.70000000000000018 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=357 \N BLOCKER \N Tclin \N \N Homo sapiens 26483 2176 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 5.70000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=91 \N AGONIST \N Tclin \N \N Homo sapiens 26484 2382 150 Intermediate conductance calcium-activated potassium channel protein 4 Ion channel O15554 KCNN4 KCNN4_HUMAN 5.70000000000000018 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2326 \N ACTIVATOR \N Tchem \N \N Homo sapiens 26488 1524 109 D(1B) dopamine receptor GPCR P21918 DRD5 DRD5_HUMAN 5.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=88 \N ANTAGONIST \N Tchem \N \N Homo sapiens 26489 2637 109 D(1B) dopamine receptor GPCR P21918 DRD5 DRD5_HUMAN 5.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=100 \N ANTAGONIST \N Tchem \N \N Homo sapiens 26490 2405 838 Free fatty acid receptor 1 GPCR O14842 FFAR1 FFAR1_HUMAN 5.59999999999999964 \N EC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1056 \N AGONIST \N Tchem \N \N Homo sapiens 26491 2181 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 5.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=92 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26493 2543 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 5.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=54 \N ANTAGONIST \N Tchem \N \N Homo sapiens 26495 2966 1689 P2Y purinoceptor 13 GPCR Q9BPV8 P2RY13 P2Y13_HUMAN 5.59999999999999964 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1728 \N ANTAGONIST \N Tchem \N \N Homo sapiens 26498 2181 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 5.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=92 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26499 1024 55 Beta-2 adrenergic receptor GPCR P07550 ADRB2 ADRB2_HUMAN 5.59999999999999964 \N Ki \N IUPHAR = 1 IUPHAR http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=556 http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=556 AGONIST \N Tclin \N \N Homo sapiens 26502 2337 290 5-hydroxytryptamine receptor 1F GPCR P30939 HTR1F 5HT1F_HUMAN 5.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=50 \N AGONIST \N Tclin \N \N Homo sapiens 26505 1057 221 Calcium-activated potassium channel subunit alpha-1 Ion channel Q12791 KCNMA1 KCMA1_HUMAN 5.59999999999999964 \N EC50 \N IUPHAR = \N \N \N \N ACTIVATOR \N Tclin \N \N Homo sapiens 26506 3652 339 5-hydroxytryptamine receptor 1E GPCR P28566 HTR1E 5HT1E_HUMAN 5.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=57 \N AGONIST \N Tchem \N \N Homo sapiens 26507 1222 339 5-hydroxytryptamine receptor 1E GPCR P28566 HTR1E 5HT1E_HUMAN 5.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=85 \N ANTAGONIST \N Tchem \N \N Homo sapiens 26509 3312 1672 Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 Ion channel Q9UL51 HCN2 HCN2_HUMAN \N \N \N \N UNKNOWN \N 1 DRUG LABEL \N http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206143Orig1s000lbl.pdf BLOCKER \N Tclin \N 253 Homo sapiens 26510 3312 1673 Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 Ion channel Q9P1Z3 HCN3 HCN3_HUMAN 5.70000000000000018 \N IC50 \N IUPHAR = 1 DRUG LABEL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2357 http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206143Orig1s000lbl.pdf BLOCKER \N Tclin \N 253 Homo sapiens 26514 913 228 Prostaglandin D2 receptor 2 GPCR Q9Y5Y4 PTGDR2 PD2R2_HUMAN 5.29999999999999982 \N Ki \N IUPHAR = \N \N \N \N AGONIST \N Tchem \N \N Homo sapiens 26516 2470 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.5 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=99 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26518 91 1689 P2Y purinoceptor 13 GPCR Q9BPV8 P2RY13 P2Y13_HUMAN 5.40000000000000036 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1713 \N AGONIST \N Tchem \N \N Homo sapiens 26519 432 445 Potassium voltage-gated channel subfamily A member 5 Ion channel P22460 KCNA5 KCNA5_HUMAN 5.40000000000000036 \N Kd \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2397 \N BLOCKER \N Tclin \N \N Homo sapiens 26521 99 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 5.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=198 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26524 2470 109 D(1B) dopamine receptor GPCR P21918 DRD5 DRD5_HUMAN 5.29999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=99 \N ANTAGONIST \N Tchem \N \N Homo sapiens 26528 2966 832 P2Y purinoceptor 1 GPCR P47900 P2RY1 P2RY1_HUMAN 5.29999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1728 \N ANTAGONIST \N Tchem \N \N Homo sapiens 26530 1817 494 Prostaglandin E2 receptor EP4 subtype GPCR P35408 PTGER4 PE2R4_HUMAN 7.59999999999999964 \N Ki \N IUPHAR = \N \N \N \N AGONIST \N Tclin \N \N Homo sapiens 26532 3505 361 Hydroxycarboxylic acid receptor 2 GPCR Q8TDS4 HCAR2 HCAR2_HUMAN 5.29999999999999982 \N EC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1590 \N AGONIST \N Tclin \N \N Homo sapiens 26535 2044 151 Nuclear receptor subfamily 1 group I member 2 Nuclear hormone receptor O75469 NR1I2 NR1I2_HUMAN 5.29999999999999982 \N EC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2770 \N AGONIST \N Tchem \N \N Homo sapiens 26536 1209 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 5.29999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=203 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26541 3639 830 P2Y purinoceptor 6 GPCR Q15077 P2RY6 P2RY6_HUMAN 5.20000000000000018 \N EC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1734 \N AGONIST \N Tchem \N \N Homo sapiens 26542 3639 904 P2Y purinoceptor 11 GPCR Q96G91 P2RY11 P2Y11_HUMAN 5.20000000000000018 \N EC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1734 \N AGONIST \N Tbio \N \N Homo sapiens 26546 1422 393 Thromboxane A2 receptor GPCR P21731 TBXA2R TA2R_HUMAN 5.20000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1895 \N AGONIST \N Tclin \N \N Homo sapiens 26547 1672 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 5.20000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=224 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26549 3643 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 5.09999999999999964 \N Kd \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=349 \N ALLOSTERIC MODULATOR \N Tclin \N \N Homo sapiens 26552 1034 494 Prostaglandin E2 receptor EP4 subtype GPCR P35408 PTGER4 PE2R4_HUMAN 5.09999999999999964 \N Ki \N IUPHAR = \N \N \N \N AGONIST \N Tclin \N \N Homo sapiens 26553 1176 1698 Potassium voltage-gated channel subfamily A member 7 Ion channel Q96RP8 KCNA7 KCNA7_HUMAN 5.09999999999999964 \N Kd \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2560 \N BLOCKER \N Tclin \N \N Homo sapiens 26554 3323 1699 Potassium voltage-gated channel subfamily B member 1 Ion channel Q14721 KCNB1 KCNB1_HUMAN 5.59999999999999964 \N EC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1052 \N ACTIVATOR \N Tclin \N \N Homo sapiens 26555 912 393 Thromboxane A2 receptor GPCR P21731 TBXA2R TA2R_HUMAN 5.09999999999999964 \N Ki \N IUPHAR = \N \N \N \N AGONIST \N Tclin \N \N Homo sapiens 26557 109 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 5 \N Kd \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=341 \N ALLOSTERIC MODULATOR \N Tclin \N \N Homo sapiens 26558 831 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 8.90000000000000036 \N Ki \N IUPHAR = 1 IUPHAR http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=354 http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=354 ANTAGONIST \N Tclin \N \N Homo sapiens 26562 1817 493 Prostaglandin E2 receptor EP2 subtype GPCR P43116 PTGER2 PE2R2_HUMAN 7.5 \N Ki \N IUPHAR = \N \N \N \N AGONIST \N Tclin \N \N Homo sapiens 26563 1215 302 Potassium voltage-gated channel subfamily KQT member 2 Ion channel O43526 KCNQ2 KCNQ2_HUMAN 5 \N EC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2598 \N ACTIVATOR \N Tclin \N \N Homo sapiens 26564 342 1667 Potassium voltage-gated channel subfamily KQT member 4 Ion channel P56696 KCNQ4 KCNQ4_HUMAN 5 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2337 \N BLOCKER \N Tclin \N \N Homo sapiens 26565 1579 138 Sodium channel protein type 2 subunit alpha Ion channel Q99250 SCN2A SCN2A_HUMAN \N \N \N \N UNKNOWN \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL79 BLOCKER \N Tclin \N \N Homo sapiens 26567 2176 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 5 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=91 \N AGONIST \N Tclin \N \N Homo sapiens 26574 4109 1683 Transient receptor potential cation channel subfamily A member 1 Ion channel O75762 TRPA1 TRPA1_HUMAN 4.90000000000000036 \N EC50 \N IUPHAR = \N \N \N \N ACTIVATOR \N Tclin \N \N Homo sapiens 26575 91 1686 Transient receptor potential cation channel subfamily M member 4 Ion channel Q8TD43 TRPM4 TRPM4_HUMAN 5.79999999999999982 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1713 \N BLOCKER \N Tchem \N \N Homo sapiens 26576 1797 187 Voltage-dependent L-type calcium channel subunit alpha-1C Ion channel Q13936 CACNA1C CAC1C_HUMAN 4.90000000000000036 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2522 \N BLOCKER \N Tclin \N \N Homo sapiens 26581 3643 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 4.79999999999999982 \N Kd \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=349 \N ALLOSTERIC MODULATOR \N Tclin \N \N Homo sapiens 26585 1034 143 Prostaglandin E2 receptor EP1 subtype GPCR P34995 PTGER1 PE2R1_HUMAN 4.79999999999999982 \N Ki \N IUPHAR = 1 IUPHAR \N \N AGONIST \N Tclin \N \N Homo sapiens 26586 2346 1698 Potassium voltage-gated channel subfamily A member 7 Ion channel Q96RP8 KCNA7 KCNA7_HUMAN 4.79999999999999982 \N Kd \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2342 \N BLOCKER \N Tclin \N \N Homo sapiens 26588 1579 61 Sodium channel protein type 5 subunit alpha Ion channel Q14524 SCN5A SCN5A_HUMAN 4.79999999999999982 \N Kd \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2623 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL79 BLOCKER \N Tclin \N \N Homo sapiens 26589 4004 391 Vasopressin V1b receptor GPCR P47901 AVPR1B V1BR_HUMAN 4.79999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2197 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26590 1524 284 5-hydroxytryptamine receptor 5A GPCR P47898 HTR5A 5HT5A_HUMAN 4.70000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=88 \N ANTAGONIST \N Tchem \N \N Homo sapiens 26591 4050 1209 Metabotropic glutamate receptor 3 GPCR Q14832 GRM3 GRM3_HUMAN 4.70000000000000018 \N Ki \N IUPHAR = \N \N \N \N AGONIST \N Tchem \N \N Homo sapiens 26592 92 1686 Transient receptor potential cation channel subfamily M member 4 Ion channel Q8TD43 TRPM4 TRPM4_HUMAN 4.70000000000000018 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2455 \N GATING INHIBITOR \N Tchem \N \N Homo sapiens 26594 2152 138 Sodium channel protein type 2 subunit alpha Ion channel Q99250 SCN2A SCN2A_HUMAN 4.90000000000000036 \N IC50 \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2624 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16 BLOCKER \N Tclin \N \N Homo sapiens 26604 913 393 Thromboxane A2 receptor GPCR P21731 TBXA2R TA2R_HUMAN 4.5 \N Ki \N IUPHAR = \N \N \N \N AGONIST \N Tclin \N \N Homo sapiens 26606 4120 813 Metabotropic glutamate receptor 7 GPCR Q14831 GRM7 GRM7_HUMAN 4.5 \N EC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1411 \N AGONIST \N Tbio \N \N Homo sapiens 26612 2966 860 P2Y purinoceptor 2 GPCR P41231 P2RY2 P2RY2_HUMAN 4.29999999999999982 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1728 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26616 362 371 Peroxisome proliferator-activated receptor alpha Nuclear hormone receptor Q07869 PPARA PPARA_HUMAN 4.29999999999999982 \N EC50 \N IUPHAR = 1 IUPHAR http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2668 http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2668 AGONIST \N Tclin \N \N Homo sapiens 26618 358 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 4.20000000000000018 \N Ki \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=297 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1482 AGONIST \N Tclin \N \N Homo sapiens 26620 3643 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 4.20000000000000018 \N Kd \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=349 \N ALLOSTERIC MODULATOR \N Tclin \N \N Homo sapiens 94116 574 2468 Tyrosine-protein phosphatase non-receptor type 7 Enzyme P35236 PTPN7 PTN7_HUMAN 6.04000000000000004 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N Tchem \N \N Homo sapiens 26632 358 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 4 \N Ki \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=297 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1482 AGONIST \N Tclin \N \N Homo sapiens 26633 358 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 4 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=297 \N AGONIST \N Tclin \N \N Homo sapiens 26634 1753 172 Alpha-1B adrenergic receptor GPCR P35368 ADRA1B ADA1B_HUMAN 4 \N Ki \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=483 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL524 AGONIST \N Tclin \N \N Homo sapiens 26641 1176 445 Potassium voltage-gated channel subfamily A member 5 Ion channel P22460 KCNA5 KCNA5_HUMAN 4 \N Kd \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2560 \N BLOCKER \N Tclin \N \N Homo sapiens 26643 3401 1690 G-protein coupled receptor family C group 6 member A GPCR Q5T6X5 GPRC6A GPC6A_HUMAN 4 \N EC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=725 \N AGONIST \N Tbio \N \N Homo sapiens 26645 1579 472 Sodium channel protein type 10 subunit alpha Ion channel Q9Y5Y9 SCN10A SCNAA_HUMAN \N \N \N \N UNKNOWN \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL79 BLOCKER \N Tclin \N \N Homo sapiens 26646 626 150 Intermediate conductance calcium-activated potassium channel protein 4 Ion channel O15554 KCNN4 KCNN4_HUMAN 4 \N EC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2322 \N ACTIVATOR \N Tchem \N \N Homo sapiens 26711 2382 795 Small conductance calcium-activated potassium channel protein 3 Ion channel Q9UGI6 KCNN3 KCNN3_HUMAN 4.90000000000000036 \N EC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2326 \N ACTIVATOR \N Tchem \N \N Homo sapiens 26714 865 395 Peroxisome proliferator-activated receptor gamma Nuclear hormone receptor P37231 PPARG PPARG_HUMAN 6.20000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2714 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26716 3862 1696 Nuclear receptor ROR-gamma Nuclear hormone receptor P51449 RORC RORG_HUMAN 4.84999999999999964 \N EC50 Inverse agonist activity at human RoRc-LBD fusion protein with GST expressed in BL-21 (BL3) cells assessed as SRC1 coactivator peptide recruitment CHEMBL = \N \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL705 \N \N \N Tchem \N \N Homo sapiens 26717 957 429 Vitamin D3 receptor Nuclear hormone receptor P11473 VDR VDR_HUMAN \N \N \N \N UNKNOWN \N 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200810 AGONIST \N Tclin \N \N Homo sapiens 26720 1805 151 Nuclear receptor subfamily 1 group I member 2 Nuclear hormone receptor O75469 NR1I2 NR1I2_HUMAN 5 \N EC50 \N IUPHAR ~ \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2805 \N AGONIST \N Tchem \N \N Homo sapiens 26729 888 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 9.90000000000000036 \N Ki \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=121 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1732 AGONIST \N Tclin \N \N Homo sapiens 26739 1723 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 9.19999999999999929 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=133 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26743 1043 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 8.90000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=149 \N AGONIST \N Tclin \N \N Homo sapiens 26752 888 130 5-hydroxytryptamine receptor 1B GPCR P28222 HTR1B 5HT1B_HUMAN 9.19999999999999929 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=121 \N AGONIST \N Tclin \N \N Homo sapiens 26755 1043 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 8.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=149 \N AGONIST \N Tchem \N \N Homo sapiens 26764 835 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 9.69999999999999929 \N Ki \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=521 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL778 AGONIST \N Tclin \N \N Homo sapiens 26770 3659 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 7.90000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=102 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26778 3659 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 7.70000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=102 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26782 835 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 9.30000000000000071 \N Ki \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=521 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL778 AGONIST \N Tclin \N \N Homo sapiens 26785 1764 339 5-hydroxytryptamine receptor 1E GPCR P28566 HTR1E 5HT1E_HUMAN 7.20000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=150 \N ANTAGONIST \N Tchem \N \N Homo sapiens 26787 2994 1700 Glucagon-like peptide 1 receptor GPCR P43220 GLP1R GLP1R_HUMAN 7 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1136 \N AGONIST \N Tclin \N \N Homo sapiens 26788 2538 143 Prostaglandin E2 receptor EP1 subtype GPCR P34995 PTGER1 PE2R1_HUMAN 7 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1919 \N AGONIST \N Tclin \N \N Homo sapiens 26790 3659 130 5-hydroxytryptamine receptor 1B GPCR P28222 HTR1B 5HT1B_HUMAN 7.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=102 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26793 1723 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 7.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=133 \N ANTAGONIST \N Tchem \N \N Homo sapiens 26794 888 290 5-hydroxytryptamine receptor 1F GPCR P30939 HTR1F 5HT1F_HUMAN 7.09999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=121 \N AGONIST \N Tclin \N \N Homo sapiens 26800 1043 339 5-hydroxytryptamine receptor 1E GPCR P28566 HTR1E 5HT1E_HUMAN 6.29999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=149 \N AGONIST \N Tchem \N \N Homo sapiens 26808 1723 339 5-hydroxytryptamine receptor 1E GPCR P28566 HTR1E 5HT1E_HUMAN 6.09999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=133 \N ANTAGONIST \N Tchem \N \N Homo sapiens 26813 76 361 Hydroxycarboxylic acid receptor 2 GPCR Q8TDS4 HCAR2 HCAR2_HUMAN 5.59999999999999964 \N EC50 \N IUPHAR = 1 SCIENTIFIC LITERATURE http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1596 http://www.ncbi.nlm.nih.gov/pubmed/17705685 AGONIST \N Tclin \N 501 Homo sapiens 94117 574 56 Prostaglandin G/H synthase 2 Enzyme P35354 PTGS2 PGH2_HUMAN 4.70000000000000018 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 26816 3659 284 5-hydroxytryptamine receptor 5A GPCR P47898 HTR5A 5HT5A_HUMAN 5.29999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=102 \N ANTAGONIST \N Tchem \N \N Homo sapiens 26817 2484 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 5 \N Kd \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=347 \N ALLOSTERIC MODULATOR \N Tclin \N \N Homo sapiens 26818 2484 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 5 \N Kd \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=347 \N ALLOSTERIC MODULATOR \N Tclin \N \N Homo sapiens 26819 2484 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 5 \N Kd \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=347 \N ALLOSTERIC MODULATOR \N Tclin \N \N Homo sapiens 26820 2484 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 5.70000000000000018 \N Kd \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=347 \N ALLOSTERIC MODULATOR \N Tclin \N \N Homo sapiens 26821 3400 838 Free fatty acid receptor 1 GPCR O14842 FFAR1 FFAR1_HUMAN 5.70000000000000018 \N EC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1054 \N AGONIST \N Tchem \N \N Homo sapiens 26828 2538 340 Prostaglandin E2 receptor EP3 subtype GPCR P43115 PTGER3 PE2R3_HUMAN 9.46000000000000085 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1919 \N AGONIST \N Tclin \N \N Homo sapiens 26832 2601 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 9.5 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=56 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26838 2601 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 9.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=56 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26839 1764 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 9.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=150 \N AGONIST \N Tclin \N \N Homo sapiens 26845 2601 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 9.09999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=56 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26847 2601 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 9.09999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=56 \N AGONIST \N Tclin \N \N Homo sapiens 26848 2994 1701 Glucagon receptor GPCR P47871 GCGR GLR_HUMAN 9 \N EC50 \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1136 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL266481 AGONIST \N Tclin \N \N Homo sapiens 26852 2601 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 9 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=56 \N AGONIST \N Tclin \N \N Homo sapiens 26853 1043 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 9 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=149 \N AGONIST \N Tclin \N \N Homo sapiens 26860 1723 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 8.80000000000000071 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=133 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26862 1043 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 8.69999999999999929 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=149 \N AGONIST \N Tclin \N \N Homo sapiens 26865 2955 417 Substance-P receptor GPCR P25103 TACR1 NK1R_HUMAN 8.59999999999999964 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2086 \N AGONIST \N Tclin \N \N Homo sapiens 26868 1723 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 8.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=133 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26870 2601 106 Alpha-1A adrenergic receptor GPCR P35348 ADRA1A ADA1A_HUMAN 8.5 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=56 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26871 2601 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 8.5 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=56 \N AGONIST \N Tclin \N \N Homo sapiens 26874 2579 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 8.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=226 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26878 1764 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 8.30000000000000071 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=150 \N AGONIST \N Tclin \N \N Homo sapiens 26879 2601 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 8.30000000000000071 \N Ki \N IUPHAR = 1 SCIENTIFIC LITERATURE http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=56 http://www.ncbi.nlm.nih.gov/pubmed/21762037 AGONIST \N Tclin \N 595 Homo sapiens 26884 2601 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 8.19999999999999929 \N Ki \N IUPHAR = 1 SCIENTIFIC LITERATURE http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=56 http://www.ncbi.nlm.nih.gov/pubmed/21762037 ANTAGONIST \N Tclin \N 595 Homo sapiens 26886 2601 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 8.09999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=56 \N ANTAGONIST \N Tchem \N \N Homo sapiens 26891 995 290 5-hydroxytryptamine receptor 1F GPCR P30939 HTR1F 5HT1F_HUMAN 8 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=40 \N AGONIST \N Tclin \N \N Homo sapiens 26894 888 105 5-hydroxytryptamine receptor 7 GPCR P34969 HTR7 5HT7R_HUMAN 8 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=121 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26907 2601 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 7.79999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=56 \N AGONIST \N Tclin \N \N Homo sapiens 26909 722 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 7.70000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=38 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26913 1764 290 5-hydroxytryptamine receptor 1F GPCR P30939 HTR1F 5HT1F_HUMAN 7.5 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=150 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26919 403 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 7.5 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=35 \N AGONIST \N Tchem \N \N Homo sapiens 26922 1016 494 Prostaglandin E2 receptor EP4 subtype GPCR P35408 PTGER4 PE2R4_HUMAN 7.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1918 \N AGONIST \N Tclin \N \N Homo sapiens 26925 995 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 7.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=40 \N AGONIST \N Tclin \N \N Homo sapiens 26928 2601 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 7.29999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=56 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26935 995 339 5-hydroxytryptamine receptor 1E GPCR P28566 HTR1E 5HT1E_HUMAN 7.20000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=40 \N AGONIST \N Tchem \N \N Homo sapiens 26938 1723 130 5-hydroxytryptamine receptor 1B GPCR P28222 HTR1B 5HT1B_HUMAN 7.20000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=133 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26940 1016 529 Prostaglandin F2-alpha receptor GPCR P43088 PTGFR PF2R_HUMAN 7.09999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1918 \N AGONIST \N Tclin \N \N Homo sapiens 26945 3659 290 5-hydroxytryptamine receptor 1F GPCR P30939 HTR1F 5HT1F_HUMAN 7 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=102 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26948 722 290 5-hydroxytryptamine receptor 1F GPCR P30939 HTR1F 5HT1F_HUMAN 6.90000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=38 \N AGONIST \N Tclin \N \N Homo sapiens 26950 1564 1702 Neurotensin receptor type 2 GPCR O95665 NTSR2 NTR2_HUMAN 6.79999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1586 \N AGONIST \N Tchem \N \N Homo sapiens 26951 1043 290 5-hydroxytryptamine receptor 1F GPCR P30939 HTR1F 5HT1F_HUMAN 6.79999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=149 \N AGONIST \N Tclin \N \N Homo sapiens 26954 2538 529 Prostaglandin F2-alpha receptor GPCR P43088 PTGFR PF2R_HUMAN 6.70000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1919 \N AGONIST \N Tclin \N \N Homo sapiens 26957 2601 130 5-hydroxytryptamine receptor 1B GPCR P28222 HTR1B 5HT1B_HUMAN 6.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=56 \N AGONIST \N Tclin \N \N Homo sapiens 26961 1723 290 5-hydroxytryptamine receptor 1F GPCR P30939 HTR1F 5HT1F_HUMAN 6.5 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=133 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26962 2560 156 Thyrotropin-releasing hormone receptor GPCR P34981 TRHR TRFR_HUMAN 6.5 \N Ki \N IUPHAR = 1 SCIENTIFIC LITERATURE http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2143 http://www.ncbi.nlm.nih.gov/pubmed/15931571 AGONIST \N Tclin \N 492 Homo sapiens 26966 722 339 5-hydroxytryptamine receptor 1E GPCR P28566 HTR1E 5HT1E_HUMAN 6.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=38 \N AGONIST \N Tchem \N \N Homo sapiens 26967 403 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 6.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=35 \N ANTAGONIST \N Tchem \N \N Homo sapiens 26968 722 131 5-hydroxytryptamine receptor 1D GPCR P28221 HTR1D 5HT1D_HUMAN 6.40000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=38 \N AGONIST \N Tclin \N \N Homo sapiens 26970 1527 438 Potassium voltage-gated channel subfamily A member 10 Ion channel Q16322 KCNA10 KCA10_HUMAN 6.29999999999999982 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2568 \N BLOCKER \N Tclin \N \N Homo sapiens 26973 403 109 D(1B) dopamine receptor GPCR P21918 DRD5 DRD5_HUMAN 6.29999999999999982 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=35 \N AGONIST \N Tchem \N \N Homo sapiens 26974 2410 622 Motilin receptor GPCR O43193 MLNR MTLR_HUMAN 6.20000000000000018 \N IC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1465 \N AGONIST \N Tchem \N \N Homo sapiens 26976 1723 284 5-hydroxytryptamine receptor 5A GPCR P47898 HTR5A 5HT5A_HUMAN 6.20000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=133 \N ANTAGONIST \N Tchem \N \N Homo sapiens 26978 722 130 5-hydroxytryptamine receptor 1B GPCR P28222 HTR1B 5HT1B_HUMAN 6.20000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=38 \N AGONIST \N Tclin \N \N Homo sapiens 26980 403 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 6.20000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=35 \N AGONIST \N Tclin \N \N Homo sapiens 26982 2407 109 D(1B) dopamine receptor GPCR P21918 DRD5 DRD5_HUMAN 6 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=941 \N AGONIST \N Tchem \N \N Homo sapiens 26983 3659 339 5-hydroxytryptamine receptor 1E GPCR P28566 HTR1E 5HT1E_HUMAN 5.90000000000000036 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=102 \N ANTAGONIST \N Tchem \N \N Homo sapiens 26985 806 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN 5.79999999999999982 \N Ki \N IUPHAR = 1 SCIENTIFIC LITERATURE http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=534 http://www.ncbi.nlm.nih.gov/pubmed/12487507 AGONIST \N Tclin \N 533 Homo sapiens 26989 1982 339 5-hydroxytryptamine receptor 1E GPCR P28566 HTR1E 5HT1E_HUMAN 5.70000000000000018 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=47 \N AGONIST \N Tchem \N \N Homo sapiens 26992 888 339 5-hydroxytryptamine receptor 1E GPCR P28566 HTR1E 5HT1E_HUMAN 5.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=121 \N AGONIST \N Tchem \N \N Homo sapiens 26993 3659 105 5-hydroxytryptamine receptor 7 GPCR P34969 HTR7 5HT7R_HUMAN 5.59999999999999964 \N Ki \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=102 \N ANTAGONIST \N Tclin \N \N Homo sapiens 26998 3170 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 5.20000000000000018 \N Kd \N IUPHAR = \N \N \N \N ALLOSTERIC MODULATOR \N Tclin \N \N Homo sapiens 26999 3170 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 5.09999999999999964 \N Kd \N IUPHAR = \N \N \N \N ALLOSTERIC MODULATOR \N Tclin \N \N Homo sapiens 27001 3096 924 G-protein coupled bile acid receptor 1 GPCR Q8TDU6 GPBAR1 GPBAR_HUMAN 5 \N EC50 \N IUPHAR = \N \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=609 \N AGONIST \N Tchem \N \N Homo sapiens 27003 3170 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 4.59999999999999964 \N Kd \N IUPHAR = \N \N \N \N ALLOSTERIC MODULATOR \N Tclin \N \N Homo sapiens 27005 694 371 Peroxisome proliferator-activated receptor alpha Nuclear hormone receptor Q07869 PPARA PPARA_HUMAN 4.25 \N IC50 \N IUPHAR = 1 CHEMBL http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2667 https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL565 AGONIST \N Tclin \N \N Homo sapiens 27007 3170 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 4.20000000000000018 \N Kd \N IUPHAR = \N \N \N \N ALLOSTERIC MODULATOR \N Tclin \N \N Homo sapiens 33631 4 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 6.70685851699999969 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33633 30 312 Cytochrome P450 1A2 Enzyme P05177 CYP1A2 CP1A2_HUMAN 7.39794000900000004 \N IC50 DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 33635 43 1707 Aldose reductase Enzyme P07943 Akr1b1 ALDR_RAT 5.89008413699999966 \N IC50 DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 33636 43 1712 Mitogen-activated protein kinase 1 Kinase P28482 MAPK1 MK01_HUMAN 5.22716507300000011 \N IC50 DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 33637 52 1709 Arachidonate 15-lipoxygenase Enzyme P12530 ALOX15 LOX15_RABIT 4.54698760900000032 \N IC50 DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Oryctolagus cuniculus 33639 80 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.1524273410000001 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33641 100 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 6 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33643 129 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 7.19382002600000003 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33647 129 312 Cytochrome P450 1A2 Enzyme P05177 CYP1A2 CP1A2_HUMAN 6.21846003100000022 \N IC50 DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 33648 130 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 6 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33650 141 312 Cytochrome P450 1A2 Enzyme P05177 CYP1A2 CP1A2_HUMAN 5.39794000900000004 \N IC50 DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 33651 147 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.74424521300000013 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33653 147 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 6.25383303599999962 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33654 156 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 6.18375870000000027 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33656 158 313 Amine oxidase [flavin-containing] A Enzyme P21397 MAOA AOFA_HUMAN 5.40793432999999979 \N IC50 DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33658 176 74 Mu-type opioid receptor GPCR P35372 OPRM1 OPRM_HUMAN 5.11193288700000004 \N Ki DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33660 176 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 5.33998877899999957 \N Ki DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33662 176 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 5.17711305200000016 \N Ki DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33666 176 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.91221858200000039 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33668 176 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.64743161400000027 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33670 176 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 5.98885263900000009 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33672 176 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.23136189900000037 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33674 176 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6.67366413900000044 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33676 176 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 5.04450467100000033 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 33678 176 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 5.2301797419999998 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33680 176 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 6.38721614299999985 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33682 176 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 4.98384448799999991 \N Ki DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33684 176 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 6.20134935499999962 \N Ki DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33686 176 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 5.74328225400000036 \N Ki DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33688 176 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 6.16813022599999972 \N Ki DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33690 176 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 6.29584948299999958 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33692 176 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 5.96778429699999968 \N Ki DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33694 176 129 Beta-3 adrenergic receptor GPCR P13945 ADRB3 ADRB3_HUMAN 4.49810583200000025 \N Ki DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33696 176 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.70114692399999967 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33698 176 148 Adenosine receptor A3 GPCR P0DMS8 ADORA3 AA3R_HUMAN 5.00357589600000008 \N Ki DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 33700 176 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 5.20669864600000043 \N Ki DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 33702 176 176 Kappa-type opioid receptor GPCR P41145 OPRK1 OPRK_HUMAN 5.17574396200000031 \N Ki DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33704 176 249 Delta-type opioid receptor GPCR P41143 OPRD1 OPRD_HUMAN 5.54898154800000043 \N Ki DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33706 176 457 Endothelin-1 receptor GPCR P25101 EDNRA EDNRA_HUMAN 4.79110201499999988 \N Ki DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33708 176 535 Tyrosine-protein kinase Fyn Kinase P06241 FYN FYN_HUMAN 6.08777794299999986 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33709 176 546 Receptor tyrosine-protein kinase erbB-2 Kinase P04626 ERBB2 ERBB2_HUMAN 5.03867384399999985 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33710 176 798 C-C chemokine receptor type 2 GPCR P41597 CCR2 CCR2_HUMAN 5.36804917400000026 \N Ki DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 33712 176 931 Substance-K receptor GPCR P21452 TACR2 NK2R_HUMAN 5.19124902799999965 \N Ki DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 33714 176 988 Androgen receptor Transcription factor P15207 Ar ANDR_RAT 4.55029024400000015 \N Ki DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 33716 176 1713 5-hydroxytryptamine receptor 1B GPCR P28564 Htr1b 5HT1B_RAT 4.40707969199999994 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 33718 176 1715 B2 bradykinin receptor GPCR P30411 BDKRB2 BKRB2_HUMAN 5.11497820499999989 \N Ki DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33720 176 1716 Melanocortin receptor 4 GPCR P32245 MC4R MC4R_HUMAN 4.8785714819999999 \N Ki DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33722 176 1717 Melanocortin receptor 5 GPCR P33032 MC5R MC5R_HUMAN 5.05017104099999958 \N Ki DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 33724 176 1718 Melanocortin receptor 3 GPCR P41968 MC3R MC3R_HUMAN 4.96669689900000044 \N Ki DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 33726 176 1720 C-C chemokine receptor type 4 GPCR P51679 CCR4 CCR4_HUMAN 4.94290470999999965 \N Ki DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33728 176 1721 Membrane-associated progesterone receptor component 1 Membrane receptor P70580 Pgrmc1 PGRC1_RAT 6.93181413800000001 \N IC50 DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 33731 180 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.87942606899999998 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33752 180 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 8.06550154900000038 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33754 180 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 8.25181197300000058 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33758 180 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 7.3767507099999996 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 33760 180 1713 5-hydroxytryptamine receptor 1B GPCR P28564 Htr1b 5HT1B_RAT 5.77083029699999983 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 33762 183 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.645891561 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33764 183 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 5.87095493999999984 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 33766 183 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 6.58335949299999967 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33768 183 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.35783236600000023 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33770 191 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 6.70774392900000027 \N Ki DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33773 191 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.30715308100000005 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33775 191 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 7.46852108299999973 \N IC50 DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1113 INHIBITOR \N Tclin \N \N Homo sapiens 33777 191 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 7.88605664800000028 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1113 INHIBITOR \N Tclin \N \N Homo sapiens 33779 191 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 8.18243462999999949 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33783 191 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.59345981999999964 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33788 191 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 6.54211810299999996 \N Ki DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33790 191 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 6.03011835600000001 \N Ki DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33792 191 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 6.42250820000000022 \N Ki DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33794 191 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 6.61618463399999968 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33796 191 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 6.21112488400000018 \N Ki DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33798 191 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 6.33629907500000034 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33800 191 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 5 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33801 191 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 6.84163750799999981 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33805 191 171 5-hydroxytryptamine receptor 3A Ion channel P46098 HTR3A 5HT3A_HUMAN 6.57024772000000024 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33807 191 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 7.22184875000000037 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 33809 200 95 Cytochrome P450 3A4 Enzyme P08684 CYP3A4 CP3A4_HUMAN 6 \N IC50 DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33810 200 621 Thromboxane-A synthase Enzyme P24557 TBXAS1 THAS_HUMAN 5.17217857199999997 \N IC50 DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 33811 249 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN 4.99839607599999969 \N Ki DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33813 249 74 Mu-type opioid receptor GPCR P35372 OPRM1 OPRM_HUMAN 6.21752737599999961 \N Ki DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33815 249 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 5.69788562300000034 \N Ki DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33817 249 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 5.82188674799999983 \N Ki DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33819 249 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 5.7406450729999996 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33821 249 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 6.02502800600000032 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33823 249 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 6.15490196000000012 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33825 249 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.86518563000000004 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33827 249 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 6.35852588900000004 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33829 249 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 8.25336580099999928 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33831 249 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 8.12551818200000042 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33833 249 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 7.02687214599999965 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33835 249 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 5.81930079899999964 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 33837 249 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 5.75621808400000035 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33839 249 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 6.82973828500000035 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33842 249 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 5.78146449499999981 \N Ki DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33844 249 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 6.59006687699999993 \N Ki DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33846 249 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 6.30016227399999984 \N Ki DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33848 249 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 6.74957999799999975 \N Ki DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33850 249 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 6.58670023600000043 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33852 249 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 6.2967086219999997 \N Ki DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33854 249 129 Beta-3 adrenergic receptor GPCR P13945 ADRB3 ADRB3_HUMAN 5.21860369499999965 \N Ki DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33856 249 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 6.54515514000000032 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33858 249 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 6.10072681299999964 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33860 249 148 Adenosine receptor A3 GPCR P0DMS8 ADORA3 AA3R_HUMAN 4.78354378499999999 \N Ki DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 33862 249 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 5.67080558500000009 \N Ki DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 33864 249 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 8.00436480499999981 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33868 249 171 5-hydroxytryptamine receptor 3A Ion channel P46098 HTR3A 5HT3A_HUMAN 7.01772876700000037 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33870 249 176 Kappa-type opioid receptor GPCR P41145 OPRK1 OPRK_HUMAN 5.57741016000000034 \N Ki DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33872 249 249 Delta-type opioid receptor GPCR P41143 OPRD1 OPRD_HUMAN 5.33960890200000016 \N Ki DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33874 249 387 Epidermal growth factor receptor Kinase P00533 EGFR EGFR_HUMAN 5.21774242600000004 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33875 249 417 Substance-P receptor GPCR P25103 TACR1 NK1R_HUMAN 5.06474471800000003 \N Ki DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33877 249 533 Tyrosine-protein kinase Lck Kinase P06239 LCK LCK_HUMAN 4.70071066599999998 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33878 249 535 Tyrosine-protein kinase Fyn Kinase P06241 FYN FYN_HUMAN 5.5456125329999999 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33879 249 546 Receptor tyrosine-protein kinase erbB-2 Kinase P04626 ERBB2 ERBB2_HUMAN 4.88325946500000008 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33880 249 931 Substance-K receptor GPCR P21452 TACR2 NK2R_HUMAN 6.00217691900000005 \N Ki DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 33882 249 49 Sodium/nucleoside cotransporter 1 Transporter O00337 SLC28A1 S28A1_HUMAN 5.31193630300000041 \N Ki DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine) DRUG MATRIX = \N \N \N \N \N \N Tbio \N \N Homo sapiens 33884 249 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 7.02227639499999956 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 33886 249 1713 5-hydroxytryptamine receptor 1B GPCR P28564 Htr1b 5HT1B_RAT 6.20065945099999993 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 33888 249 1716 Melanocortin receptor 4 GPCR P32245 MC4R MC4R_HUMAN 4.86963406300000035 \N Ki DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33890 249 1717 Melanocortin receptor 5 GPCR P33032 MC5R MC5R_HUMAN 5.67305000600000042 \N Ki DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 33892 249 1718 Melanocortin receptor 3 GPCR P41968 MC3R MC3R_HUMAN 4.86809275700000033 \N Ki DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 33894 249 1721 Membrane-associated progesterone receptor component 1 Membrane receptor P70580 Pgrmc1 PGRC1_RAT 6.73282827199999989 \N Ki DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 33898 260 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6.2757241300000004 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33905 260 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 6.17652577099999966 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33909 281 387 Epidermal growth factor receptor Kinase P00533 EGFR EGFR_HUMAN 5.26945996400000016 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33910 281 533 Tyrosine-protein kinase Lck Kinase P06239 LCK LCK_HUMAN 5.71602071600000006 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33911 281 1713 5-hydroxytryptamine receptor 1B GPCR P28564 Htr1b 5HT1B_RAT 5.86838133599999967 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 33913 285 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 5.69897000400000042 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33914 294 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 8.42712839800000069 \N Ki DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) DRUG MATRIX = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1370 AGONIST \N Tclin \N \N Homo sapiens 33916 313 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 5.95979337200000003 \N Ki DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33918 313 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 6.96657624499999972 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33920 313 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 6.13135556200000043 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33922 313 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 6.1051303429999999 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33924 313 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 7.10790539699999968 \N Ki DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL936 ANTAGONIST \N Tclin \N \N Homo sapiens 33926 313 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 6.56224943700000019 \N Ki DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33928 313 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 7.28399665600000024 \N Ki DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33930 313 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 7.4202164030000004 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33932 313 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 6.06803388500000018 \N Ki DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33934 313 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 6.4863829260000001 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33935 313 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 5.57921937999999962 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 33937 318 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 5.940058112 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33939 318 148 Adenosine receptor A3 GPCR P0DMS8 ADORA3 AA3R_HUMAN 5.52988364700000012 \N Ki DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 33941 318 268 Cytochrome P450 2C9 Enzyme P11712 CYP2C9 CP2C9_HUMAN 7.795880017 \N IC50 DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 33942 318 474 cAMP-specific 3',5'-cyclic phosphodiesterase 4A Enzyme P27815 PDE4A PDE4A_HUMAN 5.97633608200000044 \N IC50 DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33943 318 865 Mitogen-activated protein kinase 14 Kinase Q16539 MAPK14 MK14_HUMAN 5.90833304199999976 \N IC50 DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 33944 318 1712 Mitogen-activated protein kinase 1 Kinase P28482 MAPK1 MK01_HUMAN 5.7108571640000001 \N IC50 DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 33945 333 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.6903698330000001 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33947 333 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 7.22914798800000025 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33949 333 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.86043573400000017 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33951 333 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 8.15676722199999915 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33953 333 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.89619627899999976 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33955 333 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 7.49485002199999961 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33957 333 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 5.88806572399999961 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 33959 333 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 7.52287874499999987 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33961 333 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 6.6536470259999998 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33964 333 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 5.92628164999999996 \N Ki DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33971 333 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 7.24412514399999985 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33975 333 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 7.58502665199999981 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33979 333 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 7.38721614299999985 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 33981 333 1721 Membrane-associated progesterone receptor component 1 Membrane receptor P70580 Pgrmc1 PGRC1_RAT 6.95078197700000011 \N Ki DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 33984 375 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.75572287900000035 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33986 375 176 Kappa-type opioid receptor GPCR P41145 OPRK1 OPRK_HUMAN 6.01099538400000011 \N Ki DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33988 375 268 Cytochrome P450 2C9 Enzyme P11712 CYP2C9 CP2C9_HUMAN 5 \N IC50 DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 33992 389 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 6.81530856899999993 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33994 389 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 6.34486156500000043 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 94118 575 840 Interstitial collagenase Enzyme P03956 MMP1 MMP1_HUMAN 4.42999999999999972 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33996 389 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.01367622300000004 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 33998 389 129 Beta-3 adrenergic receptor GPCR P13945 ADRB3 ADRB3_HUMAN 6.46344155700000034 \N Ki DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34000 389 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 5.26150483799999957 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34002 395 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 5.83624247599999979 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34005 395 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 6.07262963700000036 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34009 402 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 7.60205999099999996 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34011 402 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.95428594100000019 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34013 402 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 6.70818731299999982 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34014 402 1721 Membrane-associated progesterone receptor component 1 Membrane receptor P70580 Pgrmc1 PGRC1_RAT 7.44369749899999977 \N Ki DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34016 403 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN 5.85823677000000043 \N Ki DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34021 403 95 Cytochrome P450 3A4 Enzyme P08684 CYP3A4 CP3A4_HUMAN 5.69897000400000042 \N IC50 DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34030 403 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 8.54975089200000049 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34034 403 988 Androgen receptor Transcription factor P15207 Ar ANDR_RAT 5.81787078600000029 \N Ki DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34036 403 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 8.70774392899999938 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34038 403 1713 5-hydroxytryptamine receptor 1B GPCR P28564 Htr1b 5HT1B_RAT 7.32790214200000012 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34042 419 804 Matrix metalloproteinase-9 Enzyme P14780 MMP9 MMP9_HUMAN 5.70136521700000021 \N IC50 DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34043 419 988 Androgen receptor Transcription factor P15207 Ar ANDR_RAT 5.96257350199999969 \N Ki DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34045 419 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 7.56863623599999968 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 34049 431 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN 8.39902710399999997 \N Ki DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201177 ANTAGONIST \N Tclin \N \N Homo sapiens 34051 431 55 Beta-2 adrenergic receptor GPCR P07550 ADRB2 ADRB2_HUMAN 9.2628073569999998 \N Ki DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177) DRUG MATRIX = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201177 ANTAGONIST \N Tclin \N \N Homo sapiens 34053 431 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 6.48811663900000024 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34055 431 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.58469270800000039 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34057 431 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 5.78041547399999978 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34059 431 129 Beta-3 adrenergic receptor GPCR P13945 ADRB3 ADRB3_HUMAN 6.59345981999999964 \N Ki DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N ANTAGONIST \N Tclin \N \N Homo sapiens 34061 432 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 6.39794000900000004 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34063 435 470 Cytochrome P450 2C19 Enzyme P33261 CYP2C19 CP2CJ_HUMAN 5.69933931200000021 \N IC50 DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34064 435 1721 Membrane-associated progesterone receptor component 1 Membrane receptor P70580 Pgrmc1 PGRC1_RAT 5.84618513599999989 \N Ki DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34073 437 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 6.27654432799999995 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34077 437 1721 Membrane-associated progesterone receptor component 1 Membrane receptor P70580 Pgrmc1 PGRC1_RAT 5.47108330000000009 \N IC50 DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34078 438 804 Matrix metalloproteinase-9 Enzyme P14780 MMP9 MMP9_HUMAN 5.28274568700000025 \N IC50 DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34079 444 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 5.86435858399999965 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34081 444 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 5.77949965400000032 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34083 444 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 6.12493873699999991 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34085 444 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.4114481940000001 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34087 444 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 6.52287874499999987 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34088 444 251 Acetylcholinesterase Enzyme P22303 ACHE ACES_HUMAN 5.16070425599999982 \N IC50 DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34089 444 1721 Membrane-associated progesterone receptor component 1 Membrane receptor P70580 Pgrmc1 PGRC1_RAT 6.80493100400000017 \N Ki DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34107 496 533 Tyrosine-protein kinase Lck Kinase P06239 LCK LCK_HUMAN 5.16781053900000042 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34108 496 535 Tyrosine-protein kinase Fyn Kinase P06241 FYN FYN_HUMAN 5.42817475100000024 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34109 511 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 5.30102999599999958 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34110 511 816 Mitogen-activated protein kinase 3 Kinase P27361 MAPK3 MK03_HUMAN 5.21317762099999982 \N IC50 DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34113 522 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 6.12551818200000042 \N Ki DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34115 522 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 7.30980392000000023 \N Ki DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34117 522 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 7.39794000900000004 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34121 522 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 6.92811799299999986 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34123 522 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 6.27327279100000013 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34125 522 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 8.47625353299999951 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34127 522 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 6.93181413800000001 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34129 522 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 7.82390874100000033 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34131 522 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 7.22184875000000037 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34133 522 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 6.15181088299999956 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34135 522 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 7.36653154399999988 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34137 522 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 6.70774392900000027 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34140 522 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 7.88605664800000028 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34142 522 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 6.17327748000000032 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34144 522 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 9.05403929599999913 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N ANTAGONIST \N Tclin \N \N Homo sapiens 34148 522 50 5-hydroxytryptamine receptor 4 GPCR O70528 HTR4 5HT4R_CAVPO 6.74232142500000009 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Cavia porcellus 34150 522 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 8.70553377399999917 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34152 522 1713 5-hydroxytryptamine receptor 1B GPCR P28564 Htr1b 5HT1B_RAT 6.22988470499999991 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34155 568 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 4.85396503700000004 \N Ki DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34157 568 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.47703440500000038 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34159 568 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.13984173900000041 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34161 568 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.15989390599999975 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34163 568 129 Beta-3 adrenergic receptor GPCR P13945 ADRB3 ADRB3_HUMAN 4.91746594700000017 \N Ki DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 94119 575 95 Cytochrome P450 3A4 Enzyme P08684 CYP3A4 CP3A4_HUMAN 5.30999999999999961 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34166 568 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 6 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34167 568 148 Adenosine receptor A3 GPCR P0DMS8 ADORA3 AA3R_HUMAN 4.85645437300000005 \N Ki DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34169 568 474 cAMP-specific 3',5'-cyclic phosphodiesterase 4A Enzyme P27815 PDE4A PDE4A_HUMAN 5.03338901299999986 \N IC50 DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34170 568 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 5.62672010699999969 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 34172 588 1707 Aldose reductase Enzyme P07943 Akr1b1 ALDR_RAT 5.02627194100000008 \N IC50 DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34173 594 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 6.68193666500000027 \N Ki DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34175 600 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 7.76447155299999991 \N Ki DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34177 600 470 Cytochrome P450 2C19 Enzyme P33261 CYP2C19 CP2CJ_HUMAN 5.52287874499999987 \N IC50 DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34178 600 988 Androgen receptor Transcription factor P15207 Ar ANDR_RAT 7.67985371400000005 \N Ki DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34180 600 48 Sodium/potassium-transporting ATPase subunit alpha-2 Ion channel D2WKD8 ATP1A2 AT1A2_PIG 5.34012181399999974 \N IC50 DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Sus scrofa 34181 600 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 9.16304326300000049 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 34183 621 74 Mu-type opioid receptor GPCR P35372 OPRM1 OPRM_HUMAN 5.23328979299999997 \N Ki DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34188 621 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 6.7235381959999998 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34193 621 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 7.72124639899999998 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34210 621 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.67778070499999998 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34213 621 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 8.70774392899999938 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34218 621 176 Kappa-type opioid receptor GPCR P41145 OPRK1 OPRK_HUMAN 5.35330226900000028 \N Ki DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34220 621 249 Delta-type opioid receptor GPCR P41143 OPRD1 OPRD_HUMAN 5.13282724899999998 \N Ki DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34222 621 387 Epidermal growth factor receptor Kinase P00533 EGFR EGFR_HUMAN 4.53958330299999968 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34223 621 535 Tyrosine-protein kinase Fyn Kinase P06241 FYN FYN_HUMAN 5.06148027500000008 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34224 621 546 Receptor tyrosine-protein kinase erbB-2 Kinase P04626 ERBB2 ERBB2_HUMAN 4.71296007199999956 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34225 621 931 Substance-K receptor GPCR P21452 TACR2 NK2R_HUMAN 5.04263219200000012 \N Ki DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34227 621 1709 Arachidonate 15-lipoxygenase Enzyme P12530 ALOX15 LOX15_RABIT 4.79721208499999996 \N IC50 DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Oryctolagus cuniculus 34228 621 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 8.30451832400000001 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34230 621 1713 5-hydroxytryptamine receptor 1B GPCR P28564 Htr1b 5HT1B_RAT 5.73589084400000004 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34232 621 1716 Melanocortin receptor 4 GPCR P32245 MC4R MC4R_HUMAN 4.83508233399999998 \N Ki DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34234 621 1717 Melanocortin receptor 5 GPCR P33032 MC5R MC5R_HUMAN 5.14599776699999989 \N Ki DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34236 621 1718 Melanocortin receptor 3 GPCR P41968 MC3R MC3R_HUMAN 4.67276370699999966 \N Ki DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34238 621 1721 Membrane-associated progesterone receptor component 1 Membrane receptor P70580 Pgrmc1 PGRC1_RAT 5.77650405899999964 \N Ki DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34241 626 1714 Nitric oxide synthase, brain Enzyme P29476 Nos1 NOS1_RAT 5.55377359800000026 \N IC50 DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34242 644 268 Cytochrome P450 2C9 Enzyme P11712 CYP2C9 CP2C9_HUMAN 5 \N IC50 DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34244 654 74 Mu-type opioid receptor GPCR P35372 OPRM1 OPRM_HUMAN 6.03526907899999987 \N Ki DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34246 654 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 6.58670023600000043 \N Ki DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34248 654 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.77728352899999997 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34250 654 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 7.76955107900000019 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34252 654 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 6.23732143600000022 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34254 654 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.55160289700000043 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34256 654 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 6.20830935099999959 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34258 654 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 6.98716277499999983 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34260 654 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.33254704700000026 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34262 654 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 5.99012436599999987 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34264 654 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 7.06550154900000038 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34266 654 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 8.06449273399999988 \N Ki DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34268 654 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 6.21824462499999964 \N Ki DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34270 654 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 6.79048498499999997 \N Ki DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34272 654 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 6.29242982400000006 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34274 654 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 6.26360349800000016 \N Ki DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34276 654 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 7.02227639499999956 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34278 654 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.8847224090000001 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34280 654 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 6.24184537799999983 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34284 654 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 6.29929628300000033 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34286 654 1721 Membrane-associated progesterone receptor component 1 Membrane receptor P70580 Pgrmc1 PGRC1_RAT 6.79317412400000009 \N IC50 DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34289 660 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.17652577099999966 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34291 660 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 6.37882371799999959 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34295 660 95 Cytochrome P450 3A4 Enzyme P08684 CYP3A4 CP3A4_HUMAN 6.52287874499999987 \N IC50 DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34296 660 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 6.6903698330000001 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34304 660 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6.39577394700000035 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34306 660 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.28066871299999985 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34308 660 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 7.30980392000000023 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34310 660 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 6.94692155699999958 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34312 660 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 7.15490196000000012 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34313 660 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 7.30980392000000023 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34317 660 238 3-hydroxy-3-methylglutaryl-coenzyme A reductase Enzyme P04035 HMGCR HMDH_HUMAN 5.47237009899999993 \N IC50 DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34320 660 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 8.06298389300000018 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34322 660 1721 Membrane-associated progesterone receptor component 1 Membrane receptor P70580 Pgrmc1 PGRC1_RAT 6.96257350199999969 \N Ki DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34324 663 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 6.77728352899999997 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35075 928 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 5.95663772199999997 \N Ki DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34330 663 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 5.9314431049999996 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34334 663 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 6.14813039900000025 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34338 663 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 5.73992861199999993 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34340 667 474 cAMP-specific 3',5'-cyclic phosphodiesterase 4A Enzyme P27815 PDE4A PDE4A_HUMAN 5.44069198900000028 \N IC50 DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34341 671 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 6.11520463599999964 \N Ki DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34343 671 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 7.3467874860000002 \N Ki DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34345 671 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 7.16115090899999984 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34347 671 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 7.85387196399999965 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34350 671 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.51427857400000043 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34352 671 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 8.03621217299999913 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34354 671 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 7.63827216399999998 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34356 671 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 7.28399665600000024 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34358 671 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 7.44369749899999977 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34360 671 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.84771165600000042 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34362 671 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 8.60380065300000041 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34365 671 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 6.43889861600000035 \N Ki DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34367 671 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 8.08354605100000079 \N Ki DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34369 671 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 8.55752023099999981 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34371 671 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 8.2204035090000005 \N Ki DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34373 671 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 7.85387196399999965 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34375 671 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 6.26921772399999977 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34378 671 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 7.82390874100000033 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34382 671 470 Cytochrome P450 2C19 Enzyme P33261 CYP2C19 CP2CJ_HUMAN 6.22184875000000037 \N IC50 DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34383 671 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 7.38721614299999985 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34385 671 1713 5-hydroxytryptamine receptor 1B GPCR P28564 Htr1b 5HT1B_RAT 6.6575773189999996 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34387 671 1721 Membrane-associated progesterone receptor component 1 Membrane receptor P70580 Pgrmc1 PGRC1_RAT 6.34872198600000015 \N Ki DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34389 673 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN 7.16115090899999984 \N Ki DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34393 673 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 5.81958736699999957 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34395 700 66 Prostaglandin G/H synthase 1 Enzyme P23219 PTGS1 PGH1_HUMAN 6.46092390100000014 \N IC50 DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34396 700 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.45469288399999996 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34400 700 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 6.46980030200000034 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34402 700 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 6.06803388500000018 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34404 700 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 6.02456819100000018 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34406 700 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.06198090300000025 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34408 700 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6.17652577099999966 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34412 700 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.14206473499999994 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34414 700 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 6.34872198600000015 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34416 700 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 6.40671393299999981 \N Ki DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34418 700 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 5.88941028999999983 \N Ki DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34420 700 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 6.35753548000000013 \N Ki DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34422 700 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 6.63827216399999998 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34424 700 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 5.89551288899999992 \N Ki DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34426 700 129 Beta-3 adrenergic receptor GPCR P13945 ADRB3 ADRB3_HUMAN 5.37120251400000015 \N Ki DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34428 700 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 6.66756154000000034 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34430 700 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 6.20551195300000025 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34432 700 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 5 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34433 700 148 Adenosine receptor A3 GPCR P0DMS8 ADORA3 AA3R_HUMAN 5.5194182129999998 \N Ki DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34435 700 202 Estrogen receptor Nuclear hormone receptor P03372 ESR1 ESR1_HUMAN 8.88605664800000028 \N Ki DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol) DRUG MATRIX = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2355051 MODULATOR \N Tclin \N \N Homo sapiens 34437 700 387 Epidermal growth factor receptor Kinase P00533 EGFR EGFR_HUMAN 5.97881070099999956 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34438 700 535 Tyrosine-protein kinase Fyn Kinase P06241 FYN FYN_HUMAN 5.59980751099999985 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34439 700 546 Receptor tyrosine-protein kinase erbB-2 Kinase P04626 ERBB2 ERBB2_HUMAN 5.77754366300000033 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34440 700 931 Substance-K receptor GPCR P21452 TACR2 NK2R_HUMAN 5.82159865800000009 \N Ki DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34442 700 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 5.59705117100000038 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34444 700 1721 Membrane-associated progesterone receptor component 1 Membrane receptor P70580 Pgrmc1 PGRC1_RAT 7.52287874499999987 \N Ki DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34448 701 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 6.24260397100000031 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34454 701 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.81815641200000044 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34459 701 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 7.3372421680000004 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34462 701 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 8.00744648200000064 \N Ki DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34464 701 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 5.69572494999999979 \N Ki DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34466 701 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 7.6575773189999996 \N Ki DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34468 701 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 7.06550154900000038 \N Ki DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34470 701 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 7.44369749899999977 \N Ki DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34472 701 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 7.88605664800000028 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34474 701 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 7.4202164030000004 \N Ki DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34476 701 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 6.68824613900000031 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34480 701 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 7.39794000900000004 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34484 701 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 7.13667713999999975 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34486 701 1721 Membrane-associated progesterone receptor component 1 Membrane receptor P70580 Pgrmc1 PGRC1_RAT 5.93741801599999963 \N Ki DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34494 704 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 5.99012436599999987 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34496 708 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 6.52432881200000026 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34498 714 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN 5.82477819999999991 \N Ki DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34500 714 55 Beta-2 adrenergic receptor GPCR P07550 ADRB2 ADRB2_HUMAN 5.86327943299999976 \N Ki DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34502 719 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN 5.18621892200000012 \N Ki DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34504 719 56 Prostaglandin G/H synthase 2 Enzyme P35354 PTGS2 PGH2_HUMAN 4.37886527900000022 \N IC50 DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34505 719 74 Mu-type opioid receptor GPCR P35372 OPRM1 OPRM_HUMAN 6.13608262300000007 \N Ki DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34507 719 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 5.34601609300000025 \N Ki DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34509 719 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 5.39126008100000043 \N Ki DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34511 719 89 Adenosine receptor A2a GPCR P29274 ADORA2A AA2AR_HUMAN 5.14654515900000042 \N Ki DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34513 719 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 5.35095736600000027 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34515 719 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.51427857400000043 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34517 719 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.104025268 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34519 719 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 4.99533476700000012 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34521 719 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 5.49716336100000014 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34523 719 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 5.13164949999999997 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34525 719 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 5.12027350299999995 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34527 719 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 5.23477863400000043 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34529 719 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 5.42887372299999971 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34531 719 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 6.04624030799999979 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34533 719 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 5.46648213799999994 \N Ki DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34535 719 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 5.29422178699999968 \N Ki DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34537 719 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 5.78146449499999981 \N Ki DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34539 719 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 5.28676153800000037 \N Ki DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34541 719 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 5.676954265 \N Ki DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34543 719 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 5.78515615199999989 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34545 719 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 5.82944494100000021 \N Ki DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34547 719 129 Beta-3 adrenergic receptor GPCR P13945 ADRB3 ADRB3_HUMAN 5.26712395900000008 \N Ki DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34549 719 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.35320431099999983 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34551 719 146 Adenosine receptor A1 GPCR P30542 ADORA1 AA1R_HUMAN 5.10623823800000043 \N Ki DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34553 719 148 Adenosine receptor A3 GPCR P0DMS8 ADORA3 AA3R_HUMAN 5.57089399200000024 \N Ki DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34557 719 161 Carbonic anhydrase 2 Enzyme P00918 CA2 CAH2_HUMAN 4.52139022099999988 \N IC50 DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34558 719 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 5.13200248999999964 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34562 719 176 Kappa-type opioid receptor GPCR P41145 OPRK1 OPRK_HUMAN 5.59842715400000035 \N Ki DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34564 719 249 Delta-type opioid receptor GPCR P41143 OPRD1 OPRD_HUMAN 5.75572287900000035 \N Ki DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34566 719 251 Acetylcholinesterase Enzyme P22303 ACHE ACES_HUMAN 4.71197446499999995 \N IC50 DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34567 719 268 Cytochrome P450 2C9 Enzyme P11712 CYP2C9 CP2C9_HUMAN 7.795880017 \N IC50 DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34568 719 305 Platelet-activating factor receptor GPCR P25105 PTAFR PTAFR_HUMAN 4.6452195009999997 \N Ki DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34570 719 387 Epidermal growth factor receptor Kinase P00533 EGFR EGFR_HUMAN 4.15850913500000008 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34571 719 417 Substance-P receptor GPCR P25103 TACR1 NK1R_HUMAN 5.05814087300000015 \N Ki DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34573 719 470 Cytochrome P450 2C19 Enzyme P33261 CYP2C19 CP2CJ_HUMAN 7.795880017 \N IC50 DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34574 719 535 Tyrosine-protein kinase Fyn Kinase P06241 FYN FYN_HUMAN 4.49687692799999983 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34575 719 546 Receptor tyrosine-protein kinase erbB-2 Kinase P04626 ERBB2 ERBB2_HUMAN 4.17779921899999973 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34576 719 621 Thromboxane-A synthase Enzyme P24557 TBXAS1 THAS_HUMAN 7.85387196399999965 \N IC50 DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34577 719 931 Substance-K receptor GPCR P21452 TACR2 NK2R_HUMAN 5.47069800199999978 \N Ki DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34579 719 988 Androgen receptor Transcription factor P15207 Ar ANDR_RAT 5.11215773500000026 \N Ki DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34581 719 1713 5-hydroxytryptamine receptor 1B GPCR P28564 Htr1b 5HT1B_RAT 4.90612324499999986 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34583 719 1726 Cysteinyl leukotriene receptor 1 GPCR Q2NNR5 CYSLTR1 CLTR1_CAVPO 4.78025833900000041 \N Ki DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Cavia porcellus 34585 719 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 5.94157397599999992 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 34613 722 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 8.44490555099999973 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34621 749 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.23507701499999989 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34623 749 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 7.19382002600000003 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34625 749 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.62342304299999984 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34627 749 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6.27164621799999988 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34629 749 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 5.99310629200000022 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34631 749 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 8.35261702999999933 \N Ki DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) DRUG MATRIX = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL648 ANTAGONIST \N Tclin \N \N Homo sapiens 34633 749 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 6.78781239599999964 \N Ki DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34635 749 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 6.38510278399999986 \N Ki DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34637 749 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 6.79860287600000035 \N Ki DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34639 749 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 6.92445303900000031 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34641 749 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 6.34198860299999989 \N Ki DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34643 749 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 6.21752737599999961 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34645 749 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 5.20638420600000007 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34646 749 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 6.22402566900000043 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34648 749 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 5.86043573400000017 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34650 760 931 Substance-K receptor GPCR P21452 TACR2 NK2R_HUMAN 5.86012091400000035 \N Ki DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34654 765 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.97469413500000002 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34656 765 94 Potassium voltage-gated channel subfamily H member 2 Ion channel Q12809 KCNH2 KCNH2_HUMAN 4.85486888299999997 \N Ki DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34665 765 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 7.76955107900000019 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34669 765 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 6.70996538899999972 \N Ki DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34674 765 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 8.65955588499999962 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34676 765 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 8.55909091800000077 \N Ki DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34678 765 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 6.73282827199999989 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34682 765 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 7.35654732400000011 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34684 765 1713 5-hydroxytryptamine receptor 1B GPCR P28564 Htr1b 5HT1B_RAT 5.89859664899999991 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34686 766 74 Mu-type opioid receptor GPCR P35372 OPRM1 OPRM_HUMAN 6.05256627799999958 \N Ki DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34691 766 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 8.31515463799999921 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 34693 773 804 Matrix metalloproteinase-9 Enzyme P14780 MMP9 MMP9_HUMAN 6.2549252080000004 \N IC50 DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34694 779 74 Mu-type opioid receptor GPCR P35372 OPRM1 OPRM_HUMAN 5.24298376499999996 \N Ki DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34696 779 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 4.99033668299999977 \N Ki DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34698 779 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 5.16285365600000024 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34700 779 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.08655704500000017 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34702 779 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.24787469299999998 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34704 779 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 5.59722293000000004 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34706 779 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 4.97576069399999987 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34708 779 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 5.00877392399999977 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34710 779 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 5.42458120900000029 \N Ki DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34712 779 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 5.70752240599999983 \N Ki DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34714 779 129 Beta-3 adrenergic receptor GPCR P13945 ADRB3 ADRB3_HUMAN 4.89397918099999973 \N Ki DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34716 779 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 5.46205504100000017 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34718 779 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.264720552 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34720 779 148 Adenosine receptor A3 GPCR P0DMS8 ADORA3 AA3R_HUMAN 5.20003947300000036 \N Ki DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34722 779 176 Kappa-type opioid receptor GPCR P41145 OPRK1 OPRK_HUMAN 5.20711825500000014 \N Ki DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34724 779 202 Estrogen receptor Nuclear hormone receptor P03372 ESR1 ESR1_HUMAN 5.29387989000000037 \N Ki DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34726 779 268 Cytochrome P450 2C9 Enzyme P11712 CYP2C9 CP2C9_HUMAN 6.52287874499999987 \N IC50 DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34727 779 931 Substance-K receptor GPCR P21452 TACR2 NK2R_HUMAN 5.05256627799999958 \N Ki DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34729 779 988 Androgen receptor Transcription factor P15207 Ar ANDR_RAT 8.09745322100000031 \N Ki DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34731 779 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 7.46852108299999973 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 34733 781 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 5.92922353700000038 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34735 781 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 6.76195389699999971 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34737 781 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.1726307269999996 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34739 781 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6.48545224699999956 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34741 781 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.27901425599999996 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34743 781 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 8.38827669199999981 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = 1 IUPHAR \N http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7155 ANTAGONIST \N Tclin \N \N Homo sapiens 34747 781 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 7.52287874499999987 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34750 814 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 6.91364016899999978 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34752 814 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.95585237900000042 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34754 814 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 8.02456819100000018 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34756 814 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 7.55284196900000016 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34758 814 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 7.795880017 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34760 814 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 5.99653946799999993 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34762 814 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.00877392399999977 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34764 814 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 6.189095719 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34767 814 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 5.96657624499999972 \N Ki DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34774 814 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.51116736599999957 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34776 814 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 5.69788562300000034 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34778 819 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 8.93181413800000001 \N Ki DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) DRUG MATRIX = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1766 AGONIST \N Tclin \N \N Homo sapiens 34780 819 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 7.95860731500000007 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 34784 824 988 Androgen receptor Transcription factor P15207 Ar ANDR_RAT 4.78592479100000023 \N Ki DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34786 824 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 5.5174122299999997 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 34788 832 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 6.66354026600000005 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34793 842 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 8.84163750799999981 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34796 867 1707 Aldose reductase Enzyme P07943 Akr1b1 ALDR_RAT 5.38795825500000003 \N IC50 DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34797 867 1712 Mitogen-activated protein kinase 1 Kinase P28482 MAPK1 MK01_HUMAN 5.35398859000000016 \N IC50 DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34798 868 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 8.68613277999999944 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34800 868 94 Potassium voltage-gated channel subfamily H member 2 Ion channel Q12809 KCNH2 KCNH2_HUMAN 4.77289264100000032 \N Ki DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34802 868 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 7.16115090899999984 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34804 868 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.08196966299999975 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34806 868 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6.61083391599999981 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 94120 575 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 5.48000000000000043 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34808 868 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 5.84679509999999958 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34810 868 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 6.38615817799999963 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34812 868 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 5.79642322499999985 \N Ki DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34814 868 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 9.07883394899999985 \N Ki DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1123 ANTAGONIST \N Tclin \N \N Homo sapiens 34817 868 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 9.03292026599999964 \N Ki DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1123 ANTAGONIST \N Tclin \N \N Homo sapiens 34819 868 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 9.38615817800000052 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34821 868 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 8.7670038899999998 \N Ki DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34823 868 1721 Membrane-associated progesterone receptor component 1 Membrane receptor P70580 Pgrmc1 PGRC1_RAT 6.32697909300000028 \N IC50 DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34824 868 1724 SMR1-alpha2 Unclassified P70676 Vcsa2 P70676_RAT 6.53760200199999986 \N Ki DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34825 875 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN 4.89431953700000033 \N Ki DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34827 875 66 Prostaglandin G/H synthase 1 Enzyme P23219 PTGS1 PGH1_HUMAN 5.25181197299999969 \N IC50 DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34828 875 74 Mu-type opioid receptor GPCR P35372 OPRM1 OPRM_HUMAN 5.62985715299999967 \N Ki DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34830 875 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 5.41094446900000037 \N Ki DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34832 875 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 5.35261703000000022 \N Ki DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34834 875 89 Adenosine receptor A2a GPCR P29274 ADORA2A AA2AR_HUMAN 5.29584948299999958 \N Ki DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34836 875 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 5.27597002699999962 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34838 875 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.17802818200000026 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34840 875 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.43889861600000035 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34842 875 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 5.86359655199999974 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34844 875 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 5.69940451600000042 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34846 875 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 4.57480826399999962 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34848 875 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 5.22286328700000002 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34850 875 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 5.27245874299999961 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34852 875 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 5.52476477699999968 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34854 875 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 5.43723145700000021 \N Ki DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34856 875 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 5.40815658899999985 \N Ki DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34858 875 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 5.31713320400000011 \N Ki DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34860 875 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 5.65737995699999985 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34862 875 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 6.07007044000000029 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34864 875 146 Adenosine receptor A1 GPCR P30542 ADORA1 AA1R_HUMAN 5.77832500299999996 \N Ki DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34866 875 148 Adenosine receptor A3 GPCR P0DMS8 ADORA3 AA3R_HUMAN 5.90378541499999976 \N Ki DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34868 875 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 5.274006741 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34872 875 176 Kappa-type opioid receptor GPCR P41145 OPRK1 OPRK_HUMAN 5.73873713099999971 \N Ki DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34875 875 249 Delta-type opioid receptor GPCR P41143 OPRD1 OPRD_HUMAN 6.01863449100000025 \N Ki DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34877 875 251 Acetylcholinesterase Enzyme P22303 ACHE ACES_HUMAN 4.59260909600000033 \N IC50 DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34878 875 390 Vasopressin V1a receptor GPCR P37288 AVPR1A V1AR_HUMAN 4.98292490399999988 \N Ki DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34880 875 535 Tyrosine-protein kinase Fyn Kinase P06241 FYN FYN_HUMAN 4.84670355100000005 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34881 875 621 Thromboxane-A synthase Enzyme P24557 TBXAS1 THAS_HUMAN 5.36061313100000003 \N IC50 DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34882 875 865 Mitogen-activated protein kinase 14 Kinase Q16539 MAPK14 MK14_HUMAN 4.48276450300000029 \N IC50 DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34883 875 931 Substance-K receptor GPCR P21452 TACR2 NK2R_HUMAN 5.49702694099999967 \N Ki DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34885 875 49 Sodium/nucleoside cotransporter 1 Transporter O00337 SLC28A1 S28A1_HUMAN 5.31578320499999979 \N Ki DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine) DRUG MATRIX = \N \N \N \N \N \N Tbio \N \N Homo sapiens 34887 875 1709 Arachidonate 15-lipoxygenase Enzyme P12530 ALOX15 LOX15_RABIT 5.52826834900000019 \N IC50 DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Oryctolagus cuniculus 34888 875 1726 Cysteinyl leukotriene receptor 1 GPCR Q2NNR5 CYSLTR1 CLTR1_CAVPO 5.05197846699999964 \N Ki DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Cavia porcellus 34890 875 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 6.2139587900000004 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 34892 881 48 Sodium/potassium-transporting ATPase subunit alpha-2 Ion channel D2WKD8 ATP1A2 AT1A2_PIG 6.64781748199999978 \N IC50 DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Sus scrofa 34893 882 48 Sodium/potassium-transporting ATPase subunit alpha-2 Ion channel D2WKD8 ATP1A2 AT1A2_PIG 5.78330640099999993 \N IC50 DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Sus scrofa 34894 885 74 Mu-type opioid receptor GPCR P35372 OPRM1 OPRM_HUMAN 6.00656376999999964 \N Ki DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34896 885 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 6.69464863099999974 \N Ki DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34898 885 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 9.18708664300000066 \N Ki DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34900 885 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 8.52578373599999928 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34902 885 95 Cytochrome P450 3A4 Enzyme P08684 CYP3A4 CP3A4_HUMAN 6.22184875000000037 \N IC50 DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34903 885 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 8.82390874100000033 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34905 885 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 7.85387196399999965 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34907 885 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 8.08512818200000005 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34909 885 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 7.11350927500000019 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34911 885 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 8.12147820400000064 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34913 885 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 7.92081875399999991 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34915 885 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 9.69897000399999953 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34917 885 129 Beta-3 adrenergic receptor GPCR P13945 ADRB3 ADRB3_HUMAN 5.72769415600000009 \N Ki DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34919 885 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 8.2612194419999998 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34921 885 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 8.36855623099999946 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34925 885 268 Cytochrome P450 2C9 Enzyme P11712 CYP2C9 CP2C9_HUMAN 5.22184875000000037 \N IC50 DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34926 885 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 8.10017949799999926 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34928 885 1713 5-hydroxytryptamine receptor 1B GPCR P28564 Htr1b 5HT1B_RAT 8.29929628300000033 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34930 887 74 Mu-type opioid receptor GPCR P35372 OPRM1 OPRM_HUMAN 6.46218090500000031 \N Ki DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34932 887 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 6.22988470499999991 \N Ki DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 94121 575 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 4.83999999999999986 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34936 887 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 9.12667939800000028 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34938 887 95 Cytochrome P450 3A4 Enzyme P08684 CYP3A4 CP3A4_HUMAN 5.52287874499999987 \N IC50 DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34939 887 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 9.38510278400000075 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34941 887 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 8.37263414300000086 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34943 887 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 8.3767507099999996 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34945 887 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6.90308998700000043 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34948 887 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 8.44249279799999996 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34950 887 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 9.1095789810000003 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34952 887 129 Beta-3 adrenergic receptor GPCR P13945 ADRB3 ADRB3_HUMAN 5.60537323600000015 \N Ki DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34954 887 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 8.89962945499999947 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34956 887 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 9.18309616099999992 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34960 887 268 Cytochrome P450 2C9 Enzyme P11712 CYP2C9 CP2C9_HUMAN 5.52287874499999987 \N IC50 DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34961 887 470 Cytochrome P450 2C19 Enzyme P33261 CYP2C19 CP2CJ_HUMAN 5.52287874499999987 \N IC50 DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 34962 887 50 5-hydroxytryptamine receptor 4 GPCR O70528 HTR4 5HT4R_CAVPO 6.08671609800000013 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Cavia porcellus 34964 887 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 8.89619627899999976 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34966 887 1713 5-hydroxytryptamine receptor 1B GPCR P28564 Htr1b 5HT1B_RAT 7.95860731500000007 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34968 888 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 5.92190584999999992 \N Ki DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34970 888 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 8.52870828900000078 \N Ki DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34972 888 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 9.41228903500000058 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34974 888 95 Cytochrome P450 3A4 Enzyme P08684 CYP3A4 CP3A4_HUMAN 5.30102999599999958 \N IC50 DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34975 888 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 9.42365865000000014 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34977 888 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 8.64397414299999944 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34979 888 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 8.36351210399999978 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34981 888 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 7.32790214200000012 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34984 888 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 8.75202673399999931 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34986 888 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 8.74232142500000009 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34988 888 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 8.82102305299999934 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34990 888 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 8.6903698330000001 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 34994 888 50 5-hydroxytryptamine receptor 4 GPCR O70528 HTR4 5HT4R_CAVPO 6.80410034800000041 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Cavia porcellus 34996 888 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 8.34872198599999926 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 34998 888 1713 5-hydroxytryptamine receptor 1B GPCR P28564 Htr1b 5HT1B_RAT 9.41566877600000041 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35000 897 95 Cytochrome P450 3A4 Enzyme P08684 CYP3A4 CP3A4_HUMAN 5.73598541999999956 \N IC50 DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35001 901 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 5.79128998000000017 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35003 901 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 6.31247103900000006 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35005 901 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.69464863099999974 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35007 901 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 6.70333481000000031 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35009 901 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 5.95979337200000003 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35011 901 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6.47886191599999961 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35013 901 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 5.60362627199999963 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35015 901 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 7.43179827600000031 \N Ki DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) DRUG MATRIX = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200406 ANTAGONIST \N Tclin \N \N Homo sapiens 35017 901 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 6.96257350199999969 \N Ki DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35019 901 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 6.78515615199999989 \N Ki DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35021 901 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 7.02227639499999956 \N Ki DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35023 901 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 7.09691001299999957 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35025 901 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 6.64397414300000033 \N Ki DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35027 901 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.74860515000000039 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35029 901 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 5.82131076000000025 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35030 901 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 5.84679509999999958 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35036 916 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 6.43179827600000031 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35038 916 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.14813039900000025 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35040 916 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6.28988263499999967 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35049 924 474 cAMP-specific 3',5'-cyclic phosphodiesterase 4A Enzyme P27815 PDE4A PDE4A_HUMAN 5.80161787000000029 \N IC50 DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP) DRUG MATRIX = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932 INHIBITOR \N Tclin \N \N Homo sapiens 35050 924 49 Sodium/nucleoside cotransporter 1 Transporter O00337 SLC28A1 S28A1_HUMAN 7.53760200199999986 \N Ki DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine) DRUG MATRIX = \N \N \N \N INHIBITOR \N Tbio \N \N Homo sapiens 35052 924 1709 Arachidonate 15-lipoxygenase Enzyme P12530 ALOX15 LOX15_RABIT 5.15764042699999958 \N IC50 DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Oryctolagus cuniculus 35053 928 74 Mu-type opioid receptor GPCR P35372 OPRM1 OPRM_HUMAN 5.84618513599999989 \N Ki DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35055 928 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 5.96697855499999985 \N Ki DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35057 928 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 5.11503480200000027 \N Ki DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35059 928 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 5.73541827100000035 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35061 928 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 4.1560699200000002 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35063 928 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 4.65789328500000011 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35065 928 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 5.12906964200000015 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35067 928 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 5.83297820399999978 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35069 928 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 6.43415218099999997 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35071 928 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.43368037800000003 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35073 928 148 Adenosine receptor A3 GPCR P0DMS8 ADORA3 AA3R_HUMAN 6.69680394299999993 \N Ki DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35077 928 176 Kappa-type opioid receptor GPCR P41145 OPRK1 OPRK_HUMAN 5.61243222099999972 \N Ki DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35079 928 312 Cytochrome P450 1A2 Enzyme P05177 CYP1A2 CP1A2_HUMAN 5.39794000900000004 \N IC50 DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35080 928 313 Amine oxidase [flavin-containing] A Enzyme P21397 MAOA AOFA_HUMAN 4.86220295700000005 \N IC50 DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35081 928 474 cAMP-specific 3',5'-cyclic phosphodiesterase 4A Enzyme P27815 PDE4A PDE4A_HUMAN 5.31884925000000042 \N IC50 DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35082 928 510 C-C chemokine receptor type 5 GPCR P51681 CCR5 CCR5_HUMAN 4.73792878700000042 \N Ki DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35084 928 617 C-X-C chemokine receptor type 2 GPCR P25025 CXCR2 CXCR2_HUMAN 5.37582107400000009 \N Ki DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35086 928 798 C-C chemokine receptor type 2 GPCR P41597 CCR2 CCR2_HUMAN 6.02045162499999975 \N Ki DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35088 928 816 Mitogen-activated protein kinase 3 Kinase P27361 MAPK3 MK03_HUMAN 5.82102305300000022 \N IC50 DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35089 928 49 Sodium/nucleoside cotransporter 1 Transporter O00337 SLC28A1 S28A1_HUMAN 5.23747147799999979 \N Ki DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine) DRUG MATRIX = \N \N \N \N \N \N Tbio \N \N Homo sapiens 35091 928 1709 Arachidonate 15-lipoxygenase Enzyme P12530 ALOX15 LOX15_RABIT 4.79409223700000009 \N IC50 DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Oryctolagus cuniculus 35092 928 1713 5-hydroxytryptamine receptor 1B GPCR P28564 Htr1b 5HT1B_RAT 5.66857270299999971 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35094 928 1720 C-C chemokine receptor type 4 GPCR P51679 CCR4 CCR4_HUMAN 5.35684353400000024 \N Ki DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35096 928 1721 Membrane-associated progesterone receptor component 1 Membrane receptor P70580 Pgrmc1 PGRC1_RAT 4.33253770800000026 \N Ki DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35100 937 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 5.97551433200000037 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35102 937 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.99740201899999992 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35104 937 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 6.4202164030000004 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35106 937 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 5.86838133599999967 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35108 937 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 5.77134304199999981 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35110 937 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 6.9100948889999998 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35112 937 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 7.3467874860000002 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35116 937 387 Epidermal growth factor receptor Kinase P00533 EGFR EGFR_HUMAN 5.25562877299999975 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35117 937 533 Tyrosine-protein kinase Lck Kinase P06239 LCK LCK_HUMAN 5.2581396060000003 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35118 937 535 Tyrosine-protein kinase Fyn Kinase P06241 FYN FYN_HUMAN 5.40066286700000031 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35119 937 1709 Arachidonate 15-lipoxygenase Enzyme P12530 ALOX15 LOX15_RABIT 6.2225731780000002 \N IC50 DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Oryctolagus cuniculus 35120 937 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 6.7304870560000003 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35122 937 1721 Membrane-associated progesterone receptor component 1 Membrane receptor P70580 Pgrmc1 PGRC1_RAT 5.795880017 \N Ki DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35124 939 95 Cytochrome P450 3A4 Enzyme P08684 CYP3A4 CP3A4_HUMAN 5.69897000400000042 \N IC50 DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35125 939 931 Substance-K receptor GPCR P21452 TACR2 NK2R_HUMAN 6.28316227699999974 \N Ki DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35127 945 74 Mu-type opioid receptor GPCR P35372 OPRM1 OPRM_HUMAN 5.76649624000000038 \N Ki DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35130 945 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 5.98842955599999982 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35132 945 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.7896814799999996 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35134 945 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.5861974830000003 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 94122 575 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 4.66000000000000014 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35136 945 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 7.95860731500000007 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35138 945 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 5.78120200199999967 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35140 945 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6.15614457700000006 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35142 945 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.0132282659999996 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35145 945 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 6.80687540200000019 \N Ki DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35147 945 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 6.8326826650000001 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35149 945 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 6.9355420109999999 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35153 945 176 Kappa-type opioid receptor GPCR P41145 OPRK1 OPRK_HUMAN 5.55315228999999988 \N Ki DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35155 945 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 7.06048074699999972 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35157 953 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 7 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35158 954 55 Beta-2 adrenergic receptor GPCR P07550 ADRB2 ADRB2_HUMAN 5.72376804199999967 \N Ki DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35161 954 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.84527179300000022 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35163 954 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.63078414299999963 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35165 954 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6.54515514000000032 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35167 954 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 6.82681373199999975 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35171 954 840 Interstitial collagenase Enzyme P03956 MMP1 MMP1_HUMAN 5.2404076909999997 \N IC50 DRUGMATRIX: Peptidase, Matrix Metalloproteinase-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35172 954 50 5-hydroxytryptamine receptor 4 GPCR O70528 HTR4 5HT4R_CAVPO 6.89619627899999976 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Cavia porcellus 35174 954 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 9.38090666899999981 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35178 956 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.30016227399999984 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35180 956 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 6.57675412599999998 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35196 956 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 6.32513885899999995 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35199 956 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 5.73612732299999983 \N Ki DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35207 956 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 7.36653154399999988 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35211 956 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 7.48148605999999994 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35213 960 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 5.43262069200000042 \N Ki DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35215 960 369 Caspase-1 Enzyme P29466 CASP1 CASP1_HUMAN 4.91392504600000013 \N IC50 DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35216 960 533 Tyrosine-protein kinase Lck Kinase P06239 LCK LCK_HUMAN 4.49603236799999983 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35217 960 535 Tyrosine-protein kinase Fyn Kinase P06241 FYN FYN_HUMAN 5.28844583199999985 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35218 960 546 Receptor tyrosine-protein kinase erbB-2 Kinase P04626 ERBB2 ERBB2_HUMAN 5.60467360699999961 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35219 960 50 5-hydroxytryptamine receptor 4 GPCR O70528 HTR4 5HT4R_CAVPO 5.68235445699999975 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Cavia porcellus 35221 960 1709 Arachidonate 15-lipoxygenase Enzyme P12530 ALOX15 LOX15_RABIT 4.86678054299999996 \N IC50 DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Oryctolagus cuniculus 35222 960 1713 5-hydroxytryptamine receptor 1B GPCR P28564 Htr1b 5HT1B_RAT 4.80504187799999993 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35224 966 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 6.2628073569999998 \N Ki DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35227 966 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 5.95389521300000002 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35231 966 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 6.86012091400000035 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35233 966 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 9.1319436379999992 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1108 ANTAGONIST \N Tclin \N \N Homo sapiens 35235 966 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.0685421289999999 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35237 966 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6.62342304299999984 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35239 966 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.99567862600000012 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35241 966 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 9.02733440799999975 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35243 966 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 6.27984069700000003 \N Ki DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35245 966 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 6.27002571399999997 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35247 966 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 5.78225292700000004 \N Ki DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35249 966 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 6.59176003500000007 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35251 966 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 9.17457388200000068 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35255 966 50 5-hydroxytryptamine receptor 4 GPCR O70528 HTR4 5HT4R_CAVPO 6.19928292200000008 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Cavia porcellus 35257 966 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 8.00966114500000081 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35259 966 1721 Membrane-associated progesterone receptor component 1 Membrane receptor P70580 Pgrmc1 PGRC1_RAT 5.69464863099999974 \N Ki DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35261 977 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 6.22438955199999988 \N Ki DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35265 977 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.50598462499999997 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35268 977 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 6.18521985399999963 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35270 977 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 6.34065436399999971 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35272 977 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 7.58838029400000025 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35274 977 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.70136521700000021 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35276 977 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6.90517962000000018 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35278 977 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 5.99131468100000042 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35280 977 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.47198365900000017 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35282 977 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 7.38404994800000036 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35285 977 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 5.54255715900000023 \N Ki DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35289 977 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 6.55361818799999973 \N Ki DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35291 977 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 6.86264588900000039 \N Ki DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35293 977 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 6.93741801599999963 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35295 977 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 6.61493022400000008 \N Ki DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35297 977 129 Beta-3 adrenergic receptor GPCR P13945 ADRB3 ADRB3_HUMAN 5.71917132200000022 \N Ki DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35299 977 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 7.39685562699999988 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 94123 575 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 4.67999999999999972 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35301 977 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 7.10568393700000023 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35303 977 148 Adenosine receptor A3 GPCR P0DMS8 ADORA3 AA3R_HUMAN 5.74325820700000023 \N Ki DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35305 977 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 6.34132097100000003 \N Ki DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35307 977 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 6.06018133700000039 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35311 977 251 Acetylcholinesterase Enzyme P22303 ACHE ACES_HUMAN 5.12610420800000011 \N IC50 DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35312 977 387 Epidermal growth factor receptor Kinase P00533 EGFR EGFR_HUMAN 6.2525105080000003 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35313 977 535 Tyrosine-protein kinase Fyn Kinase P06241 FYN FYN_HUMAN 6.09146136800000004 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35314 977 546 Receptor tyrosine-protein kinase erbB-2 Kinase P04626 ERBB2 ERBB2_HUMAN 5.9757196239999999 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35315 977 931 Substance-K receptor GPCR P21452 TACR2 NK2R_HUMAN 6.19091186899999979 \N Ki DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35317 977 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 6.63283051099999987 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35319 977 1713 5-hydroxytryptamine receptor 1B GPCR P28564 Htr1b 5HT1B_RAT 5.84859950199999989 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35321 977 1721 Membrane-associated progesterone receptor component 1 Membrane receptor P70580 Pgrmc1 PGRC1_RAT 5.87124542699999985 \N Ki DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35323 983 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN 5.13053358999999976 \N Ki DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35325 983 58 Cannabinoid receptor 1 GPCR P21554 CNR1 CNR1_HUMAN 4.54322416199999957 \N Ki DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35327 983 74 Mu-type opioid receptor GPCR P35372 OPRM1 OPRM_HUMAN 5.63620005499999976 \N Ki DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35329 983 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 5.33611070099999996 \N Ki DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35331 983 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 5.36967384500000033 \N Ki DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35333 983 89 Adenosine receptor A2a GPCR P29274 ADORA2A AA2AR_HUMAN 5.08586848699999994 \N Ki DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35335 983 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 5.78994914999999999 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35337 983 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 5.05197846699999964 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35339 983 95 Cytochrome P450 3A4 Enzyme P08684 CYP3A4 CP3A4_HUMAN 7.30102999599999958 \N IC50 DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35340 983 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 6.64781748199999978 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35342 983 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.61708286500000042 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35344 983 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 5.03414006299999972 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35346 983 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 5.93854752100000027 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35348 983 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 5.36171046499999981 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35350 983 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 5.20231706499999991 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35352 983 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 5.29584948299999958 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35354 983 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 5.57235162899999992 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35356 983 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 5.79182747299999967 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35358 983 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 5.80548565800000027 \N Ki DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35360 983 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 6.19654288400000031 \N Ki DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35362 983 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 5.93629144099999984 \N Ki DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35364 983 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 6.4213607899999996 \N Ki DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35366 983 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 6.52870828899999989 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35368 983 129 Beta-3 adrenergic receptor GPCR P13945 ADRB3 ADRB3_HUMAN 5.33611070099999996 \N Ki DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35370 983 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 6.17848647200000034 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35372 983 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 6.39794000900000004 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35373 983 146 Adenosine receptor A1 GPCR P30542 ADORA1 AA1R_HUMAN 5.00559485299999984 \N Ki DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35375 983 148 Adenosine receptor A3 GPCR P0DMS8 ADORA3 AA3R_HUMAN 5.73612732299999983 \N Ki DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35377 983 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 5.48531945600000004 \N Ki DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35379 983 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 5.35922052300000029 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35383 983 176 Kappa-type opioid receptor GPCR P41145 OPRK1 OPRK_HUMAN 5.46268472700000007 \N Ki DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35385 983 249 Delta-type opioid receptor GPCR P41143 OPRD1 OPRD_HUMAN 6.2941362879999998 \N Ki DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35387 983 251 Acetylcholinesterase Enzyme P22303 ACHE ACES_HUMAN 4.86400915299999959 \N IC50 DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35388 983 268 Cytochrome P450 2C9 Enzyme P11712 CYP2C9 CP2C9_HUMAN 6.69897000400000042 \N IC50 DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35389 983 312 Cytochrome P450 1A2 Enzyme P05177 CYP1A2 CP1A2_HUMAN 6.52287874499999987 \N IC50 DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35390 983 387 Epidermal growth factor receptor Kinase P00533 EGFR EGFR_HUMAN 4.48940137700000008 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35391 983 417 Substance-P receptor GPCR P25103 TACR1 NK1R_HUMAN 5.18869315999999969 \N Ki DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35393 983 470 Cytochrome P450 2C19 Enzyme P33261 CYP2C19 CP2CJ_HUMAN 7.39794000900000004 \N IC50 DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35394 983 535 Tyrosine-protein kinase Fyn Kinase P06241 FYN FYN_HUMAN 4.91592443199999973 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35395 983 546 Receptor tyrosine-protein kinase erbB-2 Kinase P04626 ERBB2 ERBB2_HUMAN 4.85686024099999969 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35396 983 621 Thromboxane-A synthase Enzyme P24557 TBXAS1 THAS_HUMAN 7.53760200199999986 \N IC50 DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35397 983 804 Matrix metalloproteinase-9 Enzyme P14780 MMP9 MMP9_HUMAN 5.15508812599999988 \N IC50 DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35398 983 931 Substance-K receptor GPCR P21452 TACR2 NK2R_HUMAN 5.69658792899999966 \N Ki DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35400 983 988 Androgen receptor Transcription factor P15207 Ar ANDR_RAT 5.17069622699999965 \N Ki DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35402 983 1713 5-hydroxytryptamine receptor 1B GPCR P28564 Htr1b 5HT1B_RAT 4.9993056840000003 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35404 983 1717 Melanocortin receptor 5 GPCR P33032 MC5R MC5R_HUMAN 4.43075487599999995 \N Ki DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35406 983 1718 Melanocortin receptor 3 GPCR P41968 MC3R MC3R_HUMAN 4.5027108939999998 \N Ki DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35408 983 1719 Neuropeptide Y receptor type 2 GPCR P49146 NPY2R NPY2R_HUMAN 4.95908134899999986 \N Ki DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35410 983 1721 Membrane-associated progesterone receptor component 1 Membrane receptor P70580 Pgrmc1 PGRC1_RAT 5.49839307800000032 \N Ki DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35412 983 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 5.87549577500000009 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 35414 1001 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 7.85387196399999965 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35416 1001 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 7.58502665199999981 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35418 1001 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 5.57806718700000026 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35420 1001 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 5.97021052900000004 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35424 1022 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 8.76955107899999931 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35426 1022 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 5.85855022700000028 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35428 1022 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 6.08039897599999968 \N Ki DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35430 1022 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 5.30950267700000023 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35433 1028 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.55909091799999988 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679 AGONIST \N Tclin \N \N Homo sapiens 35435 1028 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.40120949299999964 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679 AGONIST \N Tclin \N \N Homo sapiens 35437 1028 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 6.44855000200000017 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679 AGONIST \N Tclin \N \N Homo sapiens 35441 1028 1709 Arachidonate 15-lipoxygenase Enzyme P12530 ALOX15 LOX15_RABIT 5.48425858299999991 \N IC50 DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Oryctolagus cuniculus 35442 1028 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 6.01010543599999991 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35444 1030 535 Tyrosine-protein kinase Fyn Kinase P06241 FYN FYN_HUMAN 5.28558640800000035 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35445 1030 50 5-hydroxytryptamine receptor 4 GPCR O70528 HTR4 5HT4R_CAVPO 5.87844015599999992 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Cavia porcellus 35447 1042 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 5.53017798399999982 \N Ki DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35451 1042 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.20065945099999993 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35453 1042 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 8.33348201899999985 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35457 1042 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 8.58004425200000043 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35459 1042 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 7.95860731500000007 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35461 1042 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 8.82390874100000033 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35463 1042 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.87942606899999998 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35465 1042 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 6.71444269100000035 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35467 1042 1713 5-hydroxytryptamine receptor 1B GPCR P28564 Htr1b 5HT1B_RAT 8.88941029000000071 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35469 1043 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN 5.62123882499999983 \N Ki DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35471 1043 55 Beta-2 adrenergic receptor GPCR P07550 ADRB2 ADRB2_HUMAN 5.72170379199999957 \N Ki DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35473 1043 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 6.06348625800000018 \N Ki DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35475 1043 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 8.84466396300000035 \N Ki DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35477 1043 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 9.09908693200000052 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35479 1043 95 Cytochrome P450 3A4 Enzyme P08684 CYP3A4 CP3A4_HUMAN 6 \N IC50 DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35480 1043 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 9.35359627399999916 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35486 1043 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 8.75448733200000007 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35488 1043 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 8.83564714399999929 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35490 1043 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 8.74232142500000009 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35492 1043 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 8.48678239999999917 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35496 1043 533 Tyrosine-protein kinase Lck Kinase P06239 LCK LCK_HUMAN 5.18715346299999958 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35497 1043 535 Tyrosine-protein kinase Fyn Kinase P06241 FYN FYN_HUMAN 5.50031291699999958 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35498 1043 621 Thromboxane-A synthase Enzyme P24557 TBXAS1 THAS_HUMAN 5.51371123900000004 \N IC50 DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35499 1043 50 5-hydroxytryptamine receptor 4 GPCR O70528 HTR4 5HT4R_CAVPO 6.5783960730000004 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Cavia porcellus 35501 1043 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 8.34198860300000078 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35503 1043 1713 5-hydroxytryptamine receptor 1B GPCR P28564 Htr1b 5HT1B_RAT 10.0409586100000006 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35507 1057 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.24305976399999984 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35509 1057 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 4.72519580999999977 \N Ki DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35511 1057 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 4.92639161199999975 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35516 1057 1709 Arachidonate 15-lipoxygenase Enzyme P12530 ALOX15 LOX15_RABIT 4.94711376500000011 \N IC50 DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Oryctolagus cuniculus 35517 1057 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 5.37191773899999969 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 35519 1058 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.7097427310000004 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35521 1058 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 4.76733418099999984 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35523 1058 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 5.13318119699999986 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35525 1058 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 5.63714069700000042 \N Ki DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35527 1058 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 5.44587441799999983 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35529 1058 148 Adenosine receptor A3 GPCR P0DMS8 ADORA3 AA3R_HUMAN 4.90967139299999999 \N Ki DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35531 1058 202 Estrogen receptor Nuclear hormone receptor P03372 ESR1 ESR1_HUMAN 7.74472749500000024 \N Ki DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35533 1058 535 Tyrosine-protein kinase Fyn Kinase P06241 FYN FYN_HUMAN 4.63838547299999959 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35534 1058 988 Androgen receptor Transcription factor P15207 Ar ANDR_RAT 8.15614457699999917 \N Ki DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35536 1058 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 5.90204892900000022 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 35538 1071 1707 Aldose reductase Enzyme P07943 Akr1b1 ALDR_RAT 5.93930216000000044 \N IC50 DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35539 1082 74 Mu-type opioid receptor GPCR P35372 OPRM1 OPRM_HUMAN 4.96389033300000015 \N Ki DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35541 1082 89 Adenosine receptor A2a GPCR P29274 ADORA2A AA2AR_HUMAN 4.92992517400000008 \N Ki DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35543 1082 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 7.53760200199999986 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35545 1082 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 6.02181948299999981 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35547 1082 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 6.1095789810000003 \N Ki DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35549 1082 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 6.35261703000000022 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35551 1082 148 Adenosine receptor A3 GPCR P0DMS8 ADORA3 AA3R_HUMAN 4.73025362699999974 \N Ki DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35553 1082 176 Kappa-type opioid receptor GPCR P41145 OPRK1 OPRK_HUMAN 4.98472409299999963 \N Ki DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35559 1082 50 5-hydroxytryptamine receptor 4 GPCR O70528 HTR4 5HT4R_CAVPO 5.87745647599999987 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Cavia porcellus 35561 1082 1709 Arachidonate 15-lipoxygenase Enzyme P12530 ALOX15 LOX15_RABIT 5.2458046119999997 \N IC50 DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Oryctolagus cuniculus 35562 1082 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 6.85698519999999956 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 35564 1084 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 7.02227639499999956 \N Ki DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35566 1084 988 Androgen receptor Transcription factor P15207 Ar ANDR_RAT 7.35654732400000011 \N Ki DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35568 1084 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 8.11069829700000078 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 35570 1094 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 7.36653154399999988 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35572 1094 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.68193666500000027 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35574 1094 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 6.98296666099999985 \N Ki DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35576 1094 202 Estrogen receptor Nuclear hormone receptor P03372 ESR1 ESR1_HUMAN 6.49485002199999961 \N Ki DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35578 1094 251 Acetylcholinesterase Enzyme P22303 ACHE ACES_HUMAN 5.18681946700000029 \N IC50 DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35579 1094 470 Cytochrome P450 2C19 Enzyme P33261 CYP2C19 CP2CJ_HUMAN 5.88917468999999993 \N IC50 DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35580 1094 988 Androgen receptor Transcription factor P15207 Ar ANDR_RAT 7.74472749500000024 \N Ki DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35582 1094 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 7.58502665199999981 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 35584 1095 313 Amine oxidase [flavin-containing] A Enzyme P21397 MAOA AOFA_HUMAN 5.36754270800000022 \N IC50 DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35585 1095 988 Androgen receptor Transcription factor P15207 Ar ANDR_RAT 5.68465952299999966 \N Ki DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35587 1095 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 7.67778070499999998 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 35590 1103 66 Prostaglandin G/H synthase 1 Enzyme P23219 PTGS1 PGH1_HUMAN 5.57691804199999996 \N IC50 DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35591 1112 1709 Arachidonate 15-lipoxygenase Enzyme P12530 ALOX15 LOX15_RABIT 5.4966179369999999 \N IC50 DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Oryctolagus cuniculus 35594 1141 66 Prostaglandin G/H synthase 1 Enzyme P23219 PTGS1 PGH1_HUMAN 6.04866248100000004 \N IC50 DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid) DRUG MATRIX = 1 KEGG DRUG \N http://www.kegg.jp/entry/D01675 INHIBITOR \N Tclin \N \N Homo sapiens 35595 1142 148 Adenosine receptor A3 GPCR P0DMS8 ADORA3 AA3R_HUMAN 6.22402566900000043 \N Ki DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35597 1142 268 Cytochrome P450 2C9 Enzyme P11712 CYP2C9 CP2C9_HUMAN 5.33918193700000021 \N IC50 DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35598 1152 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 4.67302954999999987 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35600 1152 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 6.21824462499999964 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35602 1152 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 5.90587840400000008 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35604 1152 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 4.33059943000000036 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35606 1152 129 Beta-3 adrenergic receptor GPCR P13945 ADRB3 ADRB3_HUMAN 4.03170855699999997 \N Ki DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35608 1152 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.16373919699999995 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35610 1152 148 Adenosine receptor A3 GPCR P0DMS8 ADORA3 AA3R_HUMAN 5.49187446400000034 \N Ki DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35612 1152 251 Acetylcholinesterase Enzyme P22303 ACHE ACES_HUMAN 4.80824167899999999 \N IC50 DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35613 1171 268 Cytochrome P450 2C9 Enzyme P11712 CYP2C9 CP2C9_HUMAN 5.69897000400000042 \N IC50 DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35614 1171 470 Cytochrome P450 2C19 Enzyme P33261 CYP2C19 CP2CJ_HUMAN 6 \N IC50 DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35615 1175 94 Potassium voltage-gated channel subfamily H member 2 Ion channel Q12809 KCNH2 KCNH2_HUMAN 4.70442630299999998 \N Ki DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35619 1200 58 Cannabinoid receptor 1 GPCR P21554 CNR1 CNR1_HUMAN 5.62142042400000008 \N Ki DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35623 1200 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 5.71287037899999994 \N Ki DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35625 1200 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 6.93181413800000001 \N Ki DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35627 1200 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.66154350600000011 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35629 1200 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 8 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35631 1200 94 Potassium voltage-gated channel subfamily H member 2 Ion channel Q12809 KCNH2 KCNH2_HUMAN 6.30425572499999998 \N Ki DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 94124 575 1066 Cytochrome P450 3A5 Enzyme P20815 CYP3A5 CP3A5_HUMAN 5.11000000000000032 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35633 1200 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 6.57675412599999998 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35635 1200 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.87680192499999965 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35637 1200 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 5.61154354700000013 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35639 1200 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 6.9355420109999999 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35641 1200 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.15989390599999975 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35643 1200 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6.45469288399999996 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35645 1200 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.06348625800000018 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35647 1200 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 7.48148605999999994 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35649 1200 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 7.74472749500000024 \N Ki DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35651 1200 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 6.15058058600000024 \N Ki DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35653 1200 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 6.5044556619999998 \N Ki DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35655 1200 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 6.10292299700000029 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35657 1200 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 6.09963287099999985 \N Ki DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35659 1200 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 7.49485002199999961 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35661 1200 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 6.33348201899999985 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35663 1200 148 Adenosine receptor A3 GPCR P0DMS8 ADORA3 AA3R_HUMAN 5.53194820900000028 \N Ki DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35665 1200 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 6.35654732400000011 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35669 1200 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 6.21752737599999961 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35671 1200 1721 Membrane-associated progesterone receptor component 1 Membrane receptor P70580 Pgrmc1 PGRC1_RAT 7.4202164030000004 \N Ki DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35675 1201 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 7.32790214200000012 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 35677 1204 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 8.84771165599999954 \N Ki DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) DRUG MATRIX = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL989 AGONIST \N Tclin \N \N Homo sapiens 35679 1204 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 8.47495519299999955 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 35681 1205 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 8.62160209900000041 \N Ki DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) DRUG MATRIX = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL989 AGONIST \N Tclin \N \N Homo sapiens 35683 1205 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 8.53760200199999986 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 35685 1207 470 Cytochrome P450 2C19 Enzyme P33261 CYP2C19 CP2CJ_HUMAN 6.04220122500000034 \N IC50 DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35686 1208 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 8.80134291299999916 \N Ki DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) DRUG MATRIX = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200600 AGONIST \N Tclin \N \N Homo sapiens 35688 1208 988 Androgen receptor Transcription factor P15207 Ar ANDR_RAT 6.06701917799999979 \N Ki DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35690 1208 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 6.97469413500000002 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 35701 1209 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.15614457700000006 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35706 1209 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 6.15490196000000012 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35707 1212 74 Mu-type opioid receptor GPCR P35372 OPRM1 OPRM_HUMAN 5.07463633299999994 \N Ki DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35712 1212 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 8.06651271199999975 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 94125 575 931 Substance-K receptor GPCR P21452 TACR2 NK2R_HUMAN 4.84999999999999964 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35714 1212 94 Potassium voltage-gated channel subfamily H member 2 Ion channel Q12809 KCNH2 KCNH2_HUMAN 5.33025554499999998 \N Ki DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35716 1212 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 6.10072681299999964 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35718 1212 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.7108571640000001 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35722 1212 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 7.60205999099999996 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35724 1212 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 7.45593195599999969 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35732 1212 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 5.57511836299999963 \N Ki DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35734 1212 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 5.99913227800000026 \N Ki DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35736 1212 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 6.3151546380000001 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35738 1212 129 Beta-3 adrenergic receptor GPCR P13945 ADRB3 ADRB3_HUMAN 4.65529341900000038 \N Ki DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35741 1212 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.78754603900000042 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35743 1212 148 Adenosine receptor A3 GPCR P0DMS8 ADORA3 AA3R_HUMAN 5.1709536629999997 \N Ki DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35746 1212 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 8.01863449100000025 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35750 1212 176 Kappa-type opioid receptor GPCR P41145 OPRK1 OPRK_HUMAN 5.00475979800000026 \N Ki DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35752 1212 249 Delta-type opioid receptor GPCR P41143 OPRD1 OPRD_HUMAN 5.07196279400000005 \N Ki DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35754 1212 387 Epidermal growth factor receptor Kinase P00533 EGFR EGFR_HUMAN 4.39677982200000006 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35755 1212 535 Tyrosine-protein kinase Fyn Kinase P06241 FYN FYN_HUMAN 5.09745322100000031 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35756 1212 546 Receptor tyrosine-protein kinase erbB-2 Kinase P04626 ERBB2 ERBB2_HUMAN 4.70840917399999981 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35757 1212 931 Substance-K receptor GPCR P21452 TACR2 NK2R_HUMAN 5.12522836299999973 \N Ki DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35759 1212 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 7.72124639899999998 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35761 1212 1713 5-hydroxytryptamine receptor 1B GPCR P28564 Htr1b 5HT1B_RAT 6.06098022399999969 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35763 1212 1717 Melanocortin receptor 5 GPCR P33032 MC5R MC5R_HUMAN 5.04919717699999993 \N Ki DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35765 1212 1721 Membrane-associated progesterone receptor component 1 Membrane receptor P70580 Pgrmc1 PGRC1_RAT 7.0132282659999996 \N Ki DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35766 1217 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 8.69464863099999974 \N Ki DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) DRUG MATRIX = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201012 AGONIST \N Tclin \N \N Homo sapiens 35768 1217 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 7.6575773189999996 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 35770 1223 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 5.08244197900000039 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35772 1223 988 Androgen receptor Transcription factor P15207 Ar ANDR_RAT 5.04929446500000001 \N Ki DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35774 1223 50 5-hydroxytryptamine receptor 4 GPCR O70528 HTR4 5HT4R_CAVPO 5.6462760620000001 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Cavia porcellus 35777 1229 268 Cytochrome P450 2C9 Enzyme P11712 CYP2C9 CP2C9_HUMAN 6.39794000900000004 \N IC50 DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35779 1273 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 6.14813039900000025 \N Ki DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = 1 SCIENTIFIC LITERATURE \N http://www.ncbi.nlm.nih.gov/pubmed/18305010 NEGATIVE ALLOSTERIC MODULATOR \N Tclin \N 495 Homo sapiens 35781 1314 268 Cytochrome P450 2C9 Enzyme P11712 CYP2C9 CP2C9_HUMAN 5.79533748800000037 \N IC50 DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N INHIBITOR \N Tchem \N \N Homo sapiens 35784 1343 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 6.06499684899999991 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35786 1343 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 5.87451873399999958 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35788 1343 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6.1186153430000001 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35792 1343 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 6.2628073569999998 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35794 1353 74 Mu-type opioid receptor GPCR P35372 OPRM1 OPRM_HUMAN 6.00348832800000043 \N Ki DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35802 1353 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.73992861199999993 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35814 1353 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 7.55284196900000016 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35818 1353 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 8.30539480100000027 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35820 1353 1721 Membrane-associated progesterone receptor component 1 Membrane receptor P70580 Pgrmc1 PGRC1_RAT 7.44369749899999977 \N Ki DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35822 1355 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 6.5497508919999996 \N Ki DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35824 1355 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.33913452200000016 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35826 1355 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 6.36552273000000035 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35828 1355 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.5611413409999999 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35830 1355 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 6.15989390599999975 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35832 1355 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 5.86550414399999998 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35834 1355 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 5.73002032299999975 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35836 1355 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.60032627899999991 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35838 1355 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 6.77989191200000008 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35840 1355 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 6.23062267400000014 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35842 1355 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.80548565800000027 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35844 1355 148 Adenosine receptor A3 GPCR P0DMS8 ADORA3 AA3R_HUMAN 6.89962945500000036 \N Ki DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35846 1355 176 Kappa-type opioid receptor GPCR P41145 OPRK1 OPRK_HUMAN 6.33818731399999979 \N Ki DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35848 1355 931 Substance-K receptor GPCR P21452 TACR2 NK2R_HUMAN 6.30891850799999965 \N Ki DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35850 1364 56 Prostaglandin G/H synthase 2 Enzyme P35354 PTGS2 PGH2_HUMAN 6.19091186899999979 \N IC50 DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35851 1364 89 Adenosine receptor A2a GPCR P29274 ADORA2A AA2AR_HUMAN 6.04287180199999963 \N Ki DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35853 1364 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 5.68587986599999962 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35855 1364 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.63627523099999994 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35857 1364 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 5.44082379500000002 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35859 1364 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 5.61767671700000015 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35861 1364 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 5.9941762470000004 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35863 1364 148 Adenosine receptor A3 GPCR P0DMS8 ADORA3 AA3R_HUMAN 6.44237251200000038 \N Ki DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35865 1364 251 Acetylcholinesterase Enzyme P22303 ACHE ACES_HUMAN 5.52072708800000012 \N IC50 DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35866 1364 312 Cytochrome P450 1A2 Enzyme P05177 CYP1A2 CP1A2_HUMAN 5.88163605599999961 \N IC50 DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35867 1364 387 Epidermal growth factor receptor Kinase P00533 EGFR EGFR_HUMAN 6.12575017699999957 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35868 1364 470 Cytochrome P450 2C19 Enzyme P33261 CYP2C19 CP2CJ_HUMAN 5.91133244700000038 \N IC50 DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35869 1364 533 Tyrosine-protein kinase Lck Kinase P06239 LCK LCK_HUMAN 5.61394715099999964 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35870 1364 535 Tyrosine-protein kinase Fyn Kinase P06241 FYN FYN_HUMAN 5.45867042199999997 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35871 1364 546 Receptor tyrosine-protein kinase erbB-2 Kinase P04626 ERBB2 ERBB2_HUMAN 5.4790189189999996 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35872 1364 621 Thromboxane-A synthase Enzyme P24557 TBXAS1 THAS_HUMAN 5.51046337100000017 \N IC50 DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35873 1364 816 Mitogen-activated protein kinase 3 Kinase P27361 MAPK3 MK03_HUMAN 5.60477847900000015 \N IC50 DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35874 1364 865 Mitogen-activated protein kinase 14 Kinase Q16539 MAPK14 MK14_HUMAN 7.05749589399999966 \N IC50 DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35875 1364 931 Substance-K receptor GPCR P21452 TACR2 NK2R_HUMAN 5.86021533600000044 \N Ki DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35877 1364 988 Androgen receptor Transcription factor P15207 Ar ANDR_RAT 5.47926762200000006 \N Ki DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35879 1364 48 Sodium/potassium-transporting ATPase subunit alpha-2 Ion channel D2WKD8 ATP1A2 AT1A2_PIG 5.21240493600000043 \N IC50 DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Sus scrofa 35880 1364 1712 Mitogen-activated protein kinase 1 Kinase P28482 MAPK1 MK01_HUMAN 6.70774392900000027 \N IC50 DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35881 1379 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 7.49485002199999961 \N Ki DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35883 1379 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 7.12493873699999991 \N Ki DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35885 1379 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 7.795880017 \N Ki DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35887 1379 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 7.85387196399999965 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35889 1379 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 7.40893539300000015 \N Ki DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35891 1384 1709 Arachidonate 15-lipoxygenase Enzyme P12530 ALOX15 LOX15_RABIT 5.43782613700000006 \N IC50 DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Oryctolagus cuniculus 35894 1395 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 5.97922451200000005 \N Ki DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35896 1395 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 5.62967199199999957 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35898 1416 95 Cytochrome P450 3A4 Enzyme P08684 CYP3A4 CP3A4_HUMAN 5.15490196000000012 \N IC50 DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35899 1416 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 5.52287874499999987 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35900 1416 268 Cytochrome P450 2C9 Enzyme P11712 CYP2C9 CP2C9_HUMAN 5.30102999599999958 \N IC50 DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35901 1416 470 Cytochrome P450 2C19 Enzyme P33261 CYP2C19 CP2CJ_HUMAN 6.09691001299999957 \N IC50 DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35902 1423 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 6.12784372700000013 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35904 1423 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 6.26760624000000011 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35906 1423 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 5.71444269100000035 \N Ki DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35908 1423 621 Thromboxane-A synthase Enzyme P24557 TBXAS1 THAS_HUMAN 6.70333481000000031 \N IC50 DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35909 1429 89 Adenosine receptor A2a GPCR P29274 ADORA2A AA2AR_HUMAN 5.52476477699999968 \N Ki DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35911 1429 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 5.82944494100000021 \N Ki DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35913 1429 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 5.89008413699999966 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35915 1433 1709 Arachidonate 15-lipoxygenase Enzyme P12530 ALOX15 LOX15_RABIT 5.53491471199999996 \N IC50 DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Oryctolagus cuniculus 35916 1437 95 Cytochrome P450 3A4 Enzyme P08684 CYP3A4 CP3A4_HUMAN 6.39794000900000004 \N IC50 DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35917 1437 621 Thromboxane-A synthase Enzyme P24557 TBXAS1 THAS_HUMAN 5.73259358099999972 \N IC50 DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35918 1437 931 Substance-K receptor GPCR P21452 TACR2 NK2R_HUMAN 5.76955107900000019 \N Ki DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35920 1440 1707 Aldose reductase Enzyme P07943 Akr1b1 ALDR_RAT 5.43997375100000014 \N IC50 DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35921 1457 148 Adenosine receptor A3 GPCR P0DMS8 ADORA3 AA3R_HUMAN 6.27818938500000012 \N Ki DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35923 1457 387 Epidermal growth factor receptor Kinase P00533 EGFR EGFR_HUMAN 5.72376804199999967 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35924 1457 533 Tyrosine-protein kinase Lck Kinase P06239 LCK LCK_HUMAN 5.60888838600000028 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35925 1457 535 Tyrosine-protein kinase Fyn Kinase P06241 FYN FYN_HUMAN 5.80382381500000033 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35926 1457 546 Receptor tyrosine-protein kinase erbB-2 Kinase P04626 ERBB2 ERBB2_HUMAN 5.06666459000000025 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35927 1457 816 Mitogen-activated protein kinase 3 Kinase P27361 MAPK3 MK03_HUMAN 5.27868411900000023 \N IC50 DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35928 1457 865 Mitogen-activated protein kinase 14 Kinase Q16539 MAPK14 MK14_HUMAN 6.43889861600000035 \N IC50 DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35929 1457 1710 Angiotensin-converting enzyme Enzyme P12822 ACE ACE_RABIT 6.04287180199999963 \N IC50 DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Oryctolagus cuniculus 35930 1457 1712 Mitogen-activated protein kinase 1 Kinase P28482 MAPK1 MK01_HUMAN 6.53165266999999972 \N IC50 DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35931 1477 66 Prostaglandin G/H synthase 1 Enzyme P23219 PTGS1 PGH1_HUMAN 5.53101794099999999 \N IC50 DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35932 1477 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.60350424800000013 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35934 1482 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 6.66354026600000005 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35936 1482 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 6.33629907500000034 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35939 1482 840 Interstitial collagenase Enzyme P03956 MMP1 MMP1_HUMAN 5.21752737599999961 \N IC50 DRUGMATRIX: Peptidase, Matrix Metalloproteinase-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35942 1499 1709 Arachidonate 15-lipoxygenase Enzyme P12530 ALOX15 LOX15_RABIT 5.7520267340000002 \N IC50 DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Oryctolagus cuniculus 35943 1508 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.26760624000000011 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35945 1508 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 5.5201368869999996 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35947 1508 148 Adenosine receptor A3 GPCR P0DMS8 ADORA3 AA3R_HUMAN 5.62764041700000028 \N Ki DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35949 1508 865 Mitogen-activated protein kinase 14 Kinase Q16539 MAPK14 MK14_HUMAN 5.59705117100000038 \N IC50 DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35950 1508 1712 Mitogen-activated protein kinase 1 Kinase P28482 MAPK1 MK01_HUMAN 6.33535802399999959 \N IC50 DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35951 1513 95 Cytochrome P450 3A4 Enzyme P08684 CYP3A4 CP3A4_HUMAN 6.04575749099999982 \N IC50 DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35952 1513 535 Tyrosine-protein kinase Fyn Kinase P06241 FYN FYN_HUMAN 5.41005039900000018 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35953 1527 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 5.12965462900000002 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35956 1527 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 6.5497508919999996 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35958 1527 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 4.61973447499999956 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35960 1527 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 5.0841254969999996 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35962 1527 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 4.66742016500000023 \N Ki DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35964 1527 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 5.02835311800000007 \N Ki DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35966 1527 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 4.72850689800000001 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35968 1527 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 4.83977164299999973 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35970 1527 249 Delta-type opioid receptor GPCR P41143 OPRD1 OPRD_HUMAN 5.34572717300000022 \N Ki DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 94126 575 58 Cannabinoid receptor 1 GPCR P21554 CNR1 CNR1_HUMAN 4.07000000000000028 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35972 1527 621 Thromboxane-A synthase Enzyme P24557 TBXAS1 THAS_HUMAN 5.66454209900000016 \N IC50 DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35973 1527 931 Substance-K receptor GPCR P21452 TACR2 NK2R_HUMAN 5.24048324099999974 \N Ki DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35975 1527 49 Sodium/nucleoside cotransporter 1 Transporter O00337 SLC28A1 S28A1_HUMAN 5.82102305300000022 \N Ki DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine) DRUG MATRIX = \N \N \N \N \N \N Tbio \N \N Homo sapiens 35977 1527 1709 Arachidonate 15-lipoxygenase Enzyme P12530 ALOX15 LOX15_RABIT 5.26560025700000001 \N IC50 DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Oryctolagus cuniculus 35978 1527 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 4.89677800800000007 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35980 1527 1713 5-hydroxytryptamine receptor 1B GPCR P28564 Htr1b 5HT1B_RAT 5.21084250799999982 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35982 1527 1721 Membrane-associated progesterone receptor component 1 Membrane receptor P70580 Pgrmc1 PGRC1_RAT 5.00908424500000038 \N Ki DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35984 1529 1707 Aldose reductase Enzyme P07943 Akr1b1 ALDR_RAT 5.21402987499999959 \N IC50 DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 35985 1530 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 6.36051351099999973 \N Ki DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35987 1530 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.08618614800000035 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35989 1530 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 5.83863199800000032 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35991 1530 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 8.04672366299999986 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35993 1530 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 7.53760200199999986 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35995 1530 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 7.07572071400000002 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 35997 1530 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 6.2757241300000004 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 35999 1530 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.48945498999999959 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36001 1530 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 6.17587416599999983 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36004 1530 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 5.3914739660000004 \N Ki DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36011 1530 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 5.7370745310000002 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36013 1531 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN 8.23358715300000021 \N Ki DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL429 ANTAGONIST \N Tclin \N \N Homo sapiens 36015 1531 55 Beta-2 adrenergic receptor GPCR P07550 ADRB2 ADRB2_HUMAN 7.95860731500000007 \N Ki DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177) DRUG MATRIX = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL429 ANTAGONIST \N Tclin \N \N Homo sapiens 36017 1531 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 6.11747546199999981 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36019 1531 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.47807775500000016 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36021 1531 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 6.64781748199999978 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36023 1531 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 5.7137681459999996 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36025 1531 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.89380910299999972 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36027 1531 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 6.09691001299999957 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36028 1531 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 7.63827216399999998 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N ANTAGONIST \N Tclin \N \N Homo sapiens 36032 1531 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 6.49079747800000018 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36034 1532 95 Cytochrome P450 3A4 Enzyme P08684 CYP3A4 CP3A4_HUMAN 6.04575749099999982 \N IC50 DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36035 1532 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.24511677200000026 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36037 1532 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 5.67860872199999989 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36039 1532 148 Adenosine receptor A3 GPCR P0DMS8 ADORA3 AA3R_HUMAN 5.64187471500000015 \N Ki DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36041 1532 268 Cytochrome P450 2C9 Enzyme P11712 CYP2C9 CP2C9_HUMAN 5.69897000400000042 \N IC50 DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36042 1532 470 Cytochrome P450 2C19 Enzyme P33261 CYP2C19 CP2CJ_HUMAN 5.69897000400000042 \N IC50 DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36043 1532 621 Thromboxane-A synthase Enzyme P24557 TBXAS1 THAS_HUMAN 5.77108659399999979 \N IC50 DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36044 1532 988 Androgen receptor Transcription factor P15207 Ar ANDR_RAT 5.5830268270000003 \N Ki DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36046 1547 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 5.27451307399999969 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36047 1547 470 Cytochrome P450 2C19 Enzyme P33261 CYP2C19 CP2CJ_HUMAN 6.47275688399999982 \N IC50 DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36048 1552 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.33809270700000038 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36050 1552 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.63997491100000037 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36052 1552 312 Cytochrome P450 1A2 Enzyme P05177 CYP1A2 CP1A2_HUMAN 6.30102999599999958 \N IC50 DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36053 1552 313 Amine oxidase [flavin-containing] A Enzyme P21397 MAOA AOFA_HUMAN 4.68411358400000033 \N IC50 DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36054 1552 49 Sodium/nucleoside cotransporter 1 Transporter O00337 SLC28A1 S28A1_HUMAN 5.28743447200000016 \N Ki DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine) DRUG MATRIX = \N \N \N \N \N \N Tbio \N \N Homo sapiens 36056 1561 1721 Membrane-associated progesterone receptor component 1 Membrane receptor P70580 Pgrmc1 PGRC1_RAT 5.56815395399999957 \N Ki DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36057 1567 387 Epidermal growth factor receptor Kinase P00533 EGFR EGFR_HUMAN 5.54060751200000023 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36058 1567 533 Tyrosine-protein kinase Lck Kinase P06239 LCK LCK_HUMAN 5.42840761700000041 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36059 1567 535 Tyrosine-protein kinase Fyn Kinase P06241 FYN FYN_HUMAN 5.6683702819999997 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36060 1567 1709 Arachidonate 15-lipoxygenase Enzyme P12530 ALOX15 LOX15_RABIT 5.6462760620000001 \N IC50 DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Oryctolagus cuniculus 36061 1572 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 6.2254830339999998 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36063 1572 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 7.16749108700000015 \N Ki DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36065 1572 988 Androgen receptor Transcription factor P15207 Ar ANDR_RAT 8.36957212499999947 \N Ki DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36067 1572 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 9.33913452200000016 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 36071 1585 146 Adenosine receptor A1 GPCR P30542 ADORA1 AA1R_HUMAN 6.62033196600000018 \N Ki DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36074 1588 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN 6.49079747800000018 \N Ki DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36076 1588 55 Beta-2 adrenergic receptor GPCR P07550 ADRB2 ADRB2_HUMAN 7.53760200199999986 \N Ki DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36082 1588 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 9.93554201100000078 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36086 1588 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 9.0614802749999992 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36088 1588 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 8.48945499000000048 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = 1 DRUG LABEL \N http://www.ema.europa.eu/docs/en_GB/document_library/Orphan_designation/2011/05/WC500106736.pdf ANTAGONIST \N Tclin \N 574 Homo sapiens 36091 1588 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 8.25884840099999984 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36093 1588 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 9.62525165399999949 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36097 1588 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 7.72124639899999998 \N Ki DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36099 1588 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 5.99054910400000029 \N Ki DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36101 1588 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 9.20342566699999942 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36103 1588 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 7.795880017 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36104 1588 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 8.03668448900000065 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36108 1588 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 7.17392519699999998 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36110 1588 1713 5-hydroxytryptamine receptor 1B GPCR P28564 Htr1b 5HT1B_RAT 8.33818731400000068 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36112 1599 55 Beta-2 adrenergic receptor GPCR P07550 ADRB2 ADRB2_HUMAN 5.68486968299999962 \N Ki DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36115 1599 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 6.5783960730000004 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36117 1599 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.93181413800000001 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36119 1599 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 5.58286059000000012 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36121 1599 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 6.34294414699999987 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36123 1599 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 5.51855737099999999 \N Ki DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36125 1599 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 5.69897000400000042 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36126 1599 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 5.59911678399999957 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36130 1599 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 6.27245874299999961 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36132 1599 1721 Membrane-associated progesterone receptor component 1 Membrane receptor P70580 Pgrmc1 PGRC1_RAT 6.07160414799999959 \N Ki DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36134 1605 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.80687540200000019 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36137 1605 470 Cytochrome P450 2C19 Enzyme P33261 CYP2C19 CP2CJ_HUMAN 7.795880017 \N IC50 DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36138 1610 268 Cytochrome P450 2C9 Enzyme P11712 CYP2C9 CP2C9_HUMAN 5.54030602400000038 \N IC50 DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36139 1612 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.06148027500000008 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36141 1612 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.0953926359999997 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36143 1612 146 Adenosine receptor A1 GPCR P30542 ADORA1 AA1R_HUMAN 4.80726532799999973 \N Ki DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36146 1612 931 Substance-K receptor GPCR P21452 TACR2 NK2R_HUMAN 5.02650269100000013 \N Ki DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36148 1612 988 Androgen receptor Transcription factor P15207 Ar ANDR_RAT 4.69658792899999966 \N Ki DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36152 1634 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.16494389799999976 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36154 1634 95 Cytochrome P450 3A4 Enzyme P08684 CYP3A4 CP3A4_HUMAN 5.36431523699999957 \N IC50 DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36158 1634 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.66958622699999992 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36160 1634 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 7.38721614299999985 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36162 1634 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 6.38299965900000021 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36164 1634 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.8761483590000001 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36168 1634 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 6.40560744999999976 \N Ki DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36170 1634 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 6.84466396300000035 \N Ki DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36172 1634 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 6.16430942900000023 \N Ki DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36174 1634 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 7 \N Ki DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36176 1634 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 7.23657200600000028 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36178 1634 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 6.93930216000000044 \N Ki DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36180 1634 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 6.35457773100000001 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36183 1634 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 6.70996538899999972 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36187 1634 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 7.04575749099999982 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36189 1650 1712 Mitogen-activated protein kinase 1 Kinase P28482 MAPK1 MK01_HUMAN 5.50251746300000022 \N IC50 DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36192 1659 470 Cytochrome P450 2C19 Enzyme P33261 CYP2C19 CP2CJ_HUMAN 5.69897000400000042 \N IC50 DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36195 1659 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 7.0315170509999998 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 36197 1659 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 4.56141019000000014 \N Ki DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36204 1667 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 8.05700040700000031 \N Ki DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36206 1667 268 Cytochrome P450 2C9 Enzyme P11712 CYP2C9 CP2C9_HUMAN 5 \N IC50 DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36207 1667 988 Androgen receptor Transcription factor P15207 Ar ANDR_RAT 7.69897000400000042 \N Ki DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36209 1667 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 8.84163750799999981 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 36213 1688 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.2628073569999998 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36215 1688 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 7.11918640800000002 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36217 1688 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.73025362699999974 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36219 1688 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 6.95860731500000007 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36221 1688 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.48545224699999956 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36223 1688 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6.58670023600000043 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36225 1688 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 6.06905096900000007 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36227 1688 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.74232142500000009 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36229 1688 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 6.1668528880000002 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36231 1688 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 8.5044556619999998 \N Ki DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36233 1688 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 7.72124639899999998 \N Ki DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36235 1688 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 6.69680394299999993 \N Ki DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36237 1688 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 7.39794000900000004 \N Ki DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36239 1688 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 7.72124639899999998 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36241 1688 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 7.55284196900000016 \N Ki DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36243 1688 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 7.23657200600000028 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36247 1688 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 7.46852108299999973 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36249 1688 1721 Membrane-associated progesterone receptor component 1 Membrane receptor P70580 Pgrmc1 PGRC1_RAT 6.41116827399999956 \N Ki DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36251 1708 66 Prostaglandin G/H synthase 1 Enzyme P23219 PTGS1 PGH1_HUMAN 4.7893604940000003 \N IC50 DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36252 1714 58 Cannabinoid receptor 1 GPCR P21554 CNR1 CNR1_HUMAN 4.64720025699999972 \N Ki DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36254 1714 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 7.6575773189999996 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36256 1714 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.86296254500000025 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36258 1714 202 Estrogen receptor Nuclear hormone receptor P03372 ESR1 ESR1_HUMAN 8.28232949699999921 \N Ki DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol) DRUG MATRIX = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201151 AGONIST \N Tclin \N \N Homo sapiens 36260 1714 988 Androgen receptor Transcription factor P15207 Ar ANDR_RAT 5.14745901399999983 \N Ki DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36262 1714 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 4.95821268100000001 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 36265 1723 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 7.43179827600000031 \N Ki DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36267 1723 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 7.67778070499999998 \N Ki DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36269 1723 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 7.6575773189999996 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36271 1723 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 6.5044556619999998 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36273 1723 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 6.44009337500000001 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36281 1723 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 8.12378215899999923 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36283 1723 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 8.58335949299999967 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36285 1723 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 6.31875876299999995 \N Ki DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36287 1723 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 6.01818139299999988 \N Ki DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36289 1723 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 7.56863623599999968 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36291 1723 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 7.30102999599999958 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36293 1723 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 6.69897000400000042 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36294 1723 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 7.4202164030000004 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36298 1723 251 Acetylcholinesterase Enzyme P22303 ACHE ACES_HUMAN 5.87160073100000002 \N IC50 DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36299 1723 931 Substance-K receptor GPCR P21452 TACR2 NK2R_HUMAN 5.86742015200000022 \N Ki DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36301 1723 50 5-hydroxytryptamine receptor 4 GPCR O70528 HTR4 5HT4R_CAVPO 6.56224943700000019 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Cavia porcellus 36303 1723 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 6.83863199800000032 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36307 1738 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.35951856299999996 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36309 1738 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 6.97469413500000002 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36311 1738 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.86012091400000035 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36313 1738 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 6.74472749500000024 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36315 1738 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.27002571399999997 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36317 1738 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6.40893539300000015 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36319 1738 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 5.84314809900000043 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36321 1738 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 5.81958736699999957 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36323 1738 110 Histamine H1 receptor GPCR P35367 HRH1 HRH1_HUMAN 8.74472749499999935 \N Ki DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36325 1738 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 5.93930216000000044 \N Ki DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36327 1738 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 6.22767829300000031 \N Ki DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36329 1738 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 5.62967199199999957 \N Ki DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36331 1738 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.65955588499999962 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36333 1738 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 5.55965775900000025 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36344 1762 387 Epidermal growth factor receptor Kinase P00533 EGFR EGFR_HUMAN 5.28166442100000033 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36345 1762 535 Tyrosine-protein kinase Fyn Kinase P06241 FYN FYN_HUMAN 5.28600573199999957 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36346 1762 1709 Arachidonate 15-lipoxygenase Enzyme P12530 ALOX15 LOX15_RABIT 5.6724367400000002 \N IC50 DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Oryctolagus cuniculus 36347 1764 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 6.2684112350000003 \N Ki DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) DRUG MATRIX = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200843 ANTAGONIST \N Tclin \N \N Homo sapiens 36349 1764 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 6.55909091799999988 \N Ki DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36351 1764 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.2247537399999997 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36353 1764 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 8.6326440790000003 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36358 1764 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 8.92811799300000075 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36360 1764 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.67778070499999998 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36362 1764 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 7.24412514399999985 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36364 1764 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 6.69897000400000042 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36365 1764 1713 5-hydroxytryptamine receptor 1B GPCR P28564 Htr1b 5HT1B_RAT 8.03338901300000074 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36368 1765 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 6 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36373 1768 988 Androgen receptor Transcription factor P15207 Ar ANDR_RAT 4.74992171199999991 \N Ki DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36375 1775 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 6.32605800099999982 \N Ki DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36377 1775 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 6.57024772000000024 \N Ki DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36379 1775 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.2139587900000004 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36381 1775 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 7.50863830599999993 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) DRUG MATRIX = \N \N \N \N PARTIAL AGONIST \N Tclin \N \N Homo sapiens 36387 1775 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 5.66254073899999977 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36389 1775 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 7.22914798800000025 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36391 1775 1713 5-hydroxytryptamine receptor 1B GPCR P28564 Htr1b 5HT1B_RAT 6.96657624499999972 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36394 1782 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 5.99139982799999959 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36396 1782 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 5.97881070099999956 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36398 1782 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.39685562699999988 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36400 1782 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 5.90378541499999976 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36403 1782 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 6.09691001299999957 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36407 1791 95 Cytochrome P450 3A4 Enzyme P08684 CYP3A4 CP3A4_HUMAN 6.09691001299999957 \N IC50 DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36408 1794 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.14026143400000013 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36422 1796 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 6.00348832800000043 \N Ki DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36424 1796 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 6.46470588000000035 \N Ki DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36426 1796 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 6.41680122599999958 \N Ki DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36428 1796 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 6.52578373600000017 \N Ki DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36430 1796 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 6.54060751200000023 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36432 1796 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 6.63827216399999998 \N Ki DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36437 1796 171 5-hydroxytryptamine receptor 3A Ion channel P46098 HTR3A 5HT3A_HUMAN 6.20971483599999985 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36439 1796 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 7.18045606400000036 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36441 1800 54 Beta-1 adrenergic receptor GPCR P08588 ADRB1 ADRB1_HUMAN 5.13691517500000039 \N Ki DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36443 1800 56 Prostaglandin G/H synthase 2 Enzyme P35354 PTGS2 PGH2_HUMAN 4.58764026800000035 \N IC50 DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36444 1800 58 Cannabinoid receptor 1 GPCR P21554 CNR1 CNR1_HUMAN 4.77952579400000044 \N Ki DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36446 1800 74 Mu-type opioid receptor GPCR P35372 OPRM1 OPRM_HUMAN 5.60906489300000022 \N Ki DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36448 1800 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 5.50528897500000003 \N Ki DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36450 1800 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 5.3800722900000002 \N Ki DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36452 1800 89 Adenosine receptor A2a GPCR P29274 ADORA2A AA2AR_HUMAN 5.09680145300000031 \N Ki DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36454 1800 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 5.82768903100000024 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36456 1800 95 Cytochrome P450 3A4 Enzyme P08684 CYP3A4 CP3A4_HUMAN 7 \N IC50 DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36457 1800 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 6.38299965900000021 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36459 1800 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.53536144100000005 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36461 1800 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 5.18342730400000029 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36463 1800 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 5.9523358049999997 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36465 1800 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 5.45234834199999963 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36467 1800 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 5.55533076900000022 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36469 1800 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 5.29627884000000027 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36471 1800 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 5.78462684700000018 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36473 1800 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 5.96417017499999957 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36475 1800 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 5.17802818200000026 \N Ki DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36477 1800 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 6.01954210799999956 \N Ki DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36479 1800 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 5.81191562600000022 \N Ki DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36481 1800 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 6.17522353800000001 \N Ki DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36483 1800 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 6.35066514100000035 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36485 1800 129 Beta-3 adrenergic receptor GPCR P13945 ADRB3 ADRB3_HUMAN 5.38605252300000004 \N Ki DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36487 1800 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.86902330800000005 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36489 1800 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 6 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36490 1800 146 Adenosine receptor A1 GPCR P30542 ADORA1 AA1R_HUMAN 5.13649869899999967 \N Ki DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36492 1800 148 Adenosine receptor A3 GPCR P0DMS8 ADORA3 AA3R_HUMAN 5.79887610299999956 \N Ki DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36494 1800 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 5.27132163300000034 \N Ki DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 94127 575 158 D(4) dopamine receptor GPCR P21917 DRD4 DRD4_HUMAN 5.00999999999999979 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36496 1800 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 5.82477819999999991 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36498 1800 176 Kappa-type opioid receptor GPCR P41145 OPRK1 OPRK_HUMAN 5.57888987000000025 \N Ki DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36500 1800 249 Delta-type opioid receptor GPCR P41143 OPRD1 OPRD_HUMAN 5.92299567299999996 \N Ki DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36502 1800 251 Acetylcholinesterase Enzyme P22303 ACHE ACES_HUMAN 4.72911163499999976 \N IC50 DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36503 1800 268 Cytochrome P450 2C9 Enzyme P11712 CYP2C9 CP2C9_HUMAN 6.69897000400000042 \N IC50 DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36504 1800 387 Epidermal growth factor receptor Kinase P00533 EGFR EGFR_HUMAN 4.5337850529999999 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36505 1800 417 Substance-P receptor GPCR P25103 TACR1 NK1R_HUMAN 5.42992429500000018 \N Ki DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36507 1800 470 Cytochrome P450 2C19 Enzyme P33261 CYP2C19 CP2CJ_HUMAN 7.795880017 \N IC50 DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36508 1800 535 Tyrosine-protein kinase Fyn Kinase P06241 FYN FYN_HUMAN 5.38090666899999981 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36509 1800 546 Receptor tyrosine-protein kinase erbB-2 Kinase P04626 ERBB2 ERBB2_HUMAN 4.56177419199999967 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36510 1800 621 Thromboxane-A synthase Enzyme P24557 TBXAS1 THAS_HUMAN 6.58004425200000043 \N IC50 DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36511 1800 862 Type-2 angiotensin II receptor GPCR P50052 AGTR2 AGTR2_HUMAN 5.10907622900000025 \N Ki DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36513 1800 931 Substance-K receptor GPCR P21452 TACR2 NK2R_HUMAN 5.79236563300000018 \N Ki DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36515 1800 988 Androgen receptor Transcription factor P15207 Ar ANDR_RAT 5.32550628300000017 \N Ki DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36517 1800 48 Sodium/potassium-transporting ATPase subunit alpha-2 Ion channel D2WKD8 ATP1A2 AT1A2_PIG 4.71491549699999979 \N IC50 DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Sus scrofa 36518 1800 1713 5-hydroxytryptamine receptor 1B GPCR P28564 Htr1b 5HT1B_RAT 5.02853859499999967 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36520 1800 1716 Melanocortin receptor 4 GPCR P32245 MC4R MC4R_HUMAN 4.92190584999999992 \N Ki DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36522 1800 1717 Melanocortin receptor 5 GPCR P33032 MC5R MC5R_HUMAN 4.67354124299999985 \N Ki DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36524 1800 1718 Melanocortin receptor 3 GPCR P41968 MC3R MC3R_HUMAN 4.79231178700000005 \N Ki DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36526 1800 1721 Membrane-associated progesterone receptor component 1 Membrane receptor P70580 Pgrmc1 PGRC1_RAT 5.69164905099999974 \N Ki DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36528 1800 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 5.71108039399999967 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 36530 1805 74 Mu-type opioid receptor GPCR P35372 OPRM1 OPRM_HUMAN 6.0013048419999997 \N Ki DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36532 1805 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 4.9567556460000004 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36534 1805 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 4.91786116900000003 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36537 1805 176 Kappa-type opioid receptor GPCR P41145 OPRK1 OPRK_HUMAN 5.09485199800000021 \N Ki DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36541 1805 535 Tyrosine-protein kinase Fyn Kinase P06241 FYN FYN_HUMAN 4.67045975200000019 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36542 1805 865 Mitogen-activated protein kinase 14 Kinase Q16539 MAPK14 MK14_HUMAN 4.08060284499999959 \N IC50 DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36543 1805 988 Androgen receptor Transcription factor P15207 Ar ANDR_RAT 8.25492520799999951 \N Ki DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36545 1805 1709 Arachidonate 15-lipoxygenase Enzyme P12530 ALOX15 LOX15_RABIT 6.25570701699999976 \N IC50 DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Oryctolagus cuniculus 36546 1805 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 9.37365963300000082 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 36548 1820 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 5.55987839700000031 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36550 1820 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.79560866799999985 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36552 1820 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 6.09044397100000001 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 94128 575 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 5.24000000000000021 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36554 1820 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 5.51215487999999976 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36556 1820 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 6.18641901099999991 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36558 1820 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 6.09963287099999985 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36560 1820 148 Adenosine receptor A3 GPCR P0DMS8 ADORA3 AA3R_HUMAN 5.37592426900000042 \N Ki DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36562 1821 94 Potassium voltage-gated channel subfamily H member 2 Ion channel Q12809 KCNH2 KCNH2_HUMAN 5.53209605300000007 \N Ki DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36564 1821 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.30552642500000005 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36566 1821 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 5.72915818800000043 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36568 1821 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 6.74400427299999983 \N Ki DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36570 1821 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 7.10846254199999983 \N Ki DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36572 1821 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 7.04672366299999986 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36574 1821 387 Epidermal growth factor receptor Kinase P00533 EGFR EGFR_HUMAN 5.26874171399999991 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36575 1821 535 Tyrosine-protein kinase Fyn Kinase P06241 FYN FYN_HUMAN 5.90035388300000019 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36576 1821 546 Receptor tyrosine-protein kinase erbB-2 Kinase P04626 ERBB2 ERBB2_HUMAN 5.69139290599999992 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36577 1821 1709 Arachidonate 15-lipoxygenase Enzyme P12530 ALOX15 LOX15_RABIT 5.74828879499999967 \N IC50 DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Oryctolagus cuniculus 36578 1826 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.83683862500000039 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1373 INHIBITOR \N Tclin \N \N Homo sapiens 36580 1834 56 Prostaglandin G/H synthase 2 Enzyme P35354 PTGS2 PGH2_HUMAN 5.42875714899999995 \N IC50 DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36581 1834 66 Prostaglandin G/H synthase 1 Enzyme P23219 PTGS1 PGH1_HUMAN 5.99182581600000042 \N IC50 DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36582 1834 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.41408828999999958 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36584 1834 1709 Arachidonate 15-lipoxygenase Enzyme P12530 ALOX15 LOX15_RABIT 5.31051355199999975 \N IC50 DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Oryctolagus cuniculus 36585 1836 55 Beta-2 adrenergic receptor GPCR P07550 ADRB2 ADRB2_HUMAN 5.62015082100000019 \N Ki DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36587 1836 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 5.8326826650000001 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36589 1836 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.57397698399999975 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36591 1836 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 5.40000782200000007 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36593 1836 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 5.57987915200000018 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36595 1836 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 5.71264622699999958 \N Ki DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36597 1836 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 5.85263289199999992 \N Ki DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36599 1836 129 Beta-3 adrenergic receptor GPCR P13945 ADRB3 ADRB3_HUMAN 5.49485002199999961 \N Ki DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36601 1836 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 6.11520463599999964 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36603 1836 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.68465952299999966 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36605 1836 148 Adenosine receptor A3 GPCR P0DMS8 ADORA3 AA3R_HUMAN 6.61083391599999981 \N Ki DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36607 1836 249 Delta-type opioid receptor GPCR P41143 OPRD1 OPRD_HUMAN 5.77211329499999959 \N Ki DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36609 1836 387 Epidermal growth factor receptor Kinase P00533 EGFR EGFR_HUMAN 5.49525736400000042 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 94129 575 417 Substance-P receptor GPCR P25103 TACR1 NK1R_HUMAN 4.88999999999999968 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36610 1836 535 Tyrosine-protein kinase Fyn Kinase P06241 FYN FYN_HUMAN 5.32771737499999976 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36611 1836 621 Thromboxane-A synthase Enzyme P24557 TBXAS1 THAS_HUMAN 5.81673015600000021 \N IC50 DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36612 1836 865 Mitogen-activated protein kinase 14 Kinase Q16539 MAPK14 MK14_HUMAN 6.06752623499999988 \N IC50 DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36613 1836 931 Substance-K receptor GPCR P21452 TACR2 NK2R_HUMAN 5.89483057200000005 \N Ki DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36617 1848 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 5.86018385900000016 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36619 1848 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 6.89143497600000021 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36621 1848 95 Cytochrome P450 3A4 Enzyme P08684 CYP3A4 CP3A4_HUMAN 6.15490196000000012 \N IC50 DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36622 1848 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.69359642000000044 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36624 1848 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.72514968000000035 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36626 1848 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6.6825635029999999 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36628 1848 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.05998184500000026 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36630 1848 268 Cytochrome P450 2C9 Enzyme P11712 CYP2C9 CP2C9_HUMAN 6 \N IC50 DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36631 1848 312 Cytochrome P450 1A2 Enzyme P05177 CYP1A2 CP1A2_HUMAN 6.39794000900000004 \N IC50 DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36632 1848 470 Cytochrome P450 2C19 Enzyme P33261 CYP2C19 CP2CJ_HUMAN 6 \N IC50 DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36635 1856 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 6.39663907599999959 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36637 1863 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.73212458099999989 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36639 1863 312 Cytochrome P450 1A2 Enzyme P05177 CYP1A2 CP1A2_HUMAN 5.30102999599999958 \N IC50 DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36640 1863 313 Amine oxidase [flavin-containing] A Enzyme P21397 MAOA AOFA_HUMAN 6.00086945899999957 \N IC50 DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36644 1878 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 5.69897000400000042 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36645 1879 988 Androgen receptor Transcription factor P15207 Ar ANDR_RAT 8.67778070499999998 \N Ki DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36647 1879 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 7.64975198199999973 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 36649 1893 74 Mu-type opioid receptor GPCR P35372 OPRM1 OPRM_HUMAN 5.23217650199999973 \N Ki DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36651 1893 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 5.18929713899999978 \N Ki DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36653 1893 95 Cytochrome P450 3A4 Enzyme P08684 CYP3A4 CP3A4_HUMAN 5.69897000400000042 \N IC50 DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36654 1893 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.05655495099999985 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36656 1893 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 4.20873051900000039 \N Ki DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36658 1893 129 Beta-3 adrenergic receptor GPCR P13945 ADRB3 ADRB3_HUMAN 4.59233721499999969 \N Ki DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36660 1893 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 4.90886084599999961 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36662 1893 148 Adenosine receptor A3 GPCR P0DMS8 ADORA3 AA3R_HUMAN 5.07763790300000029 \N Ki DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36664 1893 176 Kappa-type opioid receptor GPCR P41145 OPRK1 OPRK_HUMAN 4.84169783100000028 \N Ki DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36666 1893 249 Delta-type opioid receptor GPCR P41143 OPRD1 OPRD_HUMAN 4.63229007799999959 \N Ki DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36668 1893 387 Epidermal growth factor receptor Kinase P00533 EGFR EGFR_HUMAN 4.25469874699999995 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36669 1893 533 Tyrosine-protein kinase Lck Kinase P06239 LCK LCK_HUMAN 4.10146129800000026 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36670 1893 535 Tyrosine-protein kinase Fyn Kinase P06241 FYN FYN_HUMAN 5.09848719100000025 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36671 1893 621 Thromboxane-A synthase Enzyme P24557 TBXAS1 THAS_HUMAN 4.67551176699999971 \N IC50 DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36672 1893 816 Mitogen-activated protein kinase 3 Kinase P27361 MAPK3 MK03_HUMAN 4.64775957999999978 \N IC50 DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36673 1893 865 Mitogen-activated protein kinase 14 Kinase Q16539 MAPK14 MK14_HUMAN 4.73935629300000016 \N IC50 DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36674 1893 931 Substance-K receptor GPCR P21452 TACR2 NK2R_HUMAN 5.00908424500000038 \N Ki DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36676 1893 988 Androgen receptor Transcription factor P15207 Ar ANDR_RAT 4.61512710600000009 \N Ki DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36678 1893 1709 Arachidonate 15-lipoxygenase Enzyme P12530 ALOX15 LOX15_RABIT 4.86021533600000044 \N IC50 DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Oryctolagus cuniculus 36679 1893 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 5.23627259600000006 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 36681 1922 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 5.0189973099999996 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36683 1922 146 Adenosine receptor A1 GPCR P30542 ADORA1 AA1R_HUMAN 5.34756025200000007 \N Ki DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36687 1922 312 Cytochrome P450 1A2 Enzyme P05177 CYP1A2 CP1A2_HUMAN 6.52287874499999987 \N IC50 DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36688 1922 474 cAMP-specific 3',5'-cyclic phosphodiesterase 4A Enzyme P27815 PDE4A PDE4A_HUMAN 4.35499060500000024 \N IC50 DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36689 1922 621 Thromboxane-A synthase Enzyme P24557 TBXAS1 THAS_HUMAN 4.73062717300000024 \N IC50 DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36690 1922 798 C-C chemokine receptor type 2 GPCR P41597 CCR2 CCR2_HUMAN 6.07211659000000026 \N Ki DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36692 1922 49 Sodium/nucleoside cotransporter 1 Transporter O00337 SLC28A1 S28A1_HUMAN 5.08868255800000036 \N Ki DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine) DRUG MATRIX = \N \N \N \N \N \N Tbio \N \N Homo sapiens 36694 1922 1709 Arachidonate 15-lipoxygenase Enzyme P12530 ALOX15 LOX15_RABIT 4.82099429199999996 \N IC50 DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Oryctolagus cuniculus 36695 1925 56 Prostaglandin G/H synthase 2 Enzyme P35354 PTGS2 PGH2_HUMAN 6.0371573190000003 \N IC50 DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36696 1925 66 Prostaglandin G/H synthase 1 Enzyme P23219 PTGS1 PGH1_HUMAN 5.97305837199999967 \N IC50 DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36699 1935 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 4.92716212499999973 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36701 1935 840 Interstitial collagenase Enzyme P03956 MMP1 MMP1_HUMAN 4.63180612200000041 \N IC50 DRUGMATRIX: Peptidase, Matrix Metalloproteinase-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36702 1937 58 Cannabinoid receptor 1 GPCR P21554 CNR1 CNR1_HUMAN 5.86296254500000025 \N Ki DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36704 1937 268 Cytochrome P450 2C9 Enzyme P11712 CYP2C9 CP2C9_HUMAN 6 \N IC50 DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36705 1937 470 Cytochrome P450 2C19 Enzyme P33261 CYP2C19 CP2CJ_HUMAN 5.39794000900000004 \N IC50 DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36706 1937 49 Sodium/nucleoside cotransporter 1 Transporter O00337 SLC28A1 S28A1_HUMAN 6.36351210399999978 \N Ki DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine) DRUG MATRIX = \N \N \N \N \N \N Tbio \N \N Homo sapiens 36708 1942 89 Adenosine receptor A2a GPCR P29274 ADORA2A AA2AR_HUMAN 5.6424462799999997 \N Ki DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36710 1942 148 Adenosine receptor A3 GPCR P0DMS8 ADORA3 AA3R_HUMAN 5.39534202799999996 \N Ki DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36712 1942 312 Cytochrome P450 1A2 Enzyme P05177 CYP1A2 CP1A2_HUMAN 6 \N IC50 DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36713 1947 268 Cytochrome P450 2C9 Enzyme P11712 CYP2C9 CP2C9_HUMAN 6.52287874499999987 \N IC50 DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36714 1947 470 Cytochrome P450 2C19 Enzyme P33261 CYP2C19 CP2CJ_HUMAN 5.52287874499999987 \N IC50 DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36715 1955 251 Acetylcholinesterase Enzyme P22303 ACHE ACES_HUMAN 5.25068117899999987 \N IC50 DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36716 1962 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 5.61780278999999982 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36718 1962 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 6.70553377400000006 \N Ki DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36720 1962 202 Estrogen receptor Nuclear hormone receptor P03372 ESR1 ESR1_HUMAN 6.63638802000000005 \N Ki DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 94130 575 1886 Somatostatin receptor type 4 GPCR P31391 SSTR4 SSR4_HUMAN 5.16999999999999993 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36724 1962 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 8.91364016900000067 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 36726 1963 127 Glucocorticoid receptor Nuclear hormone receptor P04150 NR3C1 GCR_HUMAN 6.53313237999999963 \N Ki DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36728 1963 470 Cytochrome P450 2C19 Enzyme P33261 CYP2C19 CP2CJ_HUMAN 6.09691001299999957 \N IC50 DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36729 1963 988 Androgen receptor Transcription factor P15207 Ar ANDR_RAT 7.14874165099999992 \N Ki DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36731 1963 1727 Progesterone receptor Transcription factor Q690N0 PGR Q690N0_BOVIN 8.44129142899999962 \N Ki DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Bos taurus 36733 1971 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 6.57024772000000024 \N Ki DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36735 1971 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.56066730600000003 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36742 1971 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 7.06550154900000038 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36748 1971 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 7.21467016500000025 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36751 1971 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 5.63921731000000026 \N Ki DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36758 1971 132 Alpha-2C adrenergic receptor GPCR P18825 ADRA2C ADA2C_HUMAN 7.52287874499999987 \N Ki DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36762 1971 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 6.9100948889999998 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36766 1971 470 Cytochrome P450 2C19 Enzyme P33261 CYP2C19 CP2CJ_HUMAN 5.52287874499999987 \N IC50 DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36767 1971 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 6.94309514900000035 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36769 1971 1713 5-hydroxytryptamine receptor 1B GPCR P28564 Htr1b 5HT1B_RAT 5.83743559300000037 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36771 1973 268 Cytochrome P450 2C9 Enzyme P11712 CYP2C9 CP2C9_HUMAN 5.08739006899999957 \N IC50 DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36772 1973 470 Cytochrome P450 2C19 Enzyme P33261 CYP2C19 CP2CJ_HUMAN 6.39761441000000008 \N IC50 DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36776 1982 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 6.26042765600000006 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36789 1982 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 7.58502665199999981 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36794 1982 1709 Arachidonate 15-lipoxygenase Enzyme P12530 ALOX15 LOX15_RABIT 5.55783391399999971 \N IC50 DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Oryctolagus cuniculus 36795 1982 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 7.67778070499999998 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36797 1982 1713 5-hydroxytryptamine receptor 1B GPCR P28564 Htr1b 5HT1B_RAT 6.36351210399999978 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36799 1992 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.34103515700000031 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36802 1999 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.09205147800000013 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36804 1999 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 6.61439372600000031 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36806 1999 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.57790283699999989 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N INHIBITOR \N Tclin \N \N Homo sapiens 36808 1999 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 6.90308998700000043 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36810 1999 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 5.66594856000000036 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36812 1999 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6.55284196900000016 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36814 1999 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 6.28316227699999974 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36816 1999 107 Alpha-2B adrenergic receptor GPCR P18089 ADRA2B ADA2B_HUMAN 6.06298389300000018 \N Ki DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36819 1999 111 Histamine H2 receptor GPCR P25021 HRH2 HRH2_HUMAN 5.16462654800000021 \N Ki DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36822 1999 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 6.87289520199999959 \N Ki DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36824 1999 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 7.43179827600000031 \N Ki DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36826 1999 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 7.76955107900000019 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36828 1999 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 7.69897000400000042 \N Ki DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36830 1999 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 6.39794000900000004 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36831 2004 48 Sodium/potassium-transporting ATPase subunit alpha-2 Ion channel D2WKD8 ATP1A2 AT1A2_PIG 6.16877030599999987 \N IC50 DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Sus scrofa 36832 2013 66 Prostaglandin G/H synthase 1 Enzyme P23219 PTGS1 PGH1_HUMAN 6.06752623499999988 \N IC50 DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid) DRUG MATRIX = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1071 INHIBITOR \N Tclin \N \N Homo sapiens 36833 2028 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 7.99139982799999959 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36835 2028 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.58944207700000018 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36837 2028 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 6.29756946400000039 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36839 2028 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 6.83683862500000039 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36850 2028 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 7.16813022599999972 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36852 2028 470 Cytochrome P450 2C19 Enzyme P33261 CYP2C19 CP2CJ_HUMAN 6.22184875000000037 \N IC50 DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36853 2028 1721 Membrane-associated progesterone receptor component 1 Membrane receptor P70580 Pgrmc1 PGRC1_RAT 6.08602728800000037 \N Ki DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36856 2032 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 8.49349496800000026 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36861 2032 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 6.11069829699999989 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36864 2032 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 6.34198860299999989 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36866 2032 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 6.01908806199999979 \N Ki DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36869 2032 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 6.69897000400000042 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36872 2032 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 6.16178077799999979 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36874 2032 1713 5-hydroxytryptamine receptor 1B GPCR P28564 Htr1b 5HT1B_RAT 9.04143611699999994 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36876 2033 988 Androgen receptor Transcription factor P15207 Ar ANDR_RAT 6.86327943299999976 \N Ki DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36878 2044 249 Delta-type opioid receptor GPCR P41143 OPRD1 OPRD_HUMAN 5.82944494100000021 \N Ki DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36880 2044 535 Tyrosine-protein kinase Fyn Kinase P06241 FYN FYN_HUMAN 4.621493085 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36881 2044 546 Receptor tyrosine-protein kinase erbB-2 Kinase P04626 ERBB2 ERBB2_HUMAN 4.95436412900000001 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36882 2044 558 Cholecystokinin receptor type A GPCR P32238 CCKAR CCKAR_HUMAN 5.6428277419999997 \N Ki DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36884 2044 931 Substance-K receptor GPCR P21452 TACR2 NK2R_HUMAN 5.68994426200000003 \N Ki DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36886 2044 1717 Melanocortin receptor 5 GPCR P33032 MC5R MC5R_HUMAN 4.79393007599999965 \N Ki DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36888 2056 470 Cytochrome P450 2C19 Enzyme P33261 CYP2C19 CP2CJ_HUMAN 6.11804502900000013 \N IC50 DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36889 2056 474 cAMP-specific 3',5'-cyclic phosphodiesterase 4A Enzyme P27815 PDE4A PDE4A_HUMAN 6.08777794299999986 \N IC50 DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36890 2068 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 5.64685345400000038 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36892 2068 94 Potassium voltage-gated channel subfamily H member 2 Ion channel Q12809 KCNH2 KCNH2_HUMAN 5.06831334600000005 \N Ki DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36898 2068 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 7.45593195599999969 \N Ki DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 94131 575 74 Mu-type opioid receptor GPCR P35372 OPRM1 OPRM_HUMAN 5.33999999999999986 \N IC50 \N WOMBAT-PK = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36900 2068 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 6.7235381959999998 \N Ki DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36902 2068 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 7.4202164030000004 \N Ki DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36904 2068 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 7.46852108299999973 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36906 2068 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 7.05060999300000013 \N Ki DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36910 2068 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 6 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36911 2075 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 6.3827899050000001 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36913 2090 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 6.28735029799999978 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36915 2090 94 Potassium voltage-gated channel subfamily H member 2 Ion channel Q12809 KCNH2 KCNH2_HUMAN 4.89007739300000033 \N Ki DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36917 2090 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.65836766400000002 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36919 2090 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 6.32975414700000005 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36921 2090 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 5.76522970500000032 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36923 2090 108 D(3) dopamine receptor GPCR P35462 DRD3 DRD3_HUMAN 5.86710023000000014 \N Ki DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36925 2090 114 Muscarinic acetylcholine receptor M2 GPCR P08172 CHRM2 ACM2_HUMAN 6.29499204100000043 \N Ki DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36927 2090 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 6.6575773189999996 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36929 2090 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 5.68340069799999981 \N Ki DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36931 2090 144 Sodium-dependent dopamine transporter Transporter Q01959 SLC6A3 SC6A3_HUMAN 5.60032627899999991 \N Ki DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36933 2090 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 6.30891850799999965 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36935 2090 313 Amine oxidase [flavin-containing] A Enzyme P21397 MAOA AOFA_HUMAN 6.10072681299999964 \N IC50 DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36936 2090 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 6.27164621799999988 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36949 2105 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 6.69897000400000042 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36950 2105 170 Alpha-1D adrenergic receptor GPCR P25100 ADRA1D ADA1D_HUMAN 6.12842706400000026 \N Ki DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36954 2105 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 5.83803338400000005 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36956 2105 1713 5-hydroxytryptamine receptor 1B GPCR P28564 Htr1b 5HT1B_RAT 7.39794000900000004 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36958 2106 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 5.96161830900000034 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36960 2106 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 5.48585086599999983 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36962 2106 113 Muscarinic acetylcholine receptor M1 GPCR P11229 CHRM1 ACM1_HUMAN 6.18521985399999963 \N Ki DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36964 2106 115 Muscarinic acetylcholine receptor M3 GPCR P20309 CHRM3 ACM3_HUMAN 6.17979854100000026 \N Ki DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36966 2106 116 Muscarinic acetylcholine receptor M4 GPCR P08173 CHRM4 ACM4_HUMAN 6.300248968 \N Ki DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36968 2106 117 Muscarinic acetylcholine receptor M5 GPCR P08912 CHRM5 ACM5_HUMAN 6.10490910299999978 \N Ki DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36970 2106 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 6.02650269100000013 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36971 2106 387 Epidermal growth factor receptor Kinase P00533 EGFR EGFR_HUMAN 5.8282150589999997 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36972 2106 535 Tyrosine-protein kinase Fyn Kinase P06241 FYN FYN_HUMAN 5.39104630100000026 \N IC50 DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36973 2113 94 Potassium voltage-gated channel subfamily H member 2 Ion channel Q12809 KCNH2 KCNH2_HUMAN 5.46166509299999969 \N Ki DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36975 2123 95 Cytochrome P450 3A4 Enzyme P08684 CYP3A4 CP3A4_HUMAN 5.69897000400000042 \N IC50 DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36976 2123 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 6 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36977 2123 268 Cytochrome P450 2C9 Enzyme P11712 CYP2C9 CP2C9_HUMAN 5.39794000900000004 \N IC50 DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36978 2123 313 Amine oxidase [flavin-containing] A Enzyme P21397 MAOA AOFA_HUMAN 6.83564714400000017 \N IC50 DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine) DRUG MATRIX = 1 CHEMBL \N https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1089 INHIBITOR \N Tclin \N \N Homo sapiens 36979 2123 470 Cytochrome P450 2C19 Enzyme P33261 CYP2C19 CP2CJ_HUMAN 6.09691001299999957 \N IC50 DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tchem \N \N Homo sapiens 36981 2142 94 Potassium voltage-gated channel subfamily H member 2 Ion channel Q12809 KCNH2 KCNH2_HUMAN 4.78388690299999997 \N Ki DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36984 2142 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 5.61582586100000025 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36986 2142 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 6.68402965499999979 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36990 2142 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 5 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 36993 2142 1711 Alpha-1B adrenergic receptor GPCR P15823 Adra1b ADA1B_RAT 7.3467874860000002 \N Ki DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 36995 2159 145 Cytochrome P450 2D6 Enzyme P10635 CYP2D6 CP2D6_HUMAN 6.69897000400000042 \N IC50 DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 37001 2179 161 Carbonic anhydrase 2 Enzyme P00918 CA2 CAH2_HUMAN 6.94309514900000035 \N IC50 DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 37002 2179 313 Amine oxidase [flavin-containing] A Enzyme P21397 MAOA AOFA_HUMAN 4.45507661799999966 \N IC50 DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 37003 2179 1707 Aldose reductase Enzyme P07943 Akr1b1 ALDR_RAT 4.87942606899999998 \N IC50 DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde) DRUG MATRIX = \N \N \N \N \N \N \N \N \N Rattus norvegicus 37004 2180 82 D(1A) dopamine receptor GPCR P21728 DRD1 DRD1_HUMAN 7.795880017 \N Ki DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 37006 2180 83 D(2) dopamine receptor GPCR P14416 DRD2 DRD2_HUMAN 8.86966623200000015 \N Ki DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 37008 2180 90 Alpha-2A adrenergic receptor GPCR P08913 ADRA2A ADA2A_HUMAN 7.60205999099999996 \N Ki DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 37010 2180 91 Sigma non-opioid intracellular receptor 1 Membrane receptor Q99720 SIGMAR1 SGMR1_HUMAN 7.31875876299999995 \N Ki DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 37012 2180 98 Sodium-dependent serotonin transporter Transporter P31645 SLC6A4 SC6A4_HUMAN 6.46092390100000014 \N Ki DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 37014 2180 99 Sodium-dependent noradrenaline transporter Transporter P23975 SLC6A2 SC6A2_HUMAN 6.35066514100000035 \N Ki DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 37016 2180 100 5-hydroxytryptamine receptor 1A GPCR P08908 HTR1A 5HT1A_HUMAN 5.99225222200000029 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 37018 2180 101 5-hydroxytryptamine receptor 2A GPCR P28223 HTR2A 5HT2A_HUMAN 9.25649023499999934 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 37020 2180 102 5-hydroxytryptamine receptor 2B GPCR P41595 HTR2B 5HT2B_HUMAN 7.50863830599999993 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 37022 2180 103 5-hydroxytryptamine receptor 2C GPCR P28335 HTR2C 5HT2C_HUMAN 7.95860731500000007 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) DRUG MATRIX = \N \N \N \N \N \N Tclin \N \N Homo sapiens 37024 2180 104 5-hydroxytryptamine receptor 6 GPCR P50406 HTR6 5HT6R_HUMAN 7.28399665600000024 \N Ki DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: